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…Nobody	said	it	was	easy….	
The	scientist,	Coldplay	
	
Doctoral	Thesis	–	Montse	Tersa	 	 Summary	
	
	
Summary	
Glycolipids	 are	 prominent	 constituents	 of	 biological	 membranes,	 primary	 localized	 on	 the	
surface	of	 archaeal,	 prokaryotic	 and	eukaryotic	 cells1,2.	Glycolipids	play	 a	major	 role	 in	molecular	
recognition	events	including	cell-cell	 interactions	and	host-pathogen	interactions,	as	well	as	in	the	
modulation	of	membrane	protein	function.		
Acyltransferases	 are	 enzymes	 that	 catalyze	 the	 transfer	 of	 fatty-acid	 chains	 from	activated	
fatty-acid	donors	to	a	variety	of	acceptor	molecules	of	different	chemical	structure	and	complexity,	
playing	 a	 key	 role	 in	 the	 biosynthesis	 of	 glycolipids3.	 It	 is	worth	 noting	 that	 fatty-acid	 chains	 are	
activated	by	esterification	of	their	carboxyl	groups	with	either	the	thiol	group	of	coenzyme	A	(CoA)	
or	 that	 of	 the	 acyl	 carrier	 protein	 (ACP),	 yielding	 acyl-thioesters.	 Acyltransferases	 are	 very	 often	
required	to	access	a	 lipophilic	acceptor	substrate	and	to	catalyze	its	reaction	with	a	water-soluble	
donor	 in	 the	 form	 of	 acyl-CoA	 or	 acyl-ACP	 derivatives,	 promoting	 their	 association	 to	 the	 lipid	
bilayer4.	 Therefore,	 an	 understanding	 of	 the	 molecular	 mechanism	 by	 which	 acyltransferases	
govern	substrate	recognition	and	catalysis	remains	a	major	challenge.		
Mycobacterium	 tuberculosis,	 the	 causative	agent	of	 tuberculosis	 (TB),	 is	 the	 second	most	
deadly	 infectious	 agent	 in	 the	 world	 after	 HIV5,6.	 The	 extremely	 robust	 and	 impermeable	
mycobacterial	 cell	 envelope	 is	 the	 dominant	 feature	 of	 the	 biology	 of	M.	 tuberculosis7–9.	 In	 this	
context,	 the	 cell	 envelope	 of	M.	 tuberculosis	 contains	 a	 variety	 of	 unique	 glycolipids/lipoglycans	
that	 populate	 both	 the	 inner	 and	 outer	 membranes,	 including	 phosphatidyl-myo-inositol	
mannosides	 (PIMs),	 lipomannan	 (LM)	 and	 lipoarabinomannan	 (LAM),	 which	 are	 important	
modulators	of	 the	host	 immune	 response	during	 infection8,10.	 PIMs	are	based	on	a	phosphatidyl-
myo-inositol	(PI)	lipid	anchor	carrying	one	to	six	Manp	residues	and	up	to	four	acyl	chains11,12.	PIMs	
are	 considered	 not	 only	 essential	 structural	 components	 of	 the	 cell	 envelope	 but	 also	 the	
precursors	 of	 LM	 and	 LAM13,14.	 The	 early	 steps	 of	 the	 PIMs	 biosynthesis	 involve	 the	 consecutive	
action	of	three	enzymes:	the	mannosyltransferases	PimA	and	PimB,	and	the	acyltransferase	PatA,	
to	form	Ac1PIM211,12.	The	crystal	structures	of	the	mannosyltransferases	PimA	and	PimB	show	the	
typical	organization	and	catalytic	machinery	of	GT-B	glycosyltransferases15,16.	However,	to	date,	no	
structural	 information	 is	 available	 for	 PatA,	 an	 enzyme	 that	 is	 a	 member	 of	 a	 large	 family	 of	
acyltransferases	for	which	the	molecular	mechanism	of	substrate	recognition	and	catalysis	remains	
not	well	understood2,3,17,18.	Specifically,	PatA	transfers	a	palmitoyl	moiety	at	position	6	of	the	Manp	
residue,	transferred	by	PimA,	from	Palmitoyl-CoA	to	PIM1	or	PIM2,	to	form	Ac1PIM1	and	Ac1PIM215.		
This	 study	 describes	 a	 detailed	 investigation	 of	 the	 three-dimensional	 structure,	 glycolipid	
acceptor	 and	 acyl	 donor	 substrate	 binding,	 as	 well	 as	 the	 catalytic	 mechanism	 of	 PatA	 from	M.	
smegmatis.	Using	a	combination	of	X-ray	crystallography,	biochemical	and	biophysical	techniques,	
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quantum-mechanics/molecular-mechanics	 (QM/MM)	 metadynamics	 and	 chemical	 synthesis	 we	
propose	a	model	for	substrate	recognition,	catalysis	and	enzyme	inhibition.	The	implications	of	this	
model	in	the	comprehension	of	the	early	steps	of	PIM	biosynthesis	and	the	mode	of	action	of	other	
members	of	the	bacterial	acyltransferase	family	of	enzymes	are	discussed.		
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Resumen	
Introducción		
Los	 glicolípidos	 son	 constituyentes	 importantes	 de	 las	 membranas	 biológicas,	 localizados	
principalmente	 en	 la	 superficie	 de	 las	 células	 de	 archeas,	 procariotas	 y	 eucariotas1,19.	 Éstos	
componentes	desempeñan	un	papel	 principal	 en	eventos	de	 reconocimiento	molecular,	 incluidas	
las	interacciones	célula-célula	y	las	interacciones	huésped-patógeno,	así	como	en	la	modulación	de	
la	función	de	las	proteínas	en	las	membranas.		
Las	aciltransferasas	son	enzimas	que	catalizan	 la	 transferencia	de	cadenas	de	ácidos	grasos	
de	 dadores	 de	 ácidos	 grasos	 activados	 a	 una	 variedad	 de	 moléculas	 aceptoras	 de	 diferente	
estructura	química	y	complejidad,	jugando	un	papel	clave	en	la	biosíntesis	de	los	glicolípidos20.	Vale	
la	 pena	 señalar	 que	 las	 cadenas	 de	 ácidos	 grasos	 se	 activan	 por	 esterificación	 de	 sus	 grupos	
carboxilo	con	el	grupo	tiol	del	coenzima	A	(CoA)	o	el	de	la	proteína	transportadora	de	acilo	(ACP),	
produciendo	acil-tioésteres.	Las	aciltransferasas	a	menudo	se	requieren	para	acceder	a	un	sustrato	
aceptor	lipófilo	y	para	catalizar	su	reacción	con	un	donador	soluble	en	agua	en	forma	de	derivados	
de	acil-CoA	o	acil-ACP,	promoviendo	su	asociación	a	la	bicapa	lipídica4.	Por	lo	tanto,	la	comprensión	
del	 mecanismo	 molecular	 por	 el	 cual	 aciltransferasas	 rigen	 el	 reconocimiento	 del	 sustrato	 y	 la	
catálisis	sigue	siendo	un	desafío	importante.	
Mycobacterium	 tuberculosis,	 el	 agente	 causal	 de	 la	 tuberculosis	 (TB),	 es	 el	 segundo	 agente	
infeccioso	 más	 mortal	 del	 mundo	 después	 del	 HIV5,6.	 Una	 membrana	 celular	 micobacteriana	
extremadamente	 robusta	 e	 impermeable	 es	 la	 característica	 principal	 de	 la	 biología	 de	 M.	
tuberculosis7–9.	En	este	contexto,	la	membrana	celular	de	M.	tuberculosis	contiene	una	gran	variedad	
de	glicolípidos/lipoglicanos	únicos	que	ocupan	las	membranas	interna	y	externa,	entre	ellos	se	incluyen	
los	 fosfatidil-mio-inositol	 manósidos	 (PIM),	 lipomanano	 (LM)	 y	 lipoarabinomanano	 (LAM),	 que	 son	
moduladores	 importantes	 de	 la	 respuesta	 inmune	 del	 huésped	 durante	 la	 infección8,10.	 Los	 PIM	 se	
basan	 en	 un	 anclaje	 lipídico	 de	 fosfatidil-mio-inositol	 (PI)	 que	 puede	 llevar	 asociados	 de	 uno	 a	 seis	
residuos	 de	 Manp	 y	 hasta	 cuatro	 cadenas	 acílicas11,12.	 Los	 PIM	 se	 consideran	 no	 solamente	
componentes	 estructurales	 esenciales	 de	 la	 membrana	 celular	 sino	 también	 precursores	 de	 LM	 y	
LAM13,14.	 Los	 primeros	 pasos	 en	 la	 biosíntesis	 de	 los	 PIMs	 implican	 la	 acción	 consecutiva	 de	 tres	
enzimas:	las	manosiltransferasas	PimA	y	PimB,	y	la	aciltransferasa	PatA,	para	formar	Ac1PIM211,12.	Las	
estructuras	 cristalinas	 de	 las	manosiltransferasas	 PimA	 y	 PimB	muestran	 la	 organización	 típica	 y	 la	
maquinaria	 catalítica	 de	 glucosiltransferasas	 de	 tipo	 GT-B15,16.	 Sin	 embargo,	 hasta	 la	 fecha,	 no	 hay	
información	 estructural	 disponible	 para	 PatA,	 una	 enzima	 que	 es	miembro	 de	 una	 gran	 familia	 de	
aciltransferasas	para	 las	cuales	el	mecanismo	molecular	de	reconocimiento	del	sustrato	y	 la	catálisis	
aún	 no	 esta	 muy	 detallado2,3,17,18.	 En	 concreto,	 PatA	 transfiere	 un	 palmitato	 en	 la	 posición	 6	 del	
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residuo	de	Manp,	 transferido	por	PimA,	desde	palmitoil-CoA	a	PIM1	o	PIM2,	para	 formar	Ac1PIM1	y	
Ac1PIM215.		
Este	 estudio	 describe	 una	 investigación	 detallada	 de	 la	 estructura	 tridimensional,	 el	 sitio	 de	
unión	al	glicolípido	aceptor	y	el	sitio	de	unión	al	sustrato	acilo	dador,	así	como	también	el	mecanismo	
catalítico	de	PatA	de	M.	smegmatis.	Usando	cristalografía	de	rayos	X,	técnicas	bioquímicas	y	biofísicas,	
metadinámica	de	cuántica-mecánica/molecular-mecánica	(QM/MM)	y	síntesis	química,	se	propone	un	
modelo	 para	 el	 reconocimiento	 de	 sustrato,	 la	 catálisis	 y	 la	 inhibición	 de	 la	 enzima.	 También	 se	
discuten	las	implicaciones	de	este	modelo	en	la	comprensión	de	los	primeros	pasos	de	la	biosíntesis	de	
los	PIMs	y	el	modo	de	acción	de	otros	miembros	de	la	familia	de	enzimas	aciltransferasas	bacterianas.	
La	estructura	de	PatA	
El	núcleo	central	de	PatA	consiste	en	seis	hojas	β	rodeadas	de	hélices-α.	Un	surco	largo	y	abierto	
que	corre	paralelo	a	la	superficie	de	la	proteína	contiene	el	sitio	activo.	Este	surco	también	muestra	un	
túnel	angosto	y	profundo,	en	su	mayoría	hidrofóbico,	que	se	extiende	perpendicularmente	desde	su	
base	hasta	el	núcleo	central	de	la	proteína.	La	entrada	del	túnel	hidrofóbico	muestra	varios	residuos	
cargados	compatibles	para	 interactuar	con	el	grupo	carboxilato	de	un	ácido	graso,	sugiriendo	que	el	
bolsillo	podría	jugar	un	papel	en	la	unión	del	sustrato	dador21.		
El	sitio	de	unión	del	sustrato	dador	
Se	 identificó	 una	 molécula	 de	 ácido	 palmítico	 en	 los	 mapas	 de	 diferencia	 de	 densidad	
electrónica	 de	 las	 tres	 estructuras	 cristalinas	 resueltas	 (PatA-C16).	 La	 cadena	 de	 acilo	 está	
profundamente	enterrada	en	el	túnel	hidrofóbico	y	orientada	con	el	grupo	carboxilato	orientado	hacia	
la	ranura	principal	de	la	proteína.	La	comparación	entre	las	tres	estructuras	cristalinas	resueltas	reveló	
flexibilidad	 conformacional	 en	 el	 grupo	 carboxilato	 del	 palmitato,	 ubicado	muy	 cerca	 de	 la	 cadena	
lateral	de	His12621.		
Cómo	reconoce	PatA	al	CoA?	
Se	resolvió	la	estructura	cristalina	de	PatA	en	complejo	con	S-hexadecil	Coenzima	A	(PatA-S-
C16CoA),	un	análogo	no	hidrolizable	de	palmitoil-CoA.	La	cadena	de	acilo	de	S-C16CoA	se	localiza	en	el	
túnel	 hidrofóbico	 y	 se	 sobrepone	 muy	 bien	 con	 la	 cadena	 de	 palmitato	 observada	 en	 las	 tres	
estructuras	anteriores21.	Vale	 la	pena	señalar	que	 la	posición	del	grupo	carboxilato	del	palmitato	es	
diferente	a	 la	observada	para	el	 tio-éster	del	 complejo	PatA-S-C16CoA.	El	 4-fosfopanteteinato	de	S-
C16CoA	está	claramente	definido	en	el	mapa	de	densidad	electrónica,	y	se	encuentra	en	la	entrada	del	
surco	principal.	 La	 adenosina	3',	 5'-difosfato	 (3',	 5'-ADP)	del	 ligando	 sobresale	del	 núcleo	 globular	 y	
está	expuesto	al	solvente,	como	se	observa	en	otros	enzimas	modificadoras	de	acil-CoA21.		
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Para	validar	aún	más	el	modelo,	se	diseñan	mutantes	puntuales	para	perjudicar	la	interacción	
palmitoil-CoA	con	PatA,	dificultando	así	la	formación	del	complejo,	y	se	mide	la	actividad	enzimática.	
Los	 resultados	 de	 los	 ensayos	 enzimáticos	 muestran	 como	 las	 mutantes	 de	 PatA	 no	 pudieron	 (i)	
transferir	una	 cadena	de	palmítico	a	PIM2,	o	 (ii)	 hidrolizar	palmitoil-CoA.	Estos	 resultados	 validan	el	
modelo	propuesto21.	
El	sitio	de	unión	del	sustrato	aceptor	
Para	 describir	 la	 arquitectura	 del	 sitio	 de	 unión	 del	 aceptor	 de	 PatA,	 primero	 se	 trató	 de	
cristalizar	PatA	en	presencia	de	sus	sustratos	aceptores	naturales	Ac1PIM1/Ac2PIM1,	Ac1PIM2/Ac2PIM2	o	
sus	análogos	deacilados.	Sin	embargo,	estos	intentos	no	tuvieron	éxito.	Por	lo	tanto,	para	describir	la	
arquitectura	del	sitio	de	unión	del	aceptor,	PatA	se	co-cristalizó	con	D-manopiranosa	(Manp)22.	
La	estructura	cristalina	de	PatA	co-cristalizada	con	Manp	se	resolvió	con	4	moléculas	por	unidad	
asimétrica.	La	inspección	de	los	mapas	de	densidad	electrónica	reveló	la	presencia	del	producto	6-O-
palmitoil-α-D-manopiranósido	 (C16-Man)	 en	 tres	 de	 las	 cuatro	 moléculas	 (cadenas	 B,	 C	 y	 D)	 de	 la	
unidad	 asimétrica	 (PatA-C16-Man).	 La	 cuarta	 molécula	 (cadena	 A)	 mostró	 (i)	 una	 molécula	 de	
palmitato	 libre	 localizado	 en	 el	 túnel	 hidrofóbico	 y	 (ii)	 una	 molécula	 de	 β-D-manopiranosa	 libre,	
localizada	en	la	cavidad	de	unión	del	aceptor.	En	las	tres	moléculas	en	las	que	se	observa	el	producto	
PatA-C16-Man,	el	grupo	de	palmitato	está	profundamente	enterrado	en	el	túnel	hidrofóbico	y	con	el	
grupo	 carboxilato	 orientado	 hacia	 el	 surco	 principal,	 como	 se	 observa	 en	 los	 complejos	 descritos	
anteriormente	PatA-C16	y	PatA-S-C16CoA,	y	el	anillo	Manp	está	ubicado	dentro	del	surco	principal.	La	
comparación	 estructural	 de	 las	 cuatro	 moléculas	 de	 la	 unidad	 asimétrica	 reveló	 cambios	
conformacionales	sutiles	pero	importantes	en	el	sitio	activo	en	la	cadena	A,	en	la	que	no	se	produce	
reacción.	 Específicamente,	 el	 grupo	 carboxilato	 se	 aleja	 del	 centro	 catalítico	 como	 se	observa	 en	 el	
complejo	PatA-S-C16CoA.	El	O1	de	la	Manp	en	la	conformación	β	se	estabiliza	ahora	mediante	nuevas	
interacciones.	El	O4	de	la	Manp	crea	un	enlace	de	hidrógeno	con	una	molécula	de	agua,	que	a	su	vez	
interactúa	 fuertemente	 con	 el	 grupo	 carboxilato	 de	 Glu149.	 De	manera	 similar,	 el	 O6	 de	 la	Manp	
forma	un	fuerte	enlace	de	hidrógeno	con	la	cadena	lateral	de	His12621,22.	
Para	 validar	 el	 modelo	 del	 sitio	 de	 unión	 del	 aceptor	 se	 realizaron	 estudios	 de	 dinámica	
molecular	(MD)	y	ensayos	enzimáticos.		
El	residuo	de	Manp	observado	en	el	complejo	PatA-C16-Man	se	solapó	bien	con	el	residuo	de	
Manp	 correspondiente	 de	 la	 forma	 deacilada	 de	 PIM2	 obtenida	 mediante	 técnicas	 de	 dinámica	
molecular.	La	superposición	estructural	de	los	complejos	PatA-C16-Man	y	S-C16CoA	proporciona	una	
buena	visión	de	los	sitios	de	unión	de	sustratos	donadores	y	aceptores	de	acilo22.		
Por	 otro	 lado,	 se	 diseñan	 tres	 mutantes	 puntuales	 que	 se	 predice	 que	 impactarán	 en	 la	
interacción	PIM2	con	PatA	y	se	mide	su	actividad	enzimática.	El	resultado	del	ensayo	muestra	como	la	
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actividad	 de	 transferencia	 del	 acilo	 al	 sustrato	 aceptor	 de	 todas	 las	 mutantes	 de	 PatA	 se	 ve	
gravemente	comprometida,	sin	embargo,	todas	conservan	la	capacidad	de	hidrolizar	el	sustrato	dador	
palmitoil-CoA.	
El	mecanismo	catalítico	de	PatA	
El	análisis	del	surco	que	corre	sobre	la	superficie	de	PatA	revela	un	sitio	catalítico	que	recuerda	
al	 observado	 en	 la	 familia	 de	 enzimas	 serina	 proteasas.	 En	 todas	 las	 estructuras	 cristalinas	 de	 los	
complejos	PatA-C16	y	PatA-S-C16CoA,	el	átomo	de	oxígeno	carboxilato	OE2	de	Glu200	se	encuentra	a	
2,8	 Å	 del	 átomo	 de	 nitrógeno	 ND1	 del	 anillo	 aromático	 de	 la	 His126.	 Nuestros	 complejos	 binarios	
corresponden	muy	probablemente	al	producto	de	reacción	de	hidrólisis	de	palmitoil-CoA,	por	lo	que	
uno	 de	 los	 átomos	 de	 oxígeno	 que	 se	 encuentra	 en	 el	 palmitato	 que	 interactúa	 con	 His126	 muy	
probablemente	provenga	de	una	molécula	de	agua	activada	por	His12622.	
Las	 coordenadas	 S-C16CoA	 en	 la	 estructura	 cristalina	 PatA-S-C16CoA	 se	 usan	 para	 generar	
coordenadas	 atómicas	 de	 palmitoil-CoA	 por	 sustitución	 de	 un	 átomo	 C16	 con	 un	 grupo	 carbonilo	
seguido	de	minimización	energética.	Los	cálculos	de	acoplamiento	colocan	el	resto	de	Manp	unido	a	la	
posición	2	del	inositol	en	PIM2	con	su	átomo	de	O6	posicionado	favorablemente	para	recibir	el	grupo	
de	palmitato	de	palmitoil-CoA.	
Se	propone	un	modelo	en	el	que	la	His126	actúa	como	la	base	general	para	abstraer	un	protón	
del	grupo	hidroxilo	en	la	posición	6	del	anillo	Manp	unido	a	la	posición	2	del	inositol	en	PIM1	o	PIM2,	
para	 facilitar	 el	 ataque	 nucleofílico	 en	 el	 tio-éster	 de	 palmitoil-CoA.	 El	 Glu200	 se	 involucra	 en	 un	
sistema	de	relé	de	carga	con	His126	y	el	átomo	HO6	del	resto	Manp,	contribuyendo	a	la	disposición	
estructural	apropiada	del	anillo	de	imidazol	del	residuo	de	histidina	y	modulando	su	pKa	para	actuar	
como	una	base	 en	el	 primer	paso	 y	 como	un	 ácido	en	el	 segundo	paso,	 proporcionando	asistencia	
protónica	al	 grupo	 saliente	CoA.	Vale	 la	pena	 señalar	que	el	 enlace	de	hidrógeno	His126-Glu200	 se	
encontró	 en	 una	 orientación	 syn	 relativa	 al	 carboxilato.	 El	 resultado	 del	 ataque	 nucleofílico	 es	 un	
enlace	covalente	entre	el	anillo	de	manosa	de	PIM1	o	PIM2	y	el	palmitato.	
Para	 validar	 el	 modelo	 de	 mecanismo	 catalítico	 propuesto	 se	 realizaron	 estudios	 de	
dinámica	molecular/mecánica	quántica	(MD/QM)	y	ensayos	enzimáticos	con	mutantes	de	PatA.		
Con	 los	estudios	de	dinámica	molecular/mecánica	quántica	 se	demuestra	que	PatA	puede	
acilar	 PIM2	 en	un	mecanismo	de	 reacción	de	dos	 etapas	 en	 el	 que	His126	 actúa	 como	una	base	
general	para	desprotonar	el	grupo	hidroxilo	de	un	anillo	de	manosa	en	PIM2,	facilitando	el	ataque	
nucleofílico	sobre	el	tio-éster	de	C16-CoA.	La	reacción	es	asistida	por	Glu200,	que	modula	el	pKa	de	
la	histidina	 central	 como	una	base	general	o	ácido	durante	el	 ciclo	 catalítico,	de	 forma	similar	al	
sistema	carga-liberación	de	las	serina	proteasas.	Estos	resultados	también	proporcionan	evidencias	
de	la	formación	de	un	estado	de	transición	de	tipo	tetraedro,	como	ya	han	sido	encontradas	para	el	
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plegamiento	de	tipo	hotdog	de	las	acil-CoA	tioesterasas.	Estos	resultados	remarcan	la	importancia	
del	Glu200	en	el	mecanismo,	y	ofrecen	detalles	valiosos	sobre	el	estado	de	transición	de	la	reacción	
que	serviría	para	el	diseño	de	nuevos	fármacos	quimioterapéuticos21,22.	
Para	validar	aún	más	el	modelo	propuesto,	 se	diseñan	mutantes	puntuales	de	 los	posibles	
residuos	 catalíticos	 Asp131Ala,	 Glu200Ala	 e	 His126Ala,	 y	 se	 mide	 su	 actividad.	 Los	 resultados	
muestran	la	importancia	del	papel	de	la	His126	y	Glu200,	ya	que	su	sustitución	por	alanina	inactiva	
completamente	la	enzima21,22.	
Mecanismo	de	acción	de	PatA	
PatA	 cataliza	 un	paso	 crítico	 en	 la	 biosíntesis	 de	 los	 PIM	en	micobacterias	 11,12.	 La	 enzima	
transfiere	un	grupo	palmítico	de	un	sustrato	dador	soluble,	palmitoil-CoA,	a	la	posición	6	del	anillo	
de	Manp	unido	a	 la	posición	2	del	myo-inositol	de	 los	glicolípidos	de	membrana	PIM1	o	PIM221,23.	
Por	 lo	 tanto,	 la	 interacción	 de	 la	 enzima	 con	 la	 cara	 citosólica	 de	 la	 membrana	 plasmática	
micobacteriana	podría	ser	un	requisito	para	la	modificación	de	PIM1	o	PIM2	por	PatA.	De	acuerdo	
con	 esta	 suposición,	 se	 observa	 que	 PatA	 co-localiza	 con	 la	 fracción	 de	 membrana	
micobacteriana23,24.	 El	 análisis	de	 la	 secuencia	de	aminoácidos	de	 la	enzima	 revela	 la	 falta	de	un	
péptido	señal	o	segmentos	hidrofóbicos	transmembrana,	sugiriendo	que	PatA	se	asocia	a	un	solo	
lado	 de	 la	 bicapa	 lipídica,	 una	 característica	 típica	 de	 las	 proteínas	 de	 membrana	 periféricas	 y	
monotópicas25,26.	 El	 potencial	 de	 superficie	 electrostática	 de	 PatA	 revela	 varios	 residuos	
hidrofóbicos/aromáticos	intercalados	con	residuos	cargados	positivamente	en	las	proximidades	del	
surco	 principal21.	 Es	 importante	 destacar	 que	 el	 lado	 opuesto	 de	 PatA	 muestra	 una	 superficie	
cargada	 negativamente,	 lo	 que	 sin	 duda	 contribuye	 a	 determinar	 la	 orientación	 correcta	 de	 la	
enzima	en	la	membrana.	
A	pesar	de	que	la	transferencia	de	acilo	se	cataliza	entre	el	grupo	palmitato	de	palmitoil-CoA	
y	 la	 manosa	 de	 PIM1	 o	 PIM2,	 los	 datos	 experimentales	 indican	 que	 la	 enzima	 muestra	 una	
necesidad	absoluta	de	ambas	cadenas	de	ácido	graso	de	PI	para	que	suceda	la	reacción,	apuntando	
a	 un	mecanismo	 que	 requiera	 una	 interfaz	 lípido-agua.	 Las	 cadenas	 de	 ácido	 graso	 del	 sustrato	
aceptor	 parecen	 jugar	 un	 papel	 estructural	 importante	 en	 la	 generación	 de	 un	 sitio	 activo	
competente,	ayudando/guiando	al	grupo	glicosílico	al	entorno	apropiado	del	centro	catalítico.	
Similitudes	estructurales	de	PatA	con	otras	aciltransferasas	
En	el	momento	en	que	se	publicó	 la	primera	estructura	cristalina	de	PatA,	 la	búsqueda	de	
homólogos	 estructurales	 usando	 el	 servidor	 DALI	 reveló	 solamente	 una	 proteína	 con	 similitud	
estructural	 significativa,	 la	glicerol-3-fosfato	aciltransferasa	de	Cucurbita	moschata	 (CmGPAT)27,28.	
Sin	 embargo,	 en	 la	 actualidad,	 la	 búsqueda	 de	 homólogos	 estructurales	 usando	 el	 servidor	 DALI	
revela	 tres	 proteínas	 con	 una	 similitud	 estructural	 significativa,	 CmGPAT,	 la	 aciltransferasa	 de	
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Acinetobacter	 baumannii	 LpxM	 (AbLpxM)29,	 y	 la	 1-acil-glicerol-3-fosfato	 aciltransferasa	 de	
Thermotoga	maritima	(TmPlsC)30.		
Los	alineamientos	de	las	secuencias	de	aminoácidos	revelan	que	las	enzimas	PatA	y	AbLpxM	
están	relacionadas	lejanamente	con	las	familias	CmGPAT	y	TmPlsC	de	aciltransferasas	bacterianas.		
La	superposición	del	dominio	α/β	de	PatA,	AbLpxM,	CmGPAT	y	TmPlsC	confirma	un	núcleo	
estructural	común,	sugiriendo	que	éstas	podrían	formar	parte	de	una	nueva	familia	estructural	de	
aciltransferasas.		
En	 la	 literatura,	 alineamientos	 de	 las	 secuencias	 primarias	 de	 varias	 las	 familias	 de	
aciltranferasas	 muestran	 residuos	 altamente	 conservados	 distribuidos	 en	 cuatro	 regiones	 y	
denominados	 como	Bloques	 I-IV18,31.	 El	 alineamiento	 de	 las	 secuencias	 primarias	 sugiere	 que	 las	
familias	de	aciltransferasas	PatA,	CmGPAT,	AbLpxM	y	TmPlsC	muestran	un	residuo	conservado	de	
aspartato/glutamato	que	participa	en	el	sistema	de	carga-liberación	con	la	histidina	conservada	del	
motivo	 HX4D/E	 (Bloque	 I)17,32,	 como	 es	 el	 caso	 de	 las	 dos	 aciltransferasas	 implicadas	 en	 la	
biosíntesis	de	ácido	fosfatídico	CmGPAT	y	TmPlsC.	En	cambio,	estructuras	cristalinas	muestran	que	
AbLpxM	y	PatA	parecen	usar	un	residuo	de	glutamato/aspartato	localizado	en	el	Bloque	III	en	lugar	
del	perteneciente	al	Bloque	I,	lo	que	sugiere	una	divergencia	entre	esta	familia	de	aciltransferasas.		
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Common	Abbreviations	and	Symbols	
Å	................................................................................	Ångström	
λ		...............................................................................	Wavelenght	
s	................................................................................	Second	
ACP	............................................................................	Acyl	Carrier	Protein	
AcPIM1	......................................................................	Acylated	Phosphoinositolmonomannoside		
AcPIM2	......................................................................	Acylated	Phosphoinositoldimannoside		
AcPIM3	......................................................................	Acylated	Phosphoinositoltrimannoside		
Ac2PIM1	.....................................................................	Diacylated	Phosphoinositolmonomannoside		
Ac2PIM2	.....................................................................	Diacylated	Phosphoinositoldimannoside		
Ac2PIM3	.....................................................................	Diacylated	Phosphoinositoltrimannoside		
AFM	...........................................................................	Atomic	force	microscopy	
AG		............................................................................	Arabinogalactan	
AGP	...........................................................................	Peptidoglycan-arabinogalactan	complex	
AGPAT	.......................................................................	Acyl-Glycerol-3-phosphate	Acyltransferase	
AM	.............................................................................	D-arabino-D-mannan	
ca.		............................................................................	circa	
CCD	...........................................................................	Charged-coupled	device	detector	
CMP	..........................................................................	Cytidine	monophosphate	
CL	..............................................................................	Cardiolipin	
CoA	...........................................................................	Coenzyme	A	
C-terminal	.................................................................	Carboxyl	terminal	domain	
DAG	...........................................................................	Diacylglycerol	
DAT	...........................................................................	Diacyltrehalose	
DDM	..........................................................................	n-dodecyl-β-D-maltoside	
DHAPAT	.....................................................................	Dihydroacetone	phosphate	acyltransferase	
DMSO	........................................................................	Dimethyl	sulfoxide	
DOPC	.........................................................................	1,2-Dioleoyl-sn-glycero-3-phosphocholine	
DTNB	.........................................................................	5,5'-dithiobis-(2-nitrobenzoic	acid)	
DTT	............................................................................	dithiothreitol	
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EDTA	.........................................................................	Ethylenediaminetetraacetic	acid	
EM	.............................................................................	Electron	microscopy	
FA-CoA	......................................................................	Fatty	acyl-CoA	
FAex	..........................................................................	Exogenous	fatty	acids	
FAK	............................................................................	Fatty	acid	kinase	
FakA	..........................................................................	Fatty	acid	kinase	domain	protein	
FakB	..........................................................................	Fatty	acid	kinase	binding	protein	
FAS-I	..........................................................................	Fatty	acid	synthase	I	
FAS-II	.........................................................................	Fatty	acid	synthase	II	
G3P	...........................................................................	Glycerol-3-phosphate	
Gal	.............................................................................	Galactose	
Galf	...........................................................................	β-D-galactofuranose	
GalNAc	......................................................................	N-acetyl	galactosamine	
GlcNAc	......................................................................	N-acetylglucosamine	
Glc	.............................................................................	D-Glucose	
GPAT	.........................................................................	Glycerol-3-phosphate	Acyltransferase	
GT	..............................................................................	Glycosyltransferase	
GT-B	..........................................................................	Glycosyltransferase	B	fold	
HCl	............................................................................	Hydrogen	chloride	
Hep	...........................................................................	L-glycero-D-mannose-heptose	
HEPES	........................................................................	4-(2-hydroxyethyl)-1-piperazineethanesulfonic	
acid	
HIV	............................................................................	Human	immunodeficiency	virus		
HX4D	..........................................................................	His-X4-Asp	motif	
KDO	...........................................................................	3-deoxy-D-manno-octulosonic	acid	
KdsB	..........................................................................	CMP-kdo	synthase	
HPLC	..........................................................................	High	performance	liquid	chromatography	
IM	..............................................................................	Inner	membrane	
IP	...............................................................................	Image	plate	detector	
K	................................................................................	Kelvin	
LAM	...........................................................................	Lipoarabinomannan	
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LB	..............................................................................	Luria-Bertani	
LCP	............................................................................	Lipidic	cubic	phase	
LD	..............................................................................	Lipid	droplet	
LDAO	.........................................................................	Lauryldimethylamine	N-oxide	
LM	.............................................................................	Lipomannan		
LPA	............................................................................	Lysophosphatidic	Acid	
LPAAT	........................................................................	Lysophosphatidic	Acid	Acyltransferase	
LPEAT	........................................................................	2-acylglycero-phosphatidylethanolamine	
acyltransferase	
LPS	............................................................................	Lipopolysaccaride	
MAD	..........................................................................	Multi-wavelength	anomalous	
MAG	..........................................................................	Monoacylglycerol	
MALDI-TOF	................................................................	Matrix-Assisted	Laser	Desorption/Ionization-	
Time-Of-Flight	
Man	...........................................................................	Mannose	
ManLAM		..................................................................	Mannosylated	lipoarabinomannan	
Manp	.........................................................................	D-mannopyranose	
M.	bobis	BCG	............................................................	Mycobacterium	bobis	bacillus	Calmette-Guerin	
MD	.............................................................................	Molecular	Dynamics	
MDO	..........................................................................	Membrane-derived	oligosaccharides	
Meso-DAP	.................................................................	meso-diaminopimelate	
MIR	...........................................................................	Multiple	isomorphous	replacement	
MM	............................................................................	Molecular	Mechanics	
Ms	.............................................................................	Mycobacterium	smegmatis	
MR	............................................................................	Molecular	replacement	
Mtb	...........................................................................	Mycobacterium	tuberculosis	
MPD	..........................................................................	2-methyl-2,4-pentanediol	
Mur	...........................................................................	Muramic	acid	
MurG	.........................................................................	Pyrophosphoryl-undecaprenol	N-
acetylglucosamine	transferase	
NaCl	..........................................................................	Sodium	chloride	
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NMR	..........................................................................	Nuclear	magnetic	resonance	
N-terminal	.................................................................	Amino	terminal	domain	
OD	.............................................................................	Optical	density	
OM	............................................................................	Outer	membrane	
OMP	..........................................................................	Outer	membrane	protein	
ON	.............................................................................	Over	night	
PA	..............................................................................	Phosphatidic	acid	
PAD	...........................................................................	Pixel	array	detector	
PAT		...........................................................................	Polyacyltrehalose	
PatA		..........................................................................	Phosphatidyl-myo-inositol	acyltransferase	A	
PDB	...........................................................................	Protein	data	bank	
PE	..............................................................................	Phosphatidylethanolamine	
PEG	...........................................................................	Polyethylene	glycol	
PG	.............................................................................	Peptidoglycan	
PI	...............................................................................	Phosphatidyilinositol	
PIM	............................................................................	Phosphoinositolmannoside		
PIM1	..........................................................................	Phosphoinositol	monomannoside	
PIM2	..........................................................................	Phosphoinositol	dimannoside	
PIM6	..........................................................................	Phosphoinositol	hexamannoside	
PimA	..........................................................................	Phosphatidyl-myo-inositol	mannosyltransferase	
A	
PimB’	.........................................................................	Phosphatidylinositol	mannosyltransferase	B’	
PMf	...........................................................................	Plasma	membrane	free	
PO4	............................................................................	Phosphate	
PPEtn	.........................................................................	Ethanolamine	pyrophosphate	
PS	..............................................................................	Phosphatidylserine		
QM/MM	....................................................................	Quantum	Mechanics/Molecular	Mechanics	
Rha	............................................................................	α-L-rhamnose	
r.m.s.d	.......................................................................	Root	Mean	Square	Deviation	
SAD	...........................................................................	Single-wavelength	anomalous	
SD	..............................................................................	Standard	Deviation	
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SGL		...........................................................................	Sulfoglycolipid	
S-HexaCoA	................................................................	S-hexadecyl	coenzyme	A	
SIR	.............................................................................	Single	isomorphous	replacement	
SLD	............................................................................	Small	lipid	droplet	
SN1	............................................................................	Unimolecular	nuclephilic	substitution	
SN2	............................................................................	Bimolecular	nuclephilic	substitution		
Sni	.............................................................................	Intramolecular	nuclephilic	substitution		
SUV	...........................................................................	Small	Unilamellar	Vesicles	
T	................................................................................	Temperature	
TAG	...........................................................................	Triacylglycerol	
TB		.............................................................................	Tuberculosis		
TMD	..........................................................................	Trehalose	dimycolates	
TMH	..........................................................................	Trans-membrane	helix	
TMM	.........................................................................	Trehalose	monomycolates	
Tris	............................................................................	Tris(hydroxymethyl)aminomethane	
Trp	.............................................................................	Tryptophan	
UDP	...........................................................................	Uridine	diphosphate		
UV	.............................................................................	UltraViolet	
V/V	............................................................................	Volume/volume	
WT	.............................................................................	Wild	Type	
W/V	...........................................................................	Weight/volume	
XFEL	..........................................................................	X-ray	free	electron	laser	
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1.	INTRODUCTION	
Long-chain	fatty	acids	play	a	central	role	in	a	multitude	of	important	biological	processes	in	all	
living	 organisms.	 They	 are	 prominent	 constituents	 of	 biological	 membranes,	 mainly	 in	 the	 form	 of	
phospholipids,	allowing	cells	to	be	functionally	constituted	and	differentiated	from	the	environment20.	
Long-chain	 fatty	 acids	 are	 used	 as	 energy	 storage	 and	 metabolic	 intermediates	 as	 well	 as	 being	
modulators	of	signal	transduction	pathways.	Moreover,	the	attachment	of	fatty	acids	to	proteins	and	
glycans	 generates	 a	 significant	 amount	 of	 structural	 diversity	 in	 biological	 systems33.	 This	 structural	
information	 is	 particularly	 apparent	 in	 molecular	 recognition	 events	 including	 cell-cell	 interactions	
during	critical	steps	of	development	and	host-pathogen	interactions.20		
Fatty	 acids	 are	 usually	 activated	 for	 subsequent	 reactions	 by	 esterification	 of	 their	 carboxyl	
groups	with	the	thiol	group	of	coenzyme	A	(CoA)	or	that	of	the	acyl	carrier	protein	(ACP),	yielding	acyl-
thioesters.	 In	general,	 there	are	 two	basic	 routes	 to	provide	 long-chain	 fatty	acids:	via	de	novo	 fatty	
acid	synthesis	from	the	central	metabolite	acetyl-CoA,	yielding	acyl-ACPs,	or	via	uptake	of	exogenous	
fatty	acids	or	other	compounds	that	are	converted	to	fatty	acids	such	as	alkanes	and	their	conversion	
to	 acyl-CoAs	 by	 acyl-CoA	 synthetases34,35.	 Acyltransferases	 or	 transacylases	 use	 these	 activated	 acyl	
chains	and	transfer	them	to	a	variety	of	different	substrates	or	polymerize	them	to	lipophilic	storage	
compounds.	 Lipases	 form	 another	 important	 enzyme	 class	 dealing	 with	 fatty	 acyl	 chains;	 however,	
they	 cannot	 be	 regarded	 as	 acyltransferases	 in	 the	 strict	 sense	 since	 they	 employ	 a	 completely	
different	enzyme	mechanism	to	cleave	and	transfer	fatty	acids,	which	employs	(i)	a	catalytic	triad	and	
(ii)	the	formation	of	covalent	intermediate3.		
The	aim	of	 this	 introduction	 is	 to	provide	an	overview	of	 those	bacterial	acyltransferases	 that	
(like	the	mycobacterial	acyltransferase	of	study	in	this	thesis	PatA)	(i)	employ	a	conserved	motif	with	
an	 invariant	 histidine	 residue	 followed	 by	 an	 acidic	 aminoacid	 residue,	 and	 (ii)	 their	 catalytic	
mechanism	 is	 characterized	 by	 a	 non-covalent	 transition	 state.	 In	 particular,	 this	 group	 of	 enzymes	
includes:	
• Glycerol-Phosphate	biosynthesis	acyltransferases,	
• Lipid	A	biosynthesis	acyltransferases,	
• and	a	Mycobacterial	Phosphatidyl-myo-Innositol	Mannosides	biosynthesis	acyltransferase,	PatA.	
Interestingly,	 those	enzymes	apart	 from	sharing	a	 conserved	catalytic	mechanism,	 the	amino-
acid	 sequence	 alignment	 revealed	 that	 PatA	 has	 strong	 resemblance	 with	 the	 Lipid	 A	 biosynthesis	
acyltransferases	 Laxly	 and	 LpxM36,37,	 and	 that	 they	 are	distantly	 related	 to	 the	 glycerol-3-phosphate	
(GPAT)	 and	 lysophosphatidic	 acid	 (AGPAT	 or	 LPAAT)	 families	 of	 bacterial	 acyltransferases18,38.	 In	
concrete,	all	those	enzymes	display	highly	conserved	residues	distributed	in	four	regions,	and	named	
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as	Block	I	to	IV.	According	to	multiple	sequence	alignments	weighted	by	structural	alignment	of	PatA,	a	
common	core	can	be	defined.		 	
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1.1.	Glycerol-Phosphate	Acyltransferases	
Phosphatidic	 acid	 (PA)	 is	 the	 universal	 precursor	 required	 for	 the	 production	 of	 glycerolipids.	
Glycerolipids	 include	 both	 non-polar	 lipids	 and	 polar	 phospholipids.	 Non-polar	 lipids	 are	 generally	
divided	 into	 three	 different	 classes	 depending	 on	 the	 number	 of	 fatty	 acids	 attached	 to	 glycerol:	
monoacylglycerol	 (MAG),	 diacylglycerol	 (DAG)	 and	 triacylglycerol	 (TAG).	 PA	 can	 be	 diverted	 to	
triacylglycerol	 (TAG)	 synthesis,	 or	 activated	 to	 form	 cytidine	 diphosphate-diacylglycerol	 (CDP-DAG),	
which	is	the	precursor	for	the	synthesis	of	phospholipids.	Therefore,	PA	is	an	important	branch	point	
for	 the	 synthesis	 of	 TAG	 and	 phospholipids39.	 An	 alternative	 pathway	 for	 PA	 synthesis	 is	
phosphorylation	of	DAG	by	DAG	kinase	(Figure1)31.	
	
Figure	1:	Mycobacterial	plasma	membrane	with	flow	of	key	metabolic	pathways.	PA	is	converted	in	phospholipids	or	
in	 TAG.	 SLD	 (small	 lipid	 droplet);	 LD	 (lipid	 droplet);	 FA-CoA	 (fatty	 acyl-CoA);	 PIM	 (phosphatidyl-myo-innositol	
mannoside);	LM	(Lippomannan);	LAM	(Lipoarabinomannan);	FAS-I	(fatty	acid	synthase	I);	FAS-II	(fatty	acid	synthase	II);	
CL	(cardiolipin);	PE	(phosphatidylethanolamine);	PI	(phosphatidylinositol).	
PA	 is	 the	 biosynthetic	 product	 of	 the	 esterification	 of	 two	 fatty	 acids	 onto	 the	 two	 hydroxyl	
groups	 of	 sn-glycerol-3-phosphate	 (G3P)40–43.	 Glycerol-3-phosphate	 is	 first	 acylated	 by	 glycerol-3-
phosphate	acyltransferase	 (GPAT;	EC	2.3.1.15)	 to	produce	 lysophosphatidic	 acid	 (LPA),	 to	be	 further	
acylated	by	1-acylglycerol-3-phosphate	acyltransferases	or	lysophosphatide	acyltransferase	(AGPAT	or	
LPAAT,	respectively;	EC	2.3.1.51)	to	produce	PA44,45.		
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Figure	2:	First	 two	acylation	steps	 in	membrane	 lipid	and	triacylglycerol	synthesis	 from	glicerol-3-phosphate	to	the	
central	intermediate	phosphatidic	acid.	
1.1.1.	Conserved	Motifs	of	Glycerolipid	Acyltransferases	
Glycerolipid	acyltransferases	(including	GPAT	and	LPAAT	enzymes)	from	bacteria,	plants,	yeasts,	
and	 animals	 all	 share	 the	 highly	 conserved	 active-site	 motif	 HxxxxD/E	 or	 HX4D/E,	 consisting	 on	 an	
invariant	 histidine	 and	 an	 acidic	 residue	 (aspartic/glutamic)	 separated	 by	 four	 less-conserved	 amino	
acids.	The	highly	conserved	region	containing	the	HX4D	sequence	is	referred	to	as	Block	I.	Furthermore,	
there	 are	 three	 short	 regions	 (Blocks	 II	 to	 IV)	 exhibiting	 high	 conservation	 in	 glycerolipid	
acyltransferases	from	bacteria,	yeasts,	and	animals	(enzymes	from	plants	lack	Blocks	III	and	IV)18.		
Four	regions	of	high	homology	are	shared	between	glycerolipid	acyltransferases	from	different	
species	(Table	1).	In	order	to	investigate	the	importance	of	the	conserved	amino	acids	of	Blocks	I	to	IV,	
the	E.	coli	PlsB	was	firstly	analyzed	as	a	model	for	GPAT	acyltransferases,	and	when	crystal	structure	of	
a	 distantly	 related	 soluble	 GPAT	 variant	 from	 plant	 plastids	 (squash)	 become	 available,	 some	more	
mutagenesis	studies	on	these	conserved	residues	have	defined	the	roles	of	these	blocks	 in	substrate	
binding	and	catalysis17,27,28,45.	
The	 catalytic	 site	 constituted	 by	 HX4D	motif	 is	 located	 in	 homology	 Block	 I17,18.	 Histidine	 and	
aspartate	in	HX4D	form	a	catalytic	dyad	in	which	the	negative	residue	aspartate	forms	a	charge	relay	
system	 with	 histidine	 that	 abstract	 a	 proton	 from	 the	 hydroxyl	 group	 of	 the	 acceptor	 substrate.	
Subsequently,	the	nucleophilic	oxyanion	attacks	the	carbon	atom	of	the	acyl-thioester	substrate.	The	
structure	confirms	that	the	HX4D	motif	forms	a	charge	relay	for	catalysis	similar	to	serine	hydrolases46.	
Blocks	 II	 and	 III	 participate	 in	 G3P	 binding,	 with	 mutations	 of	 the	 arginine	 residues	 in	 the	 blocks	
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causing	an	increase	in	G3P	Km.	Block	IV	is	a	less	conserved	hydrophobic	patch,	with	proline	as	the	only	
invariant	residue.		
Glycerolipid	 acyltransferases	 are	 responsible	 for	 the	 selection	of	 fatty	 acids	 incorporated	 into	
membrane	phospholipids	and	are	key	regulatory	points	in	the	pathway47,48.	
	 Sequence	
Enzyme	 Block	I	 Block	II	 Block	III	 Block	IV	
E.coli	GPAT	(PlsB)	 VPCHRSHMDYL	 GAFFIRR	 YFVEGGRSRTGR	 ITLIPIYI	
GPAT	concensus	 ϕxxHRSxϕDϕϕ	 GxϕFIRR	 ϕFϕEGTRSRxGK	 ϕϕϕϕPϕϕϕ	
E.coli	LPAAT	(PlsC)	 IANHQNNYDMV	 GNLLLDR	 MFPEGTRSR-GR	 VPIIPVCV	
LPAAT	consensus	 ϕxNHQSxϕDϕϕ	 GxϕFIDR	 ϕFPEGTRxxxGx	 ϕPϕϕPϕϕϕ	
Table	2:	Blocks	with	high	degree	of	conservation	in	GPAT	acyltransferases.	ϕ,	hydrophobic	amino	acids	(Val,	Ile,	Leu,	
Phe,	Trp,	Tyr,	or	Met).	Highly	conserved	residues	are	in	bold,	the	catalytically	essential	histidine	and	aspartate	in	Block	I	
in	italic,	and	residues	for	glycerol-3-phosphate	binding	are	underlined.		
1.1.2.	Two	Bacterial	Pathways	for	Phosphatidic	Acid	(PA)	Biosynthesis	
There	 are	 two	distinct	 pathways	 to	 carry	 out	 the	 acylation	 of	 the	 glycerol	 backbone	of	 PA	 in	
bacteria.	
• PlsB/PlsC	 Pathway	 was	 initially	 discovered	 in	 E.	 coli	 and	 is	 composed	 by	 the	 PlsB/PlsC	
acyltransferases.	 This	 system	 is	 largely	 limited	 to	 Gram-negative	 bacteria	 (mostly	 gamma-
proteobacteria),	 but	 homologs	 are	 also	 present	 in	mammals49.	 This	 protein	 family	 primarily	
uses	acyl-acyl	carrier	protein	and	products	of	fatty	acid	synthesis	as	acyl	donors,	but	may	also	
use	acyl-CoA	derived	from	exogenous	fatty	acids.	The	PlsB	enzyme	is	responsible	for	selecting	
the	 fatty	 acids	 incorporated	 into	 the	 position	 1	 of	 phospholipids	 and	 is	 a	 key	 point	 of	
regulation.	The	second	acyltransferase,	PlsC,	completes	the	synthesis	of	PA,	by	transfering	an	
acyl	group	from	acyl-ACP	or	acyl-CoA	to	position	2	of	1-acyl-glycerol-3-phosphate	(Figure	3)49.		
• PlsX/PlsY/PlsC	 Pathway	 consists	 of	 three	 steps	 for	 the	 formation	 of	 PA.	 It	 was	 recently	
discovered	in	Firmicutes,	which	include	most	clinically	important	Gram-positive	bacteria	such	
as	Staphylococcus	aureus	and	Streptococcus	pneumonia49–52.	The	first	step	 in	this	pathway	 is	
catalyzed	 by	 PlsX,	 an	 acyl-ACP:phosphate	 transacylase,	 that	 converts	 acyl-ACP	 in	 acyl-
phosphate	(acyl-PO4).	The	second	step	is	catalyzed	by	the	integral	membrane	protein	PlsY,	an	
acyl-PO4-dependent	acyltransferase,	which	transfers	the	acyl	group	of	acyl-PO4	to	position	1	of	
glycerol-3-phosphate.	The	last	step	is	similar	to	the	one	in	Gram-negatives,	with	the	difference	
that	 E.	 coli’s	 PlsC	 uses	 acyl-ACP	 or	 acyl-CoA	 as	 acyl	 donors,	 whereas	 Streptococcus	
pneumoniae	and	Bacillus	subtilis	PlsC	only	uses	acyl-ACP	(Figure	3)50,53.		 	
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The	 glycerol-3-phosphate	 and	 1-acylglycerol-3-phosphate	 acyltransferases	 sit	 at	 the	 interface	
between	 the	 soluble	 type	 II	 fatty	 acid	 biosynthetic	 pathway	 and	 the	 creation	 of	 a	 phospholipid	
molecule	 that	 drives	 membrane	 expansion.	 This	 pivotal	 position	 makes	 glycerolphosphate	
acyltransferases	key	regulators	of	both	fatty	acid	and	phospholipid	synthesis.	
	
Figure	 3:	 Overview	 of	 pathways	 for	 membrane	 phospholipid	 and	 triacylglycerol	 biosynthesis	 in	 bacteria.	 G3P,	
glycerol-3-phosphate;	 FAex,	 exogenous	 fatty	 acids;	 LPA,	 lysophosphatidic	 acid;	 PA,	 phosphatidic	 acid;	 DAG,	
diacylglycerol;	TAG,	triacylglycerol.	Modified	from20.		
1.1.2.1.	 PlsB/PlsC	Pathway	of	Gram-negative	Bacteria	PA	Biosynthesis	
In	the	first	and	most	detailed	analysed	model	system	of	E.	coli	and	other	gamma-proteobacteria,	
G3P	 is	 acylated	 to	 form	 LPA	 by	 the	 acyltransferase	 PlsB,	 and	 further	 acylated	 to	 form	 PA	 by	 the	
acyltransferase	PlsC.	PlsB-homologous	GPATs	have	also	been	identified	in	mammals	and	plants54,55.		
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1.1.2.1.1.	The	Glycerol-3-Phosphate	(G3P)	Acyltransferase	PlsB	
The	first	step	in	PA	formation	in	gamma-proteobacteria	is	the	acylation	of	the	1-position	of	G3P	
by	the	GPAT	named	PlsB,	the	first	glycerol-3-phosphate	acyltransferase	characterized	in	bacteria56.	The	
structure	of	the	soluble	GPAT	from	Cucurbita	moschata	have	been	solved	(CmGPAT;	PDB	Codes:	1IUQ	
and	1K30)27,28.	CmGPAT	catalyses	the	transfer	of	an	acyl	chain	either	from	acyl-acyl-carrier	protein	or	
acyl-CoA,	 to	 the	 sn-1	 position	 of	 glycerol-3-phosphate,	 to	 form	 1-acylglycerol-3-phosphate57.	
Importantly,	 CmGPAT	 is	 able	 to	 use	 palmitoyl-CoA	 as	 a	 donor	 substrate,	 using	 a	 bi-bi-ordered	
mechanism58.		
The	 structure	 of	CmGPAT	 crystallized	 as	 a	monomer	 and	 it	 is	 composed	 of	 two	 domains:	 a	
helical	domain	comprising	the	first	78	residues	of	the	protein	displays	a	four-helix	bundle	architecture	
of	 unknown	 function,	 and	 an	 α/β	 domain,	 consisting	 of	 a	 nine-stranded	 continuous	 β-sheet	
surrounded	 by	 11	 α-helices	 (Figure	 4).	 A	 combination	 of	 site-directed	 mutagenesis	 and	 activity	
measurements	 provided	 experimental	 support	 on	 the	 location	 of	 the	 acceptor-binding	 site	 in	
CmGPAT59.	 The	 replacement	 of	 Arg235,	 Arg237	 and	 Lys193	 by	 serine	 resulted	 in	 inactive	 enzymes.	
However,	 the	 CmGPAT	 variants	 retained	 the	 ability	 to	 bind	 stoichiometric	 quantities	 of	 acyl-ACPs,	
consistent	with	the	location	of	these	residues	in	the	positively	charged	acceptor-binding	pocket,	and	in	
close	proximity	to	the	catalytic	HX4D	motif27,28,59.		
The	location	of	the	acyl-CoA	and	acyl-ACP-binding	site	in	CmGPAT	has	been	a	matter	of	strong	
debate27,28.	On	the	basis	of	sequence	conservation	analysis,	a	structural	model	in	which	the	acyl	chain	
runs	 over	 the	 entrance	 of	 the	 main	 groove	 of	 the	 protein	 was	 first	 proposed27.	 Molecular	 surface	
calculations	 revealed	 the	 existence	 of	 three	 tunnels	with	 sufficient	 space	 to	 accommodate	 the	 acyl	
chain	of	palmitoyl-CoA60.	Furthermore,	enzymatic	analysis	of	chimeric	CmGPAT	and	Spinacea	oleracea	
GPAT	 revealed	 that	 a	 region	 comprising	 residues	 128-187	 is	 important	 for	 acyl-CoA	 selectivity.	 This	
region	 completely	 covered	 the	 narrowest	 and	 most	 hydrophobic	 of	 the	 three	 tunnels	 which	 was	
proposed	to	be	involved	in	fatty-acid	recognition28.	The	catalytic	site	is	located	at	the	base	of	the	large	
groove	of	the	protein,	displaying	the	sequence	HX4D,	a	well-conserved	motif	among	the	GPAT	family	of	
acyltransferases18.	His139	and	the	adjacent	Asp144	were	proposed	to	promote	a	charge-relay	system	
to	facilitate	the	nucleophilic	attack	on	the	thioester	of	the	acyl-CoA,	similar	mechanism	that	the	one	
observed	in	serine	protease	family17,27,28,61.		
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Figure	4:	 Tridimensional	 structure	of	CmGPAT.	 a-b)	The	active	site	of	CmGPAT	 is	 located	 into	a	main	groove,	with	a	
hydrophobic	tunnel	running	perpendicular	and	deeply	buried	into	the	core	of	the	enzyme.	The	accessory	domain	is	in	
grey21.	c)	 Proposed	 catalytic	 residues	His139	and	Asp144	are	 coloured	 in	 yellow,	 and	proposed	acceptor-binding	 site	
important	residues	Arg235,	Arg237	and	Lys193	are	shown	in	green.		
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1.1.2.1.2.	The	Acyl-G3P	Acyltransferase	PlsC		
The	 1-acylglycerol-3-phosphate	 acyltransferases	 belong	 to	 the	 evolutionarily	 conserved	
lysophospholipid	acyltransferase	family	of	intrinsic	membrane	proteins.	This	large	family	is	responsible	
not	only	for	phospholipid	synthesis	but	also	for	phospholipid	remodelling62–64.	In	humans,	mutations	in	
AGPAT	family	members	are	associated	to	many	human	diseases65.	Very	recently,	the	structure	of	the	
PlsC	from	Thermotoga	maritima	has	been	solved	(TmPlsC;	PDB	Code	5KYM)30.	TmPlsC	crystalyzed	as	a	
monomer	 and	 is	 composed	 by	 two	 domains:	 the	 N-terminal	 domain	 (residues	 1-61)	 comprises	 an	
antiparallel	two-helix	bundle	(α1	and	α2),	and	the	C-terminal	domain	forms	an	αβ-domain	that	consists	
of	a	seven-stranded	β-sheet	core	surrounded	by	 five	α-helices	and	four	310	helices	 (residues	62-247;	
Figure	5	a)30.	
	
Figure	5:	The	tertiary	structure	of	TmPlsC.	a)	The	overall	structure	of	TmPlsC.	The	N-terminal	two-helix	motif	is	colored	
orange,	and	the	core	catalytic	αβ-domain	is	coloured	blue	(α-helices),	 light	green	(β-strands)	and	light	orange	(loops).	
Proposed	 catalytic	 residues	 are	 coloured	 in	 magenta.	 b)	 A	 charged	 surface	 representation	 of	 TmPlsC	 showing	 the	
substrate	(LPA)-binding	groove,	the	entrance	to	the	acyl-chain-selectivity	tunnel,	the	two-helix	motif	and	the	active	site.	
c)	The	active	site	with	the	catalytic	residues	His	84	and	Asp	89,	Glu	156	is	proposed	to	stabilize	His	84.	Modified	from30.	
The	 two-helix	 bundle	 has	 a	 very	 distinctive	 array	 of	 amino	 acids.	 The	 first	 long	 α-helix	 α1	 is	
characterized	by	an	unbroken	string	of	25	hydrophobic	and	aromatic	residues,	a	central	kink	mediated	
by	a	pair	of	glycine	residues	(Gly25	and	Gly26),	and	basic	termini.	It	is	suggested	that	the	kink	in	helix	
α1	 allows	 it	 to	 enter	 and	 exit	 on	 the	 same	 side	 of	 the	 membrane,	 while	 the	 central	 hydrophobic	
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residues	 and	 the	 terminal	 basic	 residues	 interact	 with	 the	 apolar	 interior	 and	 negatively	 charged	
surface	of	 the	membrane,	 respectively	 (Figure	5	 a)66,67.	Helix	α2	 is	sandwiched	between	helix	α1	and	
the	 αβ-domain,	 and	 its	 exposed	 surfaces	 are	 also	 populated	with	 basic	 residues	 (Figure	 5	 a)30.	 The	
truncation	of	this	motif	reduces	the	association	with	the	membrane,	and	a	complete	removal	prevents	
membrane	association.		
The	 α/β-domain	 includes	 the	 location	 of	 the	 conserved	 catalytic	 HX4D	 motif,	 and	 the	 four	
conserved	blocks	within	the	GPAT	and	AGPAT	family18,68.	Block	I	contains	the	HX4D	motif,	and	Asn83	
and	Gln85	flank	the	catalytic	His84	and	fix	its	position	via	hydrogen	bonds	with	neighboring	backbone	
amide	nitrogen	atoms.	Block	III	contains	Glu156,	which	forms	two	stabilizing	hydrogen	bonds	to	His84	
(Figure	5	 c).	Block	 IV	 is	within	strand	β6	and	 interacts	with	the	adjacent	strand	(β2)	to	cap	the	active	
site	and	further	stabilize	Block	I.	Block	II	is	in	a	separate	region	and	it	is	suggested	that	contributes	to	
binding	of	the	phosphopantetheine	arm	of	the	acyl	donor.		
The	 catalytic	 site	 is	 located	 at	 the	 base	 of	 the	 large	 groove	 of	 the	 protein,	 displaying	 the	
sequence	HX4D,	a	well-conserved	motif	among	the	GPAT	family	of	acyltransferases	(Figure	5	c)18.	His84	
and	the	adjacent	Asp89	were	proposed	to	promote	a	charge-relay	system	to	facilitate	the	nucleophilic	
attack	on	the	thioester	of	the	substrate,	similar	mechanism	that	the	one	observed	in	serine	protease	
family	(Figure	5	c)	17,30,61.	
	
1.1.2.2.	 PlsX/PlsY/PlsC	Pathway	of	Gram-positive	Bacteria	PA	Biosynthesis	
In	Gram-positive	pathogens,	such	as	Streptococcus	pneumonia	and	Staphylococcus	aureus,	PA	is	
generated	 by	 the	 PlsX/PlsY/PlsC	 pathway.	 A	 comprehensive	 analysis	 of	 bacterial	 genomes	 revealed	
that	 this	 alternative	 PlsX/PlsY	 pathway	 is	 most	 widely	 distributed,	 whereas	 the	 PlsB/PlsC	 pathway	
seems	to	be	restricted	primarily	to	gamma-proteobacteria.	While	many	of	the	latter	organisms	such	as	
Pseudomonas	aeruginosa	possess	both	alternatives,	the	Xanthomonadales	have	solely	PlsB56,69.	
First,	PlsX	is	a	soluble	acyl-ACP:PO4	transacylase	that	converts	the	acyl-ACP	end-products	of	the	
de	novo	fatty	acid	synthesis	(FAS-II)	to	their	acyl-PO4	derivatives70.	These	activated	fatty	acids	are	then	
used	 by	 the	 integral	 membrane	 acyltransferase	 PlsY	 to	 acylate	 glycerol-3-phosphate69,70.	 The	 last	
acyltransferase	of	the	pathway,	PlsC71,	acylates	the	2-position	and	is	specific	for	acyl-ACP	thioesters	as	
acyl	donors70	to	produce	PA.	Exogenous	fatty	acids	can	access	these	acyltransferase	systems	after	their	
uptake	 by	 the	 cell	 and	 activation	 by	 fatty	 acid	 kinase	 (Fak)72.	 Fatty	 acid	 kinase	 is	 composed	 of	 two	
subunits:	a	kinase	domain	protein	(FakA)	and	a	fatty	acid	binding	protein	(FakB)	that	work	together	to	
produce	acyl-PO4.	The	acyl-PO4	arising	from	extracellular	fatty	acids	is	either	incorporated	into	the	1-
position	of	G3P	by	PlsY	or	converted	to	acyl-ACP	by	PlsX.	When	it	is	converted	to	acyl-ACP	by	PlsX,	can	
be	either	elongated	by	FAS-II	or	used	by	PlsC73.	Thus,	PlsX	is	a	key	enzyme	that	interconverts	the	two	
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acyltransferase	acyl	donors.	Moreover,	blocking	the	PlsX	reaction	results	in	the	cessation	of	fatty	acid	
synthesis	by	FAS-II.	Therefore,	PlsX	seems	 to	be	a	key	 regulatory	point	 that	 synchronizes	FAS-II	with	
phospholipid	synthesis	(Figure	6)53.	
	
Figure	6:	The	role	of	PlsX	in	S.	pneumoniae.	PlsX	plays	a	key	role	in	fatty	acid	metabolism	by	interconverting	acyl-ACP	
and	acyl-PO4.	The	 liberated	 free	 fatty	acids	are	converted	 to	acyl-PO4	by	 fatty	acid	kinase	 (FakA/B)	and	 incorporated	
into	 the	 1-position	 of	 phospholipids	 by	 the	 sn-glycerol-3-phosphate	 acyltransferase	 PlsY.	 The	 second	 acyltransferase	
(PlsC)	uses	acyl-ACP	from	FAS-II	as	the	acyl	donor.	
1.1.2.2.1.	The	Acyltransferase	PlsX	
PlsX	is	a	acyl-ACP:phosphate	transacylase	that	catalyzes	the	formation	of	acyl-PO4	from	the	acyl-
ACP,	and	plays	a	key	role	in	fatty	acid	metabolism	by	interconverting	acyl-ACP	and	acyl-PO4,	so	either	
both	molecules	can	be	used	as	a	substrate70.	Therefore,	PlsX	links	FAS-II	pathway	to	the	phospholipid	
synthesis	pathway,	and	 it	 is	crucial	 for	 the	movement	of	unsaturated	 fatty	acids	 into	the	membrane	
(Figure	 6).	 Nowadays	 there	 are	 two	 crystal	 structures	 available	 of	 the	 acyltransferase	 PlsX:	 the	
structure	 of	 the	 soluble	 PlsX	 from	 Bacillus	 subtillis	 (BsPlsX;	 pdb	 code	 1VI1)74,	 and	 PlsX	 from	
Enterococcus	faecalis	(EfPlsX;	pdb	code	1U7N)75.		
PlsX	 is	 a	 α/β/α	 sandwich	 that	 resembles	 a	 Rossmann	 fold	 and	 crystallyzed	 as	 a	 dimer.	 The	
twisted	β-sheet	has	11	mostly	parallel	strands	that	are	flanked	by	7	helices	on	one	side	and	6	helices	
on	the	other	side	of	the	sheet	(Figure	7	a)74.	The	monomer	has	a	well	defined	hydrophobic	core	and	
the	structure	is	stabilized	by	various	intra-subunit	salt	bridges	on	the	protein	surface.	The	PlsX	protein	
forms	 an	 S-shaped	 dimer	 using	 the	 novel	 dimerization	motif	 (Figure	 7	 b).	 Two	α-helices	 α9	 and	α10	
form	a	 long	hairpin	 in	 each	monomer	 that	 protrudes	 away	 from	 the	main	domain	 (Figure	 7	 c).	 The	
hairpins	associate	and	form	a	four-helix	bundle	(α9,	α10	and	α9’,	α10’)	with	a	well	defined	hydrophobic	
core.	 The	 loop	 between	 helices	 α9	 and	 α10	 is	 disordered	 in	 the	 crystal	 (Figure	 7	 c)74.	 It	 has	 been	
reported	that	PlsX	associates	with	the	membrane	in	Bacillus	subtillis,	but	the	basis	for	this	association	
has	not	been	explored	yet51.	 	
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In	the	E.	faecalis	PlsX	protein,	the	base	of	this	four-helix	bundle	includes	12	methionine	residues	
that	interact	through	Van	der	Waals	contacts	and	form	a	rather	unusual	methionine	belt	(Figure	7	c-d).	
The	dimer	is	additionally	stabilized	by	the	interaction	of	loops	and	α-helices	of	the	main	domain74.	
	
Figure	7:	Structure	of	Enterococcus	faecalis	PlsX	protein	dimer.	a-b)	Two	views	of	EfPlsX,	one	monomer	is	coloured	in	
blue	and	the	other	is	coloured	in	orange.	c-d)	α9	and	α10	of	one	monomer	are	coloured	in	light	blue	and	α9	and	α10	of	
the	other	monomer	are	 coloured	 in	 yellow.	The	 residues	 that	 forms	 the	methionine	belt	 are	 shown	and	 coloured	 in	
green. 
In	 E.	 faecalis	 the	 plsX	 gene	 is	 co-localized	 with	 a	 bacterial	 fab	 gene	 cluster	 which	 encodes	
several	 key	 fatty	 acid	 biosynthetic	 enzymes.	 The	 B.	 subtilis	 plsX	 is	 an	 essential	 gene	 and	 it	 was	
annotated	 based	 on	 its	 similarity	 to	 the	 E.	 coli	 counterpart76.	 The	 protein	 is	 a	 member	 of	 a	 large,	
conserved	protein	family	 (Pfam	02504)	 found	exclusively	 in	bacteria.	The	PlsX	sequence	homologues	
include	 both	 phosphate	 acetyltransferases	 and	 phosphate	 butaryltransferases	 that	 catalyze	 the	
transfer	of	an	acetyl	or	butaryl	group	to	orthophosphate.		
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1.1.2.2.2.	The	Gram-positive	G3P	Acyltransferase	PlsY	
PlsY	is	the	most	widely	distributed	G3P	acyltransferase	and	it	is	the	sole	G3P	acyltransferase	in	
Gram-positive	bacteria,	including	medically	important	bacteria	such	as	S.	pneumoniae	and	S.	aureus50.	
PlsY	represents	a	unique	class	of	GPAT,	since	not	only	has	a	completely	different	sequence	and	size	-	
most	 Gram-negative	 GPAT	 PlsB	 are	 approximately	 90-KDa,	 whereas	 Gram-positive	 GPAT	 PlsY	 is	
approximately	23-KDa	-	but	also	uses	acyl-phosphate	as	a	novel	and	unique	acyl	donor.	PlsY	protein	is	
an	acyl-PO4	dependent	G3P	acyltransferase.	This	precursor	 is	provided	by	the	soluble	acyltransferase	
PlsX,	previously	described,	which	catalyzes	the	formation	of	acyl-PO4	from	acyl-ACP	(Figure	6)50.		
The	 integral-membrane	 glycerol	 3-phosphate	 (G3P)	 acyltransferase	 PlsY	 catalyses	 the	
committed	 and	 essential	 step	 in	 bacterial	 phospholipid	 biosynthesis	 by	 acylation	 of	 G3P,	 forming	
lysophosphatidic	 acid.	 It	 contains	 no	 known	 acyltransferase	motifs,	 lacks	 eukaryotic	 homologs,	 and	
uses	the	unusual	acyl-phosphate	as	acyl	donor,	as	opposed	to	acyl-CoA	or	acyl-carrier	protein	for	other	
acyltransferases.		
Very	recently,	the	structure	of	Aquifex	aeolicus	PlsY	(AaPlsY)	has	been	solved	in	the	presence	of	
substrates	 and	 products77	 (PDB	 Codes	 5XJ5,	 5XJ6,	 5XJ7,	 5XJ8,	 5XJ9;	 Figure	 8).	 The	 structure	AaPlsY	
contains	a	monomer	in	the	asymmetric	unit.	The	overall	shape	of	AaPlsY	resembles	a	funnel	composed	
of	three	tilted	helices	(α1-3)	sitting	in	a	cup	composed	of	seven	TMHs	(Trans-membrane	helix;	Figure	8).	
The	membrane-perpendicular	 TMH4	is	 sandwiched	 by	 two	 bundles,	 TMH1-3	 and	 TMH5-7.	 The	 striking	
shortness	of	TMH4	is	compensated	by	the	membrane-embedded	Loop3.	The	overall	structure	 is	very	
compact;	apart	from	two	relatively	long	cytoplasmic	loops	containing	functionally	important	residues,	
the	helices	are	stitched	together	with	short	linkers	(Figure	8)77.	
	
Figure	 8:	Crystal	 structure	 and	membrane	 topology	 of	AaPlsY.	a)	 View	 from	 the	membrane	 plane.	 The	membrane	
boundary	was	defined	by	the	OPM	server68.	TMHs	and	 loops	are	appropriately	 labeled.	b)	View	from	the	cytoplasm.	
Modified	from77.	
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Figure	9:	The	active	site	of	AaPlsY.	a)	The	V-shaped	active	site	hosting	a	MAG	molecule	and	two	SO4
2-	ions.	Active	site	
residues	 from	 a	 previous	 report69,	 the	MAG,	 and	 the	 two	 sulphates	were	 shown	 in	 sticks.	b)	 Superimposition	 of	 all	
active	site	ligands.	The	MAG,	16:0-P,	G3P,	and	lysoPA	are	shown	in	stick	representations	with	the	oxygen	atoms	in	red,	
sulphur	atoms	in	yellow,	and	carbon	atoms	in	cyan,	magenta,	green,	and	blue,	respectively.	c)	Putty	representation	of	
B-factors	of	 the	AaPlsYMAG	structure.	Blue	 lines	and	 red	 tubes	 indicate	 low	and	high	B-factors,	 respectively.	 The	Cα	
atoms	of	active	site	residues	are	highlighted	as	magenta	spheres.	Modified	from77.	
Mapping	 12	 functionally	 important	 residues	 onto	AaPlsY	 reveals	 a	V-shaped	 cavity	 that	 hosts	
two	 SO42−	 and	 a	 monoacylglycerol	 (MAG	 is	 used	 for	 the	 crystallyzation	 process	 by	 LCP)	 with	 well-
defined	electron	density	(Figure	9).	It	is	noticed	that	the	MAG	and	SO42−	/1	are	positioned	in	a	way	that	
could	 mimics	 the	 lipid	 substrate	 acyl-PO4.	 As	 well,	 the	 SO42−	 /2	 at	 the	 membrane	 interface	 should	
mimic	the	phosphate	group	of	G3P.	Therefore,	this	cavity	could	be	the	active	site77(Figure	9).		
AaPlsY	 is	 small	 (192	 residues)	 and	 monomeric;	 yet	 it	 crosses	 membrane	 seven	 times	 and	
contains	pockets	that	must	host	two	substrates	with	distinct	differences	 in	solubility.	This	 implies	an	
efficient	structure	build	for	function.	Backbone	amides	from	four	consecutive	residues	(Lys104,	Gly105,	
Val106,	 and	Ala107)	 in	 Loop3,	 the	 side	 chain	of	His92,	 and	 two	α-helix	dipoles,	namely	 the	partially	
positively	 charged	 N-termini	 of	 TMH4	 and	 α2,	 form	 a	 hydrophilic	 ‘phosphate	 hole’	 deep	 in	 the	
membrane,	 securing	 the	 phosphate	 group	 of	 acyl-PO477	 (Figure	 10	 a).	 Two	 backbone	 amides	 from	
Ala40	 and	 Thr41,	 and	 the	 Thr41	 hydroxyl,	 form	 three	 H-bonds	 with	 the	 carbonyl.	 Three	 water	
molecules	further	stabilize	the	acyl-PO4	head	group	in	this	hydrophilic	interior.	According	to	the	crystal	
structures	 solved	 in	 complex	with	different	 ligands,	His92	 and	Thr41	 are	 the	only	 two	 residues	 that	
contribute	 to	acyl-PO4	binding	by	side	chains.	Mutating	Thr41	 to	alanine	had	severe	consequence	 in	
catalytic	activity,	whereas	keeping	 the	hydroxyl	by	serine	mutation	only	 reduced	half	of	 the	activity.	
Mutation	of	His92	to	alanine	also	caused	a	dramatic	80%	loss	of	activity77	(Figure	10).		
The	AaPlsYG3P	G3P	 structure	 reveals	 a	G3P	pocket	 composed	of	 a	 ‘phosphate	 clamp’	 (Ser35,	
Arg45,	 Lys104,	 and	 Ans180),	 which	 binds	 the	 phosphate	 of	 G3P,	 and	 two	 side	 chains	 (Ser142	 and	
His177),	 which	 interact	 with	 the	 2-OH77	 (Figure	 10	 c).	 Alanine	 mutations	 of	 the	 phosphate	 clamp	
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residues	had	a	severe	consequence	on	both	activity	(>92%	loss)	and	G3P	Km	(5-	to	36-fold	increase).	
Mutants	 Ser35Cys	 and	 Ser35Thr	 show	 4%	 and	 17%	 of	 the	 activity	 compared	 with	 the	 wild	 type,	
suggesting	that	the	phosphate	clamping	is	not	only	hydroxyl	selective	but	also	sensitive	to	the	hydroxyl	
position.	Stringent	too	is	the	requirement	of	Arg45,	which,	when	mutated	to	lysine,	caused	over	90%	
loss	of	activity,	and	a	14-fold	 increase	of	G3P	Km.	Similarly,	mutating	Lys104	to	arginine	reduced	the	
activity	to	25%,	although	with	little	effect	on	G3P	Km.	For	Asn180,	adding	one	more	carbon	to	the	side	
chain	(Asn180Gln)	impaired	catalytic	activity	more	than	the	Asn180Gln	mutation,	suggesting	the	G3P-
binding	pocket	 is	sensitive	to	subtle	changes.	Mutating	Asn180	to	histidine	almost	abolished	activity,	
probably	 also	 for	 steric	 reasons.	 In	 addition,	 replacing	 Asn180	 with	 the	 spatially	 similar	 aspartate	
caused	 over	 95%	 loss	 of	 activity	 with	 a	 nearly	 22-fold	 increase	 of	 Km;	 presumably,	 charge-charge	
repulsion	between	 the	acidic	 residue	and	 the	phosphate	of	G3P	 impaired	 the	 substrate	binding.	For	
the	 binding	 of	 the	 2-OH	 group,	 removing	 the	 hydroxyl	 of	 Ser142	 caused	 70%	 loss	 of	 activity.	
Remarkably,	His177	was	found	to	be	indispensable	with	various	side	chains77	(Figure	10	c).		
	
Figure	10:	Interactions	between	AaPlsY	and	its	substrates	acyl-PO4	and	G3P.	a)	Interactions	between	the	acyl-PO4	head	
group	and	the	enzyme.	b)	The	hydrophobic	groove	that	hosts	the	acyl	chain	of	acyl-PO4.	Residues	within	4.0	Å	of	the	
palmitoyl	chain	are	shown	as	green	sticks.	c)	The	G3P	binding	pocket.	Dashed	lines	in	a)	and	c)	indicate	distances	within	
3.2	Å.	When	appropriate,	the	dashed	lines	are	colored	differently	for	better	visualization.	d)	The	proposed	‘substrate-
assisted	catalysis’	mechanism	for	AaPlsY.	Modified	from77.	
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It	 has	 been	 postulated	 that	 PlsY	 acylates	 G3P	 in	 a	 similar	 mechanism	 to	 the	 ‘Asp-His’	 dyad	
thioester	GPATs,	based	on	the	fact	 that	PlsY	contains	a	critical	histidine	residue69	 (His177	 in	AaPlsY).	
Unlike	the	thioesters,	acyl-PO4	can	serve	as	a	proton	acceptor	itself.	The	last	catalytic	model	proposed	
for	AaPlsY	is	a	‘substrate-assisted	mechanism’	for	PlsY.	G3P	1-OH	is	clamped	in	close	proximity	to	the	
acyl-PO4	phosphate,	facilitating	its	nucleophilic	attack	on	the	carbonyl	carbon.	A	chemically	favorable	
hexacyclic	 transition	 state	 then	 forms,	 followed	 by	 a	 nucleophilic	 acyl	 substitution	 process	 through	
formation	and	collapse	of	the	carbonyl	tetrahedron.	The	oxyanion	intermediate	is	probably	stabilized	
by	the	phosphate	hole	and	Asn37.	Consistent	with	this	role,	Asn37	 interacts	with	neither	substrates;	
yet	 its	 alanine	mutation	 caused	 80%	 loss	 of	 activity,	with	 no	 significant	G3P	Km	defects.	Moreover,	
substitution	 of	 Asn37	 with	 the	 spatially	 similar	 aspartate	 almost	 abolished	 activity;	 presumably,	
aspartate	interferes	with	the	intermediates	by	charge-charge	repulsion77.		
1.1.2.2.3.	The	Acyl-G3P	Acyltransferase	PlsC		
The	last	step	of	the	pathway	is	similar	to	the	one	in	Gram-negative	bacteria,	with	the	difference	
that	 whereas	 PlsC	 from	 E.	 coli	 uses	 acyl-ACP	 or	 acyl-CoA	 as	 acyl	 donors,	 in	 S.	 pneumoniae	 and	 B.	
subtilis	PlsC	only	use	acyl-ACP50,51.	
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1.2.	Acyltransferases	In	Cell	Membrane	Biosynthesis	
1.2.1.	The	Cell	Envelope	in	Gram-Negative	Bacteria	
Gram-negative	 bacteria	 have	 a	 complex	 envelope	 architecture.	 Their	 envelope	 contains	 two	
membranes,	 different	 in	 structure	 and	 composition,	 which	 delimit	 an	 aqueous	 compartment,	 the	
periplasm,	containing	a	thin	layer	of	peptidoglycan	(Figure	9).		
The	 cytoplasmic	 or	 inner	 membrane	 (IM)	 is	 a	 symmetric	 bilayer	 composed	 of	
glycerophospholipids	 whereas	 the	 outer	 membrane	 (OM)	 is	 highly	 asymmetrical:	 it	 contains	
phospholipids	 in	 the	 inner	 leaflet	 while	 the	 outer	 monolayer	 mainly	 consists	 of	 lipopolysaccharide	
(LPS),	 a	 glucosamine-based	 saccharolipid	 (Figure	 11)78.	 IM	 and	OM	 also	 differ	with	 respect	 to	 their	
integral	membrane	proteins	composition:	in	the	IM	integral	proteins	span	the	membrane	as	α-helices	
almost	entirely	composed	of	hydrophobic	residues,	while	the	vast	majority	of	integral	proteins	in	the	
OM,	 outer	 membrane	 proteins	 (OMPs),	 consist	 of	 amphipathic	 β-strands	 which	 adopt	 a	 β-barrel	
structure79,80.	 A	 large	 number	 of	 OMPs	 is	 constituted	 by	 porins,	 a	 family	 of	 proteins,	 which	 form	
specific	and	non-specific	channels	that	orchestrate	the	flux	of	hydrophilic	molecules	across	the	OM81.	
Besides	 integral	membrane	proteins,	both	 IM	and	OM	contain	 lipoproteins	 that	are	anchored	to	 the	
respective	membranes	via	an	N-terminal	N-acyl-dyacylglycerylcysteine	residue82.	Such	lipoproteins	are	
located	exclusively	at	the	periplasmic	side	of	the	IM,	whereas	at	the	OM	they	can	either	extend	into	
the	periplasm	or	be	exposed	at	the	cell	surface	(Figure	11)83.		
 
Figure	11:	Schematic	structure	of	the	E.	coli	K-12	cell	envelope	The	structure	and	biosynthesis	of	LPS,	peptidoglycan,	
membrane-derived	oligosaccharides,	 lipoproteins	 and	phospholipids.	 Strains	 of	E.	 coli	 K-12	normally	 do	not	make	O-
antigen,	unless	a	mutation	in	the	O-antigen	operon	is	corrected.	The	KDO2-Lipid	A	region	of	LPS	usually	represent	the	
minimal	 substructure	 required	 for	 growth	 of	 Gram-negative	 bacteria.	 The	 red	 phospholipids	 represent	
Doctoral	Thesis	–	Montse	Tersa	 	 Introduction	
	
	 20	
phosphatidylethanolamine	 and	 the	 yellow	 phosphatidylglycerol.	 Lipopolysaccharide	 (LPS);	 membrane-derived	
oligosaccharides	(MDO);	Ethanolamine	pyrophosphate	(PPEtn).	Modified	from19.	
Lipopolysaccharide	(LPS)	 is	a	complex	glycolipid	that	 forms	the	major	component	of	 the	outer	
leaflet	 of	 the	 OM	 of	 most	 Gram-negative	 bacteria	 (Figure	 11)84.	 It	 has	 been	 estimated	 that	 one	
bacterial	 cell	 contains	millions	 of	 LPS	molecules	 that	 occupy	 three	 quarters	 of	 the	 bacterial	 surface	
with	 the	 remaining	 area	 being	 filled	 by	 proteins85.	 LPS	 not	 only	 provides	 protection	 to	 the	 cell	 as	 a	
physical	barrier	but	also	act	as	endotoxins	in	case	of	Gram-negative	pathogens86,87.	LPS	helps	stabilize	
these	 membranes,	 protects	 them	 from	 chemical	 attack,	 and	 promotes	 cell	 adhesion	 to	 various	
surfaces.	It	elicits	a	strong	immune	response	in	humans	and	other	animals,	and	is	a	main	contributor	
to	Gram-negative	 septic	 shock,	 getting	detected	at	picomolar	 levels	by	 the	 innate	 immune	 system’s	
TLR4	 receptor	 protein88.	 These	 attributes	 have	 made	 the	 study	 of	 LPS	 important	 to	 the	 fields	 of	
immunology,	bacteriology,	and	drug	discovery19,84,88–90.		
LPS	molecules	 are	 composed	 of	 three	 domains:	 the	 Lipid	 A	 domain,	 the	 core	 oligosaccharide	
and	the	O-antigen	polysaccharide	(Figure	12)88,89.		
 
Figure	12:	 Structure	of	E.	 coli	 LPS.	Smooth-type	LPS	consists	of	 three	distinct	domains:	Lipid	A,	 inner	and	outer	core	
oligosaccharides,	 and	 the	 highly	 variable	 O-antigen	 repeat.	 N-acetylglucosamine	 (GlcNAc);	 3-deoxy-D-manno-
octulosonic	acid	(KDO);	L-glycero-D-manno-heptose	(Hep);	D-glucose	(Glc);	galactose	(Gal).	Substitutions	of	various	lipid	
A	and	core	sugars	with	phosphate	groups	(P)	and	ethanolamine	(PEtN)	have	been	indicated	with	yellow	and	red	ovals,	
respectively.	 	
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In	 most	 Gram-negative	 bacteria,	 including	 E.	 coli,	 Lipid	 A	 consists	 on	 a	 bis-phosphorylated	
glucosamine	 disaccharide	 to	 which	 six	 acyl	 chains	 are	 linked	 by	 ester	 and/or	 amide	 bonds.	 The	
glucosamine	 and	 the	 phosphate	 head	 group	 are	 covalently	 connected	 to	 a	 pair	 of	 KDO	 (3-deoxy-D-
manno-oct-2-ulosonic	 acid)	 sugar	 residues	 (Figure	 12	 and	 Figure	 13)89.	 These	 KDO	 residues	 are	
connected	 to	 several	 additional	 sugar	 residues,	 and	 sometimes	 also	 to	 a	 phosphate	
(pyrophosphorylethanolamine	 or	 phosphorylcholine	 residues),	 which	 together	 form	 the	 core	
oligosaccharide	(Figure	12)88.	The	core	can	be	further	divided	into	inner	(Lipid	A	proximal)	and	outer	
core.	The	chemical	structure	of	the	outer	core	is	more	variable	whereas	the	inner	core,	that	contains	
at	 least	 a	 residue	 of	 KDO	 and	 of	 L-glycero-D-manno-heptose	 (heptose),	 is	 rather	 conserved	 across	
isolates	 of	 the	 same	 species91.	 The	 O	 antigen	 is	 the	 distal	 portion	 of	 the	 LPS	 molecule	 and	 is	
constituted	 of	 a	 variable	 number	 of	 repeating	 units	made	 of	 one	 to	 six	 sugar	 residues	 (Figure	 10).	
Notably,	the	O	antigen	is	absent	in	many	Gram-negative	species	including	pathogens	such	as	Neisseria	
meningitidis	 and	 Bordetella	 pertussis92,93.	 Among	 these	 three	 components,	 the	 Lipid	 A	moiety	 is	 of	
particular	interest	because	it	is	the	most	conserved	portion	of	LPS	as	well	as	the	only	component	that	
is	 essential	 for	 cell	 viability86,88,94.	 Furthermore,	 Lipid	 A	 is	 the	 bioactive	 component	 of	 LPS,	which	 is	
specifically	recognized	by	the	innate	immune	system.	Lipid	A	is	responsible	for	the	endotoxin	property	
of	 LPS,	 causing	 inflammatory	 response-induced	 endotoxicity	 and	 leading	 to	 host	 tissue	 damage	 or	
septic	 shock.	 Thus,	 knowledge	 about	 its	 biosynthesis	 and	 its	 possible	 repression	 represents	 an	
important	 basis	 for	 the	 development	 of	 antimicrobial	 drugs	 to	 combat	 important	 Gram-negative	
pathogens94,95.		
Although	the	overall	structure	of	Lipid	A	is	conserved	among	Gram-negative	bacteria,	different	
species	 modify	 this	 complex	 molecule	 upon	 environmental	 stimuli	 by	 removing	 or	 modifying	 the	
phosphate	 groups	 or	 acyl	 chains,	 respectively.	 As	 a	 consequence,	 the	 toxicity	 caused	 by	 Lipid	 A	
molecules	 from	 different	 species	 reveals	 widely	 varying	 extents.	 These	 also	 make	 its	 biosynthetic	
pathway	an	attractive	target	for	new	antibiotics88,96–100.		
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Figure	13:	Structure	of	KDO2-Lipid	A.	The	top	two	sugars	are	KDO	groups,	which	are	part	of	the	core	oligosaccharide,	
while	the	remainder	of	the	structure	represents	Lipid	A.	Modified	from100.	
1.2.1.1.	 Lpx	Acyltransferases	For	Synthesis	And	Modification	Of	Lipid	A	
In	E.	coli,	nine	enzymes	are	required	for	the	biosynthesis	of	KDO2-Lipid	A,	which	is	sufficient	to	
maintain	the	viability	and	fitness	of	virtually	all	Gram-negative	bacteria.	This	biosynthetic	pathway	 is	
known	as	Raetz	Pathway	(Figure	14)88.	Of	the	nine	Lipid	A	enzymes,	the	first	six	enzymes	(LpxA,	LpxC,	
LpxD,	LpxH/I/G,	LpxB,	and	LpxK)	are	essential,	and	their	deletion	cannot	be	rescued	by	compensatory	
mutations.	 The	 three	 remaining	enzymes	 (KdtA,	 LpxL,	 and	 LpxM)	are	not	essential,	 but	 they	exert	 a	
profound	effect	on	the	fitness	of	the	bacteria	and	may	serve	as	anti-virulence	targets.		
LpxA,	C	and	D	are	soluble	proteins101–103,	LpxB	and	LpxH	are	peripheral	membrane	proteins104–
106,	and	LpxK,	KdtA,	LpxL	and	LpxM	are	integral	inner	membrane	proteins29,36,37,107,108.	Their	active	sites	
are	presumed	to	face	the	cytoplasmic	surface	of	the	inner	membrane,	given	that	their	water-soluble	
co-substrates	are	cytoplasmic	molecules	(Figure	14)19.	
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Figure	14:	The	constitutive	pathway	for	KDO2-Lipid	A	biosynthesis	 in	E.	coli.	Each	enzyme	of	the	constitutive	Lipid	A	
pathway	 is	 encoded	by	 a	 single	 structural	 gene.	 The	 glucosamine	disaccharide	backbone	of	 Lipid	A	 is	 blue.	 The	KDO	
disaccharide	is	black.	The	characterized	enzymes	are	in	red.	The	red	numbers	specify	the	glucosamine	ring	positions	of	
Lipid	A	and	its	precursors.	The	black	numbers	indicate	the	predominant	fatty	acid	chain	lengths	found	in	E.	coli	Lipid	A.	
The	single	molecular	species	shown	at	the	bottom	left	represents	about	90%	of	the	total	Lipid	A	in	E.	coli,	with	most	of	
the	rest	bearing	a	C12	secondary	acyl	chain	at	position	3ʹ.	Modified	from
19.	
To	initiate	the	biosynthetic	pathway,	cytosolic	proteins	LpxA,	LpxC	and	LpxD	catalyze	a	series	of	
reactions	 converting	 uridine	 diphosphate	 N-acetylglucosamine	 (UDP-GlcNAc)	 into	 UDP-2,3-diacyl-
glucosamine.	First,	the	acyltransferase	LpxA	transfers	the	acyl	chain	from	(R)-β-hydroxymyristoyl-ACP	
to	 the	 3-OH	 group	of	UDP-GlcNAc.	 This	 acyl	 transfer	 reaction	 is	 thermodynamically	 unfavorable.	 To	
drive	 the	 reaction	 forward,	 LpxC,	 a	 Zn2+-dependent	 metalloenzyme,	 hydrolyzes	 the	 2-acetamido	
functionality,	 and	 thus	 catalyzes	 the	 first	 committed	 step	 in	 the	 pathway.	 The	 acyltransferase	 LpxD	
then	installs	another	(R)-β-hydro-	xymyristoyl	moiety	onto	the	2-amino	group,	yielding	UDP-2,3-diacyl-
glucosamine	(Figure	14).		
The	 UDP-2,3-diacyl-glucosamine	 product	 of	 LpxA-C-D	 is	 transformed	 by	 three	 membrane	
associated	 enzymes,	 LpxH,	 LpxB	 and	 LpxK,	 into	 tetra-acylated	 Lipid	 IVA.	 LpxH	 hydrolyzes	 UDP-2,3-
diacylglucosamine	 to	 yield	 2,3-diacylglucosamine	 1-phosphate.	 LpxB	 catalyzes	 formation	 of	 a	 β-1’,6-
glycosidic	bond	to	generate	the	disaccharide	backbone.	In	the	final	step	leading	up	to	Lipid	IVA,	LpxK	
phosphorylates	the	4’-position	of	this	disaccharide	(Figure	14).	
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Prior	to	late-stage	acylation,	E.	coli	requires	the	addition	of	two	KDO	sugars	to	Lipid	IVA	whereas	
Acinetobacter	 baumanii	 does	 not,	 at	 least	 in	 vitro29.	 A	 bifunctional	 enzyme	 KdtA	 catalyzes	 two	
successive	glycosyltransfer	reactions	to	form	KDO2-Lipid	IVA.	This	tetra-acyl	tetra-saccharide	is	further	
modified	 by	 late	 acyltransferases	 LpxL	 and	 LpxM	 through	 the	 addition	 of	 lauroyl	 and	 myristoyl	
secondary	acyl	chains,	respectively,	to	yield	hexa-acylated	Lipid	A	(Figure	14)88,109.	
After	KDO2-Lipid	A	is	synthesized	in	the	cytosol,	 it	 is	attached	with	core	sugars	and	flipped	out	
from	 the	 cytoplasmic	 surface	of	 the	 inner	membrane	 to	 the	periplasmic	 surface,	where	 it	 is	 further	
modified	in	some	species	of	bacteria	and	transported	to	the	outer	membrane19,84.		
There	 is	 Lipid	 A	 diversity	 among	 Gram-negative	 bacteria.	 This	 is	 dependent	 on	 the	 type	 and	
length	 of	 fatty	 acids,	 on	 the	 presence	 of	 chemical	 moieties	 or	 even	 on	 the	 lack	 of	 groups	 such	 as	
phosphates	or	fatty	acids	from	Lipid	A88,110.	Well-characterized	modifications	comprise	the	addition	of	
phosphoethanolamine111,	 4-amino-4-deoxy-l-arabinose112,	 palmitoleate	 (LpxP)113,	 and	 hydroxylation	
by	 the	 Fe2+/α-ketoglutarate-dependent	 dioxygenase	 enzyme	 (LpxO)114.	 These	 modifications	 provide	
resistance	to	stresses	such	as	harsh	pH	and	antimicrobial	peptides	(APs)110.	APs	are	directed	to	LPS	on	
the	 bacterial	 surface	 by	 electrostatic	 interactions115.	 Additionally,	 these	 Lipid	 A	 changes	 may	 help	
pathogens	 to	modulate	 the	 activation	of	 host	 defense	mechanisms	by	 altering	 the	 activation	of	 the	
TLR4/MD-2	receptor	complex116.	
1.2.1.1.1.	The	First	Two	Acyltransferases	of	the	Raetz	Pathway:	LpxA	and	LpxD	
LpxA	and	LpxD	UDP-N-acetylglucosamine-O-acyltransferases	 (LpxA	and	LpxD)	catalyze	 the	 first	
two	acylation	steps	in	the	Lipid	A	biosynthetic	pathway.	They	are	soluble	cytosolic	enzymes	and	usually	
require	3-hydroxyacyl	chains	attached	to	the	essential	acyl	donor	ACP	(Figure	14)94,117.		
LpxA	Acyltransferase	
The	structure	of	the	soluble	LpxA	from	differents	organisms	is	available	in	its	apo	form,	and	in	
complex	with	different	substrates	and	peptides,	thus	this	acyltransferase	has	been	extensively	studied.	
The	first	step	of	the	overall	Lipid	A	biosynthesis	route,	 is	the	reversible	O-acylation	of	the	3-hydroxyl	
group	of	the	sugar	nucleotide	UDP-N-acetylglucosamine	(GlcNAc)	catalyzed	by	LpxA	(Figure	14)118,119.		
LpxA	 is	 a	 28-kDa	 protein	 that	 forms	 a	 biological	 homotrimer	 in	 solution.	 Its	 molecular	
architecture	resembles	a	mushroom,	with	the	central	‘stem’	formed	by	three	copies	of	a	prism-shaped	
left-handed	 parallel	 β-helix	 domain	 at	 the	 N-terminus,	 and	 the	 ‘cap’	 formed	 by	 a	 four-helix-bundle	
domain	at	the	C-terminus.	The	 left-handed	parallel	β-helix	domain	of	LpxA	consists	of	approximately	
30	characteristic	β-strands,	with	every	 three	β-strands	 forming	one	complete	 coil	of	a	β-helix	 in	 the	
shape	 of	 an	 equilateral	 triangle.	 In	 the	middle	 of	 the	 β-helix	 domain	 exist	 two	 insertion	 loops	 that	
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connect	the	subunit	 interfaces	and	form	the	pedestal	of	the	active	site	for	 interaction	with	the	UDP-
GlcNAc	substrate	(Figure	15	A).		
	
Figure	15:	 Structure	and	 inhibition	of	 LpxA.	A)	Structure	of	the	E.	coli	LpxA/UDP-3-O-(R-3-	hydroxymyristoyl)-GlcNAc	
complex	 (PDB:	2qia).	LpxA	consists	of	a	homotrimer,	with	each	monomer	 labeled	 in	distinct	colors.	The	domains	and	
termini	 of	 the	 green	 monomer	 are	 labeled.	 LpxA	 is	 shown	 in	 the	 ribbon	 diagram,	 whereas	 the	 UDP-3-O-(R-3-
hydroxymyristoyl)-GlcNAc	molecules	are	shown	in	the	space-filling	model.	B)	The	hydrocarbon	rulers	of	LpxA	enzymes	
from	E.	 coli	 (PDB:	 2qia),	L.	 interrogans	 (PDB:	 3i3x),	 and	P.	 aeruginosa	 (PDB:	 5dg3).	C)	 LpxA	acyl	 chain	 selectivity	 and	
catalysis.	 D)	 Overlay	 of	 UDP-3-N-(R-3-hydroxylauroyl)-GlcNAc3N	 (grey)	 and	 R-3-hydroxylauroylmethyl-
phosphopantetheine	(yellow)	in	the	L.	interrogans	LpxA	complexes	(PDB:	3i3x	and	3i3a).	UDP-3-N-(R-3-hydroxylauroyl)-
GlcNAc3N	 and	 R-3-hydroxylauroylmethyl-phosphopantetheine	 are	 shown	 in	 the	 stick	model.	 The	 catalytic	 dyads	 are	
labeled,	with	 Lepstopira	 residue	 numbers	 shown	 in	 black	 and	 E.	 coli	 residue	 numbers	 shown	 in	 red.	E)	 Peptide	 920	
bound	to	E.	coli	LpxA	(PDB:	2aq9).	F)	Peptide	RJPXD33	bound	to	E.	coli	LpxA	(PDB:	4j09).	Carbon	atoms	of	peptides	in	
panels	E)	and	F)	are	colored	 in	yellow,	whereas	carbon	atoms	of	UDP-3-O-acyl-	GlcNAc	are	colored	 in	grey.	Modified	
from120.	
The	 structure	 of	 E.	 coli	 LpxA	 in	 complex	 with	 the	 product	 UDP-3-O-(R-3-	 hydroxymyristoyl)-
GlcNAc,	 reveals	 a	 product	 at	 the	 interface	 of	 two	 adjacent	 LpxA	 subunits.	 The	 glucosamine	 ring	 is	
supported	by	the	molecular	pedestal	formed	by	two	insertion	loops	mentioned	above.	The	3-OH	group	
of	the	glucosamine	ring	is	buried,	with	its	attached	fatty	acyl	chain	extending	into	the	active	site	cleft	
along	the	subunit	interface,	whereas	the	UDP	moiety	extends	toward	the	adjacent	subunit	to	the	right.	
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The	 first	 four	carbon	atoms	are	almost	perpendicular	 to	 the	 long	axis	of	 the	β-helix.	The	 rest	of	 the	
hydrocarbon	chain	runs	parallel	to	the	β-helix	(Figure	15	A).		
LpxA	acyltransferases	are	highly	selective	for	the	acyl	chain	length	of	their	ACP	substrate117.	This	
specificity	 is	 species	 dependent	 and	 is	 consistent	with	 the	 composition	 of	 Lipid	 A	 isolated	 from	 the	
respective	 bacterium.	 In	 E.	 coli	 and	 L.	 interrogans,	 LpxA	 prefers	 to	 incorporate	 14-carbon	 and	 12-
carbon	R-3-hydroxyacyl	 chains	 respectively117,121,	whereas	Pseudomonas	aeruginosa	 LpxA	 selects	 for	
an	acyl	chain	of	10-carbon	atoms	(an	R-3-hydroxydecanoyl	chain)	(Figure	15	B)117.		
Structural	analyses	of	 the	corresponding	LpxA-product	complexes	have	 revealed	 the	presence	
of	an	hydrocarbon	ruler	in	all	LpxA	enzymes:	in	E.	coli	LpxA,	along	the	hydrophobic	cleft	formed	at	the	
β-helix	domain,	His191	from	the	10th	β-coil	blocks	the	further	extension	of	the	acyl	chain	and	caps	it	to	
14	 carbons122;	 in	 L.	 interrogans	 LpxA,	 Lys171	 from	 the	 9th	 β-coil	 obstructs	 the	 hydrophobic	 cleft,	
restricting	 the	 length	 of	 the	 acyl	 chain	 to	 12	 carbons121;	 and	 in	P.	 aeruginosa	 LpxA,	Met169	 from	a	
neighboring	subunit	jams	the	cleft	even	closer	to	the	glucosamine	ring,	accommodating	the	acyl	chain	
of	only	10	carbon	atoms123.	Consistent	with	these	structural	observations,	the	elimination	of	the	steric	
blockage	of	Met169	by	a	Met169Gly	mutation	allows	P.	aeruginosa	LpxA	to	preferentially	incorporate	
a	C14	acyl	 chain	 instead	of	a	C10	acyl	 chain,	whereas	 introducing	a	 steric	block	 (Gly173Met)	 in	E.	coli	
LpxA	alters	its	preference	from	a	C14	acyl	chain	toward	a	C10	acyl	chain(Figure	15	C-D)117.		
Biochemical	 studies	performed	 in	E.	 coli	 LpxA	 suggested	 a	mechanism	 in	which	His125	 in	 the	
middle	 of	 the	 central	 β-helix	 serves	 as	 the	 catalytic	 base	 to	 active	 the	 3-OH	 group	 of	 the	 substrate	
UDP-GlcNAc,	which	 in	 turn	 attacks	 the	 thioester	 bond	 of	 the	 second	 substrate,	 acyl-ACP	 to	 replace	
ACP(Figure	15	C)117.	Such	a	mechanism	is	supported	by	the	observation	of	a	hydrogen	bond	between	
His125	 and	 the	 3-O	 atom	 of	 the	 glucosamine	 ring	 of	 UDP-3-O-acyl-GlcNAc	 in	 complex	 with	 E.	 coli	
LpxA122.	The	structures	of	L.	interrogans	LpxA	in	complex	with	UDP-3-N-(R-3-hydroxylauroyl)-GlcNAc3N	
and	 with	 R-3-hydroxylauroylmethyl-phosphopantetheine,	 a	 mimetic	 of	 acyl-ACP,	 have	 also	 been	
determined121,	and	strongly	suggest	an	ordered	bi-substrate	mechanism	for	LpxA:	the	binding	of	acyl-
ACP	 occurs	 first,	which	 is	 followed	 by	 the	 binding	 of	UDP-GlcNAc/UDP-GlcNAc3N;	 subsequently	 the	
acyl	 chain	 transfer	 occurs	 via	 a	 substrate-assisted	 mechanism	 facilitated	 by	 the	 catalytic	 histidine	
residue.		
Potent	 peptide	 inhibitors	 of	 LpxA	 have	 been	 reported	 (Figure	 15	 E-F)124,125.	 The	 Peptide	 920	
competes	with	acyl-ACP	for	LpxA	binding.	It	adopts	a	β-hairpin	conformation	binding	at	the	deep	cleft	
of	the	LpxA	trimer	interface	near	the	active	site124,126.	Interestingly,	peptide	920	not	only	occupies	the	
space	of	the	pantetheine	group	of	the	acyl-ACP	analog,	acyl-phosphopantetheine121,	but	also	overlaps	
in	 space	with	 the	 substrate	 UDP-GlcNAc	 and	 the	 UDP-GlcNAc	moiety	 of	 the	 product	 UDP-3-O-acyl-
GlcNAc.	Hence,	 the	observation	that	peptide	920	 is	a	competitive	 inhibitor	against	acyl-ACP,	but	not	
UDP-GlcNAc,	is	consistent	with	an	ordered	sequential	bi-substrate	binding	process,	in	which	acyl-ACP	
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binds	 LpxA	 first,	 and	 UDP-GlcNAc	 binds	 second	 (Figure	 15	 E).	 RJPXD33	 is	 a	 dual-specific	 peptide	
inhibitor	of	 LpxA	and	of	 the	 second	acyltransferase	of	 the	pathway,	 LpxD125,	however	 it	 is	 a	weaker	
inhibitor	 of	 LpxA	 compared	 to	 peptide	 920.	 The	 structure	 of	 RJPXD33	 reveals	 an	 extended	
conformation	 that	 is	 distinct	 from	 the	 hairpin	 structure	 of	 peptide	 920127,	 the	 peptide	 backbone	 of	
RJPXD33	 runs	parallel	with	 the	acyl	 chain	of	 the	UDP-3-O-acyl-GlcNAc	molecule,	with	 its	 amino	acid	
side	chains	reaching	out	to	the	space			occupied	by	the	acyl	chain	and	the	UDP-GlcNAc	moiety	(Figure	
15	F).		
LpxA	homologs	not	only	are	very	widespread	among	nearly	all	Gram-negative	bacteria	but	also	
occur	in	the	majority	of	higher	plants,	although	their	function	remains	unclear128.		
LpxD	Acyltransferase	
The	LpxA	product	is	deacetylated	by	LpxC	to	UDP-3-acylglucosamine,	and	a	second	acyl	chain	is	
attached	 via	 an	 amide	 linkage	 at	 position	 2	 of	 the	 glucosamine	 ring	 by	 the	N-acyltransferase	 LpxD,	
yielding	UDP-2,3-diacylglucosamine	(Figure	14).	
The	 gene	 encoding	 LpxD	 was	 initially	 discovered	 as	 firA,	 for	 its	 role	 in	 reversal	 of	 certain	
rifampin-	 resistant	 mutations129.	 By	 1993,	 firA	 was	 biochemically	 characterized	 and	 renamed	 lpxD,	
which	 is	 the	gene	 that	 encodes	 LpxD102.	 LpxD	and	 LpxA	are	encoded	 in	 the	 same	operon	and	 share	
significant	 sequence	 homology	 (45%	 similarity)	 to	 each	 other.	 Therefore,	 it	 is	 supposed	 that	 both	
enzymes	result	from	gene	duplications102,118,130.		
The	 first	 structure	 of	 LpxD	 (36-kDa)	 from	 C.	 trachomatis	 (PDB	 Code:	 2IUA)	 was	 reported	 in	
2007131,	 though	 the	 topological	 arrangement	 of	 its	 C-terminal	 domain	 is	 sharply	 different	 from	 all	
other	LpxD	ortholog	structures	 from	E.	coli	 (PDB	Code:	3EH0)132,	P.	aeruginosa	 (PDB	Code:	3PMO)133	
and	 A.	 baumannii	 (PDB	 Code:	 4E75)134.	 The	 E.	 coli	 LpxD	 structure,	 shares	 a	 common	 domain	
arrangement	 with	 LpxD	 orthologs	 from	 P.	 aeruginosa	 and	 A.	 baumannii,	 and	 is	 described	 as	 an	
homotrimer	structure	with	a	characteristic	central	axis	of	the	 left-handed	β-turn	helix	similar	to	that	
seen	in	LpxA	(Figure	15	A	and	Figure	16	A).	Each	monomer	also	contains	an	N-terminal	uridine-binding	
domain	and	a	C-terminal	helix	domain	that	engages	ACP	(Figure	16	D).	
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Figure	 16:	 LpxD	 structure	 and	 catalysis.	 A)	 Structure	 of	 E.	 coli	 LpxD	 (PDB:	 3eh0),	 revealing	 an	 intertwined	 trimer	
structure.	B)	 Proposed	 catalytic	mechanism	of	 LpxD.	C)	 A	 compulsory	ordered	bi-bi	 substrate	mechanism.	 The	 LpxD-
bound	conformations	of	acyl-ACP	(PDB:	4ihf),	hydrolyzed	acyl-ACP	with	a	fatty	acid	(PDB:	4ihg),	and	the	holo-ACP	(PDB:	
4ihh)	are	shown	below	the	 reaction.	The	movement	of	 the	4’-PPT	group	 from	the	acyl-ACP	complex	 to	 the	holo-ACP	
complex	is	shown	in	the	inset.	D)	Structure	of	the	LpxD/acyl-ACP	complex	(PDB:	4ihf).	Modified	from120.	
The	hydrocarbon	ruler	of	LpxD	was	tested	due	to	its	highly	selectivity	for	the	acyl	chain	length.	E.	
coli	 LpxD	 prefers	 to	 transfer	 an	 acyl	 chain	 of	 14	 carbon	 atoms	 over	 a	 chain	 of	 16	 carbon,	 such	
selectivity	is	caused	by	the	steric	blockage	of	the	acyl	chain	binding	grove	by	a	bulky	residue,	Met290.	
Removal	of	the	steric	blockage	by	the	Met290Ala	mutation	alters	the	selectivity	of	E.	coli	LpxD	towards	
a	16-carbon	unit	acyl	chain	(Figure	16	B)132.	
Biochemical	analysis	suggests	that	LpxD	utilizes	a	substrate-assisted	catalytic	mechanism	(Figure	
16	 C)135.	His239	 located	 in	 the	middle	of	 the	 left-handed	β-turn	helix	of	 LpxD	serves	as	 the	catalytic	
base	 to	 deprotonate	 the	 2-amino	 group	 of	 the	 glucosamine	 ring	 of	 UDP-3-O-acyl-GlcN,	 which	 then	
attacks	the	carbonyl	carbon	of	the	thiol-ester	bond	of	β-hydroxyacyl-ACP135,	with	the	oxyanion	being	
stabilized	by	the	backbone	of	Gly257.		
The	LpxD	reaction	undergoes	a	imperative	ordered	bi-substrate	mechanism	(Figure	16	C)135.	In	
such	a	mechanism,	R-3-OH-C14-ACP	(acyl-ACP)	binds	LpxD	first	to	form	the	EA	complex;	this	is	followed	
by	 the	 binding	 of	 UDP-3-O-(R-3-OH-C14)-GlcN	 to	 form	 the	 bi-substrate	 complex	 EAB;	 the	 acyl	 chain	
transfer	yields	the	bi-product	complex	EPQ;	one	of	the	products,	UDP-DAGn,	dissociates	first,	 leaving	
behind	 the	 LpxD-holoACP	 complex	 (EQ);	 finally,	 the	 holoACP	 departs	 to	 regenerate	 LpxD.	 The	 tight	
affinities	 between	 various	 forms	 of	 ACP	 and	 LpxD	 have	 enabled	 structural	 snapshots	 of	 the	
Doctoral	Thesis	–	Montse	Tersa	 	 Introduction	
	
	 29	
intermediates	 of	 the	 LpxD/acyl-ACP	 complex	 (EA),	 the	 LpxD/holo-ACP	 (EQ)	 complex,	 as	 well	 as	 a	
hydrolyzed	acyl-ACP	LpxD	complex	that	resembles	the	post-catalysis	EPQ	complex	during	the	catalytic	
cycle136.	 In	 all	 of	 these	 structural	 states,	 the	 ACP	 docks	 on	 top	 of	 the	 C-terminal	 ACP-recognition	
domain		formed	by	the	trimeric	C-terminal	helical	domain	and	the	last	β-coil	of	the	left-handed	β-helix	
domain	(Figure	16	C-D).		
1.2.1.1.2.	The	Last	Two	Acyltransferases	of	the	Raetz	Pathway:	LpxL	and	LpxM	
LpxH	hydrolyzes	the	LpxD	product,	UDP-2,3-diacylglucosamine,	to	yield	2,3-diacylglucosamine	1-
phosphate.	 LpxB	 catalyzes	 formation	 of	 a	 β-1’,6-glycosidic	 bond	 to	 generate	 the	 disaccharide	
backbone.	 In	 the	 final	 step	 leading	 up	 to	 Lipid	 IVA,	 LpxK	 phosphorylates	 the	 4’-position	 of	 this	
disaccharide	(Figure	14).		
After	 Lipid	 IVA	 is	 formed,	 E.	 coli	 requires	 the	 addition	 of	 two	 KDO	 sugars	 to	 Lipid	 IVA	 to	 be	
subsequently	acylated	by	LpxL	and	LpxM,	however	it	has	been	recently	discovered	that	Acinetobacter	
baumanii	 is	 able	 to	 acylate	 Lipid	 IVA	 without	 the	 addition	 of	 KDO	 sugars	 in	 vitro29.	 In	 E.	 coli,	 a	
bifunctional	enzyme	KdtA	catalyzes	two	successive	glycosyltransfer	reactions	to	form	KDO2-Lipid	IVA.	
This	tetra-acyl	tetra-saccharide	is	further	modified	by	late	acyltransferases	LpxL	and	LpxM	through	the	
addition	 of	 lauroyl	 and	myristoyl	 secondary	 acyl	 chains,	 respectively,	 to	 yield	 hexa-acylated	 Lipid	 A	
(Figure	12)88,109.	
LpxL	Acyltransferase	
LpxL-like	 acyltransferases	 comprises	 membrane-bound	 enzymes	 which	 do	 not	 exhibit	 any	
similarity	 to	 the	 soluble	 LpxA	 and	 LpxD.	 While	 in	 E.	 coli	 and	 related	 bacteria	 the	 two	 successive	
acylations,	first	laurate	at	position	2’	then	myristate	at	position	3’,	are	carried	out	by	homologous	LpxL	
and	LpxM,	other	Gram-negative	bacteria	possess	solely	one	or	more	 lpxL-orthologous	sequences	but	
no	 lpxM	 gene36,37,130.	 P.	 aeruginosa,	 for	 example,	 possesses	 two	 LpxL	 versions,	 each	 of	 which	 is	
presumed	to	transfer	one	of	the	secondary	lauroyl	groups	to	Lipid	IVA86.	The	lpxM	gene	is	a	product	of	
lpxL	 gene	 duplication,	 and	 thus	 LpxM	 shares	 approximately	 47%	 similarity	 to	 LpxL	 and	 represents	 a	
more	recently	emerged,	specialized	version	characterized	as	myristoyl	transferase37,130.	 It	 is	worth	to	
mention	that	 IpxL	and	 lpxM	were	 initially	discovered	as	htrB	and	msbB,	 respectively,	but	when	their	
function	was	known	they	were	renamed	LpxL	and	LpxM36,37,107.		
In	addition	to	lpxM,	lpxP	represents	a	third	lpxL	ortholog	in	E.	coli	and	closely	related	bacteria130.	
It	 encodes	 a	 palmitoleoyl	 transferase	with	 a	 high	 similarity	 to	 LpxL	 (74%	 similar	 amino	 acids).	 As	 a	
response	to	low	growth	temperatures	(12°C),	the	function	of	LpxL	can	be	replaced	by	LpxP.	LpxP	from	
E.	coli	attaches	an	unsaturated	palmitoleoyl	(C16:1)	residue	instead	of	laurate	at	position	2’	to	Lipid	A,	
which	probably	helps	to	adapt	the	outer	membrane	fluidity	to	low	temperatures108,137.		
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Although	LpxL	crystal	structure	has	not	been	reported,	LpxL	from	E.	coli	has	been	purified	and	
studied	in	detail138.	Purified	LpxL	not	only	was	able	to	perform	the	first	lauroylation	step	but	could	also	
replace	LpxM	by	performing	a	slow	second	lauroylation	in	vitro.	Furthermore,	although	lauroyl-ACP	is	
obviously	the	naturally	preferred	substrate	of	LpxL,	it	can	alternatively	utilize	several	acyl-CoAs	instead	
of	acyl-ACPs	at	a	 lower	rate	 in	vitro.	However,	 the	utilization	of	acyl-CoAs	strongly	depends	on	their	
concentration,	as	they	can	also	act	as	inhibitors138.		
LpxM	Acyltransferase	
AbLpxM	performs	the	secondary	acylation	of	 the	R-3-hydroxyacyl	chain	at	position	3’	of	KDO-
Lipid	 IVA	 (Figure	 14).	 The	 structure	 of	 the	 acyltransferase	 LpxM	 from	 Acinetobacter	 baumannii	
(AbLpxM;	PDB	Code	5KNK)29	has	been	solved.	AbLpxM	adopts	a	globular	structure	bisected	by	a	large	
seven-stranded	 β-sheet.	 The	 predicted	 transmembrane	 domain	 is	 composed	 of	 a	 single	 α-helix	
protruding	 from	 the	 globular	 domain	 and	 forms	 a	 substantial	 crystal	 contact	 with	 AbLpxM	 in	 a	
neighboring	asymmetric	unit	(Figure	17	A).		
Electrostatic	 surface	 visualization	 of	 the	AbLpxM	 structure	 revealed	 a	 very	 large	 hydrophobic	
pocket,	 which	 bound	 a	 co-purifying	 n-dodecyl-β-D-maltoside	 (DDM)	 molecule.	 Due	 to	 the	
hydrophobicity	 and	 size	 of	 the	 lipid	 substrate	 of	 AbLpxM,	 and	 given	 the	 lack	 of	 any	 other	 large	
hydrophobic	surface,	this	pocket	likely	represents	the	binding	site	of	the	acyl	chain	acceptor	(Figure	15	
B).	 This	 large	 pocket	 also	 contains	 several	 deep	 hydrophobic	 channels,	 which	 may	 serve	 as	
hydrocarbon	rulers,	and	which	may	determine	specificity	for	acyl	chain	length	on	either	acyl-ACP	or	on	
the	Lipid	A	precursors	(Figure	17	C)29.		
LpxM	also	 contains	 a	 conserved	HX4D/E	motif,	 using	 glutamate	 in	 the	A.	baumannii	 ortholog,	
which	is	present	within	the	deep	hydrophobic	cleft,	suggesting	that	the	cleft	could	be	the	the	location	
of	 the	active	 site.	 The	 conserved	 residue	Arg159	also	 resides	within	 the	 cleft	 and	 is	 positioned	 very	
close	to	the	putative	catalytic	His122	and	Glu127.	The	interaction	of	this	residue	with	the	C6-hydroxyl	
of	 the	 maltose	 from	 DDM	 suggest	 that	 Arg159	 could	 interact	 with	 the	 C1	 phosphate	 on	 the	
diglucosamine	head	group	of	 Lipid	 IVA,	 thus	 it	may	play	a	 role	 in	 substrate	binding.	The	 transferase	
activity	of	both	mutants	Arg159Ala	and	Glu127Ala	greatly	decrease,	however	whereas	the	Glu127Ala	
variant	 strongly	 respond	 to	 increasing	 Lipid	 IVA	 substrate,	 the	 Arg159Ala	 variant	 displayed	 a	much	
more	 attenuated	 response.	 This	 is	 in	 accordance	 with	 the	 hypothesis	 that	 the	 conserved	 Arg159	
residue	 contributes	 to	 either	 substrate	 recognition	 and	 binding	 or	 to	 the	 proper	 positioning	 of	
substrates	before	the	acyl	chain	transfer29.		
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Figure	17:	The	structure	of	AbLpxM.	A)	Cartoon	schematic	of	AbLpxM.	From	the	N-terminus	to	C-terminus,	the	color	
shifts	 from	 blue	 to	 red,	 and	 transmembrane	 helixes	 (TM)	 in	 dark	 blue.	 Two	 angles	 are	 shown.	B)	 Predicted	 surface	
electrostatics	map	generated	by	PyMol.	The	putative	binding	cleft	is	indicated	with	a	dashed	line.	C)	Cutaway	diagram	
showing	deep	pockets	within	the	putative	binding	cleft	 (pockets	 indicated	with	red	arrows;	cutaway	 in	black	to	show	
the	depth	of	the	binding	cleft).	
The	acyltransferase	activity	for	AbLpxM,	as	reported	for	E.	coli	LpxL138,	is	capable	of	using	Lipid	
IVA	as	a	substrate,	even	 lacking	the	KDO	moieties.	 Indeed,	AbLpxM	produces	both	penta-	and	hexa-
acylated	 Lipid	 A	 species	when	 incubate	with	 lauryl-ACP	 and	 Lipid	 IVA.	 It	 is	 also	 found	 that	AbLpxM	
could	 produce	 holo-ACP	 in	 the	 absence	 of	 any	 acyl	 chain	 acceptor,	 suggesting	 an	 acyl-protein	
thioesterase	 activity.	 Moreover,	 AbLpxM	 produce	 free	 lauric	 acid	 when	 incubate	 with	 lauryl-ACP,	
however,	this	activity	would	be	observed	only	by	direct	measurement	of	holo-ACP	production,	and	not	
by	 tracking	 radiolabeled	 lipid	 A	 precursors	 as	 has	 previously	 been	 done29,138,139.	 AbLpxM	 display	 a	
strong	 preference	 for	 lauryl-ACP	over	 the	 other	 acyl	 chain	 lengths.	 As	 the	 acyl	 chain	 length	 deviate	
from	12	carbons	in	either	direction,	the	Km	increase	and	the	specific	activity	decrease.		 	
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Whereas	LpxM	is	typically	depicted	as	accepting	KDO2-lauryl-lipid	IVA	as	its	substrate,	making	it	
the	 terminal	 enzyme	 in	 the	 Raetz	 Pathway,	 many	 LpxM	 orthologs	 exhibit	 substantial	 substrate	
promiscuity.	For	example,	Neisseria	meningitides	produces	fully	acylated	Lipid	A	even	when	the	KDO	
transferase,	 kdtA,	 is	 knocked	 out,	 suggesting	 LpxL	 and	 LpxM	 can	 use	 Lipid	 IVA	 in	 this	 species140.	
Similarly,	 P.	 aeruginosa	 can	 produce	 fully	 acylated	 Lipid	 A	 even	 when	 CMP-Kdo	 synthase	 (KdsB)	 is	
inhibited	 or	 when	 acting	 upon	 purified	 Lipid	 IVA141,142,	 suggesting	 that	 the	 presence	 of	 the	 KDO	
moieties	on	 the	 lipid	 acceptor	 is	 dispensable	 for	 some	 LpxL/LpxM	orthologs.	 In	A.	baumannii,	 LpxM	
adds	lauryl	groups	to	the	R-3-hydroxyacyl	chains	at	both	the	3’-and	2-positions	of	Lipid	A	precursors,	
producing	hepta-acylated	Lipid	A143.	This	secondary	activity	may	necessitate	flexibility	in	the	active	site	
to	accommodate	multiple	conformations	of	Lipid	A,	so	as	to	position	the	substrate	properly29.		
	
Figure	18:	Synthesis	of	hexa-	and	hepta-acylated	Lipid	A	 in	E.	coli	K-12.	 In	E.	coli,	LpxL	catalyzes	transfer	of	a	laurate	
(C12)	 group	 from	 an	 acyl	 carrier	 protein	 (ACP)	 onto	 the	 R-2=-hydroxymyristate	 acyl	 chain	 of	 KDO2-Lipid	 IVA.	
Subsequently,	 LpxM-dependent	 addition	 of	 myristate	 (C14)	 onto	 the	 R-3=-hydroxymysristate	 residue	 completes	
synthesis	 of	 hexa-acylated	 KDO2-Lipid	 A.	 Upon	 sensing	 specific	 environmental	 cues,	 PagP	 activation	 results	 in	
palmitoylation	 (C16)	 of	 the	 R-2-hydroxymyristate	 primary	 acyl	 chain,	 altering	 membrane	 fluidity	 and	 increasing	
resistance	to	antimicrobial	peptides.	Phosphatidylethanolamine	(PtdEtN)143.	
1.2.1.1.3.	Modification	of	Lipid	A	by	the	Acyltransferase	PagP	
As	 an	 adaptation	 to	 changes	 of	 the	 environmental	 conditions,	 the	 Lipid	 A	 structure	 can	 be	
further	modified	by	the	cell	after	its	transport	across	the	membrane.	A	mechanism	involving	additional	
acylation	is	exerted	by	the	outer	membrane	acyltransferase	PagP.		
PagP	is	an	outermembrane	palmitoyltransferase	that	catalyzes	the	transfer	of	a	palmitate	chain	
(16:0)	 from	 the	 sn-1	 position	 of	 a	 glycerophospholipid	 to	 the	 free	 hydroxyl	 group	 of	 the	 (R)-3-
hydroxymyristate	chain	at	position	2	of	Lipid	A	(Figure	18)2,144,145.	The	resulting	hepta-acylated	Lipid	A	
can	provide	a	more	tightly	packed	LPS	layer	and	higher	integrity	of	the	outer	membrane145,146.		
The	structure	of	E.	coli	PagP	has	been	determined	both	by	solution	nuclear	magnetic	resonance	
spectroscopy	(PDB	Code	1MM4	and	1MM5)	and	by	X-ray	crystallography	(PDB	Code	1THQ	and	3GP6),	
revealing	an	eight-strand	antiparallel	β-barrel	preceded	by	an	N-terminal	amphipathic	α-helix	 147–149.	
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Like	other	β-barrel	membrane	proteins,	 the	 center	of	 the	PagP	β-barrel	 is	 relatively	 rigid	with	more	
flexible	external	loops	where	the	active	site	residues	are	localized	(Figure	19).		
Even	 though	 the	catalytic	mechanism	remains	 to	be	elucidated,	PagP	alternates	between	 two	
dynamically	distinct	states	likely	representing	latent	and	active	conformations	in	the	outer	membrane	
environment150.	 PagP	 activity	 is	 triggered	 by	 outer	 membrane	 lipid	 asymmetry	 perturbations	 that	
enable	the	donor	phospholipid	and	acceptor	Lipid	A	substrates	to	have	access	to	the	active	site	from	
the	 external	 leaflet151–153.	 Phospholipid	 and	 Lipid	 A	 binding	 occurs	 by	 lateral	 diffusion	 through	 two	
gateways	 in	 the	 β-barrel	 wall	 known	 as	 the	 crenel	 and	 embrasure,	 respectively154.	 A	 solved	 crystal	
structure	 of	 PagP	 inhibited	 by	 the	 detergent	 lauryldimethylamine	N-oxide	 (LDAO)	 revealed	 a	 buried	
LDAO	molecule	within	 the	 rigid	β-barrel	 core,	a	 site	corresponding	with	 the	palmitoyl	group	binding	
pocket	 known	as	 the	hydrocarbon	 ruler	 (Figure	 19)149.	 A	 X-ray	 structure	of	 PagP	 crystallized	 from	a	
mixture	 of	 sodium	dodecyl	 sulfate	 (SDS)	 and	 2-methyl-2,4-pentanediol	 (MPD)	 has	 revealed	 a	 crenel	
gating	mechanism	 for	 the	 transit	 of	 the	phospholipid	between	 the	hydrocarbon	 ruler	 and	 the	outer	
membrane	external	leaflet147.	The	interior	of	the	PagP	region,	which	is	exposed	to	the	inner	leaflet	of	
the	 membrane,	 is	 mostly	 polar,	 whereas	 the	 interior	 of	 the	 other,	 LPS-exposed,	 region	 is	 strictly	
hydrophobic.	 Punctuations	 of	 the	 β-strands	 by	 proline	 residues	 enable	 the	 lateral	 access	 of	 lipid	
substrates	from	the	inner	leaflet	of	the	membrane148,149,155.		
	
Figure	19:	PagP	crystal	structure.	a)	Ribbon	diagram	of	PagP.	Electron	density	for	the	internal	LDAO	ligand	is	shown	in	
gray	 mesh,	 and	 the	 aromatic	 residues	 located	 at	 the	 presumed	 membrane/water	 interfaces	 are	 shown	 in	 black.	
Residues	38-47	of	extracellular	 loop	 L1	are	not	 visible	 in	 the	electron	density	maps	and	are	 indicated	by	 the	dashed	
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segment.	 The	 barrel	 axis	 is	 tilted	 approximately	 25°	 from	 the	 membrane	 normal	 and	 is	 shown	 as	 a	 red	 line.	 The	
horizontal	lines	represent	the	presumed	position	of	the	outer	membrane	bilayer.	b)	The	asymmetric	outer	membrane	
of	 Gram-negative	 bacteria	 consists	 of	 an	 inner	 phospholipid	 leaflet	 (indicated	 by	 the	 two	 molecules	 of	
phosphatidylethanolamine	in	the	lower	part	of	the	panel)	and	an	outward-facing	leaflet	of	lipid	A	bearing	minimally	two	
3-deoxy-d-manno-2-octulosonic	acid	(KDO)	sugars	(indicated	by	a	KDO2-Lipid	A	in	the	upper	part	of	the	panel,	shown	as	
the	palmitoylated	product	of	the	PagP	reaction).	PagP	catalyzes	the	transfer	of	a	palmitate	chain	(shown	in	red)	from	
the	 sn-1	 position	of	 a	 phospholipid	 to	 the	 Lipid	A	 acceptor.	 This	 transfer	 requires	 the	migration	of	 the	phospholipid	
donor	 to	 the	 outer	 leaflet	 of	 the	 outer	 membrane,	 presumably	 by	 mechanisms	 that	 do	 not	 directly	 involve	 PagP.	
Modified	from149.	
PagP	 is	 remarkably	 selective	 for	 a	 16-carbon	 palmitate	 chain	 because	 its	 hydrocarbon	 ruler	
excludes	lipid	acyl	chains	differing	in	length	by	a	solitary	methylene	unit149,156.	Mutation	of	Gly88	lining	
the	 hydrocarbon	 ruler	 floor	 can	 modulate	 lipid	 acyl	 chain	 selection156.	 Appropriate	 amino	 acid	
substitutions	 shorten	 the	 selected	 acyl	 chain	 by	 a	 degree	 predictable	 from	 the	 expected	 rise	 in	 the	
hydrocarbon	ruler	floor.	
However,	 although	 the	 structure	 and	dynamics	 of	 PagP	have	been	 studied	 in	 detail,	 its	 exact	
catalytic	mechanism	remains	uncertain144.	The	putative	catalytically	active	residues	His33,	Asp76,	and	
Ser77	 were	 initially	 thought	 to	 exert	 a	mechanism	 similar	 to	 that	 of	 classical	 serine	 esterases	 as	 a	
catalytic	triad.	However,	detailed	structural	analysis	revealed	that	they	are	not	organized	correctly	to	
form	such	a	triad	(Figure	19)149.	Moreover,	it	was	observed	that	typical	inhibitors	acting	against	serine	
esterases	 were	 not	 effective	 against	 PagP144.	 It	 is	 assumed	 that	 PagP	 can	 exist	 in	 different	
conformational	states	and	performs	an	induced-fit	mechanism19,144,157.		
In	E.	coli	and	related	pathogenic	Gram-negative	bacteria,	PagP	evades	host	immune	defenses	by	
resisting	 antimicrobial	 peptides113,158–160	 and	 attenuating	 the	 inflammatory	 response	 to	 infection	
triggered	by	lipopolysaccharide	through	the	TLR4/MD2	pathway161–163.	Transcription	of	the	pagP	gene	
is	 governed	 by	 the	 PhoP/PhoQ	 regulon,	 which	 controls	 expression	 of	 bacterial	 Lipid	 A	modification	
enzymes	 induced	during	 infection	by	host	 antimicrobial	 peptides164,165.	 PagP	 is	 thus	 a	 target	 for	 the	
development	 of	 anti-infective	 agents	 and	 a	 tool	 for	 the	 synthesis	 of	 novel	 vaccine	 adjuvants	 and	
endotoxin	antagonists19,144,157.	 	
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1.2.2.	The	Gram-positive	Mycobacteria	Cell	Envelope	
Mycobacterium	 tuberculosis,	 the	 causative	 agent	 of	 tuberculosis,	 is	 the	 second	 most	 deadly	
infectious	agent	 in	 the	world	after	HIV5,6.	The	extremely	 robust	and	 impermeable	mycobacterial	 cell	
envelope,	 based	 on	 sugars	 and	 lipids	 of	 unique	 chemical	 structure,	 is	 the	 dominant	 feature	 of	 the	
biology	of	M.	tuberculosis7–9.	With	this	 in	mind,	considerable	effort	has	been	placed	on	 investigating	
the	cell	envelope	structure	and	its	biosynthesis	to	identify	attractive	drug	targets166.		
According	to	the	last	model,	mycobacteria	cell	envelope	comprises	four	main	components:	the	
plasma	membrane	or	 inner	membrane,	 the	peptidoglycan-arabinogalactan	complex	 (AGP),	 the	outer	
membrane	which	is	covalently	bound	to	AGP	through	the	mycolic	acids,	and	the	external	capsular-like	
structure	(Figure	21	and	Figure	22)167–169.		
The	IM	is	composed	of	the	standard	phospholipids,	such	as	cardiolipin	(CL),	phosphatidyl-myo-
inositol	(PI)	and	phosphatidylethanolamine	(PE),	constituting	~1.16%,	~0.37	and	~0.52%	of	the	dry	cell	
mass,	respectively169.	However,	phosphatidyl-myo-innositol	mannosides	(PIMs)	are	the	most	abundant	
of	 all	 lipids	 extracted	 from	 the	 IM.	 PIMs	 are	 unique	 glycolipids	 found	 in	 abundant	 quantities	 in	 the	
inner	and	outer	membranes	of	the	cell	envelope	of	all	Mycobacterium	species.	They	are	based	on	a	PI	
lipid	anchor	carrying	one	to	six	mannose	(Manp)	 residues	and	up	to	four	acyl	chains.	 In	more	detail,	
just	the	tetra-acylated	form	of	PI	dimannosides	(Ac2PIM2)	account	for	up	to	42%	of	all	lipids	extracted	
from	 de	 IM	 (Figure	 20).	 PIMs	 are	 considered	 not	 only	 essential	 structural	 components	 of	 the	 cell	
envelope	but	also	the	structural	basis	of	the	lipoglycans,	lipomannan	and	lipoarabinomannan167,170,171.		
	
Figure	20:	The	PIM	Biosynthetic	Pathway.	Scheme	showing	the	mannosyltransferases	 involved	in	the	biosynthesis	of	
the	 two	major	products	of	 the	pathway,	PIM2	and	PIM6.	The	currently	accepted	model	propose	 that	PimA	and	PimB	
catalyze	the	two	first	consecutive	mannosylation	steps	 in	the	cytoplasmic	face	of	the	plasma	membrane.	The	identity	
and	 location	 of	 the	 enzyme/s	 responsible	 for	 the	 third	 and	 fourth	mannosylation	 steps	 is	 under	 debate,	 as	well	 the	
existence	 of	 a	 flippase.	 The	 fifth	 mannosylation	 step	 is	 catalyzed	 by	 PimE	 in	 the	 periplasmic	 face	 of	 the	 plasma	
membrane.	 The	 identity	 of	 the	 enzyme	 responsible	 for	 the	 sixth	mannosylation	 step	 is	 unknown.	 PIMs	 can	 be	 also	
acylated	 by	 the	 action	 of	 two	 acyltransferases:	 PatA	 catalyzes	 the	 transfer	 of	 an	 acyl	 chain	 to	 the	 mannose	 ring	
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transferred	by	PimA	at	the	cytosolic	face	of	the	plasma	membrane,	whereas	an	unknown	acyltransferase	catalyze	the	
transfer	of	an	acyl	chain	to	the	inositol	ring	of	the	glycolipid.	In	the	inset	the	acylation	steps	on	Ac2PIM2	are	shown	as	an	
example.	
	
Figure	21:	A	depiction	of	 the	Mycobacterium	tuberculosis	 cell	envelope.	The	cell	wall	core	consists	of	the	PG	(black	
with	colored	peptides	extending	from	it)	attached	to	the	mycolate	layer	(inner	leaflet	of	the	outer	membrane)	via	the	
AG.	 The	 galactofuranosyl	 residues	 are	 shown	 in	 blue	 and	 the	 arabinofuranosyl	 residues	 in	 red.	 The	 mycolic	 acids	
attached	to	the	arabinan	are	shown	in	black	and	are	in	a	folded	‘W’	configuration;	the	pink	mycolic	acids	are	attached	
to	trehalose	(trehalose	monomycolate	with	a	single	mycolic	acid	and	trehalose	dimycolate	with	two	mycolic	acids)	and	
are	expected	to	be	found	in	both	leaflets	of	the	outer	membrane.	Lipoarabinomannan	(arabinofuranosyl	residues	in	red	
as	 in	AG	and	mannopyranosyl	 residues	 in	purple)	 is	 shown	both	 in	 the	outer	membrane	and	plasma	membrane	as	 is	
lipomannan.	Phospholipids	are	only	shown	in	the	plasma	membrane,	but	are	also	found	in	the	outer	membrane.	The	
capsule	 is	shown	containing	glucan	(black),	mannan	(purple)	and	arabinomannan	(purple	and	red).	The	dimensions	of	
the	various	layers	are	from	published	electron	micrographic	studies.	Molecular	modeling	suggests	that	the	length	of	the	
medial	 zone	 could	 be	 as	 large	 as	 20	 nm;	 the	 arabinan	 and	 galactan	 are	 quite	 flexible	 and	 a	 very	 dense	 contracted	
configuration	is	required	for	the	much	smaller	6.5	nm	medial	zone	suggested	by	the	electron	microscopic	studies;	this	
perhaps	could	change	under	different	growth	conditions.	Modified	from172.	
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In	the	outer	part	of	the	plasma	membrane,	the	AGP	complex	comprises	the	peptidoglycan	(PG)	
in	phosphodiester	 linkage	 to	a	 linear	galactan,	 to	which	 several	 strands	of	highly	branched	arabinan	
are	 attached	 (Figure	 21	 and	 Figure	 22)173,174.	 In	 more	 depth,	 PG	 consists	 of	 a	 glycan	 backbone	 of	
alternating	 units	 of	 N-acetylglucosamine	 (GlcNAc)	 linked	 via	 β-(1à4)	 to	 modified	 muramic	 acid	
(Mur)167,175.	 These	Mur	 residues	can	be	either	N-acetylated	 (MurNAc)	or	N-glycosylated	 (MurNGlyc),	
this	MurNGlyc	modification	is	supposed	to	increase	the	strength	of	mycobacterial	PG176.	Tetrapeptide	
side	chains	attach	to	the	lactyl	moiety	of	Mur	components	of	the	backbone,	typically	consisting	of	L-
alanyl-D-glutamine-meso-diaminopimelyl-D-alanyl-D-alanine,	 that	 may	 be	 cross-linked167.	 Cross-links	
can	 comprise	 either	 (3à3)	 linkages	 between	 the	 meso-diaminopimelate	 (meso-DAP)	 residues	 of	
adjacent	peptides177	or	(4à3)	linkages	between	the	D-Ala	at	position	4	of	one	peptide	and	the	meso-
DAP	at	position	3	of	an	adjacent	peptide178.	A	small	percentatge,	about	10-12%,	of	the	Mur	residues	of	
PG	are	covalently	attached	to	arabinogalactan	(AG)	by	a	specific	linker	made	of	a	GlcNAc-1-phosphate	
residue	 attached	 to	 a	 α-L-rhamnose	 (Rha)179.	 The	 galactan	 core	 is	 composed	 by	 a	 linear	 chain	 of	
approximately	 30	 alternating	 5-	 and	 6-linked	 β-D-galactofuranose	 (Galf)	 residues180.	 The	 highly	
branched	 arabinan	 chains	 are	 connected	 to	 the	 galactan	 core	 at	 C5	 of	 some	 of	 the	 β-(1à6)	 Galf	
residues167,168,181.		
The	inner	leaflet	of	the	OM	is	formed	by	arabinogalactan	esterified	at	its	non-reducing	ends	to	
α-alkyl,	 β-hydroxy	 long-chain	 (C60-C90)	 mycolic	 acids8,182–184.	 To	 form	 the	 outer	 leaflet	 of	 the	 OM,	
mycolic	acids	can	also	be	unbound	and	esterified	with	a	variety	of	non-covalently	attached	glycolipids:	
trehalose	 mono-	 and	 di-mycolates	 (TMM	 and	 TDM,	 respectively),	 glycerol	 monomycolate,	 glucose	
monomycolate,	 PIMs,	 lipomannan	 (LM)	 and	 lipoarabinomannan	 (LAM),	 and	 lipoproteins/proteins	
some	 of	 which	 are	 glycosylated	 (Figure	 22)8,167,185,186.	 The	 organization	 and	 composition	 of	 this	
asymmetrical	outer	membrane	known	as	‘‘mycomembrane’’187,188	confer	mycobacteria	a	high	intrinsic	
resistance	 to	 many	 therapeutic	 agents	 and	 host	 defense	 mechanisms	 (Figure	 21	 and	 Figure	
22)172,189,190.		
Finally,	 the	capsular	structure	outside	the	outer	membrane	mostly	consists	of	polysaccharides	
and	proteins	with	only	minor	amounts	of	 lipids191–193.	 The	 three	major	polysaccharides	 found	 in	 the	
capsular	 material	 of	M.	 tuberculosis	 consist	 of	 a	 high	 molecular	 weight	 α-glucan	 with	 a	 structure	
similar	 to	 that	 of	 glycogen,	 a	 D-arabino-D-mannan	 (AM),	 and	 a	 D-mannan	 (Figure	 21)192–194.	 The	 α-
glucans	were	recently	suggested	to	be	required	for	virulence	of	M.	tuberculosis195–197.		
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Figure	 22:	 The	 mycobacterial	 cell	 wall.	 A	 schematic	 representation	 of	 the	 mycobacterial	 cell	 wall,	 including	 the	
glycolipids	(Phosphatidyl-myo-inositol	mannosides	(PIMs),	Lipomannan	(LM),	Lipoarabinomannan	(LAM),	Mannosylated	
lipoarabinomannan	(ManLAM)),	peptidoglycan,	arabinogalactan	and	mycolic	acids.	Intercalated	into	the	mycolate	layer	
are	 the	 acyl	 lipids	 (including	 trehalose	 monomycolate	 (TMM),	 trehalose	 dimycolate	 (TDM);	 diacyltrehalose	 (DAT);	
polyacyltrehalose	 (PAT),	 phthiocerol	 dimycocerosate	 (PDIM),	 sulfoglycolipid	 (SGL)).	 The	 capsular	 material	 is	 not	
illustrated.	Modified	from198.	
1.2.2.1.	 Phosphatidyl-myo-innositol	Mannosides	(PIMs)	
PIMs	are	based	on	PI	lipid	anchor	carrying	one	to	six	Manp	residues	and	up	to	four	acyl	chains	
(Figure	20)167,170.	Based	on	a	conserved	mannosyl-PI	anchor,	PIMs	are	thought	to	be	the	precursors	of	
the	 two	 major	 mycobacterial	 lipoglycans,	 LM	 and	 LAM	 (Figure	 22)13,14,199.	 PIMs,	 LM,	 and	 LAM	 are	
considered	 not	 only	 essential	 structural	 components	 of	 the	 mycobacterial	 cell	 envelope,	 but	 also	
important	 molecules	 implicated	 in	 host-pathogen	 interactions	 in	 the	 course	 of	 tuberculosis	 and	
leprosy,	which	have	been	the	object	of	several	reviews9,167,200–202.		
	
Figure	23:	Overview	of	the	early	stages	of	PIM	biosynthesis	 in	Mycobacterium	tuberculosis.	On	the	cytosolic	side	of	
the	plasma	membrane,	PI	 is	glycosylated	by	PimA	and	PimB,	and	acylated	by	PatA	to	 form	Ac1PIM2.	The	 identity	and	
location	of	the	enzyme/s	responsible	for	the	third	and	fourth	mannosylation	steps	is	under	debate,	as	well	the	existence	
of	a	flippase.	 	
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The	PIM	family	of	glycolipids	comprises	PI	mono-,	di-,	 tri-,	 tetra-,	penta-,	and	hexamannosides	
with	different	degrees	of	acylation(Figure	24)170,203.	The	acylated	forms	of	PIM2	and	PIM6	are	the	two	
most	abundant	classes	found	in	Mycobacterium	bovis	bacillus	Calmette-Guerin	(BCG),	M.	tuberculosis	
H37Rv,	M.	 smegmatis	 607	 and	M.	 smegmatis	 mc2	 204,205.	 The	 complete	 chemical	 structures	 of	 the	
acylated	 forms	 of	 PIM2	 and	 PIM6	 were	 unequivocally	 established	 in	 M.	 bovis	 BCG199,202.	 PIM2	 is	
composed	of	two	mannose	(Man)	residues	attached	to	positions	2	and	6	of	the	myo-inositol	ring	of	PI	
(Figure	 24),	 whereas	 PIM6	 is	 composed	 of	 a	 pentamannosyl	 group,	 t-α-Man(1à2)-α-Man(1à2)-α-
Man(1à6)-α-	Man(1à6)-α-Man(1à,	attached	to	position	6	of	the	myo-inositol	ring,	in	addition	to	the	
Manp	residue	present	at	position	2)170.	The	triacylated	forms	of	PIM2	and	PIM6	(Ac1PIM2	and	Ac1PIM6)	
show	 major	 acyl	 forms	 containing	 two	 palmitic	 acid	 residues	 (C16)	 and	 one	 tuberculostearic	 acid	
residue	(C19),	where	one	fatty	acyl	chain	is	linked	to	the	Manp	residue	attached	to	position	2	of	myo-
inositol,	and	 two	 fatty	acyl	 chains	are	 located	on	 the	glycerol	moiety	 (Figure	 24).	The	 tetra-acylated	
forms,	 Ac2PIM2	 and	 Ac2PIM6,	 are	 present	 predominantly	 as	 two	 populations	 bearing	 either	 three	
C16/one	C19	or	two	C16/two	C19205,206.	Two	fatty	acyl	chains	are	located	on	the	glycerol	moiety,	another	
fatty	acyl	chain	is	linked	to	the	Manp	residue	attached	to	position	2	of	myo-inositol,	and	finally,	the	last	
fatty	 acyl	 chain	 is	 attached	 to	 position	 3	 of	 the	myo-inositol	 unit.	 Ac1PIM4/Ac2PIM4	 seems	 to	 be	 a	
branch	 point	 intermediate	 in	 Ac1PIM6/Ac2PIM6	 and	 LM/LAM	 biosynthesis.	 The	 addition	 of	 two	 α-
(1à2)-Man	residues	to	Ac1PIM4/Ac2PIM4,	it	is	worth	to	mention	that	this	combination	is	not	found	in	
the	mannan	backbone	of	LM	and	LAM,	leads	to	the	formation	of	the	higher	order	mannosides	Ac1PIM6	
and	Ac2PIM614.	Although	LM	and	LAM	have	variations	in	their	mannan	chains,	in	both	the	overall	size	
and	 additional	 acylation,	 they	 share	 a	 core	 based	 on	 an	 α-(1à6)-linked	 backbone	 of	 20-25	 Man	
residues	frequently	branched	with	single	α-(1à2)-Man	residues9,207,208.		
1.2.2.1.1.	PIMs	Biosynthesis	
According	to	the	currently	accepted	model,	PIMs	biosynthesis	takes	place	on	both	sides	of	the	
mycobacteria	plasma	membrane170,203,209	but	is	initiated	on	the	cytoplasmic	side	by	the	mannosylation	
of	 PI,	 specifically	with	 the	 transfer	 of	 a	Manp	 residue	 from	GDP-Man	 to	 the	 2-position	 of	 the	myo-
inositol	ring	of	PI,	yielding	PI	monomannoside	(PIM1)210.	According	to	genetic,	enzymatic	and	structural	
evidence,	the	enzyme	responsible	for	this	catalytic	step	 is	PimA211–213	 (Rv2610c	and	MSMEG_2935	 in	
M.	 tuberculosis	 H37Rv	 and	M.	 smegmatis	 mc2155	 strains,	 respectively).	 This	 enzyme	 proved	 to	 be	
essential	 in	M.	tuberculosis	and	M.	smegmatis	growth	 in	vitro	and	 in	vivo	 (Figure	24	b)211,214,215.	The	
second	 enzyme	 of	 the	 biosynthetic	 pathway,	 PimB	 (Rv2188c	 and	MSMEG_4253	 in	M.	 tuberculosis	
H37Rv	and	M.	 smegmatis	mc2155	 strains,	 respectively),	 transfers	 a	Manp	 residue	 from	GDP-Man	 to	
the	 6-position	 of	 the	 myo-inositol	 ring	 of	 PIM1,	 generating	 PIM2213,216,217.	 PimB	 was	 found	 to	 be	
essential	 in	 M.	 smegmatis	 growth213.	 Both	 PIM1	 and	 PIM2	 can	 be	 further	 acylated	 by	 the	
Phosphatidylinositol	Mannosides	Acyltransferase	A	or	PatA	(Figure	24	b)170.		 	
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Figure	 24:	 PIM	 biosynthetic	 pathway	 in	 mycobacteria.	 a)	 Chemical	 structure	 of	 PIM2/6	 and	 their	 acylated	 forms	
Ac1/2PIM2	 and	 Ac1/2PIM6.	 b)	 Proposed	 pathway	 for	 the	 early	 steps	 of	 PIM	 biosynthesis	 in	 mycobacteria.	 The	 two	
pathways	originally	proposed	 for	 the	biosynthesis	of	Ac1PIM2	in	mycobacteria	are	shown:	PI	 is	mannosylated	 to	 form	
PIM1.	PIM1	is	then	mannosylated	to	PIM2,	which	is	acylated	to	form	Ac1PIM2;	PIM1	is	first	acylated	to	Ac1PIM1	and	then	
mannosylated	 to	 Ac1PIM2.	 Our	 experimental	 evidence	 suggests	 that	 although	 both	 pathways	 might	 co-exist	 in	
mycobacteria,	 the	 PI→PIM1→PIM2→Ac1PIM2	 pathway	 is	 favored.	 As	 an	 important	 part	 of	 the	 literature	 concerning	
PIMs	 studies	 refers	 to	 the	 nomenclature	 based	 on	 the	Mtb	 H37Rv	 sequences,	 we	 also	 include	 the	 Rv	 numbers	 to	
identify	the	proteins.	
Two	pathways	were	originally	proposed	for	the	biosynthesis	of	Ac1PIM2	in	mycobacteria:	In	the	
first	one,	PI	is	mannosylated	by	PimA	to	form	PIM1,	PIM1	is	then	mannosylated	by	PimB	to	form	PIM2,	
which	is	further	acylated	to	form	Ac1PIM2;	and	in	the	second	one,	PIM1	is	first	acylated	to	Ac1PIM1	and	
then	 mannosylated	 to	 form	 Ac1PIM2.	 The	 experimental	 evidence	 indicates	 that	 although	 both	
pathways	 might	 co-exist	 in	 mycobacteria,	 the	 sequence	 of	 events	 PIàPIM1àPIM2àAc1PIM2	 is	
favoured,	 by	 the	 consecutive	 action	 of	 PimA,	 followed	 by	 PimB,	 and	 finally	 the	 acyltransferase	
PatA170,213.	Finally,	Ac1PIM2	can	be	further	acylated	at	position	3	of	the	myo-inositol	ring	by	the	action	
of	a	second	acyltransferase	not	described	yet	yielding	Ac2PIM2	(Figure	24	b).		
The	 degree	 of	 acylation	 of	 PIMs	 seems	 to	 impact	 on	 the	 permeability	 and	 fluidity	 of	 the	 cell	
envelope218,	as	well	as	during	 the	glycolipid	antigen	presentation	 to	 the	 immune	system219.	Ac1PIM2	
and	Ac2PIM2	can	be	further	elongated	with	additional	Manp	residues	to	form	higher	PIM	species	(such	
as	 Ac1PIM3-Ac1PIM6/Ac2PIM3-Ac2PIM6),	 LM,	 and	 LAM.	 In	 M.	 tuberculosis	 CDC1551	 strain,	 PimC	
(MT1800,	GT-B,	GT4	family)	has	been	reported	to	transfer	the	third	Manp	residue	from	GDP-Man	to	
the	 6	 position	 of	 the	 Manp	 residue	 transferred	 by	 PimB,	 elongating	 the	 glycolipid	 until	
Ac1PIM3/Ac2PIM3	(Figure	 20)220.	 The	 fact	 that	 this	 enzyme	has	no	ortholog	 in	M.	 tuberculosis	H37Rv	
strain	nor	in	M.	smegmatis,	suggests	that	an	alternative	pathway	with	an	unknown	glycosyltransferase	
should	exist	in	these	species170,221.	Likewise,	the	fourth	mannosyltransferase	remains	to	be	identified.		 	
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PimE	 (Rv1159	 and	MSMEG_5149	 in	M.	 tuberculosis	H37Rv	and	M.	smegmatis	mc2155	 strains,	
respectively),	 a	 polytopic	membrane	 protein,	was	 identified	 as	 the	mannosyltransferase	 involved	 in	
the	 synthesis	 of	 higher	 forms	of	 PIMs.	 Specifically,	 PimE	 transfers	 a	Manp	 residue	 from	polyprenol-
phosphate-mannose	 to	 the	 2	 position	 of	 Ac1PIM4	 to	 form	 Ac1PIM5	 at	 the	 periplasmic	 face	 of	 the	
plasma	membrane	(Figure	20)209,222,223.	The	mannosyltransferase	responsible	for	the	formation	of	PIM6	
from	PIM5	is	not	yet	known.		
The	fundamentals	of	how	PIMs	are	assembled	and	exported	are	yet	not	fully	understood.	The	
first	two	or	three	mannosylation	steps	of	the	PIM	pathway	seems	to	occur	on	the	cytoplasmic	face	of	
the	 plasma	 membrane.	 Supporting	 this	 notion,	 enzymes	 involved	 in	 the	 synthesis	 of	 early	 PIM	
intermediates	were	localized	to	a	membrane	subdomain	termed	Plasma	Membrane	free	(PMf)	which	
was	clearly	resolved	from	the	cell	wall224,225.	The	inner	leaflet	of	the	inner	membrane	is	predominantly	
composed	 of	 Ac1PIM2/Ac2PIM2	 and	 all	 these	 steps	 involve	 the	 action	 of	 GDP-Man-dependent	
enzymes170,171.	 Further	 steps	 in	 the	biosynthesis	of	higher	 forms	of	PIMs	 (PIM5	and	PIM6)	 appear	 to	
rely	 upon	 integral	 membrane	 GT-C-type	 glycosiltransferases	 on	 the	 periplasmic	 side	 of	 the	 plasma	
membrane171,209.	 Since	 the	 unassisted	 translocation	 of	 apolar	 PIMs	 across	 the	 plasma	membrane	 is	
energetically	 unfavorable226,227	 such	 a	 compartmentalization	 implies	 that	 an	 unknown	 flippase	
translocates	the	glycolipid	intermediate/s	from	the	cytoplasmic	to	the	periplasmic	side	of	the	plasma	
membrane	(Figure	20)167.		
1.2.2.1.2.	The	Phosphatidylinositol	Mannosides	Acyltransferase	A	(PatA)		
The	 acyltransferase	 PatA	 (Rv2611c	 and	 MSMEG_2934	 in	 M.	 tuberculosis	 H37Rv	 and	 M.	
smegmatis	mc2155	 strains,	 respectively)21	 transfers	a	palmitoyl	moiety	 from	palmitoyl-CoA	 to	 the	6-
position	of	 the	mannose	 ring	 linked	 to	2-position	of	 inositol	 in	PIM1	or	PIM2	 resulting	 in	Ac1PIM1	or	
Ac1PIM2,	repectively	(Figure	24	b)170.		
The	M.tuberculosis	 PatA	 gene	Rv2611c	 is	 the	 third	 gene	 of	 a	 cluster	 of	 five	 ORFs	 potentially	
organized	 as	 a	 single	 transcriptional	 unit23,228–230.	 The	 second	 and	 fourth	 ORFs	 encode	 the	
phosphatidylinositol	 phosphate	 synthase	 PgsA	 (Rv2612c)229–232	 and	 the	 mannosyltransferase	 PimA,	
respectively	 (Rv2610c)228,233.	 In	 addition,	 the	mannosyltransferase	 PimB	 is	 encoded	 by	 the	 Rv2188c	
gene216,217.	 Interestingly,	the	four	enzymes	involved	in	the	biosynthetis	of	the	metabolic	end	product	
Ac1PIM2	 (PgsA,	 PimA,	 PimB	 and	 PatA)	 were	 found	 to	 be	 essential	 for	 the	 growth	 of	M.	 smegmatis	
and/or	M.	 tuberculosis23,215,228,230,233.	Specifically,	 a	 patA	 mutant	 of	M.	 smegmatis	 mc2155	 exhibited	
severe	growth	defects23,	whereas	patA	was	found	to	be	an	essential	gene	in	M.	tuberculosis	H37Rv,	by	
a	combination	of	transposon	high-density	mutagenesis	and	deep-sequencing	approaches234,235.	
This	thesis	is	focused	on	describing	the	three-dimensional	structure,	glycolipid	acceptor	and	acyl	
donor	substrate	binding,	as	well	as	the	catalytic	mechanism	of	PatA	from	M.	smegmatis.	We	propose	a	
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model	 for	 substrate	 recognition,	 catalysis	 and	 enzyme	 inhibition	 using	 a	 combination	 of	 X-ray	
crystallography,	 biochemical	 and	 biophysical	 techniques,	 quantum-mechanics/molecular-mechanics	
(QM/MM)	metadynamics	and	chemical	synthesis.	The	implications	of	this	model	in	the	comprehension	
of	 the	 early	 steps	 of	 PIM	 biosynthesis	 and	 the	 mode	 of	 action	 of	 other	 members	 of	 the	 bacterial	
acyltransferase	family	of	enzymes	are	discussed.		
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2.	OBJECTIVES	AND	HYPOTHESIS	
During	 recent	 times	major	 efforts	 have	 been	made	 to	 understand	 the	 early	 steps	 of	 the	 PIM	
biosynthetic	 pathway	 at	 the	 molecular	 level.	 In	 that	 sense,	 the	 crystal	 structures	 of	 the	
mannosyltransferases	 PimA	 and	 PimB	were	 reported,	 showing	 the	 typical	 organization	 and	 catalytic	
machinery	 of	GT-B	 glycosyltransferases.	However,	 to	 date,	 no	 structural	 information	 is	 available	 for	
PatA,	 an	 enzyme	 that	 is	 a	 member	 of	 a	 large	 family	 of	 acyltransferases	 for	 which	 the	 molecular	
mechanism	of	substrate	recognition	and	catalysis	remains	not	well	understood.	
This	 thesis	 is	 focused	on	 the	structural	characterization	of	 the	essential	membrane	associated	
acyltransferase	 involved	 in	 the	 biosynthesis	 of	mycobacterial	 phosphatidyl-myo-inositol	mannosides	
(PIMs)	 of	 M.	 smegmatis,	 the	 acyltransferase	 PatA.	 These	 studies	 would	 like	 to	 establish	 the	
mechanistic	 basis	 of	 substrate/membrane	 recognition	 and	 catalysis	 for	 an	 important	 family	 of	
acyltransferases,	providing	exciting	possibilities	for	inhibitor	design.	
The	objectives	of	these	thesis	are	the	following:		
ü to	 determine	 the	 crystal	 structure	 of	 PatA	 from	 Mycobacterium	 smegmatis	 in	
complex	with	the	donor	and	acceptor	substrates	
ü to	 validate	 the	 structural	 information	 by	 direct	 mutagenesis	 and	
biophysical/biochemical	approaches	
ü to	propose	a	model	of	action	of	the	acyltransferase	PatA	
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3.	EXPERIMENTAL	TECHNIQUES	
In	 this	 section,	 an	 overview	 of	 Macromolecular	 X-ray	 Crystallography	 is	 given.	 A	 careful	
description	of	the	materials	and	other	techniques	used	during	these	studies	can	be	found	in	Chapter	4.	
Structural	Insights	of	the	Acyltransferase	PatA.		
3.1.	Protein	Crystallography	
In	 the	 late	 1950s,	 the	 first	 crystal	 structures	 of	 proteins	 were	 solved.	 Sir	 John	 Cowdery	
Kendrew236	 solved	 the	 first	 protein	 structure,	 sperm	 whale	 myoglobin236,	 for	 which	 he	 shared	 the	
Nobel	 Prize	 in	 Chemistry	 with	Max	 Perutz	 in	 1962.	 Since	 that	 success,	 about	 120,791	 X-ray	 crystal	
structures	 of	 proteins,	 nucleic	 acids	 and	 other	 biological	 molecules	 have	 been	 determined,	 and	 14	
Nobel	 prizes	 in	 chemistry	 or	 medicine	 have	 been	 awarded	 to	 protein	 crystallographers.	 These	
structures	are	important	for	the	understanding	of	the	processes	that	take	place	in	living	organisms	and	
also	for	practical	applications	such	as	drug	design.	
Over	 the	 years,	 X-ray	 crystallography	has	become	one	of	 the	most	 powerful	 tecnique	 for	 the	
structural	resolution	of	macromolecules.	It	has	great	advantages	in	comparison	with	other	techniques	
focused	 on	 the	 same	purpose,	 since	 it	 provides	 information	 on	 an	 atomic	 scale,	 obtaining	 a	 ‘three-
dimensional	 photograph’	of	 the	 crystallized	material.	 Regarding	 to	proteins,	 their	 folding	 and	 three-
dimensional	 structure	 are	obtained,	 as	well	 as	 important	physical	 and	 chemical	 information	 such	as	
distances	and	bonding	angles,	atom	packing	and	vibrational	thermal	state,	all	of	which	are	crucial	for	
the	comprehension	of	their	biological	function.	
An	alternative	technique	used	in	structural	biology	for	determining	macromolecular	structures	
is	Nuclear	Magnetic	Resonance	(NMR).	The	main	advantatge	of	this	technique	is	that	macromolecules	
are	 in	solution	thus,	dymanics	can	be	determined.	However,	the	structural	 information	attainable	by	
NMR	 is	 limited	 when	 working	 with	 large	 macromolecules	 (above	 ca.	 200	 kDa).	 Additionally,	 other	
techniques	such	as	electron	microscopy	(EM)	or	atomic	 force	microscopy	(AFM)	offer	alternatives	to	
the	structural	study	of	macromolecules.	Finally,	bioinformatics	techniques	can	also	provide	structural	
information	about	a	protein	if	structural	data	of	this	protein	or	similar	is	already	available.	It	is	worth	
mentioning	a	new	technique	in	the	field	of	X-ray	crystallography,	X-ray	Free	Electron	Laser	(XFEL),	that	
works	 at	 the	 femtosecond	 time	 scale.	 XFEL	 consists	 of	 a	 free-electron	 laser	 that	 generates	 high-
intensity	electromagnetic	radiation	by	accelerating	electrons	to	relativistic	speeds	and	directing	them	
through	 special	magnetic	 structures.	 The	 extremely	 bright	 X-ray	 pulses	 produced	 are	 approximately	
1,000	million	 times	higher	 than	 the	one	currently	produced	 in	synchrotrons.	The	 technique	 is	 still	 in	
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early	 stages	 and	 its	 implementation	 is	 expected	 to	 be	 a	 qualitative	 jump	 in	 the	 field	 of	 structural	
biology237.	
From	1958	to	the	present,	 the	number	of	macromolecular	structures	has	grown	exponentially	
and	 90%	 of	 them	 has	 been	 solved	 by	 X-ray	 crystallography.	 However,	 this	 collection	 of	 structures	
represents	only	a	small	portion	of	the	hundreds	of	thousands	of	different	proteins	that	play	some	role	
in	 the	 processes	 of	 life.	 Therefore,	 structural	 determination	 of	 proteins	 is	 an	 essential	 part	 of	 the	
research	developed	in	hundreds	of	laboratories	around	the	world.	
 
Figure	25:	Workflow	for	solving	a	molecular	structure	using	X-ray	crystallography.	
The	obtention	of	crystals	is	the	first	step	for	the	application	of	X-ray	crystallography	technique.	
These	crystals	need	to	be	sufficiently	large,	unique	and	homogeneous	for	the	diffraction	experiments.	
Obtaining	 single	 crystals	 of	 sufficient	 quality	 for	 diffraction	 is	 currently	 the	 bottleneck	 of	molecular	
crystallography	(Figure	25).		
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A	crystal	is	defined	as	a	solid	body	constituted	by	an	ordered	group	of	atoms,	ions	or	molecules	
that	are	repeated	and	regularly	distributed	in	space.	This	minimum	unit	of	repetition	is	called	unit	or	
elementary	cell.	The	unit	cell	is	defined	by	three	axes	(a,b,c)	and	three	angles	(α,β,γ),	which	determine	
the	reference	angle	of	the	atomic	coordinates.	Furthermore,	there	are	other	repetition	operations,	in	
addition	to	the	repetitions	by	translation,	that	cause	repetitions	within	the	elementary	cell:	those	are	
the	elements	of	symmetry.	An	asymmetric	unit	is	defined	as	the	minimum	set	of	atoms	that,	applying	
the	symmetry	operations	of	a	given	space	group,	generates	the	total	content	of	atoms	in	the	unit	cell	
(Figure	26).		
	
Figure	26:	The	crystal	concept.	a)	The	asymmetric	unit,	b)	repeats	itself	through	the	elements	of	symmetry,	generating	
the	 unit	 or	 elementary	 cell.	 c)	 The	 parameters	 that	 characterize	 its	 shape	 and	 size	 are	 three	 axes	 (a,b,c)	 and	 three	
angles	(α,β,γ).	d)	The	repetition	of	the	elementary	cell,	in	the	three	directions	of	space,	generates	the	crystal.	
The	set	of	elements	of	symmetry	in	a	crystal	and	the	different	cell	types	give	rise	to	the	space	
groups,	which	represent	230	different	ways	 in	which	a	motif	can	be	repeated	in	a	three-dimensional	
space.	 These	 230	 groups	 are	 classified	 in	 the	 International	 Tables	 for	 X-ray	 Crystallography.	 Among	
those	 230	 groups,	 only	 65	 groups	 that	 do	 not	 contain	 symmetry	 planes	 or	 inversion	 centers	 are	
compatible	with	biological	macromolecules	because	of	the	intrinsic	chirality	of	these	molecules.	
It	is	important	to	highlight	that	protein	crystals	present	certain	peculiarities	in	comparison	with	
the	 inorganic	 crystals	 and	 small	 molecules.	 One	 remarkable	 difference	 is	 that,	 in	 general,	 protein	
crystals	 are	 smaller	 and	more	brittle	 than	non-protein	 crystals.	Moreover,	 they	have	weaker	optical	
properties	 and	 tend	 to	 dehydrate	 easily	 due	 to	 the	 high	 content	 of	 solvent	 (between	 25-90%,	 50%	
average)	 of	 crystals.	What	a	 priori	 seems	 to	 be	 a	 problem,	 this	 high	 percentage	 of	 solvent	 (mostly	
disordered)	 that	usually	 results	 in	weak	diffraction	pattern,	 could	also	be	an	advantage	because	 the	
presence	of	solvent	maintains	the	protein	in	an	environment	similar	to	that	found	in	solution238.	
3.1.1.	Principles	of	Crystallisation	
In	general,	 crystallisation	of	a	macromolecules	 is	not	 very	different	 from	 the	crystallisation	of	
small	molecules.	Crystals	of	any	substance	are	formed	from	a	supersaturated	solution,	which	triggers	
the	 spontaneous	 formation	 of	 the	 initial	 crystallisation	 nucleus.	 When	 the	 solubility	 limit	
(supersaturation)	is	exceeded,	the	molecules	that	are	in	excess	are	separated	from	the	aqueous	phase	
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and	 move	 to	 the	 solid	 phase,	 establishing	 an	 equilibrium	 between	 both	 phases.	 Therefore,	 the	
supersaturation	 conditions	 are	 necessary	 for	 the	 crystal	 formation,	 since	 with	 only	 saturation	 this	
change	would	not	occur,	and	thus,	the	crystal	would	not	be	formed	(Figure	27).	
So,	the	strategy	is	to	obtain	a	supersaturated	solution	that	generates	a	few	crystallisation	nuclei	
on	which	a	few	large	and	ordered	crystals	grow.	In	other	words,	the	protein	should	be	maintained	near	
the	solubility	curve,	but	in	the	supersaturation	zone	(Figure	27).	
Crystallisation	consists	on	two	well	differentiated	phases:	nucleation	and	crystalline	growth.	On	
one	hand,	 thermodynamically	stable	crystalline	aggregates	appear	 in	nucleation.	On	the	other	hand,	
protein	molecules	are	incorporated	into	the	surface	of	the	crystal	during	the	growth,	displacing	part	of	
the	water	molecules.	This	second	phase	ends	when	a	thermodynamic	equilibrium	is	achieved	or	when	
crystal	 defects	 accumulate.	 Nucleation	 can	 occur	 spontaneously	 or	 can	 be	 induced	 artificially.	
Therefore,	 the	study	of	nucleation	 is	a	 fundamental	part	of	crystalline	growth.	Several	 theories	have	
been	 proposed	 to	 explain	 this	 phenomenon,	 among	 them,	 the	 Gibbs-Thompson	 equation	 is	
elementary	to	explain	nucleation	events	(Figure	27).	
	
Figure	27:	Diagram	of	phases	of	crystallisation	process.	The	aqueous	and	saturated	phases	are	represented	in	addition	
to	 the	 zones	 of	 aggregation,	 nucleation,	 crystalline	 growth	 and	 precipitation.	 The	 green	 arrows	 show	 the	 usual	
evolution	of	a	vapor	diffusion	experiment	to	the	formation	of	crystals.	If	it	formed	precipitate,	it	would	follow	the	path	
of	the	red	arrow.	The	blue	circles	represent	the	solvent	and	the	oranges	the	precipitate.	
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3.1.2.	Requirements	Previous	to	Crystallisation	
The	 first	 thing	 to	 consider	 for	 crystallisation	 is	 whether	 the	 sample	 fullfil	 some	 important	
requirements.	There	are	five	main	aspects	to	have	into	account:	concentration,	purity,	homogeneity,	
stability	and	quantity239.		
ü Concentration:	 As	 supersaturation	 is	 needed,	 so	 a	 high	 concentration	 of	 protein	 is	 required.	
Concentrations	of	5-20	mg/ml	are	typically	considered	depending	on	protein	solubility.	
ü Purity:	Maximum	purity	 is	 required,	 although	 95%	 is	 acceptable.	 This	 is	 usually	 determined	 by	
electrophoresis	 in	the	polyacrylamide	gel.	The	impurities	can	stop	the	growth	of	the	crystal	and	
produce	irregularities	in	it,	which	translates	into	a	worse	quality	of	the	diffraction	pattern.	
ü Homogeneity:	 The	 sample	 must	 be	 homogeneous	 and	 any	 factor	 that	 leads	 to	 heterogeneity	
must	be	evaluated	and	considered	before	the	crystallisation	experiment.	
ü Stability:	 A	 special	 care	 must	 be	 taken	 not	 to	 alter	 the	 stability	 of	 the	 protein	 during	 the	
purification,	freezing/thawing	and	crystallisation	processes.	
ü Quantity:	It	is	important	to	have	the	maximum	amount	of	protein	as	possible	in	order	to	do	the	
maximum	 crystallisation	 trials.	 It	 is	 not	 recommended	 to	 use	 protein	 sample	 from	 different	
batches	of	purification,	since	this	variable	can	be	crucial	in	the	crystallisation	process.	
Once	 the	 protein	 meets	 all	 the	 requirements,	 the	 most	 popular	 strategy	 used	 to	 achieve	
supersaturation	 is	 based	 on:	 increasing	 the	 protein	 concentration	 by	 solvent	 evaporation,	 and	
incorporating	additives	to	decrease	protein	solubility.	Usually,	the	factors	that	affect	the	obtention	of	
saturated	 protein	 solutions	 are	 the	 following:	 protein	 concentration,	 pH	 and	 solution	 buffer,	
temperature,	ionic	strength,	precipitating	agent	type	and	concentration,	additives	and	ligands.	
3.1.3.	Crystallisation	Methodology	
There	 are	 several	 techniques	 for	 protein	 crystallisation:	 vapour	 diffusion,	 dialysis,	microbatch	
under	oil	and	counterdiffusion.	The	most	common	technique	is	vapour	diffusion	which	is	the	one	used	
in	this	thesis.	
Vapour	Diffusion	
In	 this	 system,	 a	 drop	of	 protein	 solution	 together	with	 a	drop	of	 the	precipitating	 agent	 are	
placed	 in	 a	 closed	 container,	 and	 are	 equilibrated	 against	 the	 precipitating	 solution	 contained	 in	 a	
reservoir.	In	this	way,	as	the	precipitant	concentration	in	the	drop	is	less	than	the	one	in	the	reservoir,	
evaporation	occurs.	It	results	in	the	decrease	of	the	volume	of	the	drop	and	an	increase	of	the	protein	
concentration	until	it	reaches	the	equilibrium.	Thus,	first	the	saturation	conditions	will	be	reached	and	
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then	supersaturation,	getting	 into	 the	nucleation	zone.	The	 final	objective	 is	 to	 reach	the	nucleation	
and	 crystalline	 growth	 zone,	 and	 this	 could	 be	 fulfilled	 by	 knowing	 the	 system	 and	 adjusting	 the	
appropriate	parameters	in	different	experiments	(Figure	28).	
There	are	two	experimental	modalities	for	the	assembly	of	this	system	(Figure	28):	
• Sitting	Drop:	The	drop	of	protein	and	precipitant	is	placed	on	a	flat	or	concave	elevation	next	to	
the	reservoir	of	precipitating	solution.	The	system	is	finally	sealed	from	the	outside	with	a	flexible	
adhesive	sheet	that	covers	the	entire	well.	
• Hanging	Drop:	The	drop	of	protein	and	precipitant	 is	placed	on	a	coverslip,	which	 is	previously	
siliconized	 to	 prevent	 dispersion.	 The	 precipitant	 solution	 is	 deposited	 in	 a	 well	 which	 will	 be	
closed	with	the	coverslip	containing	the	attached	droplet	in	an	inverted	position.	Vacuum	grease	
is	used	to	seal	it	tightly.	
	
Figure	28:	Diagram	of	vapour	diffusion	crystallisation	technique	in	sitting	drop	and	hanging	drop.	
3.1.4.	Optimal	Crystallisation	Conditions	
Crystallisation	 involves	 two	 main	 experimental	 stages:	 search	 for	 crystallisation	 and	 optimization	
conditions.	
Protein	 crystallisation	 experiments	 require	 some	preliminary	 trials	 that	 allow	 testing	 as	much	
conditions	as	possible.	There	are	multiple	variables	that	affect	crystallisation	that	must	be	taken	under	
consideration,	 such	 as	 chemical	 (pH,	 ionic	 strength,	 concentration,	 impurities,	 etc.),	 physical	
(temperature,	pressure,	vibration,	etc.)	and	biochemical	 factors	 (purity,	measurements,	 ligands,	etc.)	
must	be	taken	under	consideration.	
Nowadays,	high	throughput	techniques	allow	the	completion	of	multiple	experiments	in	a	short	
time	 and	 also	 to	 spend	 the	 minimum	 amount	 of	 sample.	 Moreover,	 there	 are	 a	 large	 number	 of	
commercial	 kits	 that	 allow	 analysing,	 in	 a	 single	 experiment,	 almost	 100	 different	 crystallisation	
conditions.	The	crystallisation	conditions	often	contain	a	buffer	that	maintains	the	pH	and	one	or	more	
precipitating	agents.	In	the	last	years,	the	appearance	of	robots	to	automate	and	monitor	the	search	
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for	 conditions	 and	 to	 store	 crystallisation	 plates	 have	 increased	 the	 number	 of	 crystallized	
biomolecules.	
Crystal	Optimization	
In	general,	the	crystals	obtained	in	this	first	stage	are	small	and/or	have	imperfections,	so	it	 is	
necessary	to	improve	their	quality.	Thus,	the	most	common	practice	is	scaling.	This	technique	consists	
in	increasing	the	work	volumes	of	the	protein	and	precipitant.	The	aim	is	to	improve	crystals	size	and	
their	degree	of	order,	to	finally	improve	the	quality	of	the	diffraction	pattern.	
At	the	same	time	as	trying	to	reproduce	the	crystals,	small	changes	are	usually	introduced	into	
the	 crystallisation	 solution	 (pH,	 temperature,	 precipitant	 concentration,	 etc.),	 the	 proportion	 of	 the	
drop	components	(protein/precipitant;	1:2,	2:1,	1:3,	etc.),	and	small	amounts	of	additives	or	ligands	in	
order	to	improve	the	quality	of	the	crystals.		
When	 the	 use	 of	 the	 above	 strategies	 is	 not	 effective,	 a	 technique	 called	 seeding	 can	 be	
useful239.	This	technique	consists	in	reducing	the	supersaturation	of	the	system	with	the	aim	of	placing	
it	 in	the	metastable	zone	inside	the	solubility	curve.	Then,	previously	formed	nuclei	or	micro	crystals	
are	added,	in	such	a	way	that	the	protein	present	in	the	solution	can	be	incorporated	into	them	and	
generate	bigger	crystals.	This	seeding	technique	include	three	variants:	micro-seeding,	macro-seeding	
and	streak-seeding.		
• Micro-seeding	consists	in	crushing	a	defective	crystal	previously	obtained,	and	using	its	nuclei	as	
a	basis	for	the	growth	of	new	crystals240.		
• Macro-seeding	is	based	on	manipulating	a	crystal	of	acceptable	size	but	with	imperfections.	The	
technique	consists	 in	performing	surface	washings	of	 the	crystal	and	using	 it	as	a	crystallisation	
nucleus.		
• Streak-seeding	 consists	 in	 introducing	 a	 natural	 fibre	 into	 a	 solution	 with	 crystalline	 nuclei	 or	
small	crystals,	and	dragging	the	nuclei	attached	to	the	fibre	to	the	solution	of	interest.	
3.1.5.	Protein-Ligand	Complex	Crystallisation	
To	get	a	better	understanding	of	 the	mechanism	of	action	of	a	biomolecule,	a	key	point	 is	 to	
have	the	description	of	the	three-dimensional	structure	of	the	protein	interacting	with	ligands,	such	as	
substrates	or	products	of	the	reaction.	For	the	protein-ligand	complexes	crystallisation	there	are	two	
main	strategies:	soaking	and	co-crystallisation241.	
• Soaking:	 The	 crystals	of	protein	are	 introduced	 into	a	 solution	 containing	 the	 ligand	at	high	
concentration.	The	ligand	can	diffuse	through	the	channels	that	already	exist	in	the	crystal	to	
get	 to	 the	 active	 or	 binding	 site	 of	 the	 crystallized	 protein.	 The	 main	 disadvantage	 of	 this	
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strategy	 is	 that	 many	 times,	 crystals	 are	 damaged	 by	 the	 entry	 of	 the	 substrate	 or,	 the	
substrate	cannot	reach	the	active/binding	site	due	to	the	crystal	packaging.	
• Co-crystallisation:	In	this	strategy,	the	ligand	is	added	to	the	protein	drop	at	the	beginning	of	
the	 crystallisation	 experiment.	 In	 general,	 the	 same	 crystallisation	 conditions	 of	 the	 apo	
protein	 can	 be	 used,	 but	 many	 times,	 for	 example	 due	 to	 conformational	 changes,	 new	
crystallisation	conditions	must	be	found.	
3.1.6.	Cryo-crystallography	
To	determine	the	crystal	structure	of	a	macromolecule,	a	complete	X-ray	diffraction	data	set	is	
required.	Typically,	 this	 involves	exposing	crystals	 to	X-rays	 radiation	over	a	 few	minutes,	 leading	 to	
radiation	 damage	 in	 the	 crystal	 and	 reduction	 of	 diffraction	 quality.	 This	 radiation	 effect	 can	 be	
mitigated	 at	 cryogenic	 temperatures.	 Nowadays,	 X-ray	 diffraction	 experiments	 are	 carried	 out	 at	
temperatures	of	about	100	K,	thus	the	crystalline	sample	 is	able	to	withstand	 intense	beams	of	 light	
such	as	those	produced	by	synchrotron	radiation.	
One	 limitation	 of	 this	 technique	 is	 the	 risk	 of	 the	 formation	 of	 ice	 crystals,	which	 affects	 the	
diffraction	pattern,	and	can	even	destroy	the	crystal.	To	avoid	this,	the	sample	must	be	treated	with	
cryopreservation	conditions.	Cryo-protectants	prevent	the	formation	of	ice	crystals242.	In	general,	the	
selection	of	an	appropriate	cryo-protectant	is	based	on	the	composition	of	the	crystallisation	condition	
of	the	protein.	The	most	common	cryoprotectants	are	usually	effective	at	a	concentration	between	15-
25%	(v/v)	and	are	included	in	the	mother	solution	of	crystallisation.	The	most	common	are	glycerol243,	
ethylene	glycol,	mineral	oil	and	PEG	400,	but	some	salts	are	also	effective,	such	as	malonate244.	
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3.2.	X-Ray	Diffraction	
3.2.1.	The	Diffraction	Phenomenon	
X-ray	diffraction	is	the	result	of	the	interaction	of	X-rays	with	the	electrons	of	the	atoms	in	the	
crystal.	 This	 interaction	 produces	 an	 electron-vibration	 coupling	 with	 variation	 of	 the	 electric	 field.	
Thus,	 part	 of	 the	 X-rays	 pass	 through	 the	 crystal	 and	 part	 are	 scattered	 by	 the	 electrons.	 These	
scattered	photons	can	be	annulled	(if	their	waves	interfere)	or,	due	to	their	periodic	nature,	they	can	
emerge	 in	 phase	 and	 reinforce	 themselves,	 generating	 the	 X-ray	 diffraction	 spectrum.	 This	
phenomenon	can	be	explained	geometrically	by	the	Bragg's	law	(William	Lawrence	and	William	Henry	
Bragg,	Nobel	Prize	in	Physics	in	1915):	 2𝑑ℎ𝑘𝑙𝑠𝑒𝑛𝜃 = 𝑛𝜆	
Equation	1.	Bragg’s	law.	
In	 this	 expression,	 different	 parallel	 atomic	 planes	 (hkl)	 separated	 by	 a	 distance	 (d)	 are	
considered,	with	an	angle	of	incidence	of	the	X-ray	beam	and	the	wavelength	of	the	beam	(λ)	(Figure	
29).	
	
Figure	29:	Bragg’s	law	scheme.	The	wave	that	falls	on	the	lower	plane	delays	a	whole	number	of	wavelength	and	leaves	
in	phase	with	the	upper	wave.	In	this	way,	it	reinforces	the	signal.	
To	better	explain	 the	diffraction	phenomenon,	 the	 reciprocal	network	concept	and	 the	Ewald	
model	 are	used	 (Figure	 30).	 In	 this	model,	 each	 family	of	Bragg’s	 planes	 is	 replaced	by	 a	 geometric	
point,	so	that	all	the	families	of	planes	contribute	to	a	reciprocal	network,	closely	related	to	the	crystal	
lattice.	 In	this	way,	the	diffraction	will	occur	when,	during	turning	the	crystal	 in	data	collection,	each	
one	 of	 the	 points	 of	 the	 reciprocal	 network	 interact	 with	 the	 surface	 of	 the	 Ewald	 sphere	 (whose	
radius	 is	 equal	 to	 the	 inverse	 of	 the	 wavelength).	 Finally,	 the	 diffracted	 beam	 can	 be	 collected	 by	
placing	the	detector	in	the	proper	position	(Figure	30).	
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To	perform	the	diffraction	experiment,	an	X-rays	source,	a	goniometer,	a	liquid	nitrogen	based	
low	temperature	system	and	a	detector	are	required.	
	
Figure	30:	Representation	of	the	Ewald’s	sphere.	When	a	reciprocal	point	meets	Ewald's	sphere	Bragg's	law	is	fulfilled.	
3.2.2.	X-Ray	Radiation	Sources	
The	history	of	X-rays	began	with	William	Crookes	in	the	19th	century.	This	physical-chemist	was	
studying	the	generation	of	high	voltage	currents	in	a	vacuum	tube	when	he	saw	that	if	it	was	close	to	
photographic	 films,	 fuzzy	 images	 were	 generated	 in	 them.	 From	 there,	Wilhem	 Röntgen	 continued	
with	Crookes’s	studies	and	discovered	these	unknown	(until	then)	X-rays.	With	this	discovery	he	was	
awarded	with	the	Nobel	Prize	in	Physics	in	1901.	
X-rays	are	extraordinarily	penetrating	electromagnetic	waves,	that	pass	through	certain	bodies,	
produced	by	the	emission	of	the	internal	electrons	in	the	atom.	In	this	way,	they	are	generated	by	the	
rapid	deceleration	of	very	energetic	electrons	when	hitting	a	metallic	target.	Normally,	the	most	used	
wavelength	in	protein	crystallography	is	of	the	order	of	1	Å,	suitable	for	atomic	distances.	In	general,	
two	main	X-ray	sources	are	used:	anode	generators	and	synchrotron	radiation	stations.	
• Rotatory	Anode	Generators:	The	conventional	diffractometers	typically	found	in	small	molecule	
crystallography	 laboratories	 contain	 high	 voltage	 tubes	 with	 a	 metal	 plate	 (usually	 copper)	
situated	 at	 the	 end,	 which	 is	 bombarded	 with	 accelerated	 electrons	 generated	 from	 an	
incandescent	filament.	When	these	excited	electrons	return	to	the	fundamental	state,	X-rays	are	
emitted	with	 a	 frequency	 proportional	 to	 the	 energy	 jump	 that	 triggered	 their	 excitation.	 This	
process	generates	a	lot	of	heat	and	therefore	the	rotatory	anode	generators	were	introduced,	in	
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which	the	metallic	anode	is	a	cylinder	that	rotates	to	achieve	a	better	cooling,	allowing	to	obtain	
much	more	intense	X-rays	than	from	a	conventional	tube.	
• Synchrotron	Radiation:	A	synchrotron	is	a	particle	(usually	electrons)	accelerator	in	which	these	
move	in	a	circular	orbit	by	the	action	of	a	magnetic	field	and	are	accelerated	at	speeds	close	to	
light	by	an	electric	field	synchronized	with	orbital	motion.	At	the	moment	in	which	the	rectilinear	
trajectory	 is	 broken	 the	electrons	emit	 a	 very	energetic	 radiation,	 synchrotron	 radiation,	which	
encompasses	different	wavelengths,	from	microwaves	to	X-rays	(Figure	31).	
	
Figure	 31:	 X-ray	 radiation	 synchrotron	 source.	 a)	 General	 scheme	 of	 a	 synchrotron.	 b)	 Exterior	 image	 of	 ALBA	
Synchrotron	(Barcelona).	
Cryo-Protection	
The	protein	 and	 solvent	 atoms	 can	 suffer	 irreparable	 damage	due	 to	 radiation,	 because	heat	
and	free	radicals	that	degrade	the	crystal	are	generated245.	To	solve	this,	a	low	temperature	system	is	
used.	This	system	cools	 the	crystal	with	a	stream	of	 liquid	nitrogen	reaching	temperatures	of	100	K.	
This	method	can	increase	the	average	life	of	the	crystal	and	its	resolution,	since	flexible	zones	are	fixed	
in	the	protein	due	to	the	decrease	of	its	thermal	vibration.	To	work	at	these	temperatures	the	crystal	
must	be	previously	cryo-protected.	After	setting	the	correct	cryoprotection	of	the	crystal,	it	is	captured	
in	a	nylon	or	similar	material	loop,	and	placed	in	a	device	called	the	goniometer.	The	goniometer	has	
several	degrees	of	freedom,	therefore	 it	allows	to	orient	the	crystal	 in	small	 intervals	of	0.2-1o	while	
the	 X-rays	 strike	 it,	 so	 that	 the	 crystal	 can	 be	 rotated	 to	 obtain	 a	 complete	 set	 of	 diffraction	 data	
(Figure	32).	
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Figure	32:	Diagram	of	the	assembly	and	data	collection	of	a	crystal.	
Detector	
Currently,	almost	all	detectors	used	in	macromolecular	crystallography	are	area	detectors.	The	
three	best	known	are:	
• Image	 Plate	 Detectors	 (IP):	 There	 is	 a	 plate	 that	 contains	 a	 lanthanide	 salt.	 Atoms	 are	 excited	
when	they	are	 irradiated	by	a	photon	from	the	diffracted	X-ray	beam.	Next,	a	 laser	sweeps	the	
plate	which	causes	a	light	emission	proportional	to	the	number	of	photons	absorbed.	This	light	is	
registered	 by	 a	 photomultiplier	 and	 becomes	 an	 image	 of	 the	 diffraction	 pattern.	 The	 process	
lasts	about	4-9	minutes	and	requires	to	erase	the	plate	in	each	measurement,	so	its	use	is	limited	
to	rotating	anode	generators.	
• Charged-Coupled	Device	Detectors	(CCD):	They	are	based	on	the	photoelectric	effect	and	convert	
the	received	light	in	the	form	of	photons	into	electric	current.	Therefore,	they	consist	of	a	sensor	
with	small	photoelectric	cells	that	register	the	image.	These	devices	are	more	sensitive	and	have	
shorter	exposure	times	than	IP	detectors.	They	are	usually	used	in	synchrotron	installations.	
• Pixel	Array	Detectors	(PAD):	This	device	contains	a	very	sensitive	silicon	layer	that	absorbs	X-rays	
and	converts	them	into	an	electrical	signal.	The	reading	system	is	extremely	efficient,	so	they	are	
present	in	synchrotron	installations.	Another	great	advantage	is	a	very	little	background	noise.	
3.2.3.	Data	Collection	
In	 this	 stage,	 a	 series	 of	 consecutive	 diffraction	 images	 are	 collected	 for	 different	 crystal	
positions.	The	goal	is	to	get	a	complete	data	set.	It	 is	essential	to	use	a	good	data	collection	strategy	
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since	the	subsequent	process	of	structural	resolution	will	depend	on	the	quality	of	data.	To	do	this,	a	
set	of	parameters	must	be	controlled	such	as	exposure	time,	angle	of	rotation	per	image	(Δϕ),	angle	of	
total	rotation,	distance	to	the	detector,	etc.246.	
3.3.	Structure	Determination	
3.3.1.	Data	Processing	
Once	the	diffraction	experiment	is	finished,	all	the	images	obtained	are	processed	to	extract	the	
net	intensities	of	the	diffracted	beams	(Figure	33).	
	
Figure	33:	Diffraction	Pattern.		
This	process	is	constituted	by	the	following	stages:	
• Indexing:	 The	 geometric	 arrangement	 (position)	 of	 the	 reflections	 in	 the	 diffraction	 pattern	
allows	us	to	extract	information	from	the	unit	cell	of	the	crystal	lattice	and	the	symmetry	of	the	
crystal.	Thus,	 the	Miller	 indices	 (hkl)	are	assigned	to	each	of	 the	 reflections,	and	 the	unit	cell,	
space	group	and	the	mosaicity	determined247,248	(the	mosaicity	estimates	the	grade	of	disorder	
in	a	crystal).	
• Integration:	 In	 this	 stage	 the	 intensities	 of	 each	 reflection	 and	 relative	 error	 are	 estimated.	
Therefore,	we	obtain	the	set	of	all	the	reflections	(hkl)	together	with	their	 intensities	(Ihkl)	and	
their	estimated	errors	(σhkl).	
• Scaling:	 In	 this	 stage	 the	 intensities	 are	 scaled	 and	 normalized,	 reducing	 the	 data	 to	 a	 set	 of	
unique	 reflections	 –	 reflections	 not	 related	 to	 each	 other	 by	 a	 symmetry	 element.	 This	
normalization	 is	 necessary	 due	 to	 experimental	 factors	 (temperature,	 intensity	 of	 the	 source	
and	decrease	of	 the	 intensities	by	destruction	of	 the	 crystalline	order).	Moreover,	due	 to	 the	
symmetry	contained	in	the	crystal	there	is	a	high	redundancy	of	data,	which	allows	obtaining	a	
set	of	statistical	parameters	that	give	an	idea	of	the	quality	of	the	data	in	terms	of	resolution.	
They	are	the	following:	
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o Multiplicity:	It	is	the	number	of	times	that	a	certain	reflection	has	been	recorded.	The	higher	
is	this	value,	the	better	the	estimate	of	errors	associated	with	the	reflection	measure.	
o Completeness:	Indicates	the	percentage	of	reciprocal	space	that	has	been	analysed.	
o <ΙI/σ(I)>:	Represents	the	relationship	between	intensity	and	background	noise.	Values	greater	
than	ca.	2	 for	 the	 last	 resolution	 layer	are	typically	accepted.	The	expression	 is	 (being	N	the	
number	of	reflections):	
< |𝐼|𝜎(𝐼) >= 1𝑁 |𝐼!!"|𝜎(𝐼!!")!!!" 	
Equation	2.	Relationship	between	intensity	and	background	noise.	
o Rmerge	 and	Rpim	 Factors:	Rmerge	evaluates	 the	difference	between	the	 intensity	of	a	 reflection	
measured	N	times	and	its	average	(Equation	3).	There	is	a	new	indicator	called	Rpim,	which	also	
takes	into	account	the	total	number	of	reflections	(Equation	4).	Maximum	values	of	ca.	0.3-0.6	
for	the	last	resolution	shell	(high-resolution	data)	are	typically	accepted.	
𝑅!"#$" = |𝐼 !!" ! − Ī !!" |!!!!!!" 𝐼!!"!!!!!!" 	
Equation	3.	Rmerge.	
𝑅!"# = 1𝑁 − 1 |𝐼 !!" ! − Ī !!" |!!!!!!" 𝐼!!"!!!!!!" 	
Equation	4.	Rpim.	
o CC1/2	and	CC:	Those	are	two	parameters	based	on	the	calculation	of	the	Pearson	correlation	
coefficient	(CC)249.	These	new	parameters	consider	that	if	the	data	set	is	divided	in	two	groups,	
the	errors	of	each	one	would	be	random.		
𝐶𝐶∗ = 2𝐶𝐶!/!1 + 𝐶𝐶!/!	
Equation	5.	Pearson	correlation	coefficient.	
• Structure	Factor	Calculation	(Fhkl):	It	is	defined	as	the	result	of	the	dispersion	of	the	X-rays	by	all	
the	atoms	of	 the	cell	 in	a	determined	direction.	The	 resultant	 is	a	wave	so	 it	has	an	associated	
vector	that	can	be	described	by	its	module,	|Fhkl|,	and	its	phase	ϕhkl.	The	modules	represent	the	
amplitudes	 of	 the	 diffracted	 beams	 and	 are	 obtained	 directly	 from	 the	 collected	 intensities.	
However,	 the	ϕhkl	 phases	 cannot	 be	measured	 directly	 and	 different	methods	 are	 required	 for	
their	calculation.	
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The	 analytical	 expression	 of	 the	 structure	 factors	 is	 shown	 in	 the	 Equation	 6.	 It	 shows	 the	
magnitude	 f,	which	 is	 the	atomic	 scattering	 factor	and	 represents	 the	amount	of	X-rays	atomic	
electrons	are	able	to	scatter:	
𝐹!!" = 𝑓!𝑒!!"(!!!!!!!!!!!)! 	
Equation	6.	Structure	Factor	(Fhkl).	
3.3.2.	Solving	the	Phase	Problem	
The	 transformation	 of	 the	 reciprocal	 space	 (diffraction	 spectrum)	 to	 the	 crystalline	 space	
(electron	 density	 function)	 involves	 the	 resolution	 of	 a	 function	 called	 the	 Fourier	 transform.	 This	
equation	relates	the	electron	density,	ρxyz	for	each	point	of	the	crystalline	unit	cell,	with	the	reciprocal	
space,	which	is	defined	by	the	structure	factors	Fhkl.	It	is	expressed	as:	
𝜌 𝑥, 𝑦, 𝑧 = 1𝑉 |𝐹!!"|!!!!!! 𝑒!!!"(!!!!!!!!!∅!!")
!!
!!!!
!!
!!!! 	
Equation	7.	Fourier	transform.	Where	V	is	the	volume	of	the	unit	cell.	
Therefore,	 to	calculate	 the	electronic	density	maps	on	which	 the	atomic	model	 is	going	 to	be	
built,	it	is	necessary	to	know	both	the	amplitudes	associated	with	the	diffracted	beam	|Fhkl|	extracted	
from	the	diffraction	pattern,	and	its	phase	ϕhkl	which	is	unknown.	This	constitutes	the	so-called	"phase	
problem"	in	protein	crystallography,	which	can	be	solved	by	three	methods:	
i) Molecular	 Replacement	 (MR):	 A	 homologous	 protein	 of	 known	 structure	 is	 used	 as	 the	 initial	
structural	model.	 This	method	 is	 based	 on	 the	 assumption	 that	 homologous	 proteins	 in	 peptide	
sequence	have	similar	folding	and,	therefore,	can	be	used	as	structural	models.	This	strategy	is	also	
used	 to	 solve	 the	 structure	of	 protein-ligand	 complexes	 in	 the	 case	 that	 the	 crystals	 belong	 to	 a	
different	space	group	than	the	crystals	of	the	protein.	The	technique	consists	in	placing	the	known	
macromolecule	 in	 the	 crystal	 of	 the	 unknown	 protein,	 for	 which	 it	 is	 necessary	 to	 know	 its	
orientation	 and	 specific	 position.	 The	 procedure	 is	 based	 on	 the	 use	 of	 the	 Patterson	 function,	
which	 is	essentially	the	Fourier	transform	of	the	 intensities	rather	than	the	structure	factors,	and	
the	calculation	of	rotation	and	translation	functions	(Figure	34).	
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Figure	 34:	 Outline	 of	 molecular	 replacement	 method.	 The	 molecule	 of	 known	 structure	 and	 model	 protein	 (A)	 is	
rotated	by	operation	(R)	and	is	transferred	by	operation	(T),	to	bring	 it	to	the	position	of	the	unknown	molecule	(A').	
Next	step	is	evaluating	if	this	is	the	correct	position	or	if	it	should	keep	looking	for	the	right	position.	
ii) Single/Multiple	 Isomorphous	 Replacement	 (SIR/MIR):	 Heavy	 atoms	with	 high	 atomic	 scattering	
factors	 are	 introduced	 in	 the	 crystal.	 Using	 the	 Patterson	 function	 and	 due	 to	 the	 difference	 of	
diffracted	 intensities	 between	 the	 heavy	 atom-containing	 crystal	 (derivative)	 and	 without	 heavy	
atoms	(native),	the	position	of	the	heavy	atoms	inside	the	unit	cell	can	be	determined	(known	as	
the	 substructure).	 From	 the	 positions	 of	 these	 heavy	 atoms,	 phases	 can	 be	 estimated	 to	 all	
reflections	in	the	dataset.	SIR:	a	single	crystal;	MIR:	several	derivative	crystals.	
iii) Single/Multi-wavelength	 Anomalous	 Diffraction	 (SAD/MAD):	 The	 effect	 of	 X-ray	 absortion	 by	
heavy	atoms	can	be	exploited	to	obtain	phase	information	experimentally.	To	perform	a	SAD/MAD	
experiment,	 incident	radiation	 is	matched	to	that	of	 the	absorption	maximum	of	 the	heavy	atom	
introduced	 in	 a	 derivative	 crystal.	 As	 a	 result,	 the	 atomic	 scattering	 factor	 is	 affected	 by	 i)	 a	
reduction	in	scattering	power,	since	some	of	the	 incident	radiation	 is	absorved	and	therefore	not	
able	to	scatter,	and	ii)	a	phase-delay	of	90	degrees	in	the	scattered	radiation.	These	changes	in	the	
atomic	 scattering	 factors	 can	 be	 used	 to	 determine	 the	 substructure	 of	 a	 derivative	 crystal	 by	
measuring	 X-ray	 diffraction	 data	 at	 one	 (SAD)	 or	 several	 (MAD)	wavelengths,	 requiring	 only	 one	
derivative	crystal.	
In	 addition,	 the	 isomorphic	 replacement	 and	 anomalous	 dispersion	methods	 (SIRAS/MIRAS)	 can	 be	
combined.	 Those	 are	 very	 powerful	 techniques	 to	 solve	 ab	 initio	 the	 phase	 problem	 for	 novel	
proteins250.	 	
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3.3.3.	Phases	Improvement	
Once	 the	 problem	 of	 the	 phase	 has	 been	 solved,	 the	 electronic	 density	 function	 can	 be	
calculated.	 The	 graphic	 representation	 of	 this	 function	 originates	 the	 electronic	 density	map,	which	
provides	 the	necessary	 information	 for	 building	of	 a	 protein	model.	Normally,	 the	 initial	 phases	 are	
just	 an	 approximation,	 and	 the	 improvement	 of	 the	 electronic	 density	 map	 is	 needed	 for	
interpretation.		
The	two	most	used	techniques	for	the	improvement	of	phases	are:		
• Solvent	Flattening:	This	technique	is	based	on	the	creation	of	a	mask	that	separates	protein	and	
solvent,	setting	a	constant	value	for	the	density	of	the	solvent.	
• Non-Crystallographic	 Symmetry	 Averaging:	 This	 technique	 averages	 density	 when	 there	 are	
several	 copies	of	 the	protein	 inside	 the	asymmetric	unit,	 reducing	 the	noise	and	 increasing	 the	
constraints	on	the	phases.	
3.3.4.	Model	Building	and	Refinement	
Once	 the	 best	 possible	 density	 map	 (2Fo-Fc)	 has	 been	 calculated,	 the	 polypeptide	 chain	 is	
modelled	on	the	electron	density	maxima,	which	is	usually	done	manually.	However,	in	case	of	having	
high	resolution	data	the	automatic	procedures	work	well.	In	cases	where	MR	has	been	used,	the	initial	
model	contains	an	important	bias	towards	the	homologous	protein	and	it	 is	necessary	to	alternate	a	
series	of	atomic	 coordinate	 refinement	 cycles,	with	a	manual	building.	Manual	 reconstruction	 is	 the	
only	way	to	eliminate	serious	errors	in	the	model	that	refinement	cannot	correct.	
Refinement	involves	the	adjustment	of	several	parameters	such	as	the	coordinate	of	each	atom	
(x,y,z),	the	thermal	B-factor	(thermal	vibration)	and	the	occupancy	(fraction	of	molecules	that	occupy	a	
position),	 in	 order	 to	 adjust	 as	 much	 as	 possible	 the	 model	 to	 the	 information	 obtained	 from	 the	
diffraction	 data.	 During	 refinement,	 stereochemical	 constraints	 are	 imposed	 to	 maintain	 distances,	
bond	 angles	 and	 appropriate	 torsions.	 The	 refinement	 is	 usually	 initiated	 as	 a	 rigid	 body	model	 in	
which	 the	 protein	 is	 considered	 as	 a	 whole,	 and	 is	 followed	 by	 statistical	 models	 of	 maximum	
likelihood.	In	the	last	stages,	it	continues	with	the	addition	of	ligands,	ions,	other	molecules	present	in	
the	crystal	and	solvent	molecules.	A	complementary	 technique	 is	 to	apply	 simulated	cooling	models	
using	 molecular	 dynamics,	 especially	 in	 the	 initial	 stages	 since	 they	 have	 a	 better	 degree	 of	
convergence	and	can	be	effective	in	eliminating	important	model	bias.	
To	evaluate	 the	 fit	of	 the	 refined	model	 into	 the	experimental	data,	 the	 reliability	or	 residual	
factor	 (Equation	 8)	 is	 calculated.	 The	 R-factor	 measures	 the	 difference	 between	 the	 observed	
amplitudes	Fo	and	calculated	Fc	from	a	model.	
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𝑅 = | 𝐹! − 𝐹! ||𝐹!| 	
Equation	8.	R-factor.	
To	avoid	bias	derived	from	over-parametrization	during	the	refinement	(overfitting),	a	statistical	
method	of	cross	validation	 is	applied.	To	do	 this,	 the	diffraction	data	 is	divided	 into	 two	groups	and	
two	R-factors	are	introduced.	The	first	group	of	reflections	contains	90-95%	of	the	data	(working	set,	
Rwork)	and	are	used	in	the	model	refinement.	The	second	group	contains	the	remaining	5-10%	(test	set,	
Rfree)	 and	 is	 used	 to	 verify	 that	 the	 refinement	 course	 actually	 leads	 to	 a	model	 that	 better	 fits	 the	
experimental	data251.	
Finally,	 differential	 electron	 density	 maps	 (Fo-Fc)	 are	 used	 in	 the	manual	 construction	 of	 the	
model.	In	those	the	peaks	of	positive	density	reveal	that	the	model	is	incomplete,	while	the	negatives	
peaks	show	incorrect	positions	in	the	model.	
The	model	 can	 be	 validated	when	 there	 are	 no	 residues	 of	 unmodeled	 electron	 density,	 the	
geometry	is	correct,	and	the	Rwork	and	Rfree	values	are	appropiate	(Rwork	<20-25%	and	Rfree	<30%).	
3.3.5.	Model	Validation	
The	validation	constitutes	the	last	stage	of	the	structural	resolution.	In	this	phase	the	geometry	
of	all	the	molecules	must	be	checked	as	well	as	their	correspondence	with	the	electron	density.	Thus,	
the	possible	existence	of	 clashes	between	atoms	 in	 the	crystal,	distances	and	bonding	angles	of	 the	
protein,	 conformation	 of	 the	 acceptable	 rotamers	 for	 the	 different	 amino	 acids,	 and	 torsion	 of	 the	
peptide	bond	(angles	phi,ϕ:	N-Cα	and	psi,	ψ:	Cα-C)	that	must	meet	the	requirements	of	Ramachandran	
can	be	determined	(Figure	35)252.	
	
Figure	35:	Ramachandran	Plot.	The	most	favourable	conformations	in	terms	of	phi,ϕ	and	psi,	ψ	of	the	peptide	bond	are	
highlighted.		
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The	final	model	is	deposited	in	the	Protein	Data	Bank	(PDB)	database,	where	it	 is	subjected	to	
new	tests.	This	file	has	a	.pdb	extension	and	contains	the	crystallographic	information	and	coordinates	
of	 the	 macromolecule,	 which	 can	 be	 visualized	 with	 numerous	 graphic	 softwares.	 Once	 the	 file	 is	
reviewed	and	approved,	an	identification	code	is	assigned	and	becomes	of	public	access.	
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4.	STRUCTURAL	INSIGHTS	OF	THE	ACYLTRANSFERASE	PatA	
4.1.	Materials	and	Methods	
4.1.1.	Expression	and	Purification	of	PatA	from	M.	smegmatis	
4.1.1.1.	 Truncated	Version	of	PatA	from	M.	smegmatis	
A	 truncated	 version	of	M.	 smegmatis	 PatA	 lacking	 the	 first	 12	 residues	 (PatA;	MSMEG_2934)	
was	 ligated	 into	 pJAM2	 vector.	 M.	 smegmatis	 mc2155	 cells	 transformed	 with	 the	 corresponding	
plasmid	pJAM2-PatA	were	grown	in	LB	medium	supplemented	with	0.05%	(v/v)	Tween	80	10%	and	50	
μg/ml	of	 kanamycin	at	37oC	 for	4	days.	 Then,	 LB	medium	supplemented	with	0.05%	 (v/v)	 tween	80	
10%	and	50	μg/ml	of	kanamycin	was	 inoculated	for	an	OD600=0.2	at	30oC	and	180	rpm	for	4-6	hours	
until	 it	 reached	a	 final	OD600=0.5-6.	 Finally,	 expression	of	PatA	was	 induced	by	 the	addition	of	0.2%	
acetamide	40%	at	30	oC	and	120	rpm	overnight	(ON).	Cells	were	collected	at	5,000	xg	for	15	minutes	
and	resuspended	 in	50	mM	Tris-HCl	pH	7.5,	500	mM	NaCl,	40	mM	 imidazole	 (solution	A)	containing	
protease	inhibitors	(Complete	EDTA-free;	Roche).	Then,	cells	were	disrupted	by	sonication	in	15	cycles	
of	60	seconds	pulses	with	90	seconds	cooling	 intervals	between	the	pulses.	PatA	was	centrifuged	at	
20,000	xg	for	20	minutes.	The	supernatant	was	filtered	first	with	a	0.4	μm	and	finally	with	a	0.22	μm	
filter	 and	 then	 the	 truncated	 version	 of	 PatA	was	 applied	 to	 a	 HisTrap	 Chelating	 column	 (1	ml,	 GE	
HealthCare)	previously	equilibrated	with	solution	A.	The	column	was	then	washed	with	solution	A	until	
no	absorbance	at	280	nm	was	detected.	Elution	was	performed	with	a	linear	20	ml	gradient	of	40–250	
mM	 imidazole	 in	 solution	 A	 at	 1	ml/min.	 The	 resulting	 PatA	 preparation	 displayed	 a	 single	 protein	
band	when	run	on	a	12%	NuPAGE	Bis-Tris	precast	gel	stained	with	SimplyBlue	SafeStain	(Invitrogen).	
The	 purified	 recombinant	 PatA	 protein	 was	 concentrated	 and	 diluted	 several	 times	 for	 a	 buffer	
exchange	to	eliminate	the	imidazole	by	using	a	Amicon-Ultra	spin	concentrator	(Merck	Millipore)	with	
a	30-kDa-molecular	mass	cutoff	and	the	final	buffer	50	mM	Tris-HCl	pH	7.5,	500	mM	NaCl.	
4.1.1.2.	 PatA	Full-Length	from	M.	smegmatis	
The	 full	 length	 version	 of	 the	 acyltransferase	 PatA	 (MSMEG_2934)21,24	 was	 purified.	 M.	
smegmatis	mc2155	 cells	 transformed	 with	 the	 corresponding	 plasmid	 pJAM3-PatA	 were	 grown	 in	
MM63	medium	(15	mM	(NH4)2SO4,	10	mM	KH2PO4,	1	mM	MgSO4.7H2O	and	17	mM	succinic	acid	pH	
7.0)	 supplemented	with	0.05%	 tween	80	10%	and	50	μg/ml	of	 kanamycin	 at	 37oC	 for	 4	days.	 Then,	
MM63	medium	(15	mM	(NH4)2SO4,	10	mM	KH2PO4,	1	mM	MgSO4.7H2O	and	17	mM	succinic	acid	pH	
7.0)	 supplemented	 with	 0.05%	 tween	 80	 10%	 and	 50	 μg/ml	 of	 kanamycin	 was	 inoculated	 for	 an	
OD600=0.2	at	30oC	and	180	rpm	for	4-6	hours	until	it	reached	a	final	OD600=0.5-6.	Finally,	expression	of	
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PatA	was	induced	by	the	addition	of	0.2%	Acetamide	40%	at	30oC	and	120	rpm	overnight	(ON).	Cells	
were	 collected	at	 5,000	 xg	 for	15	minutes	 and	 resuspended	 in	50	mM	Tris-HCl	pH	7.5	 and	500	mM	
NaCl	(solution	A)	containing	protease	inhibitors	(Complete	EDTA-free,	Roche).	The	cells	were	disrupted	
by	sonication	in	15	cycles	of	60	seconds	pulses	with	90	seconds	cooling	intervals	between	the	pulses.	
PatA	 was	 solubilized	 from	 the	mycobacterial	 membrane	 by	 the	 addition	 of	 2	 mM	 CHAPS	 and	 10%	
glycerol	(solution	B).	The	suspension	was	gently	stirred	during	1	hour	at	4oC	and	centrifuged	at	20,000	
xg	 for	 30	 minutes.	 The	 supernatant	 was	 applied	 to	 5	 ml	 TALON	 Superflow	 Metal	 Affinity	 Resin	
(Clontech)	previously	equilibrated	with	solution	B.	The	suspension	was	gently	stirred	during	1	hour	at	
4oC.	Finally,	the	suspension	is	packed	by	gravity	in	a	plastic	column	and	washed	with	30	ml	of	50	mM	
Tris-HCl	pH	7.5,	500	mM	NaCl,	10%	glycerol	(solution	C)	and	40	mM	imidazole.	Elution	was	performed	
by	gravity	gradient	with	steps	of	20	ml	of	solution	C	with	100	mM	imidazole,	200	mM	imidazole	and	
500	mM	imidazole	and	 fractions	of	1	ml	are	manually	 taken.	The	resulting	 fractions	are	analysed	by	
12%	 NuPAGE	 Bis-Tris	 precast	 gel	 stained	 with	 SimplyBlue	 SafeStain	 (Invitrogen),	 and	 fractions	 that	
correspond	to	PatA	molecular	weight	are	concentrated	and	diluted	several	times	for	a	buffer	exchange	
to	eliminate	the	imidazole	by	using	a	Amicon-Ultra	spin	concentrator	(Merck	Millipore)	with	a	30-kDa-
molecular	mass	cutoff	and	the	final	buffer	50	mM	Tris-HCl	pH	7.5	and	500	mM	NaCl.	
4.1.2.	Crystallisation	and	Data	Collection	
4.1.2.1.	 PatA-C16	Complex	
Three	crystal	forms	were	obtained,	referred	thereafter	as	PatA-C16-1,	PatA-C16-2	and	PatA-C16-3.	
The	first	and	second	crystal	forms	were	obtained	by	mixing	0.25	ml	of	the	truncated	version	of	PatA	
at	5	mg/ml	in	20	mM	Tris-HCl	pH	7.5	with	0.25	ml	of	mother	liquor	containing	100	mM	Tris-HCl	pH	7.0,	
230	mM	MgCl2	and	12-16%	(w/v)	PEG	8,000	using	the	sitting	drop	vapour	diffusion	method.	Crystals	
grew	in	7-15	days	and	were	transferred	to	a	cryo-protectant	solution	containing	25%	ethylene	glycol	
and	frozen	under	liquid	nitrogen.	Complete	X-ray	diffraction	data	sets	were	collected	at	beamline	I03	
(Diamond	Light	Source,	Oxfordshire,	UK)	and	processed	with	XDS	program253.	The	second	crystal	form	
of	 PatA	 diffracted	 to	 a	 maximum	 resolution	 of	 2.9	 Å	 and	 crystallized	 with	 four	 molecules	 in	 the	
asymmetric	 unit	 and	 space	 group	 P21	 (PatA-C16-2).	 The	 first	 crystal	 form	 of	 PatA	 diffracted	 to	 a	
maximum	resolution	of	2.06	Å	and	crystallized	with	two	molecules	 in	the	asymmetric	unit	and	space	
group	C2	(PatA-C16-1).	The	third	crystal	form	was	obtained	by	mixing	0.25	ml	of	the	truncated	version	
of	PatA	at	5	mg/ml	in	25	mM	Tris-HCl	pH	7.5,	150	mM	NaCl	with	0.25	ml	of	mother	liquor	containing	
100	mM	 Tris-HCl	 pH	 8.5	 and	 20%	 ethanol.	 Crystals	 grew	 in	 3	 days	 and	were	 transferred	 to	 a	 cryo-
protectant	solution	containing	25%	sucrose	and	frozen	under	liquid	nitrogen.	A	complete	set	of	X-ray	
diffraction	 data	 were	 collected	 at	 beamline	 X06SA	 Swiss	 Light	 Source	 (Villigen,	 Switzerland)	 and	
processed	with	XDS	program253.	PatA-C16-3	crystal	diffracted	to	a	maximum	resolution	of	2.43	Å	and	
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crystallized	with	one	molecule	in	the	asymmetric	unit	and	space	group	P42212	(Table	3).		
																																								PatA-C16-1																				PatA-C16-2																					PatA-C16-3	
Beamline	 I03	(DLS)	 I03	(DLS)	 PXI-X06SA	(SLS)	
Wavelength	(Å)	 0.97625	 0.97625	 0.99996	
Resolution	range	(Å)	 56.60	–	2.06	 92.37	–	2.90	 40.19	–	2.43	
Space	group	 C	2	 P	21	 P	42	21	2	
Unit	cell	
93.60		71.09		76.2	
90		91.95		90	
70.83		84.48		98.80	
90		110.78		90	
80.30		80.30		113.77	
90		90		90	
Total	reflections	 96616	(4273)	 73942	(5870)	 153438	(11538)	
Unique	reflections	 30533	(1973)	 23420	(1759)	 14652	(1057)	
Multiplicity	 3.2	(2.2)	 3.2	(3.3)	 10.5	(10.9)	
Completeness	(%)	 98.5	(86.7)	 96.2	(99.2)	 100.0	(100.0)	
Mean	I/sigma(I)	 10.6	(2.0)	 6.6	(1.7)	 4.6	(1.1)	
Wilson	B-factor	 21.81	 54.57	 41.10	
R-sym	 0.068	(0.410)	 0.115	(0.508)	 0.122	(0.669)	
R-factor	 0.1714	(0.2609)	 0.2389	(0.3409)	 0.2236	(0.2854)	
R-free	 0.2320	(0.3323)	 0.2737	(0.4251)	 0.2793	(0.3599)	
Number	of	atoms	 4441	 7720	 2098	
Macromolecules	 4055	 7548	 1989	
Ligands	 37	 72	 22	
Water	 349	 100	 87	
Protein	residues	 509	 1003	 256	
RMS(bonds)	 0.004	 0.005	 0.003	
RMS(angles)	 0.90	 0.99	 0.76	
Ramach.	favored	(%)	 99	 99	 97	
Ramach.	outliers	(%)	 0	 0	 0.39	
Clashscore	 1.49	 2.89	 1.01	
Average	B-factor	 20.10	 36.60	 53.70	
Macromolecules	 19.40	 36.90	 53.90	
Ligands	 26.00	 23.30	 55.90	
Solvent	 26.40	 20.60	 46.60	
Table	3:	PatA-C16	complex	data	collection	and	refinement	statistics.	Statistics	for	the	highest-resolution	shell	are	
shown	in	parentheses.	
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4.1.2.2.	 PatA-S-C16CoA	Complex	
One	crystal	form	was	obtained	by	mixing	0.25	µl	of	the	truncated	version	of	PatA	at	5.1	mg/ml	
in	1	mM	S-hexadecyl	Coenzyme	A	(S-C16CoA;	stock	solution	at	10	mM	in	20	mM	Tris-HCl	pH	7.5)	and	20	
mM	 Tris-HCl	 pH	 7.5	 with	 0.25	 ml	 of	 mother	 liquor	 containing	 100	 mM	 HEPES	 pH	 7.5,	 500	 mM	
ammonium	 sulfate	 and	 30%	 (v/v)	 2-methyl-2,4-pentanediol	 using	 the	 sitting	 drop	 vapour	 diffusion	
method.	Crystals	grew	in	7-15	days	and	were	directly	frozen	under	 liquid	nitrogen.	A	complete	X-ray	
diffraction	 data	 set	 was	 collected	 at	 beamline	 I03	 (Diamond	 Light	 Source)	 and	 processed	with	 XDS	
program253.	 PatA-S-C16CoA	 diffracted	 to	 a	maximum	 resolution	 of	 3.28	 Å	 and	 crystallized	 with	 four	
molecules	in	the	asymmetric	unit	and	space	group	P21	(Table	4).		
PatA-S-C16CoA	
Beamline	 I03	(DLS)	
Wavelength	(Å)	 0.978000	
Resolution	range	(Å)	 47.12	-	3.28	
Space	group	 P	21	
Unit	cell	
81.08	80.27	97.38	90	
110.92	90	
Total	reflections	 60657	(5816)	
Unique	reflections	 17931	(1708)	
Multiplicity	 3.4	(3.4)	
Completeness	(%)	 99.13	(94.36)	
Mean	I/sigma(I)	 11.18	(1.47)	
Wilson	B-factor	 103.69	
R-sym	 0.091	(0.898)	
R-factor	 0.2640	(0.4051)	
R-free	 0.3060	(0.4495)	
Number	of	atoms	 7597	
Macromolecules	 7400	
Ligands	 174	
Water	 23	
Protein	residues	 1011	
RMS(bonds)	 0.004	
RMS(angles)	 1.08	
Ramach.	favored	(%)	 99	
Ramach.	outliers	(%)	 0	
Clashscore	 2.46	
Average	B-factor	 111.90	
Macromolecules	 111.30	
Ligands	 139.40	
Solvent	 86.30	
Table	4:	PatA-S-C16-CoA	data	collection	and	refinement	statistics.	Statistics	for	the	highest-resolution	shell	are	shown	
in	parentheses.	
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4.1.2.3.	 PatA-C16-Man	Complex	
One	crystal	form	was	obtained	by	mixing	0.25	µl	of	the	truncated	version	of	PatA	at	5	mg/ml	in	
5	mM	D-(+)-mannose	and	20	mM	Tris-HCl	buffer	pH	7.5	with	0.25	µl	of	a	mother	liquor	containing,	100	
mM	Tris-HCl	pH	7.0,	225	mM	MgCl2	and	16%	(w/v)	PEG	8,000	using	the	sitting	drop	vapour	diffusion	
method.	Crystals	grew	in	7-15	days	and	was	transferred	to	a	cryo-protectant	solution	containing	25%	
ethylene	glycol	and	frozen	under	liquid	nitrogen.	on	a	PILATUS3	6M	pixel	detector	(100	Hz	max.	frame	
rate)	 at	 the	microfocus	 I24	 beamline	 (λ=0.9686	 Å	 -Diamond	 Light	 Source,	 UK)	 and	 integrated	 with	
XDS253	following	standard	procedures.	PatA-C16-Man	diffracted	to	a	maximum	resolution	of	2.42	Å	and	
crystallized	with	four	molecules	in	the	asymmetric	unit	and	space	group	P21	(Table	5).		
PatA-C16-Man	
Beamline	 I24	(DLS)	
Wavelength	(Å)	 0.9686	
Resolution	range	(Å)	
28.77-2.41	
(2.50-2.41)	
Space	group	 P	1	21	1	
Unit	cell	
70.69		83.86		98.43	
90		110.98		90	
Total	reflections	 133880	(12180)	
Unique	reflections	 40216	(3754)	
Multiplicity	 3.3	(3.3)	
Completeness	(%)	 97.17	(90.55)	
Mean	I/sigma(I)	 12.76	(2.44)	
Wilson	B-factor	 42.4	
R-merge	 0.1125	(0.4939)	
CC1/2	 0.989	(0.773)	
CC*	 0.997	(0.934)	
R-work	 0.1817	(0.2748)	
R-free	 0.2127	(0.3055)	
Number	of	non-H	atoms	 8086	
Macromolecules	 7824	
Ligands	 117	
Protein	residues	 1009	
RMS	(bonds)	 0.003	
RMS	(angles)	 0.57	
Ramachandran	favored	(%)	 98	
Ramachandran	allowed	(%)	 2.3	
Ramachandran	outliers	(%)	 0	
Rotamers	outliers	(%)	 0.91	
Clashscore	 1.68	
Average	B-factor	 44.52	
Macromolecules	 44.42	
Ligands	 54.39	
Solvent	 42.10	
Table	5:	PatA-C16-Man	data	collection	and	refinement	statistics.	Statistics	for	the	highest-resolution	shell	are	shown	in	
parentheses.	 	
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4.1.3.	Structure	Determination	and	Refinement	
4.1.3.1.	 PatA-C16	Complex	by	Single-wavelength	Anomalous	Diffraction	(SAD)	
PatA	crystals	of	 form	C2	 (PatA-C16-1)	were	 soaked	with	10	different	platinum	salts	 at	1	mM	
concentration	 for	 a	 time	 period	 of	 130-145	 min	 (HR2-442,	 Hampton	 Research)	 followed	 by	 flash	
freezing	 in	 liquid-N2.	 Anomalous	 data	 were	 collected	 at	 the	 theoretical	 L–I	 absorption	 edge	 of	 Pt	
(13,879.9	eV-0.8933	Å).	Oscillation	images	were	collected	at	I04	beamline	(Diamond	Light	Source)	with	
an	oscillation	angle	of	0.2	 for	a	 total	of	1,800	 images	using	a	Pilatus	6M-F	pixel	detector.	Data	were	
collected	with	an	attenuated	X-ray	beam	(5%	transmission)	and	a	0.04-s	exposure	time	per	image.	Data	
were	 integrated	 and	 scaled	 in	 XDS	 and	 experimental	 phases	 determined	 using	 the	 SHELXC/D/E	
package254.	Data	of	a	PatA	crystal	soaked	with	1	mM	K2PtCl4	for	130	min	were	used	for	experimental	
phasing	with	a	2.5-Å	data	cutoff	applied,	giving	a	mean	value	|ΔF|/σ(ΔF)	in	the	highest	resolution	shell	
of	 0.9.	 The	 substructure	 determination	 located	 two	 Pt	 atoms	 in	 the	 asymmetric	 unit	(CC=33.64,	
CC(weak)=20.71	and	CFOM=54.35).	Experimental	phases	were	determined	and	subsequently	used	for	
initial	 cycles	 of	 model	 building	 and	 density	 modifications	 by	 SHELXE.	 Buccaneer255	 and	 the	 CCP4	
suite256	were	used	for	further	model	extension	(Table	6).		
The	 structure	 determination	 of	 PatA-C16-1,	 PatA-C16-2	 and	 PatA-C16-3	 were	 carried	 out	 by	
molecular	 replacement	using	Phaser257	 and	 the	PHENIX	 suite258	 and	 the	PatA-Pt	 structure	as	model.	
Followed	 by	 cycles	 of	 manual	 rebuilding	 and	 refinement	 using	 Coot259	 and	 phenix.refine260,	
respectively.	The	structures	were	validated	by	MolProbity261.	
PatA·Pt	
Beamline	 I04	(DLS)	
Wavelength	(Å)	 0.8933	
Photon	energy	(keV)	 13.8799	
Exposure	(s)	 0.040	
Transmission	(%)	 5.01	
Beamsize	(μm)	 90	x	45	
Total	images	 1800	
Ω	Osc	(°)	 0.20	
Resolution	range	(Å)	 78.09	-	1.88	
SigAno	#	>	0.88	(Å)	 78.09	-	2.33	
Space	group	 C2	
Unit	cell	
95.99	71.04	78.200	90	
93.01	90	
Total	reflections	 254696	(8905)	
Unique	reflections	 41213	(2343)	
Multiplicity	 6.2	(3.8)	
Completeness	(%)	 96.4	(74.6)	
Mean	I/sigma(I)	 15.0	(2.1)	
Wilson	B-factor	 20.44	
R-sym	 0.076	(0.462)	
Table	6:	Data	collection	for	experimental	phasing.	♯Mean	anomalous	difference	in	units	of	its	estimated	standard	
deviation	(|F(+)-F(-)|/Sigma).		 	
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4.1.3.2.	 PatA-S-C16	Complex	by	Molecular	Replacement	
The	structure	determination	of	PatA-S-C16CoA	was	carried	out	by	molecular	replacement	using	
Phaser257	and	the	PHENIX	suite258	and	the	PatA-Pt	structure	as	model.	Followed	by	cycles	of	manual	
rebuilding	 and	 refinement	 using	 Coot259	 and	 phenix.refine260,	 respectively.	 The	 structures	 were	
validated	by	MolProbity261.	
4.1.3.3.	 PatA-C16-Man	Complex	by	Molecular	Replacement	
Structure	determination	of	PatA	was	resolved	using	as	a	template	the	previously	reported	PatA	
structure	in	complex	with	palmitate	(PDB	5F2T)21	and	molecular	replacement	methods	implemented	in	
Phaser257	and	the	PHENIX	suite258.	Model	rebuilding	was	carried	out	with	Buccaneer255	and	the	CCP4	
suite256.	The	final	manual	building	was	performed	with	Coot259	and	refinement	with	phenix.refine260.	
The	 structure	 was	 validated	 by	MolProbity261.	 Atomic	 coordinates	 and	 structure	 factors	 have	 been	
deposited	 with	 the	 Protein	 Data	 Bank,	 accession	 code	 5OCE.	 Molecular	 graphics	 and	 structural	
analyses	were	performed	with	the	UCSF	Chimera	package262.	
4.1.4.	N-Terminal	Sequence	Analyses	
Samples	were	applied	to	a	NuPAGE	4–12%	gel.	The	gel	was	then	washed	with	NuPAGE	transfer	
buffer	(Invitrogen)	for	15	min	at	room	temperature.	Proteolytic	fragments	were	electrotransferred	to	
a	PVDF	membrane	using	the	iBlot	dry	blotting	system	(Invitrogen)	for	7	min.	The	PVDF	membrane	was	
then	washed	 for	 10	min	with	Milli-Q	 purified	water.	 Bands	were	 stained	with	 a	 solution	 containing	
0.1%	Coomassie	brilliant	blue	R-250,	 40%	methanol	 and	1%	acetic	 acid	 and	 subjected	 to	N-terminal	
sequence	 analysis	 using	 Applied	 Biosystems	 494	 procise	 cLC	 protein	 sequencer	 in	 the	 Functional	
Genomics	 Center	 Zurich	 at	 the	 ETH	 Zurich,	 Switzerland.	 Two	 sequences	 were	 found,	 MVTLSG	 and	
VTLSGR,	indicating	that	the	purified	protein	corresponds	to	full-length	PatA,	with	the	N-terminal	Met	
cleaved	off	by	about	50%.		
4.1.5.	PatA	Acyltransferase	Activity	Assay	
The	 truncated	 version	 of	 PatA	 transferase	 activity	 was	 measured	 in	 the	 assay	 with	
mycobacterial	membranes24.	Briefly,	M.	 smegmatis	mc2155	 cells	were	broken	by	 sonication	and	 the	
membrane	 (100,000	 xg	 pellet)	 fraction	 was	 obtained	 by	 differential	 centrifugation.	 The	 reaction	
mixtures	contained	250	mg	of	membrane	proteins,	1.2	mg	of	purified	PimASM,	10	mg	of	purified	PatA	
or	the	mutated	versions,	0.1	mCi	GDP-[14C]mannose	(specific	activity	of	55	mCi/mmol,	ARC	Inc.),	0.12	
mM	palmitoyl-CoA	(Sigma-Aldrich)	in	DMSO	with	final	concentration	in	the	reaction	mixture	2%	(v/v),	
62	mM	ATP,	10	mM	MgCl2,	and	25	mM	Tris-HCl	pH	7.5	 in	the	final	volume	of	50	ml.	Reactions	were	
incubated	100	min	at	37oC	and	stopped	with	300	ml	of	CHCl3/CH3OH	 (2:1,	by	volume).	The	 samples	
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were	 left	 rocking	30	min	at	 room	 temperature,	 and	centrifuged	at	1,500	xg	 for	10	min.	The	organic	
phase	(bottom)	was	analysed	by	thin	layer	chromatography	on	aluminium-coated	silica	60	F254	plates	
(Merck)	 developed	 in	 CHCl3/CH3OH/conc.	 NH4OH/H2O	 (65:25:0.5:4),	 and	 quantified	 by	 scintillation	
spectrometry24.	 All	 enzymatic	 activity	 measurements	 were	 determined	 in	 duplicates.	 Following	 the	
same	procedure,	palmitate	was	assayed	as	a	possible	inhibitor	or	substrate	at	different	concentrations.	
4.1.6.	PatA	Palmitoyl-CoA	Hydrolytic	Activity	Assay	
4.1.6.1.	 Hydrolytic	Activity	of	the	Truncated	PatA	in	the	Absence	PIM2	
The	hydrolytic	activity	of	the	truncated	version	of	PatA	and	PatA	mutants	against	palmitoyl-CoA	
was	measured	as	 following	a	methodology	described	 for	other	acyltransferases263.	A	 typical	 reaction	
contained	20	mM	Tris-HCl	pH	8.3,	 0.2	mM	disulfide	 [5,5’-dithiobis-(2-nitrobenzoic	 acid)]	 (DTNB),	 0.2	
mM	palmitoyl-CoA	and	4	μM	PatA	or	its	variants.	All	reactions	were	carried	out	at	37°C	in	a	CARY	300	
Bio	UV	Visible/Spectrophotometer.	The	spectrum	of	the	product	TNB-2	formed	after	the	interaction	of	
the	DTNB	and	 the	CoA	 liberated	 from	 the	hydrolysis	of	 the	 substrate	palmitoyl-CoA	by	 the	enzyme,	
was	 measured	 continuously	 at	 412	 nm	 during	 20	 min.	 All	 enzymatic	 activity	 measurements	 were	
determined	in	duplicates.		
4.1.6.2.	 Hydrolytic	Activity	of	the	Full-length	PatA	in	the	Presence	of	PIM2	
Enzymatic	activity	of	full-length	PatA	against	palmitoyl-CoA	by	using	diacylated	and	deacylated	
PIM2	as	acceptors	of	the	reaction	was	measured	as	following	a	methodology	previously	described	for	
other	acyltransferases263.	Reactions	were	performed	in:	i)	5%	(v/v)	DMSO	in	order	to	solubize	PIM2	or	
ii)	 1	mM	DOPC-SUVs	with	 incorporation	of	 PIM2	by	 vortexing	 the	mixture	 for	 4	min.	 Both	 reactions	
contained	 20	mM	 Tris-HCl	 pH	 8.3,	 0.6	mM	 disulfide	 [5,5ʹ-dithiobis(2-nitrobenzoic	 acid)]	 (DTNB),	 0.2	
mM	palmitoyl-CoA,	0.2	mM	PIM2	or	decetylated	PIM2	and	3.5	μM	PatA.	All	reactions	were	carried	out	
at	room	temperature	 in	a	UV-Vis	NanoDrop™	One/OneC.	The	spectrum	of	the	product	TNB-2	formed	
after	the	interaction	of	the	DTNB	and	the	CoA	liberated	from	the	hydrolysis	of	the	substrate	palmitoyl-
CoA	 by	 the	 enzyme,	 was	 measured	 continuously	 at	 412	 nm	 during	 20	 min.	 All	 enzymatic	 activity	
measurements	were	determined	in	triplicates.		
4.1.7.	Preparation	of	Small	Unilamellar	Vesicles	(SUVs)	
1,2-dioleoyl-sn-glycero-3-phosphoglycerol	 (DOPC)	 lipid	 vesicles	were	 prepared	 in	 20	mM	 Tris-
HCl	pH	8.3.	A	dry	lipid	film	was	prepared	from	a	chloroform:methanol	(2:1)	DOPC	solution	by	removing	
the	 solvent	under	a	 stream	of	N2	and	high	vacuum.	DOPC	SUVs	were	prepared	by	dispersion	of	 the	
lipids	 in	 buffer	 by	 vigorous	 vortexing	 and	 following	 sonication	 with	 a	 probe	 tip	 sonicator	 (MSE	
Soniprep	150	(MSE,	UK))	for	10	min	(5	seconds	on	and	off	cycles)	at	100	μm	amplitude.		 	
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4.1.8.	Chemical	Synthesis	of	PIM2	
PIM2	 (1)	 was	 obtained	 using	 a	 route	 adapted	 from	 published	 procedures264,265,	 starting	 from	
mannose	 donor	 2,	 known	 inositol	 derivative	 3	 and	 (S)-1,2-di-O-palmitoyl	 glycerol	 9266.	 2	was	 easily	
obtained	 in	 two	 steps	 from	 ethyl	 2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside.267	
Removal	of	the	2-O-acetate	group	in	basic	methanol	(MeONa	in	MeOH)	and	protection	of	the	liberated	
alcohol	with	FMOC	chloroformate	and	pyridine	in	dichloromethane	gave	2	in	75%	overall	yield.	Chiral	
inositol	3	was	prepared	from	methyl	α-D-glucopyranoside	following	a	biomimetic	approach	described	
in	the	literature268.	Finally,	known	dipalmitoylglycerol	9	was	prepared	from	commercially	available	(S)-
(+)	1,2-isopropylidene	glycerol	by	a	four-steps	sequence.	Benzylation	of	the	primary	position	of	(S)-(+)	
1,2-isopropylidene	 glycerol	 (BnBr,	NaH,	DMF),	 acidic	 hydrolysis	 of	 the	 ketal	 (trifluoroacetic	 acid	 in	 a	
THF/	H2O	mixture,	88%	yield	for	the	two	steps),	bis-palmitoylation	with	palmitic	acid	and	DCC/DMAP	in	
refluxing	 toluene	 (90%)	 and	 removal	 of	 the	 benzyl	 protecting	 group	by	 hydrogenolysis	 (H2,	 catalytic	
Pd(OH)2/C,	70%)	gave	9.	
Treatment	of	myo-inositol	derivative	3	with	3.0	equiv.	of	mannose	donor	2	under	NIS/TMSOTf	
activation	 in	 dichloromethane	 gave	 the	 bis-α-glycosylated	 inositol	 4	 in	 good	 yield.	 The	 FMOC	
protecting	groups	were	removed	with	NEt3	in	THF	(82%)	and	the	liberated	alcohol	functions	of	5	were	
protected	 with	 freshly	 distilled	 benzyloxymethyl	 chloride	 (BOM-Cl)	 in	 a	 concentrated	 chloroform	
solution	to	give	6	in	high	yield.	These	experimental	conditions	are	crucial	to	get	a	high	yield	of	the	bis-
BOM	ether.	Elaboration	of	 the	phosphodiester	bond	of	1	was	carried	out	without	purification	of	 the	
intermediates.	 Removal	 of	 the	 acetate	 group	 on	 6	 was	 done	 by	 treatment	 of	 6	 with	 sodium	
methanolate	 in	methanol	and	7	was	obtained	 in	quantitative	yield.	Alcohol	7	was	 then	 transformed	
into	H-phosphonate	8	with	PCl3,	triethylamine	and	imidazole	in	toluene.	After	work-up	of	the	reaction,	
crude	H-phosphonate	8	 was	 reacted	with	9	 under	 pivaloyl	 chloride	 activation	 in	 pyridine,	 followed,	
without	work-up,	by	oxidation	of	the	intermediate	H-phosphonate	to	the	phosphate	10	with	iodine	in	
a	pyridine/water	mixture.	10	was	obtained	in	a	rewarding	83%	isolated	yield	for	the	three	steps	from	7.	
Final	 deprotection	 of	 all	 protecting	 groups	was	 carried	 out	 in	 one	 step	 by	 hydrogenolysis	with	 20%	
palladium	 hydroxide	 on	 carbon	 as	 catalyst	 in	 a	 2/3	 THF/methanol	 mixture	 and	 gave	 the	 targeted	
Ac2PIM2	1	in	74%	isolated	yield.	
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For	further	details	please	see	Annex	I.	
	
4.1.9.	Preparation	of	Deacylated	PIM2		
Deacylated	 PIM2	 was	 prepared	 by	 mild	 alkali	 hydrolysis	 of	 acylated	 PIM2	 purified	 from	M.	
tuberculosis	(BEI	Resources,	NIAID,	NR-14846).	To	this	end,	1	mg	of	dried	sample	was	resuspended	in	
100	μl	of	a	chloroform:methanol	 (2:1).	After	 the	addition	of	100	μl	of	0.2	M	NaOH	 in	methanol,	 the	
sample	was	incubated	during	30	min	at	37°C.	Then,	the	sample	was	carefully	neutralized	with	glacial	
acetic	 acid	 to	 pH	 7.0.	 The	 deacylated	 PIM2	 was	 extracted	 by	 sequentially	 adding	 200	 μl	 of	
chloroform:methanol	(2:1),	200	μl	of	chloroform	and	100	μl	of	water.	The	sample	was	mixture	by	using	
a	Vortex	device	and	then	centrifuged	at	5,000	xg	for	5	min.	The	upper	aqueous	phase	contained	the	
deacylated	 form	 of	 PIM2.	 PIM2	 extraction	 was	 repeated	 by	 adding	 100	 μl	 of	 water	 to	 the	 bottom	
organic	phase.	The	two	water	phases	were	pooled	and	the	identity	of	deacylated	PIM2	was	confirmed	
by	MALDI-TOF.	
PCl3, imidazole
3
8
4  R1 = Ac, R2 = Bn, R3 = FMOC
5  R1 = Ac, R2 = Bn, R3 = OH
6  R1 = Ac, R2 = Bn, R3 = BOM
7  R1 = OH, R2 = Bn, R3 = FMOC
2
9
10
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NEt3
BOMCl, CHCl3
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MeONa, MeOH
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Figure	 36:	 Mass	 spectrometry	 of	 deacylated	 PIM2.	 a)	 Extracted	 ion	 chromatogram	 at	 m/z	 657.166,	
representing	 PIM2	deacylated.	b)	 Low	 collision	 energy	 spectrum	of	 the	 XIC	 peak	 at	 3.49.	 c)	 High	 collision	
energy	spectrum	of	the	XIC	peak	at	3.49.	
4.1.10.	Molecular	Docking	Calculations	
The	 crystal	 structure	 of	 mycobacterial	 PatA	 in	 complex	 with	 S-C16CoA	 (PatA-S-C16CoA)	 was	
investigated	using	the	structure	preparation	function	in	MOE2013.08269.	First,	S-C16CoA	coordinates	in	
PatA-S-C16CoA	crystal	structure	(chain	A)	were	used	to	generate	palmitoyl-CoA	atomic	coordinates	by	
substitution	of	C16	atom	with	a	carbonyl	group.	Then	the	model	was	prepared	using	the	Amber12EHT	
force	 field,	 an	 all-atom	 force	 field,	 combining	 two-dimensional	 Extended	 Hueckel	 Theory	 (EHT)	 and	
Amber12	 force	 field,	 with	 Born	 solvation,	 and	 hydrogen	 atoms	 were	 added	 using	 Protonate3D	
function270,271.	 The	 docking	 site	 of	 PIM1	 and	 PIM2	was	 defined	 by	 14	 residues	 of	 the	 PatA-S-C16CoA	
crystal	structure.	PIM2	structure	was	retrieved	from	the	PDB	(ligand	code	XPX)	and	after	substitution	of	
acyl	chains	with	acetyl	groups,	the	molecule	was	energy	minimized	using	MOE	with	a	0.1	kcal/mol·Å	
r.m.s.	gradient	threshold.	PIM1	structure	was	constructed	by	removing	one	mannose	ring	of	PIM2.	The	
PIM1	and	PIM2	structures	were	submitted	 to	conformational	 search	using	LowModeMD	with	default	
parameters	 in	MOE2013.08272.	 The	 same	procedure	was	 carried	out	with	PIM1,	 in	which	a	mannose	
residue	 GOLD	 (Genetic	 Optimization	 for	 Ligand	 Docking;	 Cambridge	 Crystallographic	 Data	 Center	
(CCDC),	 version	 5.2.2)	 was	 used	 with	 default	 genetic	 algorithm	 parameter	 settings273,274	 for	 all	
calculations,	 with	 the	 exception	 that	 the	 search	 efficiency	 parameter	 was	 set	 to	 200%	 to	 improve	
predictive	accuracy	by	calculating	the	optimal	number	of	genetic	algorithm	operations	for	the	 ligand	
due	 to	 their	 large	 flexibility.	 The	 ASP	 scoring	 function	 implemented	 in	 GOLD	was	 used	 to	 rank	 the	
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docked	 poses;	 this	 fitness	 function	 has	 been	 optimized	 for	 the	 prediction	 of	 ligand-binding	
positions275,276.	PIM1	and	PIM2	were	docked	into	the	PatA-palmitoyl-CoA	complex.	Only	docking	poses	
having	 a	 C6-hydroxyl	 group	 of	 the	mannose	 closed	 to	 the	 thioester	 of	 palmitoyl-CoA	were	 kept	 for	
analysis.	The	best	solutions	were	assessed	by	their	respective	docking	score	and	by	visual	inspection.	
4.1.11.	Quantum	Mechanics/Molecular	Mechanics	Molecular	Dynamics	
Simulations	
The	 initial	 structure	 of	 the	 PatA-PIM2-C16-CoA	 enzymatic	 complex	was	 obtained	 by	molecular	
docking	in	our	previous	work.		
Protonation	 states	 of	 all	 ionisable	 residues	 were	 selected	 from	 close	 inspection	 of	 intermolecular	
interactions.	 The	 total	 model	 was	 composed	 by	 49,756	 atoms,	 including	 11	 Na+	 counterions	 and	
15,192	water	molecules	surrounding	the	enzyme.		
Classical	 molecular	 dynamics	 (MD)	 simulations	 were	 performed	 to	 equilibrate	 the	 ternary	 complex	
using	the	Amber11	software.	The	FF99SB277,	GLYCAM06278,	and	TIP3P279	force-fields	were	selected	to	
describe	the	protein,	carbohydrates	and	water	molecules,	respectively.	Gaff	parameters280	were	used	
to	describe	C16-CoA.	Weak	spatial	 constraints	were	applied	 to	 the	Man1	sugar	 in	 the	 first	25	ns	and	
released	afterwards.	Analysis	of	the	trajectories	was	carried	out	using	standard	tools	of	AMBER281	and	
VMD282.	
QM/MM	MD	simulations	were	done	using	the	Car-Parrinello	code283	which	is	based	on	Density	
Functional	 Theory	 (DFT).	 The	 QM	 zone	 was	 composed	 by	 84	 atoms	 in	 total,	 including	 the	 reactive	
mannose	 (Man1)	 and	half	 of	 the	 inositol	 ring	 that	 is	 attached	 to	 it,	 a	 segment	of	 the	Palmitoyl-CoA	
substrate,	 the	 catalytic	 histidine	 (His126)	 and	 also	 the	 charge	 relay	 glutamate	 Glu200.	 Capping	
hydrogens	were	 used	 to	 define	 the	QM/MM	 interface.	 The	QM	 region	was	 enclosed	 in	 an	 isolated	
supercell	 of	 size	 22.0×20.0×20.7	 Å253.	 Kohn−Sham	 orbitals	were	 expanded	 in	 a	 planewave	 basis	 set	
with	a	kinetic	energy	cut-off	of	70	Ry.	Norm-conserving	Troullier-Martins284	ab	initio	pseudopotentials	
were	used	for	all	elements.	The	calculations	were	performed	using	the	Perdew,	Burke,	and	Ernzerhoff	
(PBE)	generalized	gradient-corrected	approximation.	A	fictitious	electronic	mass	of	700	au	and	a	time	
step	of	5	au	were	used	to	ensure	an	adiabaticity	of	7.4·10	−5	au·ps−1	 ·atom−1	for	 the	 fictitious	kinetic	
energy.	The	reaction	free	energy	landscape	(FEL)	was	explored	using	metadynamics284.	Three	collective	
variables,	 as	 described	 in	 the	 main	 text,	 were	 used	 to	 monitor	 the	 reaction.	 A	 hill	 height	 of	 1.0	
kcal/mol	and	the	deposition	time	of	30	fs	(250	MD	steps)	was	considered.	Gaussian	widths	were	tuned	
according	to	the	oscillations	of	each	collective	variable	(0.45	Å,	0.45	Å	and	0.65	Å	for	CV1,	CV2	and	CV3	
respectively).	An	upper	wall	at	3.2	Å	was	set	up	for	the	first	collective	variable,	and	lower	walls	at	2.6	Å	
and	-3.2	Å	for	the	second	and	the	third	collective	variables.	The	first	step	of	the	reaction	was	observed	
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after	511	deposited	Gaussians,	reaching	the	reaction	intermediate.	The	simulation	was	stopped	after	
the	 deposition	 of	 367	 more	 Gaussians	 in	 the	 intermediate	 well,	 when	 the	 S-CoA	 leaving	 group,	
negatively	 charged,	 flipped	 up	 and	 performed	 strong	 hydrogen	 bonds	 with	 Arg201.	 The	 reaction	
transition	 state	 was	 further	 verified	 by	 isocommittor	 analysis	 using	 20	 trajectories.	 To	 reduce	 the	
computational	 cost	 of	 the	3D	exploration,	we	 took	 a	 snapshot	of	 the	 reaction	 intermediate	 and	we	
performed	a	second	metadynamics	simulation	in	which	we	onlyt	activated	CV3.	In	this	case,	since	we	
expected	a	lower	free	energy	barrier,	we	decreased	the	hill	height	to	0.6	kcal/mol,	keeping	the	same	
deposition	time	as	in	the	previous	metadynamics	simulation.	The	Gaussian	width	was	set	to	0.20	Å	and	
an	upper	and	lower	wall	were	defined	at	2.0	Å	and	-2.0	Å.	First	crossing	criterion	was	used	to	stop	the	
simulation285.	
4.1.12.	Sequence	Alignment	and	Structural	Analysis	
The	sequence	of	PatA	from	M.	smegmatis	 (A0QWG5)	was	subjected	to	basic	 local	alignment	
search	 tool	 (BLAST)	and	several	orthologues	 in	Mycobacteria	sp.	were	 found.	Afterwards,	 they	were	
aligned	using	the	ClustalW	server	(http://www.ebi.ac.uk/Tools/msa/clustalw2/).		
The	 structure	 weighted	 sequence	 alignment	 was	 performed	 using	 PROMALS3D286.	 For	 labelling	 the	
conserved	 and	 similar	 residues,	 BoxShade	 server	 was	 used	 (http://embnet.vital-
it.ch/software/BOX_form.html).	Structural	analysis	and	graphics	for	publications	were	performed	with	
PyMOL	(version	0.99)287	and	Chimera262.	
		 84	
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4.2.	Results	and	Discussion	
The	 comprehension	 of	 the	 early	 steps	 of	 PIM	 biosynthetic	 pathway	 has	 been	 a	 major	 goal	
during	the	recent	years	due	to	 its	 importance	into	the	search	of	drug	targets	against	M.	tuberculosis.	
The	 crystal	 structures	 of	 the	 glycosyltransferases	 PimA	 and	 PimB	 have	 been	 reported15,16,25,212.	
However,	 to	 date,	 no	 structural	 information	 is	 available	 for	 PatA,	 an	 enzyme	 that	 is	 a	member	 of	 a	
large	 family	 of	 acyltransferases	 for	 which	 the	 molecular	 mechanism	 of	 substrate	 recognition	 and	
catalysis	remains	not	well	understood2,3,17,18.	Specifically,	PatA	transfers	a	palmitate	at	position	6	of	the	
Manp	 residue,	 transferred	 by	 PimA,	 from	 Palmitoyl-CoA	 to	 PIM1	 or	 PIM2,	 to	 form	 Ac1PIM1	 and	
Ac1PIM215.		
This	 chapter	 provides	 a	 detailed	 investigation	 of	 the	 three-dimensional	 structure,	 glycolipid	
acceptor	 and	 acyl	 donor	 substrate	 binding,	 as	 well	 as	 the	 catalytic	 mechanism	 of	 PatA	 from	 M.	
smegmatis,	 as	 well	 as	 a	 model	 for	 substrate	 recognition,	 catalysis	 and	 enzyme	 inhibition.	 The	
implications	of	this	model	in	the	comprehension	of	the	early	steps	of	PIM	biosynthesis	and	the	mode	of	
action	of	other	members	of	the	bacterial	acyltransferase	family	of	enzymes	are	discussed.		
The	 references	 of	 this	 chapter	 are	 based	 on	 the	 publications,	 mentioned	 in	 “Publications”	 section,	
Structural	 basis	 for	 selective	 recognition	 of	 acyl	 chains	 by	 the	membrane-associated	 acyltransferase	
PatA	 (Albesa-Jové	et	al.	2016)	and	The	Molecular	Mechanism	Of	Substrate	Recognition	And	Catalysis	
Of	The	Membrane	Acyltransferase	PatA	(Tersa	et	al.	2017).	
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4.2.1.	Overall	Structure	of	PatA	
Despite	much	 effort,	 we	were	 unable	 to	 produce	 recombinant	 PatA	 from	M.	 tuberculosis.	 In	
contrast,	 recombinant	 PatA	 from	Mycobacterium	 smegmatis	was	 purified	 to	 homogeneity	 following	
the	 protocol	 described	 in	 section	 4.1.	 Materials	 and	 Methods.	 The	 amino-acid	 sequences	 of	 M.	
tuberculosis	and	M.	smegmatis	versions	of	PatA	displayed	74%	sequence	 identity	and	84%	sequence	
similarity.	All	 residues	that	participate	 in	both	of	the	catalytic	and	substrate	recognition	mechanisms	
are	strictly	conserved	between	both	proteins.	
	
Figure	37:	 Structural	 similarity	of	M.	 tuberculosis	H37Rv	and	M.	smegmatis	mc2155	PatA.	Catalytic	amino	acids	are	
indicated	as	asterisks.	Amino	acids	 involved	 in	palmitate	and	pantotheinate	binding	are	 indicated	as	black	and	white	
circles,	 respectively.	 Residues	 proposed	 to	 interact	 with	 PIM1	 and	 PIM2	 are	 shown	 as	 white	 and	 black	 triangles,	
respectively.	Amino	acids	mutated	are	underlined.		
	
Figure	38:	Recombinant	production	of	truncated	version	of	PatA.	On	the	left	side	of	the	figure,	amino	acid	sequence	of	
PatA	construct	used	for	production	in	M.	smegmatis.	The	recombinant	PatA	construct	lacks	the	first	12	residues	of	the	
protein.	On	the	right	side	of	the	figure,	SDS-PAGE	showing	purified	monomeric	PatA	of	a	molecular	mass	of	34	kDa.	
The	crystal	structure	of	PatA	from	M.	smegmatis	was	solved	using	single-wavelength	anomalous	
dispersion	 (SAD)	 with	 a	 K2PtCl4	 derivative	 at	 2.06	Å	 resolution	 in	 C2	 space	 group	 (PatA-C16-1;	 PDB:	
5F2T;	Table	6).	Two	other	crystal	forms	were	obtained	in	P21	(PatA-C16-2;	PDB:	5F2Z)	and	P42212	(PatA-
C16-3;	 PDB:	 5F31)	 space	 groups,	 and	 the	 corresponding	 crystal	 structures	 solved	 at	 2.90	 and	 2.43	Å	
resolution,	 respectively,	 by	 using	molecular	 replacement	methods.	 The	 high	 quality	 of	 the	 electron	
density	maps	allowed	the	trace	of	residues	41	to	302	(PatA-C16-1),	48	to	295	(PatA-C16-2)	and	48	to	303	
(PatA-C16-3).	 PatA-C16-1	 crystal	 form	 will	 be	 used	 for	 the	 structure	 description	 since	 it	 displays	 the	
highest	resolution	(Table	3).	
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A	close	inspection	of	the	three	crystal	structures	revealed	that	the	protein	crystallized	as	a	monomer,	
displaying	a	high	degree	of	structural	flexibility	in	the	N-	and	C-terminal	regions	(coloured	in	green	in	
Figure	 39	 (root-mean-square	 deviation	 (r.m.s.d.)	 value	 of	 1.6	 and	 8.4	 Å	 for	 Cα	 atoms	 in	 41–47	 and	
288–302	residue	ranges	for	the	N-	and	C-terminus,	respectively).		
	
Figure	39:	Structural	flexibility	at	the	N-	and	C-terminus	of	PatA-C16-1,	-2	and	-3	complexes.	Cartoon	representation	
showing	the	superimposed	monomers	obtained	from	crystal	structures	of	PatA-C16-1,	PatA-C16-2,	and	PatA-C16-3.	The	N-	
and	C-terminus	are	coloured	blue.	
The	central	core	of	PatA	consists	on	a	six-stranded	β-sheet	with	topology	β1-β2-β3-β4-β7-β8	(β8	is	
antiparallel)	surrounded	by	α-helices,	with	an	overall	size	of	45X40X40	Å	 (Figure	40	a-b).	A	 long	and	
open	groove	that	runs	parallel	to	the	protein	surface	contains	the	active	site.	This	groove	is	flanked	by	
α4,	β2,	α8,	β4,	α9,	α10	and	the	connecting	loops	β1-α7	(residues	124-130),	β2-α8	(residues	148-154),	β3-α9	
(residues	173-181),	β4-β5	(residues	198-208),	β6-α10	(residues	219-221)	and	α11-α12	(residues	282-291;	
Figure	40	c-d).	Strikingly,	the	groove	also	displays	a	narrow	and	deep,	mostly	hydrophobic	tunnel	that	
runs	perpendicular	 from	 its	 floor	 to	 the	 central	 core	of	 the	protein	 (Figure	 40	 e-f).	 The	walls	of	 the	
tunnel	 comprise	 the	entire	 central	β-sheet,	 two	α-helices	α7	and	α8,	 and	 the	connecting	 loops	β1-α7	
(residues	124-130)	and	α8-β6	 (residues	167-170).	The	cavity	extends	entirely	 through	the	core	and	 is	
closed	at	the	bottom	by	β8,	the	connecting	loop	α5-α6	and	part	of	the	α6	(Figure	40	e-f).	Interestingly,	
the	entrance	of	the	hydrophobic	pocket	displays	several	charged	residues	compatible	to	interact	with	
a	buried	carboxylate	group	of	a	fatty	acid	moiety,	strongly	suggesting	the	pocket	might	play	a	role	in	
the	donor	substrate	binding.	 	
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Figure	 40:	Overall	 structure	 of	 PatA.	 a-b)	 Cartoon	 representation	 showing	 the	general	 fold	 and	 secondary	 structure	
organization	 of	 PatA.	 Secondary	 structure	 elements	 are	 labelled.	 The	 central	 core	 β-sheet	 is	 shown	 in	 orange.	 c-d)	
Surface	 representation	of	 PatA	 showing	 the	 location	of	 the	main	 groove	 and	 the	 active	 site.	 The	 groove	 entrance	 is	
flanked	by	two	important	α-helices,	α11-α12.	The	groove	ends	up	into	a	cavity	mainly	flanked	by	α4.	e-f)	The	main	groove	
runs	perpendicular	to	a	hydrophobic	tunnel,	which	is	deeply	buried	into	the	core	of	PatA.	 	
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4.2.2.	The	Acyl-CoA	Binding	Site	of	PatA	
Strikingly,	one	molecule	of	palmitic	acid	was	unambiguously	identified	in	the	difference	electron	
density	maps	of	PatA-C16-1,	PatA-C16-2	and	PatA-C16-3	crystal	structures	(Figure	41	a-d).	 It	 is	thought	
that	 acyl	 molecule	 is	 associated	 to	 the	 enzyme	 due	 to	 the	 hydrolysis	 of	 palmitoyl-CoA	 during	 the	
isolation	 and	 purification	 of	 PatA	 from	M.	 smegmatis	mc2155.	 Supporting	 this	 notion,	 the	 chemical	
structure	of	Ac1PIM2	was	clearly	established	by	using	a	combination	of	analytical	techniques	including	
mass	 spectrometry	 and	 two-dimensional	 NMR205.	 The	 major	 acyl	 form	 observed,	 corresponded	 to	
PIM2	with	 the	 glycerol	moiety	 being	 di-acylated	 by	 C16/C19	 and	 the	mannose	 residue	 transferred	 by	
PimA	 bearing	 a	 C16.	 This	 structural	 profile	 was	 also	 identified	 in	 its	 hexamannosylated	 derivative	
Ac1PIM2206.		
The	acyl	chain	is	deeply	buried	into	the	hydrophobic	pocket,	and	oriented	with	the	carboxylate	
group	facing	the	groove	and	the	acyl	tail	extending	into	the	globular	core	of	the	monomer	(Figure	41	
a-d).	
	
Figure	 41:	 The	 palmitate	 binding	 site	 of	 PatA.	a-d)	 Four	views	of	PatA-C16-1	crystal	 structure	showing	 the	palmitate	
chain	deeply	buried	into	the	hydrophobic	tunnel.	e-f)	Two	views	of	PatA	showing	the	cap	which	closes	the	bottom	of	
the	hydrophobic	tunnel.	The	2mFo-DFc	electron	density	map	countered	at	1	σ	for	the	palmitate	ligand	is	shown.		 	
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Interestingly,	the	comparison	of	the	three	crystal	structures	revealed	conformational	flexibility	
in	the	carboxylate	moiety	of	the	palmitate	(Figure	42),	located	in	close	proximity	with	the	lateral	chain	
of	His126.	The	Arg164	guanidinium	group	engages	the	side	chain	of	Tyr83	and	Asp131.	This	tryptophan	
residue,	together	with	Met198,	makes	an	important	Van	der	Waals	interaction	with	the	acyl	chain.	The	
acyl	chain	undergoes	a	kink	at	position	C6	and	terminates	in	a	pocket	mainly	formed	by	hydrophobic	
residues,	 including	 Leu122	 and	 Leu124 (β1),	 Ala133,	 Trp136	 and	 Leu137	 (α7),	 Phe144	 (α7-β2	 loop),	
Thr146	(β2),	Phe169	(α8-β3	 loop),	Phe235	and	Val237	(β7),	Met248	and	Val250	(β8),	and	two	cysteine	
residues	Cys196	(β4)	and	Cys239	(β7).	
	
Figure	42:	Structural	superposition	of	the	palmitate	molecules	as	visualized	in	the	PatA-C16-1,	PatA-C16-2,	and	PatA-
C16-3	structures.	
The	 connecting	 loop	 α5-α6	 (residues	 101-106)	 and	 part	 of	 α6	 form	 a	 flexible	 and	 mostly	
hydrophobic	 cap	 that	 closes	 the	 bottom	 of	 the	 cavity,	 suggesting	 that	 PatA	 might	 be	 able	 to	
discriminate	the	length	of	the	acyl	chain	groups	(Figure	41	e-f).	It	is	worth	noting	that	Ac1PIM2	was	the	
main	 product	 formed	 in	 the	 reaction	when	 endogenous	 or	 crude	mycobacterial	 phospholipids	 from	
Mycobacterium	phlei	were	used	as	the	lipid	acceptors	and	a	series	of	acyl-CoA	derivatives	of	fatty	acids	
were	used	as	C14-labelled	donor	 substrates204,288.	Palmitoyl-CoA	 (C16)	 gave	higher	 incorporation	 than	
myristyl-CoA	(C14).	Interestingly,	the	oleyl-CoA	(C18:1)	was	a	much	better	substrate	than	the	saturated	
counterpart	 stearyl-CoA	 (C18).	 Finally,	 the	 tuberculostearic	 acid	 (C19:1)	 had	a	 low	 specific	 activity	 and	
the	small	incorporation	of	label	that	was	observed	may	be	not	significant288.	
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4.2.2.1.	 How	does	PatA	recognize	CoA?		
To	this	end,	the	crystal	structure	of	PatA	in	complex	with	S-hexadecyl	Coenzyme	A	(S-C16CoA),	a	
nonhydrolyzable	analogue	of	palmitoyl-CoA,	was	solved	at	3.28	Å	resolution	in	P21	space	group	(PatA-
S-C16CoA;	PDB:	5F34;	Table	4).	The	acyl	chain	of	S-C16CoA	is	localized	into	the	hydrophobic	tunnel,	and	
superimposes	very	well	with	the	acyl	chain	moiety	of	palmitoyl	observed	in	the	PatA-C16-1,	PatA-C16-2	
and	PatA-C16-3	complexes	(Figure	43	a-d).	It	is	worth	noting	that	the	position	of	the	carboxylate	group	
of	 palmitate	 is	 different	 to	 that	 observed	 for	 the	 thioether	 in	 the	 PatA-S-C16CoA	 complex.	 The	 4-
phosphopantetheinate	moiety	of	S-C16CoA	is	clearly	defined	in	the	electron	density	map,	and	located	
at	the	entrance	of	the	main	groove,	in	close	contact	with	a	highly	conserved	region	flanked	by	the	β2-
α8	 (residues	 149-153),	 β3-α9	 (residues	 174-180)	 and	 β4-β5	 (residues	 199-207)	 loops,	 and	 two	 alpha	
helices,	α9	(residues	181-190)	and	α10	(residues	221-230).		
	
Figure	 43:	 The	 palmitoyl-CoA	 binding	 site	 of	 PatA.	 a-d)	 Four	 views	 of	 PatA-S-C16CoA	 crystal	 structure	 showing	 the	
binding	 mechanism	 of	 S-C16CoA.	 The	 palmitoyl	 moiety	 is	 deeply	 buried	 into	 the	 hydrophobic	 tunnel,	 whereas	 the	
coenzyme	 A	 moiety	 extends	 outwards	 through	 the	 side	 of	 the	 main	 groove.	 The	 2mFo-DFc	 electron	 density	 map	
countered	at	1	σ	for	the	palmitate	ligand	is	shown.		
The	 adenosine	 3’,5’-diphosphate	 (3’,5’-ADP)	 moiety	 of	 the	 ligand	 (disordered	 in	 other	
monomers	of	the	asymmetric	unit)	sticks	out	from	the	globular	core	and	is	exposed	to	the	bulk	solvent,	
as	observed	 in	other	acyl-CoA	modifying	enzymes289	 (Figure	44	a-c).	The	approximate	volume	of	 the	
palmitoyl-CoA-binding	pocket	was	ca.	2,801	Å290.	
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Figure	44:	Structural	 flexibility	of	S-C16CoA	as	visualized	 in	 the	PatA-S-C16CoA	complex.	a-b)	Cartoon	representation	
showing	the	four	superimposed	monomers	obtained	from	the	crystal	structure	PatA-S-C16CoA.	N-	and	C-terminus	are	
indicated.	c)	Close	view	of	the	S-C16CoA	binding	site	in	PatA.	Both	palmitoyl	and	pantetheine	moieties	binding	to	PatA	
are	 conserved	 in	 all	 four	monomers	 in	 the	 asymmetric	 unit.	 The	phosphorylated	ADP	of	 S-C16CoA	was	 visible	 in	one	
molecule	of	the	asymmetric	unit,	exposed	to	the	bulk	solvent.		
To	 further	 validate	 the	 model,	 we	 designed	 site-directed	 mutations	 predicted	 to	 impair	 the	
palmitoyl-CoA	interaction	with	PatA.	Thus,	the	double	substitution	Phe182Trp/Leu197Trp	would	block	
the	groove	region	of	PatA,	hindering	the	formation	of	the	complex	(Figure	43	b).	As	depicted	in	Figure	
45,	 the	 PatA	 Phe182Trp/Leu197Trp	 variant	 could	 not	 (i)	 transfer	 a	 palmitoyl	moiety	 to	 PIM2,	 or	 (ii)	
hydrolyse	palmitoyl-CoA,	supporting	the	proposed	model.	
	
Figure	45:	Enzymatic	activity	of	selected	PatA	variants.	In	the	upper	panel,	the	acyltransferase	activity	of	purified	PatA	
and	 variants	 involved	 in	 substrate	 binding	 are	 shown.	 Reaction	 mixtures	 contained	 crude	 membranes	 from	 M.	
smegmatis	mc2155	and	GDP-[14C]-mannose	as	a	tracer	(lane	1),	supplemented	with	PimA	(lanes	2-7)	and	palmitoyl-CoA	
(lanes	 3-7)	 and	 purified	 PatA	 (lane	 3),	 PatA-His284Ala	 (lane	 4),	 PatA-Asp149Ala	 (lane	 5),	 double	 mutant	 PatA-
Phe182Trp/Leu197Trp	 (lane	 6)	 and	 PatA-Arg164Ala	 (lane	 7).	 The	 lipids	 were	 extracted	 from	 reaction	 mixtures	 and	
analysed	 by	 TLC	 and	 autoradiography.	 In	 the	 lower	 panel,	 the	 hydrolytic	 activity	 against	 palmitoyl-CoA	 is	 shown	 as	
determined	by	spectrophotometric	analysis.	All	enzymatic	activities	measurements	were	determined	in	duplicates.	 	
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The	 residues	 that	 contact	 the	 bound	 palmitic	 acid	 are	 highly	 conserved	 in	 the	 PatA	 mycobacterial	
homologues	(Figure	46).		
	
Figure	 46:	 Multiple	 sequence	 alignment	 of	 PatA	 with	 mycobacterial	 orthologs.	 Orthologs	 shown	 are	 from	
Mycobacterium	smegmatis	(Msme,	A0QWG5),	M.	tuberculosis	(Mtub,	O06203),	M.	bovis	(Mbov,	Q7TY87),	M.	marinum	
(Mmar,	B2HN43),	M.	avium	(Mavi,	AIV25898.1),	M.	ulcerans	(Mulc,	ABL05460.1),	M.	vanbaalenii	(Mvan,	ABM13371.1),	
M.	 gilvum	 (Mgil,	 ADT99794.1),	M.	 abscessus	 (Mabs,	 AIV11722.1),	M.	 leprae	 (Mlep,	 Q7AQJ0),	M.	 africanum	 (Mafr,	
F8M2W4),	and	M.	canettii	(Mcan,	L0PY90).	Strictly	conserved	positions	are	shown	in	orange	background.	The	secondary	
structural	elements	corresponding	to	the	three	distinct	3D	structures	of	PatA	are	shown	above	the	alignment.	Catalytic	
amino	acids	 are	 indicates	 as	 asterisks.	Amino	acids	 involved	 in	palmitate	and	pantotheinate	binding	are	 indicated	as	
black	 and	 white	 circles,	 respectively.	 Residues	 proposed	 to	 interact	 with	 PIM1	and	 PIM2	 based	 on	 the	 dockings	 are	
shown	as	white	and	black	triangles,	respectively.	Amino	acids	mutated	are	underlined.		 	
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4.2.3.	The	Phosphatidylinnositol	Mannosides	Binding	Site	
To	 describe	 the	 architecture	 of	 the	 PatA	 acceptor	 binding	 site,	 it	was	 first	 tried	 to	 crystallize	
PatA	 in	 the	presence	of	Ac1PIM1/Ac2PIM1,	Ac1PIM2/Ac2PIM2	or	 their	deacylated	analogues.	However,	
these	attempts	were	unsuccessful.	Therefore,	to	describe	the	architecture	of	the	acceptor	binding	site,	
PatA	was	co-crystallized	with	D-mannopyranose	(Manp).	
The	crystal	structure	of	PatA	from	M.	smegmatis	co-crystallized	with	Manp	was	solved	by	using	
molecular	 replacement	 methods	 (Figure	 47).	 PatA	 crystallized	 in	 the	 P21	 space	 group	 with	 four	
molecules	 (ca	260	residues	each)	 in	the	asymmetric	unit,	and	diffracted	to	a	maximum	resolution	of	
2.42	 Å	 (Figure	 49	 and	 Figure	 50).	 Careful	 inspection	 of	 the	 electron	 density	 maps	 revealed	 the	
presence	of	the	product	6-O-palmitoyl-α-D-mannopyranoside	(C16-Man)	in	three	of	the	four	molecules	
(chains	B,	C	and	D)	of	the	asymmetric	unit	 (PatA-C16-Man).	The	fourth	molecule	(chain	A)	showed	(i)	
one	molecule	of	 free	palmitate	 located	 in	the	hydrophobic	pocket	and	(ii)	one	molecule	of	 free	β-D-
mannopyranose,	 located	 in	 the	 acceptor	 binding	 cavity	 (Figure	 49	 a-b	 and	 Figure	 50).	 Because	
palmitoyl-CoA	was	not	present	during	the	crystal	screening	experiments,	we	believe	that	the	palmitate	
molecule	 is	 associated	 with	 the	 enzyme	 during	 the	 isolation	 and	 purification	 of	 PatA	 from	 M.	
smegmatis	mc2155,	 as	previously	described21.	 This	 suggests	 that	 PatA	 is	mediating	 the	 formation	of	
C16-Man	in	three	of	the	four	molecules	of	PatA	in	the	asymmetric	unit.		
	
Figure	 47:	Overall	 structure	 of	 the	 PatA-C16-Man	 complex.	 a)	Cartoon	 representation	 showing	 the	 general	 fold	 and	
secondary	structure	organization	of	PatA.	β-strands	and	α-helices	are	shown	in	orange	and	yellow	respectively.	The	C16-
Man	product	is	shown	in	black	and	red.	b-c)	Two	views	of	the	electrostatic	surface	representation	of	PatA	showing	the	
location	of	the	C16-Man	product.	The	Man	moiety	of	C16-Man	localizes	into	the	main	groove,	in	close	proximity	to	α4.	In	
contrast,	the	palmitate	moiety	C16-Man	localizes	in	a	hydrophobic	cavity,	deeply	buried	into	the	core	of	PatA.		
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PatA	 in	 complex	 with	 Manp	 crystallized	 as	 a	 monomer,	 displaying	 a	 conserved	 α/β	
architecture21.	 The	 central	 core	 comprises	 a	 six-stranded	 β-sheet	 (β1-β2-β3-β4-β7-β8	 of	 with	 β8	 is	
antiparallel)	bound	by	several	α-helices	(Figure	47	a).	A	surface-exposed,	open	groove	with	an	overall	
size	of	25x10x10	Å	contains	the	active	site.	This	long	groove	is	flanked	by	several	secondary	structure	
elements	 including	 α4,	 β2,	 α8,	 β4,	 α9,	 α10	 and	 the	 connecting	 loops	 β1-α7	 (residues	 124-130),	 β2-α8	
(residues	 148-154),	 β3-α9	 (residues	 173-181),	β4-β5	 (residues	 198-208),	β6-α10	 (residues	 219-221)	 and	
α11-α12	 (residues	 282-291)21.	 A	 deep	hydrophobic	 cavity	 extends	 through	 the	 core	of	 PatA,	with	 the	
entrance	located	in	the	floor	of	the	main	groove	and	closed	at	the	bottom	by	β8,	the	connecting	loop	
α5-α6	and	part	of	the	α6	(Figure	47	and	Figure	48).		
Strikingly,	 the	 careful	 inspection	 of	 the	 electron	 density	 maps	 revealed	 the	 presence	 of	 the	
product	C16-Man	in	three	of	the	four	molecules	of	the	asymmetric	unit,	and	in	the	fourth	molecule	of	
the	 asymmetric	 unit	 the	 reaction	 between	 palmitoyl	 and	 D-mannopyranose	 did	 not	 take	 place,	
showing	one	molecule	of	free	palmitate	located	in	the	hydrophobic	pocket	and	one	molecule	of	free	β-
D-mannopyranose,	located	in	the	acceptor	binding	cavity	(Figure	49	a-b	and	Figure	50).		
	
Figure	 48:	 The	 acceptor	 binding	 site	 of	 PatA.	 a-d)	 Four	 views	 of	 the	 PatA-C16-Man	 crystal	 structure	 showing	 the	
palmitoyl	chain	deeply	buried	into	the	hydrophobic	cavity	and	the	mannose	unit	located	in	the	acceptor	binding	site,	at	
the	 end	 of	 the	 main	 groove.	 The	 final	 electron	 density	 maps	 (2mFo-DFc	 contoured	 at	 1σ)	 of	 the	 6-O-palmitoyl-α-D-
mannopyranoside	is	coloured	in	grey.	 	
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Figure	49:	Four	crystallographically	 independent	PatA-C16-Man	complex	protomers	 reveal	 two	different	states.	a-b)	
The	asymmetric	unit	of	the	P21	crystal	form	contains	four	PatA	molecules	(shown	here	in	orange,	red,	yellow	and	blue).	
Three	independent	molecules	coloured	in	red,	yellow	and	blue	were	observed	in	complex	with	the	reaction	product	C16-
Man.	 The	 fourth	molecule	 in	 the	 asymmetric	 unit	 (coloured	 in	 orange)	was	 observed	 in	 complex	with	 β-D-Man	 and	
palmitoyl.	c)	Structural	superposition	of	the	four	PatA	protomers	observed	in	the	asymmetric	unit.		
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Figure	50:	Electron	density	maps	of	the	refined	PatA-C16-Man	complex.	Two	views	of	the	final	electron	density	maps	
(2mFo-DFc	contoured	at	1σ)	corresponding	to	the	PatA-C16-Man	structure	(reference	chain).		
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It	 is	believed	that	the	palmitate	molecule	is	associated	to	the	enzyme	due	to	the	hydrolysis	of	
palmitoyl-CoA	during	the	isolation	and	purification	of	PatA	from	M.	smegmatis	mc2155,	as	previously	
described21.	Supporting	this	notion,	the	major	acyl	 forms	observed	 in	Ac1PIM2	corresponded	to	PIM2	
with	 the	 glycerol	moiety	being	di-acylated	by	C16/C19	 and	 the	mannose	 residue	 transferred	by	PimA	
bearing	a	C16205.	The	palmitate	group	is	deeply	buried	into	the	hydrophobic	cavity,	and	oriented	with	
the	 carboxylate	 group	 facing	 the	 groove	 and	 the	 acyl	 tail	 extending	 into	 the	 globular	 core	 of	 the	
monomer,	 as	 observed	 in	 the	 PatA-C16	 and	 PatA-S-hexadecyl	 Coenzyme	 A	 (S-C16CoA)	 complexes	
(Figure	47	and	Figure	48)21.	Manp	ring	is	located	within	a	cavity	located	at	the	end	of	the	main	groove	
and	comprising	helices	α4	and	α8,	and	the	connecting	loops	β1-α7	(residues	83-90),	β2-α8	(residues	148-
154)	and	α11-α12	(residues	282-291).	Manp	ring	is	stabilized	by	Van	der	Waals	interactions	with	the	side	
chains	 of	 four	 aromatic	 residues	 Tyr83,	 Trp84,	 Trp130,	 and	Phe160.	 The	O6	 atom	of	 the	Manp	 ring	
makes	 an	 important	 hydrogen	 bond	 with	 NE2	 atom	 of	 His126,	 whereas	 O2	 atom	 makes	 a	 weak	
hydrogen	bond	with	NH2	atom	of	Arg164	(Figure	48).		
It	 is	worth	noting	 that	 the	Manp	 residue	observed	 in	 the	PatA-C16-Man	 complex	 superimposed	well	
with	 the	 corresponding	 Manp	 residue	 of	 the	 deacylated	 form	 of	 PIM2	 obtained	 by	 docking	
calculations21.	The	structural	superposition	of	the	PatA-C16-Man	and	S-C16CoA	complexes	gives	a	very	
nice	 view	 of	 the	 acyl	 donor	 and	 acceptor	 substrates	 binding	 sites	 (Figure	 51).	 The	 4-
phosphopantetheinate	moiety	of	S-C16CoA	localizes	 in	the	opposite	side,	at	the	entrance	of	the	main	
groove,	flanked	by	the	β2-α8	(residues	149-153),	β3-α9	(residues	174-180)	and	β4-β5	(residues	199-207)	
loops,	and	 two	alpha	helices,	α9	 (residues	181-190)	and	α10	 (residues	221-230).	The	adenosine	3’,5’-
diphosphate	 (3’,5’-ADP)	 moiety	 of	 S-C16CoA	 (disordered	 in	 three	 of	 the	 four	 protomers	 of	 the	
asymmetric	unit)	protrudes	from	the	groove	and	is	exposed	to	the	bulk	solvent,	as	observed	in	other	
acyl-CoA	modifying	enzymes	(Figure	51)18,289.	
	
Figure	51:	The	donor	and	acceptor	binding	mechanism.	a)	Cartoon	representation	showing	the	location	of	C16-Man	and	
S-C16CoA	into	PatA.	β-strands	and	α-helices	are	shown	in	orange	and	yellow	respectively.	b-c)	Two	views	showing	the	
structural	superposition	of	C16-Man	and	S-C16CoA.	 	
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4.2.3.1.	 Inhibition	Mecanism	of	PatA	
The	crystal	structure	of	PatA-C16-Man	certainly	provide	one	possible	mechanism	of	enzyme	inhibition.	
The	 PatA-C16-Man	 complex	 revealed	 the	 presence	 of	 the	 product	 C16-Man	 in	 three	 of	 the	 four	
molecules	 (chains	 B,	 C	 and	 D)	 of	 the	 asymmetric	 unit,	 as	 a	 consequence	 of	 the	 chemical	 reaction	
between	 the	 palmitate	 and	 α-D-mannopyranose.	 Interestingly,	 careful	 inspection	 of	 the	 electron	
density	 maps	 revealed	 that	 in	 the	 fourth	 molecule	 (chain	 A)	 of	 the	 assymetric	 unit	 the	 reaction	
between	 palmitate	 and	 D-mannopyranose	 did	 not	 take	 place,	 showing	 (i)	 one	 molecule	 of	 free	
palmitate	 located	 in	 the	 hydrophobic	 pocket	 and	 (ii)	 one	 molecule	 of	 free	 β-D-mannopyranose,	
located	in	the	acceptor	binding	cavity	(Figure	52	a).		
The	structural	comparison	of	the	four	molecules	of	the	asymmetric	unit	revealed	subtle	but	important	
conformational	 changes	 in	 the	 active	 site	 (Figure	 52	 b).	 Specifically,	 the	 carboxylate	moiety	moves	
away	from	the	catalytic	centre	as	observed	in	the	PatA-S-C16CoA	complex,	 in	closed	contact	with	the	
main	 chain	 of	 residues	 Val147	 and	 Glu14921.	 Importantly,	 the	 Man	 O1	 in	 β	 configuration	 is	 now	
stabilized	by	new	interactions	with	the	side	chains	of	Tyr83,	Trp130	and	Arg164	residues	(Figure	52	b).	
The	Man	O4	makes	hydrogen	bond	with	 a	water	molecule,	which	 in	 turn	 strongly	 interact	with	 the	
carboxylate	moiety	 of	 Glu149.	 Similarly,	 the	Man	 O6	makes	 a	 strong	 hydrogen	 bond	with	 the	 side	
chain	of	His126	(Figure	52	b).		
	
Figure	52:	The	crystal	structure	of	PatA-C16-Man	suggest	a	possible	mechanism	of	enzyme	inhibition.	a-d)	Four	views	
of	PatA-C16-Man	crystal	structure	showing	the	palmitoyl	chain	deeply	buried	into	the	hydrophobic	cavity	and	the	β-Man	
residue	located	in	the	acceptor	binding	site,	at	the	end	of	the	main	groove.		
Ac1PIM2	 appears	 to	 be	 a	metabolic	 end	 product	 that	 accumulates	 at	 high	 steady-state	 levels	 in	 the	
cells	 as	well	 as	 a	precursor	 for	more	polar	 forms	of	PIMs,	 lipomannan	and	 LAM12.	 Interestingly,	 the	
four	enzymes	involved	in	the	biosynthesis	of	Ac1PIM2,	the	phosphatidyl-myo-inositol	synthase	PgsA1,	
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PimA,	 PimB	 and	 PatA,	 were	 found	 to	 be	 essential	 for	 the	 growth	 of	 M.	 smegmatis	 and/or	 M.	
tuberculosis12,215,228,230.	 Thus,	 the	 structural	 data	 presented	 here	 offers	 exciting	 possibilities	 for	
inhibitor	design	and	the	discovery	of	chemotherapeutic	agents	against	this	major	human	pathogen.		
4.2.3.2.	 Molecular	Docking		
Docking	 calculations	 placed	 the	 polar	 head	 of	 PIM2,	 the	 better	 substrate	 of	 PatA	making	 important	
interactions	within	a	region	located	at	the	end	of	the	main	groove	and	comprising	helices	α
4	and	α8,	
and	 the	 connecting	 loops	 β1-α7	 (residues	 83-90),	 β2-α8	 (residues	 148-154)	 and	α11-α1224,233	 (residues	
282-291;	Figure	 53).	As	 a	 consequence,	 the	O6	atom	of	 the	Manp	 ring	 linked	 to	position	2	of	myo-
inositol	 in	PIM2	 is	 predicted	 to	be	positioned	 favourably	 for	 activation	by	His126	and	 to	 receive	 the	
palmitate	group	from	palmitoyl-CoA	(Figure	53;	distance	His126	NE2	atom	to	Manp	O6	atom	is	2.8	Å).		
The	model	also	predicts	an	important	role	of	residues	Glu149,	Arg164	and	His284	to	bind	PIM2	in	the	
active	site.	In	the	model,	Glu149	OE1	atom	is	found	at	2.9	Å	of	the	Manp	residue	O4	atom	and	Arg164	
NH2	atom	is	placed	at	3.1	Å	of	the	O2	atom	of	the	Manp	ring,	whereas	His284	ND1	atom	is	at	only	2.5	
Å	of	myo-inositol	O3	atom	(Figure	54).	The	myo-inositol	moiety	and	the	Manp	ring	linked	to	position	6	
of	myo-inositol	 in	 PIM2	 also	 interact	with	 Tyr80	 and	Gln287.	 The	
approximate	 volume	 of	 the	 PIM2-
binding	pocket	was	ca.	1,741	Å	(Figure	54)290.		
	
Figure	 53:	Docking	 calculations	 of	 the	 phosphatidylinositol	 mannosides	 binding	 site.	 a-b)	 Two	 views	 showing	 the	
docking	 calculations	 in	which	PIM2	attaches	 to	 the	end	 side	of	 the	main	 groove,	 close	 to	 the	hydrophobic	 tunnel.	c)	
Close	view	of	the	binding	site,	showing	the	location	of	predicted	residues	involved	in	PIM2	interaction	that	have	been	
mutated	(His126,	Glu149,	Arg164,	His284)	along	with	mutated	residues	involved	in	CoA	binding	(Leu197	and	Phe182).		 	
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Figure	54:	Structural	comparison	of	the	PIM1	and	PIM2	binding	sites.	a-b)	Two	views	showing	the	docking	calculations	
in	which	PIM1	(green)	attaches	to	the	end	side	of	the	main	groove,	and	close	to	the	hydrophobic	tunnel.	c-d)	Two	views	
showing	the	comparison	of	the	docking	calculations	for	PIM1	and	PIM2	(grey).	
4.2.3.3.	 Enzymatic	Assays	
To	 further	 validate	 the	 proposed	 model,	 we	 designed	 three	 single-point	 substitution,	 Glu149Ala,	
Arg164Ala	 and	 His284Ala,	 predicted	 to	 impact	 the	 PIM2	 interaction	 with	 PatA	 (Figure	 53	 c).	 As	
depicted	 in	 Figure	 55,	 the	 transferase	 activity	 of	 all	 PatA	 variants	 was	 severely	 compromised,	
nevertheless	preserving	the	capability	to	hydrolyse	palmitoyl-CoA.	
	
Figure	 55:	 Duplicate	 enzymatic	 activity	 measurements	 of	 selected	 PatA	 variants.	 In	 the	 upper	 panel,	 the	
acyltransferase	activity	of	purified	PatA	and	variants	involved	in	catalysis	are	shown.	Reaction	mixtures	contained	crude	
membranes	from	M.	smegmatis	mc2155	and	GDP-[14C]-mannose	as	a	tracer	(lane	1),	supplemented	with	PimA	(lane	2	
to	6)	and	palmitoyl-CoA	(lanes	3	to	6)	and	purified	PatA	(lane	3),	PatA-Asp131Ala	(lane	4),	PatA-Glu200Ala	(lane	5)	and	
PatA-His126Ala	(lane	6).	In	the	lower	panel,	the	hydrolytic	activity	against	palmitoyl-CoA	is	shown.	 	
Doctoral	Thesis	–	Montse	Tersa	 	 Results	and	Discussion	
	
	 102	
4.2.4.	The	Catalytic	Mechanism	of	PatA	
Analysis	of	the	cleft	running	over	the	surface	of	PatA	revealed	a	catalytic	site	reminiscent	to	that	
observed	 in	 the	 serine	protease	 family	of	enzymes.	 In	 serine	proteases,	 the	cleavage	of	 the	peptide	
bond	is	mediated	by	nucleophilic	attack	of	the	serine	hydroxyl	group	on	the	scissile	carbonyl	bond.	The	
active	site	comprises	a	catalytic	triad	consisting	of	the	Oγ	atom	of	the	serine,	the	imidazole	ring	of	a	
histidine,	 and	 the	 carboxylate	 group	 of	 an	 aspartic/glutamic	 acid,	 involved	 in	 a	 charge	 relay	 system	
that	increases	the	nucleophilicity	of	the	serine	hydroxyl	and	modulates	the	pKa	of	the	central	histidine	
as	a	general	base	or	acid	during	the	catalytic	cycle60.	
In	 all	 crystal	 structures	 of	 palmitoyl-PatA	 and	 PatA-S-C16CoA	 complexes,	 the	 carboxylate	 OE2	
oxygen	atom	of	Glu200	was	found	at	2.8	Å	of	the	ND1	nitrogen	atom	of	the	aromatic	imidazole	ring	of	
the	 invariant	 His126	 (Figure	 56).	 It	 is	 worth	 noting	 that	 when	 the	 individual	 palmitate	 molecules	
observed	 in	 the	 three	 crystal	 structures	 of	 PatA-C16	 were	 superimposed,	 they	 showed	 important	
structural	flexibility	at	the	carboxylate	region	(Figure	42),	suggesting	that	the	carboxylate	group	is	not	
in	 a	 catalytically	 competent	 position	 in	 the	 crystal	 structures.	 Moreover,	 the	 palmitate	 is	 not	 a	
substrate	 neither	 an	 inhibitor	 of	 the	 reaction	 catalysed	 by	 PatA	 (Figure	 57).	 Our	 binary	 complexes	
correspond	most	 likely	 to	 the	 hydrolysis	 reaction	 product	 of	 palmitoyl-CoA,	 thus	 one	 of	 the	 oxygen	
atoms	 found	 in	 the	 palmitate	 that	 interacts	 with	 His126	 most	 likely	 come	 from	 a	 water	 molecule	
activated	by	His126.		
	
Figure	 56:	 Catalytic	mechanism	 of	 PatA.	a)	Active	 site	 configuration	of	PatA,	 as	 visualized	 in	 the	 crystal	 structure	 in	
complex	with	S-C16CoA	 (PatA-S-C16CoA).	b)	Active	site	configuration	of	PatA	as	visualized	 in	 the	docking	of	palmitoyl-
CoA	and	PIM2	(the	atomic	coordinates	of	palmitoyl-CoA	were	derived	 from	S-C16CoA	following	 in	silico	addition	of	an	
oxygen	atom	at	position	C16	of	S-C16CoA).	The	charged	relay	system	formed	between	Glu200,	His126	and	the	6-OH	of	
the	mannose	linked	to	the	2-position	of	inositol	(ino)	is	highlighted.	
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Figure	 57:	 Palmitate	 is	 neither	 a	 substrate	 or	 inhibitor	 of	 PatA.	 a)	 Reaction	 mixtures	 contained	 250	 μg	 of	 crude	
membranes	from	M.	smegmatis	mc2155	and	0.1	μCi	GDP-[14C]-mannose	as	a	tracer	supplemented	with	purified	PimA	
and	PatA	 (lane	1	 to	3),	and	120	μM	(lane	2)	and	240	μM	(lane	3)	palmitate.	The	 lipids	were	extracted	 from	reaction	
mixtures	and	analysed	by	TLC	and	autoradiography	as	described	 in	Methods	section.	b)	Reaction	mixtures	contained	
250	 μg	 crude	 membranes	 from	 M.	 smegmatis	 mc2155	 and	 0.1	 μCi	 GDP-[14C]-mannose	 as	 a	 tracer	 (lane	 1),	
supplemented	with	purified	PimA	(lanes	2	to	7),	purified	PatA	(lanes	3	to	7),	120	μM	palmitoyl-CoA	(lanes	4	to	7),	and	
palmitate	at	60	μM,	120	μM	and	240	μM,	respectively.		
The	S-C16CoA	coordinates	 in	PatA-S-C16CoA	crystal	 structure	were	used	 to	generate	palmitoyl-
CoA	 atomic	 coordinates	 by	 substitution	 of	 C16	 atom	 with	 a	 carbonyl	 group	 followed	 by	 energy	
minimization.	Docking	calculations	placed	the	Manp	moiety	attached	to	the	2-position	of	myo-inositol	
in	 PIM2	with	 its	 O6	 atom	 favourably	 positioned	 to	 receive	 the	 palmitate	 group	 from	 palmitoyl-CoA	
(Figure	56	b).		
In	the	proposed	model	His126	acts	as	the	general	base	to	abstract	a	proton	from	the	hydroxyl	
group	at	position	6	of	the	Manp	ring	linked	to	the	2-position	of	inositol	in	PIM1	or	PIM2,	to	facilitate	the	
nucleophilic	attack	on	the	thioester	of	palmitoyl-CoA	(Figure	58).	The	Glu200	gets	involved	in	a	charge	
relay	system	with	His126	and	the	HO6	atom	from	the	Manp	moiety,	contributing	to	the	appropriate	
structural	arrangement	of	the	imidazole	ring	of	the	histidine	residue	and	modulating	its	pKa	to	act	as	a	
base	in	the	first	step	and	as	an	acid	in	the	second	step,	providing	protonic	assistance	to	the	departing	
CoA	 leaving	 group.	 It	 is	 worth	 noting	 that	 the	 His126-Glu200	 hydrogen	 bond	 was	 found	 in	 a	 syn	
orientation	 relative	 to	 the	 carboxylate60.	 The	 result	 of	 the	 nucleophilic	 attack	 is	 a	 covalent	 bond	
between	the	mannose	ring	of	PIM1	or	PIM2	and	palmitate.		
	
Figure	58:	Proposed	catalytic	mechanism	for	PatA.	
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4.2.4.1.	 Molecular	Dynamics	
To	 gain	 insight	 into	 the	 chemical	 reaction	 mechanism	 catalysed	 by	 PatA,	 a	 PatA-PIM2-C16CoA	
ternary	complex	was	modelled,	taking	into	account	the	experimental	structural	data	available	(Figure	
59)21.	
	
Figure	 59:	PatA-PIM2-C16CoA	 ternary	 complex	modelled	with	molecular	 dynamics.	a)	 Ternary	complex	of	PatA	with	
PIM2	 and	 C16-CoA.	 b)	 Time	 evolution	 of	 the	 RMSD	 during	 the	 classical	 molecular	 dynamics	 simulation	 of	 the	 PatA	
complex	 with	 PIM2	 and	 C16-CoA.	 The	 system	 was	 considered	 equilibrated	 after	 20	 ns.	 c)	 Evolution	 of	 the	 distance	
corresponding	 to	 the	 nucleophilic	 attack	 of	 Man1	 of	 PIM2	 on	 the	 thioester	 carbonyl	 of	 C16-CoA	 (green	 line)	 and	
hydrogen	bond	distance	between	O6H	and	His126	(red	line).		 	
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Molecular	dynamics	(MD)	simulations	(38	ns)	were	performed	at	room	temperature	to	relax	the	
system	and	 sample	 all	 the	 accessible	 enzyme-substrate	 conformations	 (Figure	 59).	 A	 snapshot	 from	
the	 equilibrated	 complex	 was	 used	 as	 a	 starting	 point	 for	 the	modelling	 of	 the	 enzymatic	 reaction	
using	QM/MM	metadynamics291.	Three	collective	variables	(CVs;	Figure	60)	were	selected	to	account	
for	the	main	changes	taking	place	during	the	reaction.	The	first	collective	variable	(CV1)	was	defined	as	
the	difference	of	distances	between	O6-C16	and	C16-S.	This	variable	describes	the	nucleophilic	attack	of	
the	O	atom	of	the	CH2OH	group	of	one	of	the	mannosyl	residues	of	PIM2	(Man1	in	Figure	59	a)	on	the	
carbonyl	of	the	thioester	bond	of	C16-CoA.	We	named	this	variable	as	“nucleophile	attack”.	The	second	
collective	variable	 (CV2)	was	selected	as	 the	difference	between	the	O6-H6	and	Nε-H	distances.	This	
variable	 accounts	 for	 the	 proton	 transfer	 between	 the	 CH2OH	 group	 of	Man1	 and	 His126,	 thus	we	
named	 it	 as	 “CH2OH	 proton	 transfer”.	 The	 third	 collective	 variable	 (CV3),	 named	 as	 “His	 proton	
transfer”,	was	taken	as	the	distance	difference	between	Nε-H	and	H-S,	thus	it	accounts	for	the	transfer	
of	 the	 His126	 proton	 to	 the	 S	 atom	 of	 C16CoA.	 Similar	 ideas	 were	 previously	 used	 with	 success	 to	
model	 chemical	 reactions	 in	enzymes292.	 It	 is	 important	 to	note	 that	 the	CVs	used	do	not	 self-select	
any	specific	reaction	pathway:	it	does	not	impose	whether	proton	transfer	takes	place	in	concert	with	
nucleophilic	 attack	 or	 is	 a	 later	 event	 along	 the	 reaction	 coordinate.	 Likewise,	 the	 CVs	 used	 do	 not	
impose	whether	 the	 reaction	 is	 fully	 concerted	or	 an	 intermediate	 species	 forms	along	 the	 reaction	
coordinate.		
	
Figure	60:	Collective	variables	used	in	the	metadynamics	simulation.	
The	 free	 energy	 landscape	 reconstructed	 from	 the	 QM/MM	 metadynamics	 simulation	 (Figure	 61)	
shows	two	minima	connected	by	a	unique	transition	state,	suggesting	a	concerted	reaction.	However,	
analysis	of	the	structures	along	the	minimum	energy	pathway	reveals	that	the	minimum	on	the	 left-
hand	side	of	the	FEL	does	not	correspond	to	the	products	of	the	reaction.	Instead,	the	thioester	bond	
is	 cleaved	 but	 the	 leaving	 group	 bears	 a	 negative	 charge	 (i.e.	 a	 thiolate	 leaving	 group).	 Additional	
analysis	by	 free	QM/MM	MD	confirmed	 that	 this	 species	 is	 a	 stable	 reaction	 intermediate,	 thus	 the	
reaction	 is	clearly	stepwise.	Apparently,	 reorientation	of	 the	 thiolate	after	cleavage	of	 the	C-S	bond,	
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forming	 a	 strong	 interaction	 with	 Arg201	 (Figure	 62),	 makes	 proton	 transfer	 from	 His126	 difficult.	
Therefore,	we	decided	to	model	the	second	step	of	the	reaction	(protonation	of	the	thiolate	 leaving	
group)	separately,	using	as	unique	collective	variable	 the	distance	difference	between	Nε-H	and	H-S.	
Analysis	of	the	corresponding	free	energy	profile	(Figure	61)	reveals	a	concerted	proton	transfer	step,	
leading	to	the	reaction	products	Ac1PIM2	and	CoA.		
	
Figure	 61:	 QM/MM	 studies	 on	 PatA	 mediated	 catalysis.	 a)	 Free	 energy	 landscape	 reconstructed	 from	 the	
metadynamics	simulation	of	the	first	step	of	the	enzymatic	reaction	(projection	on	CV1	and	CV2).	b)	Free	energy	profile	
corresponding	to	the	second	reaction	step.	c)	Representative	structures	along	the	reaction	coordinate,	obtained	from	
the	 minimum	 free	 energy	 reaction	 pathway.	 Red	 broken	 lines	 represent	 bonds	 that	 are	 being	 broken	 or	 formed,	
whereas	dotted	black	lined	represent	relevant	hydrogen	bond	interactions.	d)	Proposed	catalytic	mechanism	for	PatA.		
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Figure	62:	Interaction	of	the	thiolate	leaving	group	with	Arg201.	
To	 get	 a	 detailed	 picture	 of	 the	 atomic	 reorganization	 during	 the	 enzymatic	 reaction,	 we	
extracted	configurations	along	the	reaction	coordinate	of	both	reaction	steps	(Figure	61).	The	reaction	
starts	with	 the	 approach	 of	 the	mannosyl	 CH2OH	 to	 the	 carbonyl	 of	 the	 thioester	 of	 Palm-CoA:	 the	
O6···C16	distance	evolves	from	4	Å	to	2.8	Å	(Figure	59).	At	this	point,	the	C-S	thioester	bond	starts	to	
stretch	as	 the	catalytic	histidine	 (His126)	abstracts	a	proton	 from	the	mannosyl	CH2OH,	 leading	 to	a	
transition	state	(TS;	32	kcal/mol	above	the	reactants)	in	which	the	thioester	carbon	atom	exhibits	a	4-
fold	tetrahedral	coordination	(Figure	61).	The	transition	state	decays	towards	a	reaction	intermediate	
in	 which	 the	 C-S	 bond	 is	 broken	 and	 the	 mannosyl	 residue	 is	 acylated.	 The	 Nδ-H	 of	 the	 catalytic	
histidine	is	involved	in	a	low	barrier	hydrogen	bond	with	the	carboxylate	side	chain	of	Glu200	(Figure	
61	and	Figure	63).	 In	the	second	reaction	step,	a	concerted	double	proton	transfer	between	Glu200,	
His126	 and	 the	 thiolate	 leaving	 group	 takes	 place	 (GluH···HisH	 ···S-	→	Glu-···HHis···HS),	 restoring	 the	
original	 tautomeric	 state	 and	 protonation	 of	 His126	 and	 Glu200,	 respectively	 (Figure	 61).	 The	 free	
energy	barrier	of	 this	 reaction	 step	 is	6.5	kcal/mol	and	 the	products	 state	 is	4.6	kcal/mol	below	 the	
reaction	intermediate.	 	
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Figure	63:	QM/MM	distances	along	the	reaction.	a)	Distances	involved	in	the	nucleophilic	attack.	b)	Distances	involves	
in	the	charge	relay	system.		
Therefore,	it	has	been	shown	that	PatA	is	able	to	acylate	PIM2	in	a	two-step	reaction	mechanism	
in	which	His126	acts	as	a	general	base	to	deprotonate	the	hydroxyl	group	of	a	mannose	ring	in	PIM2,	
facilitating	 the	 nucleophilic	 attack	 on	 the	 thioester	 of	 C16-CoA.	 The	 reaction	 is	 assisted	 by	 Glu200,	
which	modulates	the	pKa	of	the	central	histidine	as	a	general	base	or	acid	during	the	catalytic	cycle,	
similarly	to	the	charge-relay	system	of	serine	proteases293.	These	results	also	provide	evidence	of	the	
formation	of	a	tetrahedral-like	transition	state,	as	previously	found	for	the	closely	related	hotdog-fold	
acyl-CoA	thioesterase294.	These	results	emphasize	the	relevance	of	the	charge-relay	glutamate,	Glu200,	
and	 offer	 valuable	 detail	 on	 the	 reaction	 transition	 state	 that	 would	 serve	 for	 the	 design	 of	 new	
chemotherapeutic	drugs.		 	
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4.2.4.2.	 Enzymatic	Assays		
To	further	validate	the	proposed	model,	we	designed	three	single-point	substitution,	Asp131Ala,	
Glu200Ala	 and	 His126Ala,	 predicted	 to	 impact	 the	 transferase	 and	 the	 hydrolytic	 activity	 of	 PatA	
(Figure	53	c).	As	depicted	in	Figure	64,	the	functional	role	of	His126	and	Glu200	was	clearly	confirmed,	
since	their	substitution	by	alanine	completely	inactivated	the	enzyme.	
	
Figure	64:	Enzymatic	activity	of	selected	PatA	variants.	In	the	upper	panel,	the	acyltransferase	activity	of	purified	PatA	
and	 variants	 involved	 in	 catalysis	 are	 shown.	 Reaction	 mixtures	 contained	 crude	 membranes	 from	M.	 smegmatis	
mc2155	and	GDP-[14C]-mannose	as	a	tracer	(lane	1),	supplemented	with	PimA	(lane	2-6)	and	palmitoyl-CoA	(lanes	3-6)	
and	purified	PatA	(lane	3),	PatA-Asp131Ala	(lane	4),	PatA-Glu200Ala	(lane	5)	and	PatA-His126Ala	(lane	6).	In	the	lower	
panel,	 the	 hydrolytic	 activity	 against	 Palmitoyl-CoA	 is	 shown	 as	 determined	 by	 spectrophotometric	 analysis.	 All	
enzymatic	activities	measurements	were	determined	in	duplicates.		
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4.2.5.	A	Model	of	Action	for	PatA	
Biological	 membranes	 are	 primarily	 used	 as	 physico-chemical	 barriers	 allowing	 cells	 to	 be	
functionally	 constituted	 and	 differentiated	 from	 the	 environment.	 Biological	 membranes	 also	 play	
critical	roles	in	all	living	organisms,	mediating	the	selective	transport	of	molecules	across	the	cell,	the	
modulation	 of	 the	 cellular	 response,	 as	 well	 as	 the	 occurrence	 of	 a	 diverse	 and	 important	 set	 of	
biochemical	 reactions295,296.	Many	of	 the	enzymes	 that	work	 in	biological	membranes	are	very	often	
required	to	interact/recognize	both	hydrophobic	and	hydrophilic	substrates,	located	in	the	membrane	
and	the	aqueous	environment	of	the	cytosol/organelles,	respectively4,297.		
To	 perform	 their	 biochemical	 functions,	 these	 enzymes	 interact	 with	 membranes	 by	 two	
different	mechanisms.	Whereas	integral	membrane	enzymes	are	permanently	attached	(e.g.	through	
hydrophobic	 α-helices	 and	 transmembrane	 β-sheets),	 peripheral	 proteins	 temporarily	 associate	 to	
membranes	by	(i)	a	stretch	of	hydrophobic	residues	exposed	to	the	solvent,	(ii)	electropositive	surface	
patches	 that	 interact	 with	 acidic	 phospholipids	 (e.g.	 amphipathic	 α-helices),	 (iii)	 protein-protein	
interactions	and/or	post-translational	modifications.		
PatA	 catalyses	 a	 critical	 step	 in	 the	 biosynthesis	 of	 PIMs	 in	 mycobacteria11,12.	 The	 enzyme	
transfers	a	palmitoyl	moiety	from	a	water-soluble	substrate	donor	palmitoyl-CoA,	to	the	6-position	of	
the	 Manp	 ring	 linked	 to	 2-position	 of	myo-inositol	 of	 the	 membrane	 glycolipids	 PIM1	 or	 PIM221,23.	
Therefore,	 a	 close	 interaction	 of	 the	 enzyme	 with	 the	 cytosolic	 face	 of	 the	 mycobacterial	 plasma	
membrane	might	be	a	strict	requirement	for	PIM1	or	PIM2	modification	by	PatA.	Supporting	this	notion,	
PatA	was	 found	to	co-localize	with	the	mycobacterial	membrane	fraction23,24.	Analysis	of	 the	amino-
acid	 sequence	 of	 the	 enzyme	 revealed	 the	 lack	 of	 a	 signal	 peptide	 or	 hydrophobic	 transmembrane	
segments,	 suggesting	 that	 PatA	 associates	 to	 only	 one	 side	 of	 the	 lipid	 bilayer,	 a	 typical	 feature	 of	
peripheral	and	monotopic	membrane	proteins25,26.		
To	 perform	 their	 biochemical	 functions,	 these	 proteins	 very	 often	 display	 a	 high	 content	 of	
solvent	exposed	positively	charged	residues	in	the	form	of	amphipathic	helices,	promoting	membrane	
surface	interaction	with	anionic	phospholipids.	Protein-membrane	interaction	appears	to	be	mediated	
following	 different	 thermodynamic	 steps:	 first,	 peptide	 binding	 is	 initiated	 by	 the	 electrostatic	
attraction	of	the	positively	charged	residues	to	the	anionic	membrane,	second,	most	likely	followed	by	
the	transition	of	the	peptide	into	the	plane	of	binding,	and	third,	a	change	of	the	conformation	of	the	
bound	peptide298.	 The	penetration	of	 the	protein	 depends	on	 the	 chemical	 nature	 of	 the	 lipids	 and	
peptides	involved	and	also	on	the	mechanistic	nature	of	the	processes	involved,	in	which	both	location	
and	timing	of	membrane	association	can	be	tightly	controlled.		 	
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Interestingly,	the	electrostatic	surface	potential	of	PatA	revealed	several	hydrophobic/aromatic	
residues	interspersed	with	positively	charged	residues	in	the	vicinity	of	the	major	groove	(Figure	65)21.	
This	region	comprises	the	amphipathic	helices	α3,	α4,	α8,	and	α12	the	connecting	 loop	β2-α8	(residues	
148-154).	 Importantly,	 the	 opposite	 side	 of	 PatA	 displays	 a	 negatively	 charged	 surface,	 certainly	
contributing	to	determine	the	correct	orientation	of	the	enzyme	into	the	membrane	(Figure	65).		
Moreover,	 the	 structural	 comparison	between	PatA	and	a	 lipid	A	biosynthesis	 acyltransferase	
AbLpxM	crystal	structures	suggest	that	α1	and	α2	(N-terminal	helices)	are	deeply	inserted	into	the	lipid	
bilayer.	Altogether,	the	structural	data	support	a	model	in	which	PatA	is	permanently	associated	to	the	
membrane	(Figure	65).		
	
Figure	 65:	A	model	 of	 action	 for	 PatA.	 a)	 Electrostatic	 surface	 representation	of	 PatA.	 PatA	 is	 a	 polar	 protein,	with	
hydrophobic	and	positively	charged	residues	oriented	towards	the	plasma	membrane.	Negatively	charged	residues	are	
facing	the	cytosol.	The	first	N-terminal	three	α-helices	of	AbLpxM	are	shown	in	green,	whereas	the	remaining	secondary	
structure	elements	are	shown	in	grey.	b-c)	Two	views	of	the	active	site	of	PatA	and	the	location	of	the	acyl	donor	and	
acceptor	binding	sites.	
Despite	the	fact	that	acyl	transfer	 is	catalysed	between	the	palmitate	moiety	of	palmitoyl-CoA	
and	 the	 mannosyl	 group	 of	 PIM1	 or	 PIM2,	 our	 experimental	 data	 indicate	 the	 enzyme	 displays	 an	
absolute	 necessity	 of	 both	 fatty	 acid	 chains	 of	 PI	 in	 order	 for	 the	 transfer	 reaction	 to	 take	 place,	
pointing	 to	 a	 mechanism	 requiring	 a	 lipid-water	 interface	 (Figure	 66).	 The	 fatty	 acid	 chains	 of	 the	
acceptor	substrate	seem	to	play	an	important	structural	role	in	the	generation	of	a	competent	active	
site,	assisting/guiding	the	glycosylated	moiety	to	the	appropriate	environment	in	the	catalytic	centre.		
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4.2.5.1.	 PIM2	Acyl	Chains	are	Essential	for	PatA	Enzymatic	Activity	
To	 further	 advance	 in	 the	 understanding	 of	 how	 does	 PatA	 recognizes	 its	 lipid	 acceptor	
substrate,	the	contribution	of	the	fatty	acid	moieties	of	PIM2	in	the	enzymatic	activity	was	explored.	It	
is	worth	noting	that	previous	reports	indicate	that	PIM2	is	the	preferred	substrate	of	PatA	in	vitro24,233.	
Consequently,	PIM2	was	chemically	synthesized	containing	 two	palmitate	groups	as	 fatty	acid	chains	
and	compared	its	acceptor	capacity	with	that	of	the	deacylated	version	of	PIM2.	The	full-length	PatA	
specific	hydrolysis	activity	against	palmitoyl-CoA	by	using	diacylated	and	deacylated	PIM2	as	acceptors	
of	 the	 reaction	 and	 in	 the	 presence	 and	 absence	 of	 DOPC	 SUVs	was	 studied.	 Only	 residual	 specific	
hydrolysis	 activity	 (up	 to	 5%)	 of	 PatA	 against	 deacylated	 PIM2	 was	 observed,	 similar	 to	 the	 one	
observed	in	abscense	of	any	acceptor.	Maximum	hydrolysis	activity	in	the	presence	of	DOPC	SUVs	and	
diacylated	PIM2	(0.09	±	0.004	μmol	CoA/min*mg	PatA),	about	10-fold	higher	than	without	DOPC	SUVs	
was	observed.	Thus,	the	enzymatic	activity	assays	indicate	that	(i)	the	presence	of	the	PIM2	acyl	groups	
and	(ii)	an	artificial	model	lipid	membrane	(DOPC	SUVs)	are	essential	for	the	enzymatic	activity	of	PatA,	
strongly	 supporting	 the	 notion	 that	 the	 acyl	 chains	 of	 the	 acceptor	 glycolipid	 play	 a	 prominent	
structural	 role	 in	 the	 arrangement	 of	 its	 sugar	 moiety/moieties	 into	 the	 catalytic	 centre	 and	 the	
generation	of	a	competent	active	site	(Figure	66).		
	
Figure	 66:	 Enzymatic	 activity	 of	 full-length	 PatA	 against	 palmitoyl-CoA	by	 using	 diacylated	 and	 deacylated	 PIM2	 as	
acceptors	of	the	reaction	and	in	the	presence	and	absence	of	DOPC	SUVs.		
Thus,	a	model	of	interfacial	catalysis	was	proposed,	in	which	PatA	recognizes	the	fully	acylated	
PIM1	 or	 PIM2	 substrates	with	 their	 polar	 heads	within	 the	 acceptor	 binding	 pocket	 located	 into	 the	
main	groove	and	the	fatty	acid	moieties	likely	in	close	contact	with	α1,	α2	and	α4.	The	conformation	of	
the	 first	 two	α-helices	α1	 and	α2	 in	 a	membrane	environment	 remains	 still	 intriguing.	 The	palmitoyl	
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CoA	binding	site	involves	two	grooves	(Figure	47	and	Figure	51).	The	palmitate	chain	is	deeply	buried	
into	the	hydrophobic	pocket	that	runs	perpendicular	to	the	main	groove,	 in	the	core	of	the	enzyme.	
The	4-phosphopantetheinate	moiety	 is	 located	at	 the	entrance	of	 the	main	groove,	 in	 close	 contact	
with	a	highly	conserved	region	flanked	by	the	β2-α8	(residues	149-153),	β3-α9	(residues	174-180)	and	
β4-β5	(residues	199-207)	loops,	and	two	alpha	helices,	α9	(residues	181-190)	and	α10	(residues	221-230).	
The	 adenosine	 3’,5’-diphosphate	 (3’,5’-ADP)	 moiety	 of	 the	 ligand	 (disordered	 in	 three	 of	 the	 four	
protomers	of	the	asymmetric	unit)	sticks	out	from	the	globular	core	and	is	exposed	to	the	bulk	solvent.	
This	 structural	 configuration	 of	 the	 acyl-CoA	 binding	 site	 seems	 to	 be	 preserved	 in	 the	 homolog	
enzymes	TmPlsC,	AbLpxM	and	CmGPAT,	supporting	a	common	binding	mode	for	acyl-CoAs28–30.		
Interestingly,	TmPlsC,	AbLpxM	and	CmGPAT	prefer	acyl-ACP	as	donor	substrates,	nevertheless	
they	 can	 also	 function	 with	 acyl-CoA	 derivatives49,58,122,	 suggesting	 the	 enzymes	 preserve	 common	
structural	 features	 to	 recognize	both	acyl	donor	 substrates,	which	might	 certainly	 involve	 important	
conformational	changes.	
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4.2.6.	Structural	Similarities	of	PatA	with	Other	Acyltransferases	
4.2.6.1.	 Structural	Homologs	of	PatA:	CmGPAT,	AbLpxM	and	TmPlsC	
At	the	time	that	PatA	crystal	structure	was	published,	a	structure	homologue	search	using	DALI	server	
revealed	 only	 one	 protein	 with	 significant	 structural	 similarity,	 the	 glycerol-3-phosphate	
acyltransferase	 from	 Cucurbita	 moschata	 (Figure	 4)27,28.	 However,	 at	 the	 present	 time,	 structure	
homologue	search	using	DALI	server	reveal	three	proteins	with	significant	structural	similarity:	
i) Glycerol-3-phosphate	acyltransferase	from	Cucurbita	moschata27,28	(CmGPAT;	Figure	4):	
CmGPAT	 catalyses	 the	 transfer	 of	 an	 acyl	 chain	 either	 from	 acyl-ACP	 or	 acyl-CoA,	 to	 the	 sn-1	
position	 of	 glycerol-3-phosphate,	 to	 form	 1-acylglycerol-3-phosphate57,58.	CmGPAT	 is	 able	 to	 use	
palmitoyl-CoA	as	a	donor	substrate,	as	PatA	does,	following	a	bi-bi	ordered	mechanism58.		
ii) Acyltransferase	LpxM	from	Acinetobacter	baumannii29	(AbLpxM;	Figure	18):	
AbLpxM	 catalyses	 the	 transfer	 of	 two	 lauroyl	 (C12)	 groups	 at	 the	 R-3’-	 and	 R-2-hydroxymyrsitate	
positions	 of	 lipid	 A19,84,143,299,300.	 LpxM	 from	 Escherichia	 coli	 (EcLpxM)	 prefers	 acyl-acyl-carrier	
protein	(acyl-ACP)	donors	but	can	also	function	with	acyl-CoA	substrates19.		
iii) 1-acyl-glycerol-3-phosphate	acyltransferase	from	Thermotoga	maritime30	(TmPlsC;	Figure	5):	
TmPlsC	catalyzes	the	transfer	of	a	palmitate	chain	(C16)	either	from	acyl-ACP	or	acyl-CoA,	to	the	sn-
2	position	of	1-acylglycerol-3-phosphate	to	form	PA.	TmPlsC	prefers	acyl-acyl-carrier	protein	(acyl-
ACP)	donors	but	can	also	function	with	acyl-CoA	substrates30.	
PatA	 and	 AbLpxM	 enzymes	 are	 distantly	 related	 to	 CmGPAT	 and	 TmPlsC	 families	 of	 bacterial	
acyltransferases,	 and	 to	 the	 dihydroacetone	 phosphate	 (DHAPAT)	 and	 2-acylglycero-
phosphatidylethanolamine	(LPEAT)	families	of	eukaryotic	acyltransferases18,21,38	(Figure	67).	
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Figure	67:	Structure	weighted	sequence	alignment	of	PatA	with	prokaryotic/eukaryotic	acyltransferases.	The	protein	
sequences	were	extracted	from	UniProt	accession	numbers	A0QWG5	from	M.	smegmatis	(PatA_Msmeg);	P24205	from	
Escherichia	 coli	 (MSBB	 or	 LpxM_ECOLI);	 O06659	 from	 Shigella	 flexneri	 (MSBB	 or	 LpxM_SHIFL);	 P0ACV0	 from	 E.	 coli	
(HTRB	 or	 LpxL_ECOLI);	 P45239	 from	 Haemophilus	 influenzae	 (HTRB	 or	 LpxL_HAEIN);	 P10349	 from	 C.	 moscata	
(GPAT_CUCMO);	Q43869	 from	Spinacia	oleracea	 (GPAT_SPIOL);	P0A7A7	PlsB	 from	E.	 coli	 (PLSB_ECOLI);	Q7UBC6	PlsB	
from	 S.	 flexneri	 (PLSB_SHIFL);	 O80437	 from	 Arabidopsis	 thaliana	 (GPAT6_ARATH);	 O15228	 from	 Homo	 sapiens	
(DHAPAT_HUMAN);	Q8L7R3	from	Arabidopsis	thaliana	 (LPCT1_ARATH);	Q99943	from	H.	sapiens	 (PLCA_HUMAN);	and	
Q53EU6	 from	H.	 sapiens	 (GPAT3_HUMAN).	Conserved	positions	are	 shown	 in	black	and	grey	background.	Conserved	
hydrophobic	residues	are	indicated	with	an	h.	The	secondary	structural	elements	corresponding	to	the	3D	structure	of	
PatA	are	 shown	above	 the	alignment.	Catalytic	amino	acids	and	 those	 involved	 in	palmitate	binding	are	 indicated	as	
asterisks	and	black	circles,	respectively.		
GPAT,	 LPAAT,	DHAPAT,	and	LPEAT	display	highly	 conserved	 residues	distributed	 in	 four	 regions,	and	
named	as	Blocks	I-IV18,31.	According	to	multiple	sequence	alignments	among	the	LpxM,	GPAT,	LPAAT,	
DHAPAT	and	LPEAT	families,	weighted	by	structural	alignment	of	PatA	and	CmGPAT,	a	common	core	
can	 be	 defined	 (Figure	 67).	 It	 is	 worth	 noting	 that	 the	 classical	 names	 of	 Blocks	 I-IV	 have	 been	
respected	as	reported	in	the	literature,	introducing	two	new	regions	as	Blocks	0	and	V.		
According	to	the	literature	and	structural	analysis,	Block	I	is	localized	in	the	long	groove	and	it	contains	
the	 catalytic	motif	HxxxD/E.	 Block	 II	 is	 placed	 in	 a	 region	near	 the	donor	 substrate,	 it	 could	help	 to	
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stack	 the	 acyl	 chain.	 Block	 III	 is	 localized	 adjacent	 to	 the	 catalytic	 site	 and	 contains	 the	 catalytic	
glutamate/aspartate	that	is	porposed	to	protonate	the	catalytic	histidine	in	PatA	and	AbLpxM.	Block	IV	
is	adjacent	to	Block	V	and	could	 it	has	a	structural	 function.	Block	O	and	V	are	two	adjacent	regions	
localized	in	an	area	that	close	the	hydrophobic	tunnel	that	accommodates	the	acyl	chain	(Figure	67).		
As	depict	in	Figure	68,	the	structural	alignment	of	the	PatA	homologs	detected	by	DALI	server	reveal	
several	 regions	with	 similar	physic-chemical	properties	 (highlighted	 in	yellow).	 The	conserved	blocks	
previously	 described	 are	 conserved,	 however,	 new	 regions	 between	 these	 homologs	 seems	 to	 be	
outlined,	as	α-helices	9	and	10.		
Critical	 residues	 and	 their	 interactions	 in	 the	 reaction	 centre	 and	 in	 the	 donor	 binding	 site	 are	
essentially	 preserved	 in	 all	 these	 acyltransferase	 families,	 strongly	 supporting	 a	 common	 structural	
core	 and	 catalytic	 mechanism.	 Therefore,	 the	 high	 variability	 of	 acceptor	 substrates	 of	 these	
acyltransferases	 families	 is	 reflected	 in	 the	 lack	of	 conserved	 regions	 regarding	 the	acceptor	binding	
site.		
	
Figure	 68:	 Structure-based	 Alignment	 of	 PatA,	 AbLpxM,	 CmGPAT	 and	 TmPlsC.	 The	 uniprot	 accession	 numbers	
A0QWG5	from	M.	smegmatis	(MsPatA),	S3TFW2	from	A.	baumannii	(AbLpxM),	P10349	from	C.	moschata	(CmGPAT)	and	
Q9X219	from	T.	maritime	(TmPlsC);	and	the	X-ray	crystal	structures	with	pdb	codes	5f2t	(MsPatA),	5kn7	(AbLpxM),	1iuq	
(CmGPAT)	and	5kym	(TmPlsC)	were	used	to	generated	the	structure-based	alignment.	Conserved	positions	are	shown	in	
highlighted	 in	 red,	 equivalent	 residues	 from	 physic-chemical	 point	 of	 view	 are	 highlighted	 in	 yellow	 and	 catalytic	
residues	are	remarked	in	a	red	square.	The	secondary	structural	elements	corresponding	to	the	3D	structure	of	PatA	are	
shown	above	the	alignment.	 	
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PatA	and	CmGPAT	
CmGPAT	belongs	 to	a	 large	 family	of	 glycerol-3-phosphate	acyltransferases	 (GPAT),	which	are	
critical	 in	the	biosynthesis	and	regulation	of	phospholipids	composition	in	prokaryotic	and	eukaryotic	
cells31,56,301.	The	structure	of	CmGPAT	is	composed	of	two	domains:	(i)	a	helical	domain	comprising	the	
first	78	residues	of	the	protein	displays	a	four-helix	bundle	architecture	of	unknown	function,	and	(ii)	
an	α/β	domain,	consisting	of	a	nine-stranded	continuous	β-sheet	surrounded	by	11	α-helices	(Figure	
70	a).	As	depicted	in	Figure	70	a,	the	central	β-sheet	of	CmGPAT	superimposes	well	with	that	observed	
in	PatA,	with	the	exception	of	its	outermost	strands	β1,	β2	and	β9,	which	are	missing	in	PatA	(Figure	70).	
	
Figure	 69:	 Structural	 similarities	 between	 PatA	 and	 CmGPAT.	 a)	 Structural	 superposition	 of	 PatA	 and	 CmGPAT.	
Secondary	structure	elements	are	labelled.	The	localization	of	the	fatty	acid	and	acceptor	binding	sites	in	CmGPAT	are	
indicated.	 b-c)	 The	 active	 site	 of	 CmGPAT	 is	 located	 into	 a	 main	 groove,	 with	 a	 hydrophobic	 tunnel	 running	
perpendicular	 and	 deeply	 buried	 into	 the	 core	 of	 the	 enzyme.	d)	 Structural	 superposition	 of	 the	 proposed	 acceptor	
binding	site	in	PatA	and	CmGPAT,	showing	donor	and	acceptor	PatA	substrates	for	spatial	reference	in	white	colour.	e)	
Structural	superposition	of	the	CoA	binding	site	in	PatA	and	CmGPAT.		 	
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Figure	70:	Structural	comparison	between	PatA	and	CmGPAT.	a)	Structural	superposition	of	the	β-sheet	core	of	PatA	
(orange)	and	that	of	the	CmGPAT	(green).	b)	Structural	superposition	of	the	acyl	binding	tunnels	 in	PatA	(yellow)	and	
CmGPAT	(green).	c)	Localization	of	the	fatty	acid	binding	site	in	CmGPAT	is	revealed	by	docking	calculations.		
Interestingly,	the	suggested	PIM1/PIM2-binding	site	in	PatA	is	located	in	the	same	region	of	the	
glycerol-3-phosphate-binding	 site	 in	 CmGPAT	 (Figure	 70	 d).	 A	 sulphate	 ion	 observed	 in	 the	 crystal	
structure	of	CmGPAT	superimposed	very	well	with	the	phosphate	moiety	of	the	inositol	ring	of	PIM1	or	
PIM2	 (Figure	 70	 d).	 It	 is	 worth	 noting	 that,	 as	 acceptors	 exhibit	 a	 marked	 diversity	 of	 chemical	
structures	 compared	 with	 acyl-CoA	 or	 acyl-ACP	 donors,	 the	 acceptor-binding	 sites	 reflect	 this	
variability	by	showing	different	rearrangements	of	secondary	structural	elements	(Figure	70	d).	
A	 region	 comprising	 residues	 128-187	 is	 important	 for	 acyl-CoA	 selectivity.	 This	 region	
completely	covered	the	narrowest	and	most	hydrophobic	of	the	three	tunnels,	tunnel-2	(Figure	70	b-c),	
which	 was	 proposed	 to	 be	 involved	 in	 fatty-acid	 recognition28.	 Strikingly,	 the	 acyl-binding	 pocket	
identified	 in	the	crystal	structures	of	the	palmitoyl-PatA	and	PatA-S-C16CoA	complexes	superimposed	
very	well	with	 tunnel-2	 of	CmGPAT	 (Figure	 71).	On	 the	basis	 of	 the	 experimental	 location	of	 the	 S-
C16CoA	 in	 PatA,	 a	 palmitoyl-CoA	 molecule	 was	 fitted	 into	 tunnel-2	 and	 subjected	 to	 energy	
minimization	 (Figure	 70	 and	 Figure	 71).	 First,	 the	 palmitate	 moiety	 accommodates	 into	 the	
hydrophobic	 tunnel.	 The	 walls	 of	 the	 tunnel	 are	 covered	 with	 mainly	 conserved,	 hydrophobic	 and	
aromatic	 residues	 including	 Leu135	 (β3),	 Pro145	 and	 Ile148	 (α7),	 Ile159	 (α8),	 Thr163	 (α8-β4	 loop),	
Phe165	(β4),	Phe180	(α10),	Leu186	(β5),	Leu226	and	Trp228	(β6),	Leu274	and	Leu276	(β7)	and	Leu305,	
with	Phe120	and	Ile123	(α6)	making	up	the	cap.		 	
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Interestingly,	 the	CoA-binding	site	observed	 in	PatA	 is	also	conserved	 in	CmGPAT.	Specifically,	
the	acyl	donor	is	located	in	the	region	corresponding	to	the	entrance	of	the	main	groove	(Figure	70	c-
e).	 The	 two	α-helices	α9	 and	α10,	 flanking	 the	entrance	of	 acyl-CoA	 to	 the	main	 groove	of	PatA,	 are	
structurally	equivalent	to	α11	(residues	201–222)	and	α12	(residues	251–265)	in	CmGPAT	(Figure	70	e).	
The	 substitution	of	 Leu261	 (α12)	 by	 an	aromatic	 residue,	which	 is	 located	at	 the	 interface	of	α11-α12	
helices,	caused	major	changes	 in	the	selectivity	of	CmGPAT	for	acyl-ACP	derivatives59.	Overall,	major	
secondary	 structural	 elements	 are	 structurally	 preserved	 across	 both	 families	 of	 acyltransferases	
supporting	a	common	binding	mode	for	palmitoyl-CoA.	
In	 CmGPAT,	 the	 catalytic	 site	 is	 also	 located	 at	 the	 base	 of	 the	 large	 groove	 of	 the	 protein,	
displaying	 the	 sequence	HX4D,	 a	well-conserved	motif	 among	 the	GPAT	 family	 of	 acyltransferases18.	
His139	 and	 the	 adjacent	 Asp144	were	 proposed	 to	 promote	 a	 charge-relay	 system	 to	 facilitate	 the	
nucleophilic	 attack	 on	 the	 thioester	 of	 the	 acyl-CoA17,27,28,61.	 In	 PatA,	 His126	 occupies	 the	 same	
location	to	that	observed	for	His139	in	CmGPAT.	However,	the	aspartic	acid	Asp131	of	the	HX4D	motif	
displays	a	completely	different	arrangement	when	compared	with	Asp144	(Figure	71).	Specifically,	the	
carboxylate	 group	 of	 Asp131	makes	 a	 strong	 hydrogen	 bond	with	 the	 side	 chain	 OH	 of	 Tyr83,	 and	
additional	electrostatic	interactions	with	the	lateral	chains	of	Trp130,	Tyr163	and	Arg164,	suggesting	a	
structural	role	for	this	residue.	In	that	sense,	the	replacement	of	Asp131	by	alanine	preserved	37%	of	
the	enzymatic	activity	for	PIM2	(Figure	64).		
	
Figure	71:	Structural	superposition	of	the	catalytic	site	of	PatA	(grey)	and	CmGPAT	(green)	with	palmitoyl-CoA	docked	
into	CmGPAT.		
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PatA	and	AbLpxM	
A	detailed	comparison	of	the	PatA-Man-C16	complex	with	that	of	AbLpxM	in	complex	with	a	n-
dodecyl-β-D-maltoside	 molecule,	 provide	 insights	 into	 the	 molecular	 mechanism	 of	 acceptor	
recognition	(Figure	72	a-d).	As	depicted	in	Figure	72,	the	central	β-sheet	of	AbLpxM	superimposes	very	
well	with	that	observed	in	PatA.	Strikingly,	the	main	groove	and	the	acyl-binding	pocket	 identified	 in	
the	crystal	structures	of	PatA-Man-C16,	PatA-S-C16CoA	and	PatA-C16	complexes	superimposed	very	well	
with	 the	 corresponding	main	 groove	 and	 a	 hydrophobic	 cavity	 observed	 in	AbLpxM	 (Figure	 72	 and	
Figure	73).		
	
Figure	 72:	Structural	 similarities	 between	 PatA	 and	AbLpxM.	a-b)	Cartoon	 representation	 showing	 two	views	of	 the	
structure	weighted	 sequence	alignment	of	PatA	with	AbLpxM.	PatA	β-strands	and	α-helices	are	 shown	 in	orange	and	
yellow,	respectively.	The	Man-C16	product	is	shown	in	black	and	red.	The	first	N-terminal	three	α-helices	of	AbLpxM	are	
shown	 in	 green,	 whereas	 the	 remaining	 secondary	 structure	 elements	 are	 shown	 in	 grey.	 c)	 Structure	 weighted	
sequence	alignment	of	a	selected	region	of	PatA	and	AbLpxM,	comprising	residues	that	code	for	the	four	N-terminal	α-
helices.	 d)	 Cartoon	 representation	 showing	 the	 structural	 superposition	 of	 PatA	 and	 AbLpxM.	 Both	 structures	 are	
coloured	as	in	panel	a).	The	Man-C16	product	is	shown	in	black	and	red.	The	S-C16CoA	acyl	donor	substrate	derivative	is	
shown	in	light	blue	and	red.	The	DDM	molecule	is	shown	in	orange.		 	
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On	the	basis	of	the	experimental	location	of	the	S-C16CoA	in	PatA,	and	taking	into	account	that	
AbLpxM	displayed	a	strong	preference	for	lauryl	chains	(C12)	over	other	acyl	chain	lengths	tested	(C10,	
C14	 and	 C16)29,	 a	 lauryl-CoA	 molecule	 was	 fitted	 into	 equivalent	 cavity	 and	 subjected	 to	 energy	
minimization	 (Figure	 73).	 The	 lauryl	 moiety	 accommodates	 into	 the	 hydrophobic	 cavity,	 which	 is	
shorter	than	that	observed	in	the	PatA-S-C16CoA	complex,	pointing	to	the	occurrence	of	a	hydrocarbon	
ruler	 mechanism29,149,302.	 The	 walls	 of	 the	 tunnel	 are	 covered	 with	 hydrophobic	 residues	 including	
Leu118	 (β2),	 Val120	 (β2-α7	 loop),	 Trp126	 and	Met129	 (α7),	Met139	 and	 Ile141(β3),	 Val188	 (β5),	 and	
Leu190	(β5-β6	loop);	with	Ile97	and	Ile100	(β1),	Phe106	(α6),	Trp132	(α7),	Phe136	(α7-β3	loop),	Leu229	
(β8),	and	Ile243	and	Met241	(β9),	building	the	bottom	cap29.		
	
Figure	73:	PatA	and	AbLpxM	share	a	common	acyl	donor	binding	site.	a-b)	Structural	superposition	of	the	acyl	binding	
tunnel	 in	 AbLpxM	 (orange)	 and	 the	 palmitate	 residue	 of	 C16-CoA	 (black)	 observed	 in	 PatA	 (yellow)	 c-d)	 Structural	
superposition	of	PatA	(orange)	and	AbLpxM	(green)	and	the	localization	of	the	C16-CoA	binding	site.		
The	 CoA-binding	 site	 observed	 in	 PatA	 is	 also	 conserved	 in	 AbLpxM.	 Specifically,	 the	 4-
phosphopantetheinate	moiety	of	S-C16CoA	is	located	at	the	entrance	of	the	main	groove	(Figure	73	c-
d).	 The	 two	α-helices	α9	 and	α10,	 flanking	 the	entrance	of	 acyl-CoA	 to	 the	main	groove	of	PatA,	 are	
structurally	 equivalent	 to	 α9	 (residues	 170-183)	 and	 α10	 (residues	 213-223)	 in	 AbLpxM,	 as	 also	
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observed	 in	CmGPAT,	 pointing	 to	 a	 common	 binding	mode	 (Figure	 73	 c-d)21,29.	AbLpxM	 crystallized	
with	 one	 molecule	 of	 n-dodecyl-β-D-maltoside,	 with	 the	 glucosyl	 residues	 deeply	 buried	 into	 a	
hydrophobic	pocket	located	in	one	side	of	the	main	groove.	Strikingly,	the	first	glucose	moiety	of	DDM	
superimposed	well	with	the	Man	residue	of	Man-C16	located	in	the	acceptor	binding	site	of	PatA.	The	
second	glucose	moiety	of	DDM	superimposed	well	with	the	inositol	residue	of	PIM211,21.	Interestingly,	
the	 C12	 acyl	 chain	 of	 DDM	 localizes	 in	 a	 hydrophobic	 cavity	 formed	 by	 α1,	 α2	 and	 α4	 in	 AbLpxM,	
conserved	in	PatA,	suggesting	a	binding	mode	for	the	acyl	chains	of	the	lipid	acceptor	substrates29.	
In	 AbLpxM,	 the	 catalytic	 site	 is	 also	 located	 at	 the	 base	 of	 the	 large	 groove	 of	 the	 protein,	
displaying	 the	 sequence	HX4D,	 a	well-conserved	motif	 among	 the	GPAT	 family	 of	 acyltransferases18.	
His122	from	Block	I,	and	the	adjacent	Asp192	from	Block	III,	are	proposed	to	promote	a	charge-relay	
system	 to	 facilitate	 the	nucleophilic	 attack	on	 the	 thioester	 of	 the	 acyl-CoA17,27,28,61.	 In	 PatA,	His126	
occupies	 the	 same	 location	 to	 that	 observed	 for	His122	 in	AbLpxM	and	PatA	Glu200	 is	 in	 the	 same	
position	of	Asp192,	showing	a	very	similar	catalytic	mechanism	(Figure	74).		
	
Figure	74:	Structural	superposition	of	the	catalytic	site	of	PatA	(grey)	and	AbLpxM	(green)	with	palmitoyl	docked	into	
AbLpxM.	
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PatA	and	TmPlsC	
The	structure	of	TmPlsC	is	composed	of	two	domains:	(i)	a	helical	domain	comprising	the	first	61	
residues	of	the	protein	displays	a	two-helix	bundle	architecture	and	it	has	been	proved	to	be	inserted	
into	the	lipid	bilayer,	and	(ii)	an	α/β	domain	that	comprise	the	following	62-247	residues,	consisting	of	
a	seven-stranded	continuous	β-sheet	surrounded	by	nine	α-helices	(Figure	5	a).	As	depicted	in	Figure	
75,	the	central	β-sheet	of	TmPlsC	superimposes	well	with	that	observed	in	PatA,	with	the	exception	of	
its	outermost	strands	β6,	β5	and	α4	which	are	missing	in	TmPlsC	(Figure	75).	
	
Figure	75:	Superposition	of	the	α/β	domain	of	PatA	and	TmPlsC,	a	common	main	groove	and	a	common	structural	
core	is	share	in	both	enzymes.	Structural	superposition	of	the	core	of	PatA	(orange),	the	α/β	domain	of	TmPlsC	(green)	
and	the	S-C16-CoA	(black).		
A	 detailed	 comparison	 of	 the	 PatA-S-C16-CoA	 complex	 with	 α/β	 domain	 of	 TmPlsC,	 provide	
insights	 into	the	molecular	mechanism	of	acceptor	recognition	(Figure	75).	As	depicted	 in	Figure	75,	
four	out	of	the	six	PatA	β-strands	superimposes	very	well	the	central	β-sheets	of	TmPlsC	(β8,	β7,	β4	and	
β1).	However,	and	β2	and	β3	are	not	observed	in	TmPlsC	central	β-sheet	core.		
Interestingly,	Robertson	et	al.	proposed	a	model	in	which	TmPlsC	acyl-binding	poket	is	different	than	
the	 acyl-binding	 poket	 of	 PatA	 (Figure	 76	 a)30.	 In	 their	 model	 the	 acyl	 chain	 runs	 parallel	 to	 main	
groove,	not	perpendicular	as	 is	 the	case	of	PatA	(Figure	76	b).	 In	this	model	the	hydrophobic	tunnel	
proposed	 to	 accommodate	 the	 substrate	 in	 TmPlsC	 includes	 residues	 Tyr20,	 Ile21,	 Gly25,	 Ile49	 and	
Phe52	 (coloured	 in	 yellow	 in	 Figure	 76	 b).	 The	model	 is	 based	 in	 an	MD	 simulation	 and	 enzymatic	
activity	measurements,	Gly25	 is	proposed	 to	 close	 the	hydrocarbon	 ruler	hydrophobic	 tunnel	of	 the	
C16	acyl	chain,	which	is	the	preferred	chain	length	for	TmPlsC29,30,149,302.	The	mutation	of	this	Gly25	by	a	
bulkier	 residue	 (Gly25Met)	 leads	 to	 an	 increase	 of	 the	 C14-CoA	 activity	 and	 a	 decrease	 of	 C16-CoA	
activity30.		 	
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It	 is	 important	having	into	account	that	TmPlsC	substrate	perform	the	second	acylation	of	PA,	thus	it	
seems	 that	 two	 acyl	 chains	 need	 to	 be	 accommodated	 into	 the	 enzyme,	 this	 could	 involve	 the	
existence	of	two	acyl-binding	sites.	Even	though	the	surface	analysis	of	TmPlsC	reveals	the	collapse	of	
the	PatA	acyl-binding	poket	in	TmPlsC	(Figure	76	c),	when	the	S-C16-CoA	molecule	from	the	PatA-S-C16-
CoA	complex	is	fitted	into	TmPlsC	it	accommodates	well.	Interestingly,	the	residues	that	are	in	contact	
with	 the	palmitate	are	Val80,	 Ile90,	 Ile93,	Val97,	Ala98,	Phe102,	 Ile152,	Phe154,	Thr158,	Val186	and	
catalytic	 His84	 (coloured	 in	 red	 in	 Figure	 76	 b).	 To	 further	 clarify	 the	 acyl-binding	 site	 of	 TmPlsC,	
enzymatic	assays	with	a	TmPlsC	mutant	of	residue	Ala98,	which	is	located	at	the	end	of	the	PatA	acyl-
binding	poket	in	TmPlsC,	for	a	bulkier	residue	could	reveal	the	use	of	this	conserved	tunnel	in	TmPlsC	
in	solution.	
	
Figure	76:	TmPlsC	and	PatA	acyl-binding	poket	models.	a)	An	MD-derived	model	of	TmPlsC	bound	in	the	lipid	bilayer.	
The	color-coding	is	as	follows:	N-terminal	two-helix	motif,	orange;	core	catalytic	αβ-domain,	blue	and	green;	active	site	
histidine,	yellow;	LPA	substrate,	salmon	carbons;	acyl	donor,	teal	carbons;	membrane	phospholipids,	yellow	acyl	chains,	
red/orange	phosphate	groups	and	blue	head	groups.	The	blue-to-green	scale	reflects	 the	water-to-lipid	occupancy	of	
one	half	of	 the	 lipid	bilayer	relative	to	the	proposed	 location	of	 the	TmPlsC-substrate	complex.	The	scale	 is	based	on	
biophysical	 studies31	 in	which	H2O,	 phospholipid	 head	 group	 (PG),	 carbonyl	 glycerol	 (CG)	 and	hydrocarbon	CH2	and	
CH3	zones	identify	the	highest	probability	of	finding	these	moieties	within	one	leaflet	of	the	bilayer.	Modified	from30.	b)	
TmPlsC	 residues	 proposed	 to	 be	 interacting	with	 the	 donor	 substrate	 acyl-chain	 (in	 yellow)	 and	 residues	 that	would	
interact	 with	 the	 acyl	 chain	 in	 the	 case	 that	 TmPlsC	 would	 have	 the	 same	 acyl-binding	 pocket	 than	 PatA	 (in	 red).	
Catalytic	residues	His84	and	Asp89	are	coloured	in	dark	blue	and	hydrocarbon	ruler	proposed	residue	Gly25	is	coloured	
in	cyan.	c)	TmPlsC	surface	analysis	of	the	acyl-binding	pocket	model.	 In	red,	residues	that	would	interact	with	the	acyl	
chain	in	the	case	that	TmPlsC	would	have	the	same	acyl-binding	poket	than	PatA.	 In	yellow,	proposed	residues	of	the	
acyl-binding	pocket	of	TmPlsC.	In	orange,	the	two-helix	motif	proposed	to	interact	with	the	lipid	bilayer.		
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In	 TmPlsC,	 the	 catalytic	 site	 is	 also	 located	 at	 the	 base	 of	 the	 large	 groove	 of	 the	 protein,	
displaying	 the	 sequence	HX4D,	 a	well-conserved	motif	 among	 the	GPAT	 family	 of	 acyltransferases18.	
His184	 from	Block	 I,	 and	 the	 adjacent	 Asp89	 from	Block	 I,	 are	 proposed	 to	 promote	 a	 charge-relay	
system	 to	 facilitate	 the	nucleophilic	 attack	on	 the	 thioester	 of	 the	 acyl-CoA17,27,28,61.	 In	 PatA,	His126	
occupies	 the	 same	 location	 to	 that	observed	 for	His84	 in	TmPlsC.	However,	 the	PatA	Asp131	of	 the	
HX4D	motif	displays	a	completely	different	arrangement	when	compared	with	Asp89	(Figure	77).	The	
catalytic	mechanism	proposed	for	TmPlsC	is	very	similar	to	the	one	proposed	for	CmGPAT,	while	PatA	
and	AbLpxM	share	the	same	model.		
	
Figure	77:	Structural	superposition	of	the	catalytic	site	of	PatA	(grey)	and	TmPlsC	(green)	with	palmitate	docked	into	
TmPlsC.	
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4.2.6.2.	 New	Family	of	Acyltransferases	with	a	Common	Structural	Core	
In	Figure	76	is	depict	the	superposition	of	the	α/β	domain	of	PatA,	AbLpxM,	CmGPAT	and	TmPlsC.	The	
four	acyltransferases	seem	to	share	a	common	structural	core	of	six	α-helices	(α11,	α10,	α9,	α8,	α7	and	
α6)	and	four	β-sheets	(β1,	β4,	β7	and	β8).	PatA	and	AbLpxM	share	four	more	β-strands	(β2,	β3,	β5	and	β6),	
being	β2	and	β3	also	shared	wih	CmGPAT	(Figure	78).		
	
Figure	 78:	 PatA,	 AbLpxM,	 TmPlsC	 and	 CmGPAT	 have	 a	 common	 structural	 core.	 Structural	 superposition	 of	 the	
structural	core	of	PatA	(orange),	AbLpxM	(green),	TmPlsC	(blue),	CmGPAT	(yellow)	and	S-C16-CoA	(black).		
The	 superposition	 of	 the	 α/β	 domain	 of	 PatA,	 AbLpxM,	 CmGPAT	 and	 TmPlsC	 confirms	 a	 common	
structural	 catalytic	 core,	 however	 the	 α-helix	 motif	 of	 the	 N-terminal	 domain	 that	 those	 enzymes	
display	is	still	 intriguing.	AbLpxM	has	a	long	α-helix	at	the	Nt	domain29,	TmPlsC	has	a	two-helix	motif	
that	 is	 predicted	 to	 interact	with	 the	 lipid	 bilayer30,	CmGPAT	 has	 a	 four-helix	 bundle	 reported	with	
unknown	 function28,	 and	 the	 first	 50	 N-terminal	 residues	 of	 PatA	 cannot	 be	 observed	 in	 a	 crystal	
structure	yet.	In	that	sense,	membrane	association	studies	could	be	performed	to	shed	some	light	on	
how	these	enzymes	associate	with	the	lipid	bilayer,	and	how	the	different	number	of	α-helices	affect	
to	the	membrane	association.		
Interestingly,	 the	 primary	 sequence	 alignment	 suggests	 that	 PatA,	 CmGPAT,	 AbLpxM	 and	 TmPlsC	
families	of	 acyltransferases	display	 a	 conserved	aspartate/glutamate	 residue	 that	participates	 in	 the	
charge	relay	system	with	the	conserved	histidine	of	the	HX4D/E	motif	(Block	I)17,32.	This	is	the	case	of	
the	 two	acyltransferases	 involved	 in	PA	biosynthesis	CmGPAT	and	TmPlsC	 (Figure	 79	 a).	 In	 contrast,	
according	 to	 the	 crystal	 structures	 AbLpxM	 and	 PatA	 seem	 to	 use	 a	 glutamate/aspartate	 residue	
located	 in	Block	 III	 (Figure	 79	 b),	 suggesting	a	divergence	among	 this	 family	of	acyltransferases.	The	
structural	 divergence	 of	 the	 carboxylate	 group	 acting	 as	 a	 pKa	modulator	 of	 the	 catalytic	 histidine	
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residue	might	be	due	to	the	requirement	of	the	acyltransferases	to	accommodate	acceptor	molecules	
of	different	nature,	as	observed	in	PatA	and	AbLpxM.		
	
Figure	79:	Divergence	in	the	catalytic	mechanism	of	acyltranferases,	PatA	is	in	orange,	AbLpxM	is	in	green,	TmPlsC	is	
in	dark	blue	and	CmGPAT	is	in	yellow.	a)	Catalytic	mechanism	of	PatA	and	AbLpxM,	histidine	of	Block	I	is	activated	by	
PatA	glutamate/AbLpxM	aspartate	of	Block	 III.	b)	Catalytic	mechanism	of	TmPlsC	and	CmGPAT,	histidine	of	Block	 I	 is	
activated	by	aspartates	of	Block	I	from	the	motif	HX4D.	c)	PatA,	AbLpxM,	TmPlsC	and	CmGPAT	catalytic	mechanisms.	
To	 further	 confirm	 the	 existence	 of	 this	 new	 structural	 family	 of	 acyltransferases	 with	 a	 common	
structural	core	but	a	divergence	in	the	catalytic	mechanism	new	crystal	structures	needed.	However,	
this	new	family	of	acyltransferases	seems	to	be	emerging	from	the	current	available	data.		
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5.	CONCLUSIONS	
During	 recent	 years	 major	 efforts	 have	 been	 made	 to	 understand	 the	 early	 steps	 of	 the	 PIM	
biosynthetic	 pathway	 at	 the	 molecular	 level.	 In	 this	 work,	 we	 focused	 in	 the	 study	 of	 the	
acyltransferase	 PatA.	 PatA	 is	 an	 essential	 membrane	 associated	 acyltransferase	 involved	 in	 the	
biosynthesis	 of	 mycobacterial	 phosphatidyl-myo-inositol	 mannosides.	 The	 enzyme	 transfers	 a	
palmitoyl	 moiety	 from	 palmitoyl-CoA	 to	 the	 6-position	 of	 the	mannose	 ring	 linked	 to	 2-position	 of	
inositol	in	PIM1/PIM2.		
The	conclusions	of	this	thesis	are	the	following:		
I. After	 years	 of	 research,	 we	 have	 been	 able	 to	 determine	 the	 crystal	 structure	 of	 PatA	 in	
complex	with	palmitoyl,	a	nonhydrolisable	analogue	of	palmitoyl-CoA	(S-hexadecyl	Coenzime	A),	
the	 product	 6-O-palmitoyl-α-D-mannopyranoside,	 and,	 one	 molecule	 of	 palmitate	 and	 one	
molecule	of	free	β-D-mannopyransoide.	
II. PatA	crystallized	as	a	monomer,	displaying	a	high	degree	of	structural	flexibility	in	the	N-	and	C-
terminal	regions.	The	central	core	of	PatA	consists	on	a	six-stranded	β-sheet	surrounded	by	α-
helices.	A	long	and	open	groove	that	runs	parallel	to	the	protein	surface	contains	the	active	site.	
The	groove	also	displays	a	narrow	and	deep,	mostly	hydrophobic	tunnel	that	runs	perpendicular	
from	its	floor	to	the	central	core	of	the	protein.		
III. The	 donor	 binding	 site	 is	 defined	 by	 a	 molecule	 of	 palmitic	 acid	 carried	 over	 from	 the	
purification	 and	bound	 into	 a	 hydrophobic	 tunnel	 of	 all	 PatA.	 The	 acyl	 chain	 is	 deeply	 buried	
into	the	hydrophobic	pocket,	and	oriented	with	the	carboxylate	group	facing	the	groove	and	the	
acyl	tail	extending	into	the	globular	core	of	the	monomer.		
IV. The	acceptor	binding	site	is	defined	by	a	Manp	residue	located	within	a	cavity	located	at	the	end	
of	the	main	groove	as	well	as	the	product	6-O-palmitoyl-α-D-mannopyranoside.		
V. Enzyme	 catalysis	 is	 mediated	 by	 an	 unprecedented	 charge	 relay	 system,	 which	 markedly	
diverges	 from	 the	 canonical	 HX4D	 motif.	 We	 propose	 a	 model	 in	 which	 His126	 acts	 as	 the	
general	base	to	abstract	a	proton	from	the	hydroxyl	group	at	position	6	of	the	Manp	ring	linked	
to	the	2-position	of	inositol	in	PIM1	or	PIM2,	to	facilitate	the	nucleophilic	attack	on	the	thioester	
of	palmitoyl-CoA.	The	Glu200	gets	 involved	 in	a	charge	relay	system	with	His126	and	the	HO6	
atom	 from	 the	Manp	 moiety,	 contributing	 to	 the	 appropriate	 structural	 arrangement	 of	 the	
imidazole	ring	of	the	histidine	residue	and	modulating	its	pKa	to	act	as	a	base	in	the	first	step	
and	as	an	acid	 in	 the	 second	step,	providing	protonic	assistance	 to	 the	departing	CoA	 leaving	
group.	 The	 result	 of	 the	 nucleophilic	 attack	 is	 a	 covalent	 bond	between	 the	mannose	 ring	 of	
PIM1	or	PIM2	and	the	palmitoyl	residue.	
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VI. Despite	the	fact	that	acyl	transfer	 is	catalysed	between	the	palmitoyl	moiety	of	palmitoyl-CoA	
and	the	mannosyl	group	of	PIM1	or	PIM2,	our	experimental	data	indicate	the	enzyme	displays	an	
absolute	necessity	of	both	fatty	acid	chains	of	PI	in	order	for	the	transfer	reaction	to	take	place,	
pointing	to	a	mechanism	requiring	a	lipid-water	interface.	The	fatty	acid	chains	of	the	acceptor	
substrate	 seems	 to	play	 an	 important	 structural	 role	 in	 the	 generation	of	 a	 competent	 active	
site,	assisting/guiding	 the	glycosylated	moiety	 to	 the	appropriate	environment	 in	 the	catalytic	
centre.		
VII. The	crystal	structure	of	PatA	in	the	presence	of	β-D-mannopyranose	and	palmitate	suggest	an	
inhibitory	 mechanism	 for	 the	 enzyme.	 These	 studies	 establish	 the	 mechanistic	 basis	 of	
substrate/membrane	 recognition	 and	 catalysis	 for	 an	 important	 family	 of	 acyltransferases,	
providing	 exciting	 possibilities	 for	 inhibitor	 design	 and	 the	 discovery	 of	 chemotherapeutic	
agents	against	this	major	human	pathogen.	
VIII. The	search	of	structural	homologs	reveals	that	AbLpxM,	CmGPAT	and	TmPlsC	are	homologs	of	
PatA.	By	the	structural	comparison	of	the	α/β	domain	of	these	enzymes	with	PatA	the	existence	
of	a	common	core	can	be	defined.		
IX. The	primary	sequence	alignment	suggests	that	PatA,	CmGPAT,	AbLpxM	and	TmPlsC	families	of	
acyltransferases	display	a	conserved	aspartate/glutamate	residue	that	participates	in	the	charge	
relay	 system	 with	 the	 conserved	 histidine	 of	 the	 HX4D/E	 motif	 (Block	 I).	 However,	 crystal	
structures	 of	 these	 enzymes	 reveal	 that	CmGPAT	 and	 TmPlsC	mechanisms	 are	 in	 accordance	
with	 the	 primary	 secuence	 alignments.	 In	 contrast,	 AbLpxM	 and	 PatA	 seem	 to	 use	 a	
glutamate/aspartate	 residue	 located	 in	Block	 III,	 suggesting	a	divergence	among	 this	 family	of	
acyltransferases.	
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ANNEX	I	
Chemical	synthesis	of	PIM222.		
Scheme	1	
	
	
	
C44H44O7S	
M	=	716.89	g.mol-1	
Ethyl	3,4,6-tri-O-benzyl-2-O-(9-fluorenylmethyloxycarbonyl)-1-thio-	
α-D-mannopyranoside		
(2)	
A	freshly	prepared	sodium	methoxide	solution	(30	ml,	0.5	M	in	methanol)	was	added	to	a	solution	of	
ethyl	2-O-acetyl-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside	(13.90	g,	0.026	mol)	in	methanol	(100	
ml)	at	0°C.	The	reaction	mixture	was	stirred	at	room	temperature	and	the	progress	of	the	reaction	was	
monitored	 by	 TLC.	 The	 methanol	 was	 removed	 in	 vacuo	 and	 the	 residue	 was	 extracted	 by	
dichloromethane.	 The	 organic	 phase	 was	 washed	 with	 water,	 dried	 over	 MgSO4,	 filtered	 and	
concentrated	in	vacuo	to	give	a	yellow	oil	which	was	used	without	further	purification.	To	a	solution	of	
the	oil	in	anhydrous	dichloromethane	(60	ml)	was	added	pyridine	(4	ml)	followed	by	9-fluorenylmethyl	
chloroformate	(FMOC-Cl)	(10.06	g,	0.039	mol).	The	reaction	mixture	was	stirred	at	room	temperature	
overnight.	The	reaction	mixture	was	quenched	with	water	and	extracted	with	dichloromethane.	The	
organic	 phase	 was	 washed	 with	 water,	 dried	 over	MgSO4,	 filtered	 and	 concentrated	 in	 vacuo.	 The	
residue	was	chromatographed	on	silica	gel	(Petroleum	ether/dichloromethane	=	1:2)	to	afford	2	(13.87	
g,	75%	yield	over	two	steps).		
[α]D	25	=	+	37.7°	(c	=	1.0,	CH2Cl2)	
1H	NMR	(400MHz,	CDCl3):	δ	1.33	(t,	3H,	3J	=	7.5	Hz,	SCH2CH3),	2.59-2.77	(m,	2H,	SCH2CH3),	3.76	(dd,	1H,	
2J	=	11.0	Hz,	3J	=	1.5	Hz,	H-6),	3.89	(dd,	1H,	2J	=	11.0	Hz,	3J	=	4.5	Hz,	H-6),	3.97	(dd,	1H,	3J	=	9.5,	2.5	Hz,	
H-3),	4.04	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-4),	4.23	(ddd,	1H,	3J	=	9.5,	4.5,	1.5	Hz,	H-5),	4.30	(dd,	1H,	3J	=	7.5,	
7.5	Hz,	CH-Fmoc),	4.36	(dd,	1H,	2J	=	10.0	Hz,	3J	=	7.0	Hz,	CH2-Fmoc),	4.47	(dd,	1H,	2J	=	10.0	Hz,	3J	=	7.0	
Hz,	CH2-Fmoc),	5.32	(dd,	1H,	3J	=	2.5,	1.5	Hz,	H-2),	5.48	(d,	1H,	3	J	=	1.5	Hz,	H-1).	
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13C	NMR	 (100MHz,	 CDCl3):	 δ	 14.9	 (SCH2CH3),	 25.5	 (SCH2CH3),	 46.6	 (CH-Fmoc),	 68.9	 (C-6),	 70.3	 (CH2-
Fmoc),	72.0,	73.4	and	75.3	(CH2Ph),	72.0	(C-5),	74.6	(C-4),	74.6	(C-2),	78.6	(C-3),	82.1	(C-1),	154.8	(CO-
Fmoc).	
HRMS	C44H44O7SNa	:	Calcd.	[M	+	Na]+	739.2706.	Found	739.2709.	
1H	NMR		
	
13C	NMR	
	
	
(3)	 	
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Known	compound:	prepared	according	to	Bender	and	Budhu268.	
1H	NMR	
	
	
	
	
(S)-1,2-di-O-palmitoyl	glycerol	
(9)	
Known	compound:	prepared	according	to	Martin	and	colleagues266.	
1H	NMR	
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C113H108O21	
M	=	1802.09	g.mol-1	
(4)	
Myo-inositol	derivative	3	 (1.02	g,	2.1	mmoles)	and	thiomannoside	2	 (4.54	g,	6.3	mmoles)	were	dried	
under	vaccum	for	three	hours,	they	were	then	dissolved	in	CH2Cl2	(26	ml)	and	powdered	4Å	molecular	
sieves	was	added.	The	mixture	was	stirred	at	room	temperature	for	15	minutes.	The	reaction	mixture	
was	 cooled	 to	 -15°C	 and	 were	 sequentially	 added	 N-iodosuccinimide	 (1.86	 g,	 8.24	 mmoles)	 and	
TMSOTf	 (1M	 solution	 in	 CH2Cl2,	 0.65	ml,	 0.65	mmoles).	 The	 dark	 red	mixture	was	 stirred	 for	 three	
hours	and	allowed	to	warm	to	room	temperature.	The	reaction	was	quenched	by	adding	a	phosphate	
buffer	solution	(pH	=	7)	and	the	aqueous	phase	was	extracted	twice	with	CH2Cl2.	The	combined	organic	
phase	was	washed	with	saturated	Na2S2O3	and	brine,	dried	with	MgSO4	and	the	solvent	evaporated.	
Chromatography	(toluene/ethyl	acetate	98/2	to	92/8)	gave	4	as	colourless	oil	in	two	fractions	(1.10	g,	
pure	by	NMR,	32%	and	1.32	g,	>	85%	pure,	32%,	total	yield	64%).	
	[α]D	25	=	+	14.5°	(c	1.17,	chloroform)	
1H	NMR	(400MHz,	CDCl3:	δ	2.5	(s,	3H,	Ac);	3.23	(m,	2H,	2	x	H-6M);	3.30	(dd,	1H,	2J	=	11.5,	3J	=	3.0	Hz,	H-
6M);	3.39	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-5I);	3.50	(dd,	1H,	3J	=	10.0,	2.5	Hz,	H-3I);		3.55	(dd,	1H,	2J	=	11.0,	3J	
=	2.0	Hz,	H-6M);	3.88	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-4I);		3.97	(dd,	1H,	3J	=	8.5,	2.5	Hz,	H-3M);	3.99-4.08	(m,	
2H,	H-3M,	H-5M);	4.11	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-4M);	4.13-4.21	(m,	3H,	H-4M,	H-5M,	H-6I);	4.36	(dd,	
1H,	3J	=	2.5,	2.5	Hz,	H-2I);	4.82	(dd,	1H,	3J	=	9.5,	2.5	Hz,	H-1I);	5.09	(d,	1H,	3J	=	1.5	Hz,	H-1M);	5.12	(dd,	
1H,	3J	=	2.5,	1.5	Hz,	H-2M);	5.19	(dd,	1H,	3J	=	2.5,	1.5	Hz,	H-2M);	5.40	(d,	1H,	3J	=	1.5	Hz,	H-1M).	
13C	NMR	(100MHz,	CDCl3):	δ	20.6	(CH3-Ac),	46.5	and	46.6	(CH-Fmoc),	67.9	and	68.1	(C-6M),	70.2	and	
70.2	(CH2-Fmoc),	71.7	and	71.9	(C-5M),	71.7,	71.8,	72.4,	73.3,	73.4,	74.6,	75.1,	75.3	and	75.8	(CH2Ph),	
72.8	and	72.8	(C-2M),	73.9	and	74.0	(V-4M),	74.6	(C-2I),	75.5	(C-6I),	76.0	(C-1I),	77.2	and	77.8	(C-3M),	
78.5	(C-3I),	80.9	(C-5I),	81.1	(C-4I),	98.1	and	99.2	(C-1M),	154.6	and	154.8	(CO-Fmoc),	170.8	(CO-Ac).	
HRMS	C113H108O21Na	:	Calcd.	[M	+	Na]+	1823.7281.	Found	1823.7264.	
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13C	NMR	
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C83H88O17	
M	=	1357.60	g.mol-1	
(5)	
4	 (1.23	g,	0.68	mmoles)	was	dissolved	 in	THF	 (10	ml)	and	 treated	with	NEt3	 (1.2	ml,	8.3	mmoles)	at	
room	temperature	for	4	hours.	The	mixture	was	concentrated	in	vacuo.	Chromatography	on	silica	(1%	
to	5%	methanol	in	CH2Cl2)	gave	5	(765	mg,	82%).	
[α]D	25	=	+55.0°	(c	=	1.45,	chloroform)	
1H	NMR	(400MHz,	CDCl3:	δ	2.15	(s,	3H,	Ac);	2.41	and	2.46	(2d,	2	x	1H,	3J	=	2.5	Hz,	OH-M);	3.17	(dd,	1H,	
2J	=	10.5,	3J	=	1.5	Hz,	H-6M);	3.24	(dd,	1H,	2J	=	9.5,	3J	=	2.0	Hz,	H-6M);	3.27	(dd,	1H,	2J	=	9.5,	3J	=	2.5	Hz,	
H-6M);	3.39	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-5I);	3.46	(dd,	1H,	2J	=	10.5,	3J	=	2.5	Hz,	H-6M);	3.50	(dd,	1H,	3J	=	
10.0,	2.5	Hz,	H-3I);		3.83	(dd,	1H,	3J	=	8.5,	2.5	Hz,	H-3M);	3.88-3.96	(m,	5H,	H-2M,	H-3M,	H-4M,	H-4I,	H-
5M);	3.98	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-4M);	4.11-4.15	(m,	2H,	H-2M,	H-5M);	4.16	(dd,	1H,	3J	=	10.0,	9.5	
Hz,	H-6I);	4.37	(dd,	1H,	3J	=	2.5,	2.5	Hz,	H-2I);	4.87	(dd,	1H,	3J	=	10.0,	2.5	Hz,	H-1I);	5.07	(d,	1H,	3J	=	1.5	
Hz,	H-1M);	5.22	(d,	1H,	3J	=	1.5	Hz,	H-1M).	
13C	NMR	(100MHz,	CDCl3):	δ	21.0	(CH3-Ac),	67.9	and	68.2	(C-6M),	68.4	and	68.7	(C-5M),	71.1	and	71.3	
(C-2M),	 72.0,	 72.1,	 72.3,	 73.3,	 73.4,	 75.1,	 75.7	 and	76.0	 (CH2-Bn),	 73.3	 (C-2I),	 73.9	 and	73.9	 (C-4M),	
74.9	 (C-1I),	75.5	 (C-6I),	78.7	 (C-3I),	79.4	and	80.0	(C-3M),	81.0	 (C-5I),	81.2	 (C-4I),	100.1	and	100.7	(C-
1M),	170.1	(C=O).		
HRMS	C83H88O17Na.	Calcd.	[M	+	Na]+	1379.5919.	Found	1379.5896.		
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C99H104O19	
M	=	1597.90	g.mol-1	
(6)		
5	(950.3	mg,	0.78	mmoles)	was	dissolved	in	anhydrous	chloroform	(4	ml)	and	treated	sequentially	with	
tetrabutylammonium	 iodide	 (144.1	 mg,	 0.39	 mmoles)	 and	 diisopropylethylamine	 (453	 µL,	 3.12	
mmoles)	at	room	temperature.	The	mixture	was	brought	to	40°C	and	freshly	distilled	benzyloxymethyl	
chloride	 (BOM-Cl,	330	µL,	2.34	mmoles)	was	added.	The	reaction	was	 left	at	40°C	overnight.	At	 that	
time,	some	monoprotected	compounds	were	still	present,	BOM-Cl	(110	µL,	0.78	mmoles)	was	added	
and	the	mixture	 left	at	40°C	until	completion	of	the	reaction.	The	mixture	was	quenched	with	water	
and	diluted	with	CH2Cl2.	The	water	phase	was	extracted	twice	with	CH2Cl2,	the	organic	phase	was	dried	
on	MgSO4	and	the	solvent	evaporated.	Chromatography	on	silica	(petroleum	ether/Ethyl	acetate	85/	
to	72/25)	gave	the	product	as	a	white	solid	(1.026	g,	91%).	
[α]D	25	=	+63.2°	(c	1.70,	chloroform)	
1H	NMR	(400MHz,	CDCl3:	δ	1.90	(s,	3H,	Ac);	3.23	(dd,	1H,	2J	=	11.0,	3J	=	1.5	Hz,	H-6M);	3.27	(br	d,	1H,	2J	
=	10.5	Hz,	H-6M);	3.30	(dd,	1H,	2J	=	11.0,	3J	=	2.5	Hz,	H-6M);	3.36	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-5I);	3.47	
(dd,	1H,	3J	=	10.0,	2.5	Hz,	H-3I);		3.52	(br	d,	1H,	2J	=	11.0	Hz,	H-6M);	3.86	(dd,	1H,	3J	=	10.0,	9.5	Hz,	H-4I);	
3.90	(dd,	1H,	3J	=	9.5,	3.0	Hz,	H-3M);	3.96-4.00	(m,	3H,	H-2M,	H-3M,	H-5M);	4.03	(dd,	1H,	3J	=	3.0,	1.5	
Hz,	H-2M);	4.09-4.19	(m,	4H,	2	x	H-4M,	H-5M,	H-6I);	4.32	(dd,	1H,	3J	=	2.5,	2.5	Hz,	H-2I);	4.76,	4.80,	4.84	
and	4.92	(4d,	4	x	1H,	2J	=	7.5	Hz,	CH2-BOM);	5.21	(d,	1H,	3J	=	1.5	Hz,	H-1M);	5.34	(d,	1H,	3J	=	1.5	Hz,	H-
1M).	
13C	NMR	 (100MHz,	 CDCl3):	 δ	 20.3	 (CH3-Ac),	 68.3	 and	 68.5	 (C-6M),	 69.3,	 69.4,	 72.1,	 72.1,	 72.1,	 73.2,	
73.3,	74.89	75.1,	75.1,	76.0	(CH2-Bn),	71.8	and	72.1(C-5M),	73.5	(C-2I),	74.1	and	75.7	(C-2M),	74.4	and	
74.5	 (C-4M),	75.2	 (C-6I),	75.7	 (C-1I),	78.2	and	79.1	 (C-3M),	78.7	 (C-3I),	81.1	 (C-4I	and	C-5I),	94.1	and	
95.1	(CH2-BOM),	98.9	and	100.3	(C-1M),	170.5	(C=O).	HRMS	C99H104O19Na:	Calcd.	[M	+	Na]+		1619.7045.	
Found	1619.7070.	 	
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C97H102O18	
M	=	1555.87	g.mol-1	
(7)		
6	(468	mg,	0.29	mmoles)	was	dissolved	in	10	ml	of	a	sodium	methanolate	solution	in	methanol	and	the	
mixture	was	stirred	at	room	temperature	overnight.	The	reaction	was	quenched	with	a	bit	of	dry	 ice	
and	 the	 solvent	evaporated.	The	 residue	was	 taken	up	 in	CH2Cl2	and	washed	with	water.	The	water	
phase	was	extracted	two	times	with	CH2Cl2	and	the	organic	phase	dried	on	MgSO4.	Evaporation	of	the	
solvent	gave	7	(453	mg,	99%)	which	was	used	for	the	next	step	without	any	purification.	
1H	NMR	
	
	
C97H102O20PNa	
M	=	1641.83	g.mol-1		
(8)		
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Imidazole	 (317	 mg,	 0.46	 mmoles)	 was	 dissolved	 in	 toluene	 (10	 ml)	 at	 -10°C	 and	 treated	 with	
triethylamine	(370µL,	2.7	mmoles)	and	PCl3	(87	µL,	1	mmole).	To	this	solution	was	added	7	(512.0	mg,	
0.31	mmoles)	 dissolved	 in	 toluene	 (5	 ml	 +	 5	 ml	 rinse)	 and	 the	 reaction	 was	 left	 to	 come	 at	 room	
temperature	overnight.	The	reaction	was	treated	a	4/1	pyridine/water	mixture	(17	ml)	and	stirred	for	
10	min	at	room	temperature.	CH2Cl2/water	extraction	and	solvent	evaporation	gave	crude	8	which	was	
used	directly	for	the	next	step.		
31P	NMR	(162MHz,	CDCl3/CD3OD	1/1):	δ	2.98.	
1H	NMR	
	
31P	NMR	
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C132H168O25PNa	
M	=	2208.73	g.mol-1	
(10)		
Crude	8	(0.31	mmoles)	and	9	(567	mg,	1.0	mmole)	were	dissolved	in	anhydrous	pyridine	(10	ml)	and	
treated	with	pivaloyl	chloride	(410	µL,	3.3	mmoles)	at	room	temperature	overnight.	At	that	time,	TLC	
show	the	reaction	to	be	finished.	The	reaction	mixture	was	treated	with	a	solution	of	iodine	(172	mg,	
0.66	mmoles)	 in	2%	aqueous	pyridine	 for	15	minutes.	The	mixture	was	diluted	with	chloroform	and	
washed	with	10%	aqueous	sodium	thiosulfate	solution.	The	water	phase	was	reextracted	twice	with	
chloroform	 and	 the	 combined	 organic	 phase	 washed	 with	 a	 1M	 triethylammonium	 hydrogen	
carbonate	 aqueous	 solution.	 This	 aqueous	 phase	 was	 extracted	 twice	 with	 chloroform	 and	 the	
combined	organic	phase	was	dried	with	MgSO4	and	the	solvent	evaporated.	Chromatography	on	silica	
(1%	to	8%	methanol	in	CH2Cl2)	gave	10	as	a	sticky	oil	(574	mg,	83%	overall	from	7).	
[α]D	25	=	+20.1°	(c	=	1.25,	chloroform/methanol	1/1)		
1H	NMR	(400MHz,	THF/D2O	85/15,	313	K):	δ	0.90	(t,	6H,	3J	=	6.5	Hz,	CH3-palm);	1.22-1.35	(m,	48H,	CH2-
palm);	1.48-1.57	(m,	4H,	CH2-palm);	2.21	(t,	2H,	3J	=	7.5	Hz,	CH2-C=O	palm);		2.26	and	2.31	(2dt,	2	x	1H,	
2J	=	15.0	Hz,	3J	=	7.5	Hz,	CH2-C=O	palm);		3.26	(br	d,	1H,	2J	=	10.5	Hz,	H-6M);	3.41-3.51	(m,	4H,	3	x	H-6M,	
H-5I);	3.64	(m,	1H,	H-3I);	3.85	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-4I);	3.96	(dd,	1H,	3J	=	9.5,	2.5	Hz,	H-3M);	3.99	
(dd,	 1H,	 3J	 =	 9.5,	 9.5	 Hz,	 H-4M);	 4.03-4.10	 (m,	 2H,	 H-3M,	 H-4M);	 4.10-4.21	 (m,	 3H,	 2	 x	 H-5M,	 CH-
benzyl);	4.21-4.34	(m,	4H,	2	x	H-1G,	H-6I,	CH-benzyl);	4.37	(m,	1H,	H-2M);	4.42-4.50	(m,	4H,	2	x	H-3G,	
H-2M,	CH-benzyl);	4.51-4.94	(m,	23H,	H-2I,	H-1I,	19	x	CH-benzyl,	2	x	CH-BOM);	5.00	and	5.02	(2d,	2	x	
1H,	2J	=	13.5	Hz,	2	x	CH-BOM);	5.36	(m,	1H,	H-2G),	5.59	and	5.67	(2	br	s,	2	x	1H,	2	x	H-1M).	
13C	NMR	(100MHz,	THF/D2O	85/15,	313	K):	δ	14.1	(CH3-palm),	23.2,	25.5,	29.8,	29.9,	30.0,	3.01,	30.2,	
30.2,	30.3,	32.5	(CH2-palm),	34.3	and	34.6	(CH2-C=O-palm),	63.4	(C-3G),	64.6	(C-1G),	69.5	and	69.8	(C-
6M),	69.5,	69.8,	71.7,	 	 	 	71.5	(C-2G),	71.7	or	72.3	(C-2I),	72.3	and	72.5	(C-5M),	73.7	and	73.8	(C-2M),	
75.3	and	75.7	(C-4M),	76.6	(C-1I),	78.4	(C-6I),	79.2	and	80.1	(C-3M),	79.9	(C-3I),	82.1	(C-4I,	C-5I),	94.2	
and	94.6	(CH2-O-BOM),	99.3	and	100.2	(C-1M),	173.5	and	173.5	(C=O-palm).	
31P	NMR	(162MHz,	THF/D2O	85/15,	313	K):	δ	-2.31.	 	
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HRMS	C132H169O25P	:	Calcd.	[M	-1]-		2184.1612.	Found	2184.1672.	
1H	NMR	
	
13C	NMR	
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31P	NMR	
	
	
C53H98O23PNa	
M	=	1157.31	g.mol-1	
(1)		
10	 (256	 mg,	 0.12	 mmoles)	 was	 dissolved	 in	 a	 3/2	 methanol/THF	 mixture	 and	 treated	 at	 room	
temperature	with	hydrogen	and	a	catalytic	amount	of	20%	Pd(OH)2/C.	The	reaction	was	monitored	by	
TLC	and	allowed	to	proceed	for	5	hours.	The	catalyst	was	filtered	on	Celite	(1/1	chloroform/methanol	
elution)	 and	 the	 filtrate	 was	 evaporated.	 Chromatography	 (CHCl3/MeOH/	 H2O	 60/35/1	 to	 60/35/8)	
gave	1	as	a	white	solid	(98	mg,	74%).	
[α]D	25	=	+9.3°	(c	=	0.44,	dichlorométhane/methanol	1/1)	
1H	NMR	(700MHz,	CDCl3/CD3OD):	δ	0.79	(t,	6H,	3J	=	7.0	Hz,	CH3-palm);	1.17	(m,	48H,	CH2-palm);	1.50	
(m,	4H,	CH2-palm);	2.22	(m,	2H,	CH2-C=O	palm);		2.27	(t,	2H,	3J	=	7.5	Hz,	CH2-C=O	palm);	3.19	(dd,	1H,	3J	
=	9.5,	9.5	Hz,	H-5I);	3.37	(dd,	1H,	3J	=	10.0,	2.5	Hz,	H-3I);	3.50	(dd,	1H,	3J	=	9.5,	9.5	Hz,	H-4I);	3.55	and	
3.57	(2dd,	2	x	1H,	3J	=	9.5,	9.5	Hz,	2	x	H-4M);	3.63	and	3.67	(2dd,	2	x	1H,	3J	=	9.5,	5.0	Hz,	2	x	H-6M);	
3.67-3.74	(m,	5H,	2	x	H-3M,	2	x	H-6M,	H-6I);	3.85	and	3.88	(2ddd,	2	x	1H,	3J	=	10.0,	5.0,	2.5	Hz,	2	x	H-
5M);	3.89-3.96	(m,	4H,	2	x	H-1G,	H-1I,	H-2M);	3.97	(dd,	1H,	3J	=	3.0,	1.5	Hz,	H-2M);	4.10	(dd,	1H,	2J	=	
12.0	Hz,	3J	=	7.5	Hz,	H-3G);	4.19	(br,	1H,	H-2I);	4.34	(dd,	1H,	2J	=	12.0	Hz,	3J	=	2.5	Hz,	H-3G);	5.00	and	
5.03	(2d,	2	x	1H,	3J	=	1.0	Hz,	2	x	H-1M);	5.18	(m,	1H,	H-2G).	 	
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13C	NMR	(176MHz,	CDCl3/CD3OD):	δ	13.8,	22.6,	24.8,	24.9,	29.1,	29.1,	29.3,	29.4,	29.5,	29.6,	29.6,	31.8,	
34.0,	34.2,	60.7	and	61.0	(2	x	C-6M),	62.6	(C-3G),	63.1	(C-1G),	66.5	and	66.6	(2	x	C-4M),	69.7	and	69.9	
(2	x	C-2M),	69.9	(C-3I),	70.2	(C-2G,	2	x	C-3M),	72.3	and	72.6	(2	x	C-5M),	72.6	(C-4I),	72.9	(C-5I),	76.4	(C-
1I),	77.9	(C-6I),	78.2	(C-2I),	101.1	(2	x	C-1M),	173.8	and	174.1	(C=O).	
31P	NMR	(162MHz,	CDCl3/CD3OD	1/1):	δ	-0.55.	
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membranes. PatA is an essential membrane associated acyltransferase involved in the
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transfers a palmitoyl moiety from palmitoyl–CoA to the 6-position of the mannose ring linked
to 2-position of inositol in PIM1/PIM2. We report here the crystal structures of PatA from
Mycobacterium smegmatis in the presence of its naturally occurring acyl donor palmitate and a
nonhydrolyzable palmitoyl–CoA analog. The structures reveal an a/b architecture, with the
acyl chain deeply buried into a hydrophobic pocket that runs perpendicular to a long groove
where the active site is located. Enzyme catalysis is mediated by an unprecedented charge
relay system, which markedly diverges from the canonical HX4D motif. Our studies establish
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L
ong-chain fatty acids play a central role in a variety of
important biological processes in all living organisms. They
are prominent constituents of biological membranes, mainly
in the form of phospholipids, allowing cells to be functionally
constituted and differentiated from the environment1. Long-
chain fatty acids are used as energy storage and metabolic
intermediates as well as being modulators of signal transduction
pathways2,3. Moreover, the attachment of fatty acids to proteins
and glycans generates a signiﬁcant amount of structural diversity
in biological systems4. This structural information is particularly
apparent in molecular recognition events including cell–cell
interactions during critical steps of development and host–
pathogen interactions. Fatty acids are usually activated for
subsequent reactions by esteriﬁcation of their carboxyl groups
with the thiol group of coenzyme A (CoA) or that of the acyl
carrier protein (ACP), yielding acyl-thioesters5. Acyltransferases
are key enzymes that catalyse the transfer of activated acyl chains
to acceptor molecules of different chemical structure and
complexity6. Importantly, acyltransferases are involved in the
biosynthesis of triacylglycerols and a diverse group of naturally
occurring polyesters composed of 3-hydroxyalkanoic acids,
the most important storage lipids found in eukaryotes and
prokaryotes, respectively5. Moreover, acyltransferases participate
in the biosynthesis of the lipid A moiety of lipopolysaccharide,
modulating virulence of some Gram-negative human
pathogens7,8. Therefore, the understanding of the mechanism of
action for these enzymes at the molecular level, particularly those
ﬁrmly associated to the lipid bilayer, represents a major challenge.
The phosphatidyl-myo-inositol mannosides (PIMs) are
glycolipids of exceptional chemical structure found in abundant
quantities in the inner and outer membranes of the cell envelope
of all Mycobacterium species9. PIMs are based on a phosphatidyl-
myo-inositol (PI) lipid anchor carrying one to six Manp
residues and up to four acyl chains, with tri- and tetra-acylated
phosphatidyl-myo-inositol dimannoside (PIM2) and phosphatidyl-
myo-inositol hexamannoside (PIM6) as the predominant
species (Fig. 1a)10,11. PIMs are thought to be the precursors
of the two major mycobacterial lipoglycans, lipomannan and
lipoarabinomannan (LAM). PIMs, lipomannan and LAM are
considered not only essential structural components of the
mycobacterial cell envelope10–13 but also important molecules
implicated in host–pathogen interactions in the course of
tuberculosis and leprosy14,15. The biosynthesis of PIMs is
initiated by the phosphatidyl-myo-inositol mannosyltransferase
PimA (Rv2610c in Mycobacterium tuberculosis (M. tuberculosis)
H37Rv), which catalyses the transfer of Manp residue from
GDP-Man to the 2-position of the myo-inositol ring of PI,
to form phosphatidyl-myo-inositol monomannoside (PIM1) on the
cytoplasmic face of the plasma membrane (Fig. 1b)12,16. PimA was
found to be essential forMycobacterium smegmatis (M. smegmatis)
mc2155 and M. tuberculosis growth in vitro and in vivo12,17. The
second mannosylation step involves the action of another essential
enzyme PimB (Rv2188c inM. tuberculosis H37Rv), which transfers
a Manp residue to the 6-position of the myo-inositol ring of PIM1
to form PIM2 (refs 17,18). Both PIM1 and PIM2 can be acylated
with palmitate at position 6 of the Manp residue transferred by
PimA by the acyltransferase PatA (Phosphatidyl-myo-inositol
mannosides AcylTransferase A; Rv2611c in M. tuberculosis
H37Rv), to form Ac1PIM1 and Ac1PIM2, respectively19–21. This
enzyme has been proved (i) to be important for the optimal growth
of M. smegmatis mc2155 and (ii) an essential enzyme for the
growth of M. tuberculosis in vitro10,21. Two models were originally
proposed for the biosynthesis of Ac1PIM2 in mycobacteria. In the
ﬁrst model, PI is mannosylated to form PIM1. PIM1 is then
mannosylated to form PIM2, which is acylated to form Ac1PIM2.
In the second model, PIM1 is ﬁrst acylated to Ac1PIM1 and then
mannosylated to Ac1PIM2. Recent evidence indicates that although
both pathways might co-exist in mycobacteria, the sequence of
events PI-PIM1-PIM2-Ac1PIM2 is favoured (Fig. 1b)13.
Finally, Ac1PIM2 can be further acylated on position 3 of the
myo-inositol ring to form Ac2PIM2. However, this acyltransferase
as well as most of the mannosyltransferases that catalyse the
formation of higher PIMs still remains to be identiﬁed10.
During recent years major efforts have been made to under-
stand the early steps of the PIM biosynthetic pathway at the
molecular level. In that sense, the crystal structures of the
mannosyltransferases PimA and PimB were reported, showing
the typical organization and catalytic machinery of GT-B
glycosyltransferases22–25. However, to date, no structural
information is available for PatA, an enzyme that is a member
of a large family of acyltransferases for which the molecular
mechanism of substrate recognition and catalysis remains not
well understood5,7,26,27. Here, X-ray crystallography, site-directed
mutagenesis and enzymatic activity data are used to deﬁne the
three-dimensional structure, acceptor/donor substrate binding,
membrane binding and catalytic mechanism of PatA from
M. smegmatis. Our results reveal that the enzyme has an a/b
architecture and shares with other important eukaryotic/
prokaryotic acyltransferases an acid/base catalytic mechanism
involving conserved histidine and aspartic/glutamic acid residues.
Results
Overall structure of PatA. The crystal structure of PatA from
M. smegmatis was solved using single-wavelength anomalous
dispersion with a K2PtCl4 derivative at 2.06Å resolution in C 2
space group (PatA–C16-1). Two other crystal forms were
obtained in P 21 (PatA–C16-2) and P 42212 (PatA–C16-3) space
groups, and the corresponding crystal structures solved at 2.90
and 2.43Å resolution, respectively, by using molecular replace-
ment methods (see Methods and Supplementary Information for
details; Supplementary Fig. 1; Supplementary Tables 1 and 2).
The high quality of the electron density maps allowed the trace of
residues 41 to 302 (PatA–C16-1), 48 to 295 (PatA–C16-2) and 48
to 303 (PatA–C16-3; Supplementary Fig. 2). We have decided to
use the PatA–C16-1 crystal form for our description since it
displays the highest resolution. A close inspection of the three
crystal structures revealed that the protein crystallized as a
monomer, displaying a high degree of structural ﬂexibility in the
N- and C-terminal regions (coloured in green in Supplementary
Fig. 3; root-mean-square deviation (r.m.s.d.) value of 1.6 and
8.4 Å for Ca atoms in 41–47 and 288–302 residue ranges for the
N and C terminus, respectively). The central core of PatA consists
of a six-stranded b-sheet with topology b1 b2b3 b4b7
 b8 (b8 is antiparallel) surrounded by a-helices, with an overall
size of 45 40 40Å (Fig. 2a,b). A long and open groove that
runs parallel to the protein surface contains the active site. This
groove is ﬂanked by a4, b2, a8, b4, a9, a10 and the connecting
loops b1–a7 (residues 124–130), b2–a8 (residues 148–154), b3–a9
(residues 173–181), b4–b5 (residues 198–208), b6–a10 (residues
219–221) and a11–a12 (residues 282–291; Fig. 2c,d). Strikingly,
the groove also displays a narrow and deep, mostly hydrophobic
tunnel that runs perpendicular from its ﬂoor to the central core of
the protein (Fig. 2e,f). The walls of the tunnel comprise the entire
central b-sheet, two a-helices a7 and a8, and the connecting loops
b1–a7 (residues 124–130) and a8–b6 (residues 167–170). The
cavity extends entirely through the core and is closed at the
bottom by b8, the connecting loop a5–a6 and part of the a6
(Fig. 2b,e). Interestingly, the entrance of the hydrophobic pocket
displays several charged residues compatible to interact with a
buried carboxylate group of a fatty acid moiety, strongly
suggesting the pocket might play a role in the donor substrate
binding.
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Membrane association. PatA catalyses an essential step in the
biosynthesis of PIMs in M. tuberculosis10. The enzyme transfers a
palmitoyl moiety from palmitoyl–CoA to the 6-position of the
Manp ring linked to 2-position of myo-inositol in PIM1 or PIM2.
A close interaction of the enzyme with the cytosolic face of the
mycobacterial plasma membrane might be a strict requirement
for PIM1 or PIM2 modiﬁcation by PatA. Supporting this notion,
PatA was found to co-localize with the mycobacterial membrane
fraction19,28. Analysis of the amino-acid sequence of the
enzyme revealed the lack of a signal peptide or hydrophobic
transmembrane segments, suggesting that PatA associates to only
one side of the lipid bilayer, a typical feature of peripheral
and monotopic membrane proteins24,29. To perform their
biochemical functions, these proteins very often display a high
content of solvent exposed positively charged residues in the form
of amphiphatic helices, promoting membrane surface interaction
with anionic phospholipids30. Protein–membrane interaction
appears to be mediated following different thermodynamic
steps: (i) peptide binding is initiated by the electrostatic
attraction of the positively charged residues to the anionic
membrane, (ii) most likely followed by the transition of
the peptide into the plane of binding and (iii) a change of the
conformation of the bound peptide31. The penetration of the
protein depends on the chemical nature of the lipids and peptides
involved and also on the mechanistic nature of the processes
involved, in which both location and timing of membrane
association can be tightly controlled. The electrostatic surface
potential of PatA revealed a clear solvent-exposed area adjacent to
the major groove that contain several hydrophobic patches
interspersed with clusters of positively charged residues32.
Speciﬁcally, this region comprises the a2, the amphiphatic
helices a3, a4 and a8, the connecting loop b2–a8 (residues
148–154), and likely the a1 and a12 helices located at the N and C
terminus of the protein (Supplementary Fig. 4). Interestingly, the
opposite side of PatA displays a negatively charged surface, which
would generate a signiﬁcant electrostatic repulsion with the lipid
bilayer. Thus, the polar character of PatA certainly contributes to
determine the correct orientation of the enzyme into the
membrane (Supplementary Fig. 4).
The acyl–CoA-binding site. Strikingly, one molecule of palmitic
acid was unambiguously identiﬁed in the difference electron
density maps of PatA–C16-1, PatA–C16-2 and PatA–C16-3
crystal structures (Fig. 3a–d). We believe that acyl molecule is
associated to the enzyme due to the hydrolysis of palmitoyl–CoA
during the isolation and puriﬁcation of PatA from M. smegmatis
mc2155. Supporting this notion, the chemical structure of
Ac1PIM2 was clearly established by using a combination of
analytical techniques including mass spectrometry and two-
dimensional NMR20. The major acyl form observed,
corresponded to PIM2 with the glycerol moiety being
di-acylated by C16/C19 and the mannose residue transferred by
PimA bearing a C16. This structural proﬁle was also identiﬁed in
its hexamannosylated derivative Ac1PIM6 (ref. 21). The acyl chain
is deeply buried into the hydrophobic pocket, and oriented with
the carboxylate group facing the groove and the acyl tail
extending into the globular core of the monomer (Fig. 3).
The residues that contact the bound palmitic acid are
highly conserved in the PatA mycobacterial homologues
(Supplementary Fig. 5). Interestingly, the comparison of the
three crystal structures revealed conformational ﬂexibility in the
carboxylate moiety of the palmitate (Supplementary Fig. 3),
located in close proximity with the lateral chain of H126. The
R164 guanidinium group engages the side chain of Y83 and
D131. This tryptophan residue, together with M198, makes an
important van der Waals interaction with the acyl chain. The acyl
chain undergoes a kink at position C6 and terminates in a pocket
mainly formed by hydrophobic residues, including L122 and
L124 (b1), A133, W136 and L137 (a7), F144 (a7–b2 loop),
T146 (b2), F169 (a8–b3 loop), F235 and V237 (b7), M248 and
V250 (b8), and two cysteine residues C196 (b4) and C239 (b7).
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Figure 1 | Proposed pathway for the early steps of PIM biosynthesis in mycobacteria. (a) Chemical structure of PIM2/6 and their acylated forms
Ac1/2PIM2 and Ac1/2PIM6. (b) The two pathways originally proposed for the biosynthesis of Ac1PIM2 in mycobacteria are shown: (i) PI is mannosylated to
form PIM1. PIM1 is then mannosylated to PIM2, which is acylated to form Ac1PIM2; (ii) PIM1 is ﬁrst acylated to Ac1PIM1 and then mannosylated to Ac1PIM2.
Our experimental evidence indicates that although both pathways might co-exist in mycobacteria, the sequence of events PI-PIM1-PIM2-Ac1PIM2 is
favoured. As an important part of the literature concerning PIMs studies refers to the nomenclature based on the Mtb H37Rv sequences, we also include
the Rv numbers to identify the proteins.
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Interestingly, the connecting loop a5–a6 (residues 101–106) and
part of a6 form a ﬂexible and mostly hydrophobic cap that closes
the bottom of the cavity, suggesting that PatA might be able to
discriminate the length of the acyl chain groups (Fig. 3e,f). It is
worth noting that Ac1PIM2 was the main product formed in the
reaction when endogenous or crude mycobacterial phospholipids
from Mycobacterium phlei were used as the lipid acceptors
and a series of acyl–CoA derivatives of fatty acids were used as
14C-labelled donor substrates33,34. Palmitoyl–CoA (C16:0) gave
higher incorporation than myristyl–CoA (C14:0). Interestingly,
the oleyl–CoA (C18:1) was a much better substrate than
the saturated counterpart stearyl–CoA (C18:0). Finally, the
tuberculostearic acid (C19:1) had a low speciﬁc activity and the
small incorporation of label that was observed may be not
signiﬁcant34.
How does PatA recognize CoA? To this end, the crystal
structure of PatA in complex with S-hexadecyl Coenzyme A
(S-C16CoA), a nonhydrolyzable analogue of palmitoyl–CoA, was
solved at 3.28Å resolution in P 21 space group (PatA–S-C16CoA;
Supplementary Table 1; Fig. 4). The acyl chain of S-C16CoA is
localized into the hydrophobic tunnel, and superimposes very
well with the acyl chain moiety of palmitate observed in the
PatA–C16-1, PatA–C16-2 and PatA–C16-3 complexes. It is worth
noting that the position of the carboxylate group of palmitate
is different to that observed for the thioether in the
PatA–S-C16CoA complex. The 4-phosphopantetheinate moiety
of S-C16CoA is clearly deﬁned in the electron density map, and
located at the entrance of the main groove, in close contact with a
highly conserved region ﬂanked by the b2–a8 (residues 149–153),
b3–a9 (residues 174–180) and b4–b5 (residues 199–207) loops,
and two alpha helices, a9 (residues 181–190) and a10 (residues
221–230; Supplementary Fig. 6). The adenosine 30,50-diphosphate
(30,50-ADP) moiety of the ligand (disordered in other monomers
of the asymmetric unit) sticks out from the globular core and is
exposed to the bulk solvent, as observed in other acyl–CoA
modifying enzymes (Supplementary Fig. 7)35. The approximate
volume of the palmitoyl–CoA-binding pocket was ca.
2,801Å3(ref. 36) To further validate the model, we designed
site-directed mutations predicted to impair the palmitoyl–CoA
interaction with PatA. Thus, the double substitution
F182W/L197W would block the groove region of PatA,
hindering the formation of the complex (Fig. 4b and
Supplementary Fig. 8). As depicted in Fig. 5a, the PatA
F182W/L197W variant could not (i) transfer a palmitoyl moiety
to PIM2, or (ii) hydrolyze palmitoyl–CoA, supporting the
proposed model (Supplementary Fig. 9).
The phosphatidylinositol mannosides binding site. Although
we were unable to co-crystallize PatA in complex with
Ac1PIM1/Ac2PIM1, Ac1PIM2/Ac2PIM2 or their deacylated
analogs, the three-dimensional structure suggests the possible
binding mode for the polar head of PIM1 or PIM2 acceptor
substrates within the active site. Docking calculations placed
the polar head of PIM2, the better substrate of PatA making
important interactions within a region located at the end of the
main groove and comprising helices a4 and a8, and the con-
necting loops b1–a7 (residues 83–90), b2–a8 (residues 148–154)
and a11–a12 (residues 282–291; Fig. 6)13,28. As a consequence, the
O6 atom of the Manp ring linked to position 2 of myo-inositol in
PIM2 is predicted to be positioned favourably for activation by
H126 and to receive the palmitate group from palmitoyl–CoA
(Fig. 6; distance H126 NE2 atom to Manp O6 atom is 2.8 Å). The
model also predicts an important role of residues E149, R164 and
H284 to bind PIM2 in the active site. In the model, E149 OE1
atom is found at 2.9 Å of the Manp residue O4 atom and R164
NH2 atom is placed at 3.1 Å of the O2 atom of the Manp ring,
whereas H284 ND1 atom is at only 2.5 Å of myo-inositol O3
atom. The myo-inositol moiety and the Manp ring linked to
position 6 of myo-inositol in PIM2 also interact with Y80 and
Q287. The approximate volume of the PIM2-binding pocket was
ca. 1741Å3 (ref. 36). Interestingly, docking calculations put the
myo-inositol and Manp moieties of PIM1 in an equivalent
position to that observed for PIM2, leaving free space in the
pocket, a fact that might account for the acceptor substrate
speciﬁcity of PatA (Supplementary Fig. 10). To experimentally
validate the proposed model, we designed three single-point
substitution, E149A, R164A and H284A, predicted to impact the
PIM2 interaction with PatA (Fig. 6c; Supplementary Fig. 8). As
depicted in Fig. 5a, the transferase activity of all PatA variants was
severely compromised, nevertheless preserving the capability to
hydrolyse palmitoyl–CoA (Supplementary Fig. 9).
Structural similarity with other acyltransferases. Structure
homologue search using DALI server revealed only one protein
with signiﬁcant structural similarity, that of the glycerol-3-
phosphate acyltransferase from Cucurbita moschata (CmGPAT;
α3
β1α4
α2
α6 β2
α7 β3
β8
α8 α9
β4
α10
β7
α11
α12
C
N
C
Nα4
β8
β7
β1
β4
β2 β3
α7
α8
α6
α9
α4
Main groove
Main groove
entrance
Tunnel
Tunnel
Main groove
Active
site
β5
β6
90°
90°
90°
a b
c d
e f
Main groove
Tunnel
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pdb codes 1IUQ and 1K30; Z-score of 8.9; r.m.s.d. value of 3.9 Å
for 164 aligned residues; Fig. 7a)37,38. CmGPAT catalyses the
transfer of an acyl chain either from acyl–acyl-carrier protein
(acyl–ACP) or acyl–CoA, to the sn-1 position of glycerol-3-
phosphate, to form 1-acylglycerol-3-phosphate39. Importantly,
CmGPAT is able to use palmitoyl–CoA as a donor substrate,
as PatA does, using a bi–bi-ordered mechanism40. CmGPAT
belongs to a large family of glycerol-3-phosphate acyltransferases
(GPAT), which are critical in the biosynthesis and regulation
of phospholipids composition in prokaryotic and eukaryotic
cells41–43. The structure of CmGPAT is composed of two
domains: (i) a helical domain comprising the ﬁrst 78 residues
of the protein displays a four-helix bundle architecture of
unknown function, and (ii) an a/b domain, consisting of a
nine-stranded continuous b-sheet surrounded by 11 a-helices
(Fig. 7a). As depicted in Fig. 7a, the central b-sheet of CmGPAT
superimposes well with that observed in PatA, with the exception
of its outermost strands b1, b2 and b9, which are missing in PatA
(see also Supplementary Fig. 11).
A combination of site-directed mutagenesis and activity
measurements provided experimental support on the location
of the acceptor-binding site in CmGPAT (Fig. 7b–d)44. The
replacement of R235, R237 and K193 by serine resulted in
inactive enzymes. However, the CmGPAT variants retained the
ability to bind stoichiometric quantities of acyl–ACPs, consistent
with the location of these residues in the positively charged
acceptor-binding pocket, and in close proximity to the
catalytic HX4D motif37,38,44. Interestingly, the suggested
PIM1/PIM2-binding site in PatA is located in the same region
of the glycerol-3-phosphate-binding site in CmGPAT (Fig. 7d).
A sulfate ion observed in the crystal structure of CmGPAT
superimposed very well with the phosphate moiety of the inositol
ring of PIM1 or PIM2 (Fig. 7d). It is worth noting that, as
acceptors exhibit a marked diversity of chemical structures
compared with acyl–CoA or acyl–ACP donors, the acceptor-
binding sites reﬂect this variability by showing different
rearrangements of secondary structural elements (Fig. 7d).
The location of the acyl–CoA and acyl–ACP-binding site in
CmGPAT has been a matter of strong debate37,38. On the basis of
sequence conservation analysis, a structural model in which the
acyl chain runs over the entrance of the main groove of the
protein was ﬁrst proposed37. Molecular surface calculations
revealed the existence of three tunnels with sufﬁcient space to
accommodate the acyl chain of palmitoyl–CoA45. Furthermore,
enzymatic analysis of chimeric CmGPAT and Spinacea oleracea
GPAT revealed that a region comprising residues 128–187 is
important for acyl–CoA selectivity. This region completely
covered the narrowest and most hydrophobic of the three
tunnels, tunnel-2 (Fig. 7b,c), which was proposed to be involved
in fatty-acid recognition38. Strikingly, the acyl-binding pocket
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Figure 3 | The palmitate binding site of PatA. (a–d) Four views of PatA–C16-1 crystal structure showing the palmitate chain deeply buried into the
hydrophobic tunnel. (e,f) Two views of PatA showing the cap which closes the bottom of the hydrophobic tunnel. The 2mFo-DFc electron density
map countered at 1 s for the palmitate ligand is shown.
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identiﬁed in the crystal structures of the palmitoyl–PatA
and PatA-S-C16CoA complexes superimposed very well with
tunnel-2 of CmGPAT (Supplementary Fig. 11). On the basis of
the experimental location of the S-C16CoA in PatA, a palmitoyl–
CoA molecule was ﬁtted into tunnel-2 and subjected to energy
minimization (Fig. 7d,e; Supplementary Fig. 11; see Methods for
details). First, the palmitate moiety accommodates into the
hydrophobic tunnel. The walls of the tunnel are covered with
mainly conserved, hydrophobic and aromatic residues including
L135 (b3), P145 and I148 (a7), I159 (a8), T163 (a8–b4 loop),
F165 (b4), F180 (a10), L186 (b5), L226 and W228 (b6), L274 and
L276 (b7) and L305, with F120 and I123 (a6) making up the cap.
Interestingly, the CoA-binding site observed in PatA is also
conserved in CmGPAT. Speciﬁcally, the acyl donor is located in
the region corresponding to the entrance of the main groove
(Fig. 7c,e). The two a-helices a9 and a10, ﬂanking the entrance of
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Figure 4 | The palmitoyl–CoA binding site of PatA. (a–d) Four views of PatA-S-C16CoA crystal structure showing the binding mechanism of S-C16CoA.
The palmitoyl moiety is deeply buried into the hydrophobic tunnel, whereas the coenzyme A moiety extends outwards through the side of the main groove.
The 2mFo-DFc electron density map countered at 1 s for the palmitate ligand is shown.
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Figure 5 | Enzymatic activity of selected PatA variants. (a) In the upper panel, the acyltransferase activity of puriﬁed PatA and variants involved in
substrate binding are shown (see Supplementary Fig. 9 for duplicates). Reaction mixtures contained crude membranes from M. smegmatis mc2155 and
GDP-[14C]-mannose as a tracer (lane 1), supplemented with PimA (lanes 2–7) and palmitoyl–CoA (lanes 3–7) and puriﬁed PatA (lane 3), PatA-H284A
(lane 4), PatA-E149A (lane 5), double mutant PatA-F182W/L197W (lane 6) and PatA-R164A (lane 7). The lipids were extracted from reaction mixtures
and analysed by TLC and autoradiography as described in Methods section. In the lower panel, the hydrolytic activity against palmitoyl–CoA is shown.
(b) In the upper panel, the acyltransferase activity of puriﬁed PatA and variants involved in catalysis are shown (see Supplementary Fig. 9 for duplicates).
Reaction mixtures contained crude membranes from M. smegmatis mc2155 and GDP-[14C]-mannose as a tracer (lane 1), supplemented with PimA (lane
2–6) and palmitoyl–CoA (lanes 3–6) and puriﬁed PatA (lane 3), PatA-D131A (lane 4), PatA-E200A (lane 5) and PatA-H126A (lane 6). In the lower panel,
the hydrolytic activity against palmitoyl–CoA is shown as determined by spectrophotometric analysis. All enzymatic activities measurements were
determined in duplicates (Supplementary Fig. 9)
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acyl–CoA to the main groove of PatA, are structurally equivalent
to a11 (residues 201–222) and a12 (residues 251–265) in
CmGPAT (Fig. 7e). The substitution of L261 (a12) by an
aromatic residue, which is located at the interface of a11–a12
helices, caused major changes in the selectivity of CmGPAT for
acyl–ACP derivatives44. Overall, major secondary structural
elements are structurally preserved across both families of
acyltransferases supporting a common binding mode for
palmitoyl–CoA.
The catalytic mechanism of PatA. Analysis of the cleft running
over the surface of PatA revealed a catalytic site reminiscent to
that observed in the serine protease family of enzymes. In serine
proteases, the cleavage of the peptide bond is mediated by
nucleophilic attack of the serine hydroxyl group on the scissile
carbonyl bond. The active site comprises a catalytic triad
consisting of the Og atom of the serine, the imidazole ring of a
histidine, and the carboxylate group of an aspartic/glutamic
acid, involved in a charge relay system that increases the
nucleophilicity of the serine hydroxyl and modulates the pKa
of the central histidine as a general base or acid during the
catalytic cycle45. In all crystal structures of palmitoyl–PatA and
PatA–S-C16CoA complexes, the carboxylate OE2 oxygen atom of
E200 was found at 2.8 Å of the ND1 nitrogen atom of the
aromatic imidazole ring of the invariant H126 (Fig. 8a). It is
worth noting that when the individual palmitate molecules
observed in the three crystal structures of palmitoyl–PatA were
superimposed, they showed important structural ﬂexibility at the
carboxylate region (Supplementary Fig. 3c), suggesting that the
carboxylate group is not in a catalytically competent position in
the crystal structures. Moreover, the palmitate is not a substrate
neither an inhibitor of the reaction catalysed by PatA
(Supplementary Fig. 12). Our binary complexes correspond
most likely to the hydrolysis reaction product of palmitoyl–
CoA, thus one of the oxygen atoms found in the palmitate
that interacts with H126 most likely come from a water
molecule activated by H126. The S-C16CoA coordinates in
PatA–S-C16CoA crystal structure were used to generate
palmitoyl–CoA atomic coordinates by substitution of C16 atom
with a carbonyl group followed by energy minimization. Docking
calculations placed the Manp moiety attached to the 2-position of
myo-inositol in PIM2 with its O6 atom favourably positioned to
receive the palmitate group from palmitoyl–CoA (Fig. 8b;
see Online Methods for details). We propose a model in which
H126 acts as the general base to abstract a proton from the
hydroxyl group at position 6 of the Manp ring linked to
the 2-position of inositol in PIM1 or PIM2, to facilitate the
nucleophilic attack on the thioester of palmitoyl–CoA (Fig. 8d).
The E200 gets involved in a charge relay system with H126 and
the HO6 atom from the Manp moiety, contributing to the
appropriate structural arrangement of the imidazole ring of the
histidine residue and modulating its pKa to act as a base in
the ﬁrst step and as an acid in the second step, providing protonic
assistance to the departing CoA leaving group. It is worth noting
that the H126-E200 hydrogen bond was found in a syn
orientation relative to the carboxylate45. The result of the
nucleophilic attack is a covalent bond between the mannose
ring of PIM1 or PIM2 and palmitate. As depicted in Fig. 5b, the
functional role of H126 and E200 was clearly conﬁrmed, since
their substitution by alanine completely inactivated the enzyme
(Supplementary Fig. 9).
In CmGPAT, the catalytic site is also located at the base
of the large groove of the protein, displaying the sequence
HX4D, a well-conserved motif among the GPAT family of
acyltransferases27. H139 and the adjacent D144 were proposed to
promote a charge-relay system to facilitate the nucleophilic attack
on the thioester of the acyl–CoA26,37,38,46. In PatA, H126
occupies the same location to that observed for H139 in
CmGPAT. However, the aspartic acid D131 of the HX4D motif
displays a completely different arrangement when compared with
D144 (Fig. 8c). Speciﬁcally, the carboxylate group of D131 makes
a strong hydrogen bond with the side chain OH of Y83, and
additional electrostatic interactions with the lateral chains of
W130, Y163 and R164, suggesting a structural role for this
residue. In that sense, the replacement of D131 by alanine
preserved 37% of the enzymatic activity for PIM2 (Fig. 5b;
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Figure 6 | The phosphatidylinositol mannosides binding site. (a,b) Two
views showing the docking calculations in which PIM2 attaches to the end
side of the main groove, close to the hydrophobic tunnel. (c) Close view of
the binding site, showing the location of predicted residues involved in PIM2
interaction that have been mutated (H126, E149, R164, H284) along with
mutated residues involved in CoA binding (L197 and F182).
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Figure 9 | Structure weighted sequence alignment of PatA with eukaryotic/prokaryotic acyltransferases. (a) The protein sequences were extracted
from UniProt accession numbers A0QWG5 from M. smegmatis (PatA_Msmeg); P24205 from Escherichia coli (MSBB_ECOLI); O06659 from Shigella ﬂexneri
(MSBB2_SHIFL); P0ACV0 from E. coli (HTRB_ECOLI); P45239 from Haemophilus inﬂuenzae (HTRB_HAEIN); P10349 from C. moscata (GPAT_CUCMO);
Q43869 from Spinacia oleracea (GPAT_SPIOL); P0A7A7 PlsB from E. coli (PLSB_ECOLI); Q7UBC6 PlsB from S. ﬂexneri (PLSB_SHIFL); O80437 from
Arabidopsis thaliana (GPAT6_ARATH); O15228 from Homo sapiens (DHAPAT_HUMAN); Q8L7R3 from Arabidopsis thaliana (LPCT1_ARATH); Q99943 from
H. sapiens (PLCA_HUMAN); and Q53EU6 from H. sapiens (GPAT3_HUMAN). Conserved positions are shown in black and grey background. Conserved
hydrophobic residues are indicated with an h. The secondary structural elements corresponding to the 3D structure of PatA are shown above the alignment.
Catalytic amino acids and those involved in palmitate binding are indicated as asterisks and black circles, respectively. (b) Structural similarity of
M. tuberculosis H37Rv andM. smegmatismc2155 PatA. Catalytic amino acids are indicated as asterisks. Amino acids involved in palmitate and pantotheinate
binding are indicated as black and white circles, respectively. Residues proposed to interact with PIM1 and PIM2 based on the dockings are shown as white
and black triangles, respectively. Amino acids mutated are underlined.
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Supplementary Fig. 9). Altogether, the structural information
strongly supports a common catalytic mechanism for both
families of enzymes.
Discussion
Amino-acid sequence alignment revealed that PatA has strong
resemblance to HtrB and MsbB, two key acyltransferases involved
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in the biosynthesis of bacterial lipopolysaccharides (Fig. 9a)47,48.
HtrB and MsbB catalyse the last steps of Kdo2-lipid A
biosynthesis in Gram-negative bacteria, consecutively adding
the secondary lauroyl and myristoyl residues to the distal
glucosamine unit. Both enzymes prefer acyl–ACP donors but
can also function with acyl–CoA substrates7,8. The fact that HtrB,
MsbB and PatA preferentially use lauroyl (C12), myristoyl (C14)
or palmitoyl (C16) derivatives might suggest the occurrence of a
hydrocarbon ruler mechanism for acyl moieties recognition.
PatA, HtrB and MsbB enzymes are distantly related to the
glycerol-3-phosphate (GPAT), lysophosphatidic acid (LPAAT),
dihydroacetone phosphate (DHAPAT) and 2-acylglycero-
phosphatidylethanolamine (LPEAT) families of acyltransferases
(Fig. 9)5,27. GPAT, LPAAT, DHAPAT, and LPEAT display highly
conserved residues distributed in four regions, and named as
blocks 1–4 (refs 27,41). According to multiple sequence
alignments among the HtrB, MsbB, GPAT, LPAAT, DHAPAT
and LPEAT families, weighted by structural alignment of PatA
and CmGPAT, a common core can be deﬁned (Fig. 9). It is worth
noting that we respected the classical names of blocks 1–4 as
reported in the literature, introducing two new regions as blocks 0
and 5. Critical residues and their interactions in the reaction
centre are essentially preserved in all these acyltransferase
families, strongly supporting a common catalytic mechanism.
Interestingly, the alignment suggests that members of the GPAT,
LPAAT, DHAPAT and LPEAT families display a conserved
aspartate residue that participates in the charge relay system with
the conserved histidine of the HX4D motif (block 1)26,49. In
contrast, HtrB, MsbB and PatA seem to use a glutamate/aspartate
residue located in block 3, suggesting a divergence among these
families of acyltransferases. The structural divergence of the
carboxylate group acting as a pKa modulator of the catalytic
histidine residue might be due to the requirement of the
acyltransferases to accommodate acceptor molecules of different
nature, as observed in PatA and CmGPAT. Nevertheless, the
hydrophobic nature of residues involved in fatty-acid recognition
is well conserved, suggesting a common binding mode.
Finally, Ac1PIM2 appears to be a metabolic end product that
accumulates at high steady-state levels in the cells as well as a
precursor for more polar forms of PIMs, lipomannan and LAM10.
Interestingly, the four enzymes involved in the biosynthetis
of Ac1PIM2, the phosphatidyl-myo-inositol synthase PgsA1
(Rv2612c in M. tuberculosis H37Rv), PimA (Rv2610c), PimB
(Rv2188c in Mtb H37Rv) and PatA (Rv2611c), were found
to be essential for the growth of M. smegmatis and/or
M. tuberculosis10,12,17,50. Importantly, the amino-acid sequences
of M. smegmatis and M. tuberculosis versions of PatA displayed
74% identity and 84% similarity (Fig. 9b). All residues that
participate in the catalytic mechanism and palmitoyl binding,
as well as those proposed to interact with the CoA and PIM2
substrates are strictly conserved between both proteins. Thus, the
structural data presented here offers exciting possibilities for
inhibitor design and the discovery of chemotherapeutic agents
against this major human pathogen.
Methods
Expression and puriﬁcation of PatA in M. smegmatis. A truncated version of
PatA lacking the ﬁrst 12 residues of the protein (PatA; MSMEG_2934)28, was
puriﬁed as previously described with the following modiﬁcations. M. smegmatis
mc2155 cells transformed with the corresponding plasmid pJAM2-patA were
grown in MM63 medium (15mM (NH4)2SO4, 10mM KH2PO4, 18mM
FeSO4.7H2O, pH 7.0) supplemented with 1mM MgSO4, 0.025% (v/v) tyloxapol
and 0.2% (w/v) succinate and 20 mgml 1 of kanamycin. When the culture reached
OD600¼ 0.6 the expression of PatA was induced by adding 0.2% acetamide. After
16 h at 37 C, cells were collected at 4,000g for 10min and resuspended in 50mM
Tris-HCl pH 7.5, 500mM NaCl, 40mM imidazole (solution A) containing protease
inhibitors (Complete EDTA-free, Roche). The cells were resuspended in solution A
(1 g of cells per 5ml of solution A) and disrupted by sonication in 15 cycles of 60 s
pulses with 90 s cooling intervals between the pulses. PatA was solubilized from the
mycobacterial membrane by the addition of 2mM CHAPS. The suspension was
gently stirred during 1 h at 4 C and centrifuged at 11,000g for 20min. The
supernatant was applied to a HisTrap Chelating column (1ml, GE HealthCare)
equilibrated with solution A. The column was then washed with solution A until no
absorbance at 280 nm was detected. Elution was performed with a linear gradient
of 40–500mM imidazole in solution A at 1mlmin 1. The resulting PatA
preparation displayed a single protein band when run on a 12% NuPAGE Bis–Tris
precast gel stained with SimplyBlue SafeStain (Invitrogen). The puriﬁed
recombinant PatA protein was stored at 4 C and then concentrated for
crystallization screening by using a Vivaspin 20 spin concentrator (Vivascience)
with a 10-kDa-molecular mass cutoff.
Site-directed mutagenesis. The PatA-H126A, PatA-D131A, PatA-E149A,
PatA-R164A, PatA-E200A and PatA-H284A mutants, and double mutant
PatA-F182W/L197W were synthetized by GenScript using the pJAM2-patA
construct, and further expressed and puriﬁed to apparent homogeneity as
described for the recombinant PatA enzyme.
PatA–C16 complex crystallization and data collection. Three crystal forms
were obtained, referred thereafter as PatA–C16-1, PatA–C16-2 and PatA–C16-3.
The ﬁrst and second crystal forms were obtained by mixing 0.25 ml of PatA at
5mgml 1 in 20mM Tris-HCl pH 7.5 with 0.25 ml of mother liquor containing
100mM Tris-HCl pH 7.0, 230mM MgCl2 and 12–16% (w/v) PEG 8,000. Crystals
grew in 7–15 days and were transferred to a cryo-protectant solution containing
25% ethylene glycol and frozen under liquid nitrogen. Complete X-ray diffraction
data sets were collected at beamline I03 (Diamond Light Source, Oxfordshire, UK)
and processed with XDS program51. The second crystal form of PatA diffracted to
a maximum resolution of 2.9 Å and crystallized with four molecules in the
asymmetric unit and space group P 21 (Supplementary Table 1; PatA–C16-2).
The ﬁrst crystal form of PatA diffracted to a maximum resolution of 2.06Å and
crystallized with two molecules in the asymmetric unit and space group C 2
(Supplementary Table 1; PatA–C16-1). The third crystal form was obtained by
mixing 0.25 ml of PatA at 5mgml 1 in 25mM Tris-HCl pH 7.5, 150mM NaCl
with 0.25 ml of mother liquor containing 100mM Tris-HCl pH 8.5 and 20%
ethanol. Crystals grew in 3 days and were transferred to a cryo-protectant solution
containing 25% sucrose and frozen under liquid nitrogen. A complete set of X-ray
diffraction data were collected at beamline X06SA Swiss Light Source (Villigen,
Switzerland) and processed with XDS program. PatA–C16-3 crystals diffracted
to a maximum resolution of 2.43Å and crystallized with one molecule in the
asymmetric unit and space group P 42 21 2 (Supplementary Table 1).
PatA-S-C16CoA complex crystallization and data collection. One crystal form
was obtained by mixing 0.25 ml of PatA at 5.1mgml 1 in 1mM S-hexadecyl
Coenzyme A (S-C16CoA; stock solution at 10mM in 20mM Tris-HCl pH 7.5) and
20mM Tris-HCl pH 7.5 with 0.25 ml of mother liquor containing 100mM HEPES
pH 7.5, 500mM ammonium sulfate and 30% (v/v) 2-methyl-2,4-pentanediol.
Crystals grew in 7–15 days and were directly frozen under liquid nitrogen.
A complete X-ray diffraction data set was collected at beamline I03 (Diamond
Light Source) and processed with XDS program51. PatA-S-C16CoA diffracted
to a maximum resolution of 3.28Å and crystallized with four molecules in the
asymmetric unit and space group P 21 (Supplementary Table 1).
PatA structure determination and reﬁnement. PatA crystals of form C 2
(PatA–C16-1) were soaked with 10 different platinum salts at 1mM concentration
for a time period of 130–145min (HR2-442, Hampton Research) followed by ﬂash
freezing in liquid-N2. Anomalous data were collected at the theoretical L–I
absorption edge of Pt (13,879.9 eV–0.8933 Å). Oscilation images were collected at
I04 beamline (Diamond Light Source) with an oscillation angle of 0.2 for a total of
1,800 images using a Pilatus 6M-F pixel detector. Data were collected with an
attenuated X-ray beam (5% transmission) and a 0.04-s exposure time per image.
Data were integrated and scaled in XDS and experimental phases determined using
the SHELXC/D/E package52. Data of a PatA crystal soaked with 1mM K2PtCl4
for 130min were used for experimental phasing with a 2.5-Å data cutoff applied,
giving a mean value |DF|/s(DF) in the highest resolution shell of 0.9. The
substructure determination located two Pt atoms in the asymmetric unit
(CC¼ 33.64, CC(weak)¼ 20.71 and CFOM¼ 54.35). Experimental phases were
determined and subsequently used for initial cycles of model building and density
modiﬁcations by SHELXE. Buccaneer53 and the CCP4 suite54 were used for further
model extention. The structure determination of PatA–C16-1, PatA–C16-2,
PatA–C16-3 and PatA–S-C16CoA were carried out by molecular replacement
using Phaser55 and the PHENIX suite56 and the PatA–Pt structure as model
(Supplementary Table 2). Followed by cycles of manual rebuilding and reﬁnement
using Coot57 and phenix.reﬁne58, respectively. The structures were validated by
MolProbity59.
Molecular docking calculations. The crystal structure of mycobacterial PatA in
complex with S-C16CoA (PatA–S-C16CoA) was investigated using the structure
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preparation function in MOE2013.08 (ref. 60). First, S-C16CoA coordinates in
PatA–S-C16CoA crystal structure (chain A) were used to generate palmitoyl–CoA
atomic coordinates by substitution of C16 atom with a carbonyl group. Then the
model was prepared using the Amber12EHT force ﬁeld, an all-atom force ﬁeld,
combining two-dimensional Extended Hueckel Theory (EHT) and Amber12 force
ﬁeld, with Born solvation, and hydrogen atoms were added using Protonate3D
function61,62. The docking site of PIM1 and PIM2 was deﬁned by 14 residues of the
PatA–S-C16CoA crystal structure. PIM2 structure was retrieved from the PDB
(ligand code XPX) and after substitution of acyl chains with acetyl groups, the
molecule was energy minimized using MOE with a 0.1 kcal mol 1 Å 1 r.m.s.
gradient threshold. PIM1 structure was constructed by removing one mannose ring
of PIM2. The PIM1 and PIM2 structures were submitted to conformational search
using LowModeMD with default parameters in MOE2013.08 (ref. 63). The same
procedure was carried out with PIM1, in which a mannose residue GOLD (Genetic
Optimization for Ligand Docking; Cambridge Crystallographic Data Center
(CCDC), version 5.2.2) was used with default genetic algorithm parameter
settings64,65 for all calculations, with the exception that the search efﬁciency
parameter was set to 200% to improve predictive accuracy by calculating the
optimal number of genetic algorithm operations for the ligand due to their large
ﬂexibility. The ASP scoring function implemented in GOLD was used to rank the
docked poses; this ﬁtness function has been optimized for the prediction of ligand-
binding positions66,67. PIM1 and PIM2 were docked into the PatA–palmitoyl–CoA
complex. Only docking poses having a C6-hydroxyl group of the mannose closed
to the thioester of palmitoyl–CoA were kept for analysis. The best solutions were
assessed by their respective docking score and by visual inspection.
PatA acyltransferase activity assay. PatA transferase activity was measured in
the assay with mycobacterial membranes28. Brieﬂy, M. smegmatis mc2155 cells
were broken by sonication and the membrane (100,000g pellet) fraction was
obtained by differential centrifugation. The reaction mixtures contained 250 mg of
membrane proteins, 1.2 mg of puriﬁed PimASM, 10mg of puriﬁed PatA or the
mutated versions, 0.1 mCi GDP-[14C]mannose (speciﬁc activity of 55mCimmol 1,
ARC Inc.), 0.12mM palmitoyl–CoA (Sigma-Aldrich) in DMSO with ﬁnal
concentration in the reaction mixture 2% (v/v), 62 mM ATP, 10mM MgCl2, and
25mM Tris-HCl pH 7.5 in the ﬁnal volume of 50 ml. Reactions were incubated
100min at 37 C and stopped with 300 ml of CHCl3/CH3OH (2:1, by volume).
The samples were left rocking 30min at room temperature, and centrifuged at
1,500g for 10min. The organic phase (bottom) was analysed by thin layer
chromatography on aluminium-coated silica 60 F254 plates (Merck) developed in
CHCl3/CH3OH/conc. NH4OH/H2O (65:25:0.5:4), and quantiﬁed by scintillation
spectrometry28. All enzymatic activity measurements were determined in
duplicates. Following the same procedure, palmitate was assayed as a possible
inhibitor or substrate at different concentrations (Supplementary Fig. 12).
PatA palmitoyl–CoA hydrolytic activity assay. The hydrolytic activity of
PatA and PatA variants against palmitoyl–CoA was measured as following a
methodology described for other acyltransferases68,69. A typical reaction contained
20mM Tris-HCl pH 8.3, 0,2mM disulﬁde (5,50-dithiobis-(2-nitrobenzoic acid))
(DTNB), 0,06mM palmitoyl–CoA and 4 mM PatA or its variants. All reactions
were carried out at 37 C in a CARY 300 Bio UV Visible/Spectrophotometer. The
spectrum of the product TNB 2 formed after the interaction of the DTNB and the
CoA liberated from the hydrolysis of the substrate palmitoyl–CoA by the enzyme,
was measured continuously at 412 nm during 20min. All enzymatic activity
measurements were determined in duplicates (Fig. 5).
Structural analysis and sequence alignment. The sequence of PatA from M.
smegmatis (A0QWG5) was subjected to basic local alignment search tool (BLAST)
and several orthologs in Mycobacteria sp. were found. Afterwards, they were
aligned using the ClustalW server (http://www.ebi.ac.uk/Tools/msa/clustalw2/).
The structure weighted sequence alignment was performed using PROMALS3D
server (http://prodata.swmed.edu/promals3d/promals3d.php). For labelling the
conserved and similar residues, BoxShade server was used (http://embnet.vital-it.
ch/software/BOX_form.html). Structural analysis and graphics for publications
were performed with PyMOL (version 0.99) and Chimera70.
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ABSTRACT: Glycolipids play a central role in a variety of
important biological processes in all living organisms. PatA is a
membrane acyltransferase involved in the biosynthesis of
phosphatidyl-myo-inositol mannosides (PIMs), key structural
elements, and virulence factors of Mycobacterium tuberculosis.
PatA catalyzes the transfer of a palmitoyl moiety from palmitoyl-
CoA to the 6-position of the mannose ring linked to the 2-position
of inositol in PIM1/PIM2. We report here the crystal structure of
PatA in the presence of 6-O-palmitoyl-α-D-mannopyranoside,
unraveling the acceptor binding mechanism. The acceptor mannose ring localizes in a cavity at the end of a surface-exposed
long groove where the active site is located, whereas the palmitate moiety accommodates into a hydrophobic pocket deeply
buried in the α/β core of the protein. Both fatty acyl chains of the PIM2 acceptor are essential for the reaction to take place,
highlighting their critical role in the generation of a competent active site. By the use of combined structural and quantum-
mechanics/molecular-mechanics (QM/MM) metadynamics, we unravel the catalytic mechanism of PatA at the atomic-electronic
level. Our study provides a detailed structural rationale for a stepwise reaction, with the generation of a tetrahedral transition state
for the rate-determining step. Finally, the crystal structure of PatA in the presence of β-D-mannopyranose and palmitate suggests
an inhibitory mechanism for the enzyme, providing exciting possibilities for inhibitor design and the discovery of
chemotherapeutic agents against this major human pathogen.
Glycolipids (GLs) are prominent constituents of biologicalmembranes, primarily localized on the surface of archaeal,
prokaryotic, and eukaryotic cells.1,2 GLs play a major role in
molecular recognition events including cell−cell interactions
and host−pathogen interactions, as well in the modulation of
membrane protein function. Acyltransferases are enzymes that
catalyze the transfer of fatty-acid chains from activated fatty-
acid donors to a variety of acceptor molecules of diﬀerent
chemical structure and complexity, playing a key role in the
biosynthesis of glycolipids.3 It is worth noting that fatty-acid
chains are activated by esteriﬁcation of their carboxyl groups
with either (i) the thiol group of coenzyme A (CoA) or (ii) that
of the acyl carrier protein (ACP), yielding acyl-thioesters.
Acyltransferases are very often required to access a lipophilic
acceptor substrate and to catalyze its reaction with a water-
soluble donor in the form of acyl-CoA or acyl-ACP derivatives,
promoting their association to the lipid bilayer.4 Therefore, an
understanding of the molecular mechanism by which
acyltransferases govern substrate recognition and catalysis
remains a major challenge.
Mycobacteria display a characteristic cell envelope based on
sugars and lipids of exceptional chemical structure. The cell
envelope delineates the biology and pathogenesis of M.
tuberculosis, the causative agent of tuberculosis (TB), also
contributing to its intrinsic resistance to chemotherapeutic
agents.5 Speciﬁcally, the cell envelope of mycobacteria
comprises four main components: the plasma membrane or
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inner membrane (IM), the peptidoglycan−arabinogalactan
complex (AGP), the outer membrane (OM) that is covalently
linked to the AGP through mycolic acids, and the external
capsular-like structure.6−8 In this context, the cell envelope of
M. tuberculosis contains a variety of unique glycolipids/
lipoglycans that populate both the inner and outer membranes,
including phosphatidyl-myo-inositol mannosides (PIMs), lip-
omannan (LM), and lipoarabinomannan (LAM), which are
important modulators of the host immune response during
infection.9−11 PIMs are based on a phosphatidyl-myo-inositol
(PI) lipid anchor carrying one to six Manp residues and up to
four acyl chains.8,12 Tri- and tetra-acylated phosphatidyl-myo-
inositol dimannoside (Ac1PIM2 and Ac2PIM2, respectively) and
phosphatidyl-myo-inositol hexamannoside (Ac1PIM6 and
Ac2PIM6 respectively) are the predominant species (Figure
1a).13−15 PIMs are considered not only essential structural
components of the cell envelope but also the precursors of LM
and LAM.16,17
According to the currently accepted model, the PIM
biosynthetic pathway takes place on both sides of the
mycobacterial inner membrane.13,18 The stages of the synthesis
of the apolar (PI−PIM2) and polar (PIM3−PIM6) forms of
PIMs are carried out on the cytoplasmic and periplasmic faces
of the inner membrane, respectively. The early steps involve the
consecutive action of three enzymes, the mannosyltransferases
PimA and PimB and the acyltransferase PatA, to form
Ac1PIM2.
8,12 PimA catalyzes the transfer of a Manp residue
from GDP-Man to the 2-position of the myo-inositol ring of PI,
yielding PI monomannoside (PIM1; Figure 1b).
19−21 PimB
transfers a Manp residue from GDP-Man to the 6-position of
the myo-inositol ring of PIM1, generating PIM2.
21−23 PIM1 and
PIM2 can be acylated with palmitate at position 6 of the Manp
residue, transferred by PimA, by the acyltransferase PatA, a
member of a large and important family of acyltransferases, to
form Ac1PIM1 and Ac1PIM2, respectively.
24 The crystal
structures of the mannosyltransferases PimA and PimB show
the typical organization and catalytic machinery of GT-B
glycosyltransferases.25,26 More recently, the crystal structure of
the acyltransferase PatA provided insight into the donor
substrate recognition. However, elucidation of the molecular
Figure 1. PIM biosynthetic pathway in mycobacteria. (a) Chemical structure of PIM2/6 and their acylated forms Ac1/2PIM2 and Ac1/2PIM6. (b) The
two proposed pathways for the early steps of PIM biosynthesis in mycobacteria are shown: (i) PI is mannosylated to form PIM1. PIM1 is then
mannosylated to PIM2, which is acylated to form Ac1PIM2. (ii) PIM1 is ﬁrst acylated to Ac1PIM1 and then mannosylated to Ac1PIM2. Our
experimental evidence suggests that although both pathways might coexist in mycobacteria, the PI→ PIM1→ PIM2→ Ac1PIM2 pathway is favored.
H37Rv numbers are shown.
Figure 2. Overall structure of the PatA-Man-C16 complex. (a) Cartoon representation showing the general fold of PatA. β-strands and α-helices are
shown in orange and yellow, respectively. The Man-C16 product is shown in black and red. (b,c) Two views of the electrostatic surface
representation of PatA showing the location of the Man-C16 product. The Manp localizes into the main groove, in close proximity to α4. The
palmitoyl moiety Man-C16 localizes in a hydrophobic cavity, deeply buried into the core of PatA.
ACS Chemical Biology Articles
DOI: 10.1021/acschembio.7b00578
ACS Chem. Biol. XXXX, XXX, XXX−XXX
B
mechanism of acceptor substrate recognition and catalysis
remains a major challenge for PatA.3,27,28
This study describes a detailed investigation of the glycolipid
acceptor binding site and the catalytic mechanism of PatA.
Using a combination of X-ray crystallography, quantum-
mechanics/molecular-mechanics (QM/MM) metadynamics,
chemical synthesis, and enzymatic activity measurements, we
propose a model for substrate recognition, catalysis, and
enzyme inhibition. The implications of this model in the
comprehension of the early steps of PIM biosynthesis and the
mode of action of other members of the bacterial
acyltransferase family of enzymes are discussed.
■ RESULTS AND DISCUSSION
Overall Structure of the PatA-6-O-palmitoyl-α-D-
mannopyranoside Complex. Despite much eﬀort, we were
unable to produce recombinant PatA from M. tuberculosis. In
contrast, recombinant PatA from Mycobacterium smegmatis was
puriﬁed as previously described.27 The amino-acid sequences of
M. tuberculosis and M. smegmatis versions of PatA displayed
74% sequence identity and 84% sequence similarity. All
residues that participate in both of the catalytic and substrate
recognition mechanisms are strictly conserved between both
proteins. To describe the architecture of the acceptor binding
site, we ﬁrst tried to crystallize PatA in the presence of
Ac1PIM1/Ac2PIM1, Ac1PIM2/Ac2PIM2, or their deacylated
analogs. However, these attempts were unsuccessful. Therefore,
we decided to crystallize PatA in the presence of Manp (Table
S1). The crystal structure of PatA fromM. smegmatis was solved
by using molecular replacement methods (Figure 2; Table S1).
PatA crystallized in the P21 space group with four molecules
(ca. 260 residues each) in the asymmetric unit and diﬀracted to
a maximum resolution of 2.42 Å (Figures S1 and S2; Table S1).
Careful inspection of the electron density maps revealed the
presence of the product 6-O-palmitoyl-α-D-mannopyranoside
(Man-C16) in three of the four molecules (chains B, C, and D;
PatA-Man-C16) of the asymmetric unit (Figures 2 and 3;
Figures S1 and S2). The fourth molecule (chain A) showed (i)
one molecule of free palmitate located in the hydrophobic
pocket and (ii) one molecule of free β-D-mannopyranose,
located in the acceptor binding cavity. Because palmitoyl-CoA
was not present during the crystal screening experiments, we
believe that the palmitate molecule is associated with the
enzyme during the isolation and puriﬁcation of PatA from M.
smegmatis mc2155, as previously described.27 This suggests that
PatA is mediating the formation of Man-C16 in three of the
four molecules of PatA in the asymmetric unit. PatA crystallized
as a monomer, displaying a conserved α/β architecture.27 The
cen t r a l co re compr i s e s a s i x - s t r anded β - shee t
(β1−β2−β3−β4−β7−β8 of with β8 is antiparallel) bound by
several α-helices (Figure 2a). A surface-exposed, open groove
with an overall size of 25 × 10 × 10 Å contains the active site.
This long groove is ﬂanked by several secondary structure
elements including α4, β2, α8, β4, α9, and α10 and the connecting
loops β1−α7 (residues 124−130), β2−α8 (residues 148−154),
β3−α9 (residues 173−181), β4−β5 (residues 198−208), β6−α10
(residues 219−221), and α11−α12 (residues 282−291).
27 A
deep hydrophobic cavity extends through the core of PatA, with
the entrance located in the ﬂoor of the main groove and closed
at the bottom by β8, the connecting loop α5−α6, and part of the
α6 (Figure 2b and c).
A structure homologue search using the DALI server
revealed only two proteins with signiﬁcant structural similarity,
namely, the acyltransferase LpxM from Acinetobacter baumannii
(AbLpxM; PDB codes 5KN7 and 5KNK; Z-score of 26.7;
RMSD value of 2.6 Å for 243 aligned residues; Figure S3),29
and the glycerol-3-phosphate acyltransferase from Cucurbita
moschata (CmGPAT; PDB codes 1IUQ and 1K30; Z-score of
8.8; RMSD value of 3.9 Å for 164 aligned residues; Figure
S3).30,31 AbLpxM catalyzes the transfer of two lauroyl (C12:0)
groups to the R-3′- and R-2-hydroxymyristate positions of lipid
A.2,28 LpxM from Escherichia coli (EcLpxM) prefers acyl−acyl-
Figure 3. The acceptor binding site of PatA. (a−d) Four views of the PatA-Man-C16 crystal structure showing the palmitoyl chain deeply buried into
the hydrophobic cavity and the mannose unit located in the acceptor binding site, at the end of the main groove. The ﬁnal electron density maps
(2mFo−DFc contoured at 1σ) of the 6-O-palmitoyl-α-D-mannopyranoside is colored in gray.
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carrier protein (acyl−ACP) donors but can also function with
acyl−CoA substrates.2 CmGPAT catalyzes the transfer of an
acyl chain either from acyl-ACP or acyl-CoA, to the sn-1
position of glycerol-3-phosphate, to form 1-acylglycerol-3-
phosphate.32,33 CmGPAT is able to use palmitoyl-CoA as a
donor substrate, as PatA does, following a bibireactions
involving two substrates and two productsordered mecha-
nism.33 PatA and AbLpxM are distantly related to CmGPAT,
and the lysophosphatidic acid (LPAAT), dihydroacetone
phosphate (DHAPAT), and 2-acylglycero-phosphatidylethanol-
amine (LPEAT) families of acyltransferases.3,27,34
The Acceptor Binding Site of PatA. The Manp ring is
located within a cavity located at the end of the main groove
and comprising helices α4 and α8 and the connecting loops
β1−α7 (residues 83−90), β2−α8 (residues 148−154), and
α11−α12 (residues 282−291; Figure 3). The Manp ring is
stabilized by van der Waals interactions with the side chains of
four aromatic residues Tyr83, Trp84, Trp130, and Phe160. The
O6 atom of the Manp ring makes a hydrogen bond with the
NE2 atom of the imidazole moiety in His126, whereas the O2
atom makes a weak hydrogen bond with the NH2 atom of
Arg164 (Figure 3). It is worth noting that the Manp residue
observed in the PatA-Man-C16 complex superimposed well
with the corresponding Manp residue of the deacylated form of
PIM2 obtained by docking calculations.
27 The structural
superposition of the PatA-ManC16 and S-C16CoA complexes
gives a view of the acyl donor and acceptor substrate binding
sites (Figure 4). The palmitoyl group is deeply buried into the
hydrophobic cavity and oriented with the carboxyl group facing
the groove and the acyl tail extending into the globular core of
the monomer (Figures 3 and 4).27 The 4-phosphopantethei-
nate moiety of S-C16CoA localizes in the opposite side, at the
entrance of the main groove, ﬂanked by the β2−α8 (residues
149−153), β3−α9 (residues 174−180), and β4−β5 (residues
199−207) loops, and two alpha helices, α9 (residues 181−190)
and α10 (residues 221−230; Figure 4). The adenosine 3′,5′-
diphosphate (3′,5′-ADP) moiety of S-C16CoA (disordered in
three of the four protomers of the asymmetric unit) protrudes
from the groove and is exposed to the bulk solvent, as observed
in other acyl-CoA modifying enzymes.
The Catalytic Mechanism of PatA. To gain insight into
the chemical reaction mechanism catalyzed by PatA, we
modeled a PatA-PIM2-C16CoA ternary complex, taking into
account the experimental structural data available (Figure
S4).27 Molecular dynamics (MD) simulations (38 ns) were
performed at RT to relax the system and sample all the
accessible enzyme−substrate conformations (Figure S4). A
snapshot of the equilibrated complex was used as a starting
point for the modeling of the enzymatic reaction using QM/
MM metadynamics.35 Three collective variables (CVs, Figure
S5) were selected to account for the main changes taking place
during the reaction. The ﬁrst collective variable (CV1) was
deﬁned as the diﬀerence of distances between O6−C16 and
C16−S. This variable describes the nucleophilic attack of the O
atom of the CH2OH group of one of the mannosyl residues of
PIM2 (Man1 in Figure S4) on the carbonyl of the thioester
bond of C16-CoA. We named this variable “nucleophile attack.”
The second collective variable (CV2) was selected as the
diﬀerence between the O6−H6 and Nε−H distances. This
variable accounts for the proton transfer between the CH2OH
group of Man1 and His126; thus we named it “CH2OH proton
transfer.” The third collective variable (CV3), named “His
proton transfer,” was taken as the distance diﬀerence between
Nε−H and H−S; thus it accounts for the transfer of the His126
proton to the S atom of C16CoA. Similar ideas were previously
used with success to model chemical reactions in enzymes.36 It
is important to note that the CVs used do not self-select any
speciﬁc reaction pathway: they do not impose whether proton
transfer takes place in concert with nucleophilic attack or is a
later event along the reaction coordinate. Likewise, the CVs
used do not impose whether the reaction is fully concerted or
an intermediate species forms along the reaction coordinate.
The free energy landscape reconstructed from the QM/MM
metadynamics simulation (Figure 5a) shows two minima
connected by a unique transition state, suggesting a concerted
reaction. However, analysis of the structures along the
minimum energy pathway reveals that the minimum on the
left-hand side of the free energy landscape does not correspond
to the products of the reaction. Instead, the thioester bond is
cleaved but the leaving group bears a negative charge (i.e., a
thiolate leaving group). Additional analysis by free QM/MM
Figure 4. The donor and acceptor binding mechanism. (a) Cartoon
representation showing the assembled active site and location of (i)
Man-C16 and (ii) S-C16CoA into PatA. β-strands and α-helices are
shown in orange and yellow, respectively. (b,c) Two views showing
the structural superposition of (i) Man-C16 and (ii) S−C16CoA.
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MD conﬁrmed that this species is a stable reaction
intermediate, thus the reaction is clearly stepwise. The
reorientation of the thiolate after cleavage of the C−S bond,
forming a strong interaction with Arg201 (Figure S6), makes
proton transfer from His126 diﬃcult. Therefore, we decided to
model the second step of the reaction (protonation of the
thiolate leaving group) separately, using as unique collective
variable the distance diﬀerence between Nε−H and H−S.
Analysis of the corresponding free energy proﬁle (Figure 5b)
reveals a concerted proton transfer step, leading to the reaction
products Ac1PIM2 and CoA.
To get a detailed picture of the atomic reorganization during
the enzymatic reaction, we extracted conﬁgurations along the
reaction coordinate of both reaction steps (Figure 5c). The
reaction starts with the approach of the mannosyl CH2OH to
the carbonyl of the thioester of Palm-CoA: the O6···C16
distance evolves from 4 to 2.8 Å (Figure S4). At this point, the
C−S thioester bond starts to stretch as the catalytic histidine
(His126) abstracts the proton from the mannosyl CH2OH,
leading to a transition state (TS; 32 kcal/mol above the
reactants) in which the thioester carbon atom exhibits a
tetrahedral coordination (Figure 5c). The transition state
decays toward a reaction intermediate in which the C−S bond
is broken and the mannosyl residue is acylated. It is worth
noting that this intermediate is not the same as the one found
for the hydrolysis of alkyl esters, for which the reaction
mechanism is stepwise and passes through a tetrahedral
intermediate.37 There is a signiﬁcant amount of evidence that
shows that such an intermediate is generally not formed for
esters bearing good leaving groups, such as aryl esters or
thioesters.38−42 The Nδ−H of the catalytic histidine is involved
in a low-barrier hydrogen bond with the carboxylate side chain
of Glu200 (Figure 5c,d and Figure S7). In the second reaction
step, a concerted double proton transfer between Glu200,
His126, and the thiolate leaving group takes place (GluH···
HisH···S− → Glu−···HHis···HS), restoring the original
tautomeric state and protonation of His126 and Glu200,
respectively (Figure 5c,d). The free energy barrier of this
reaction step is 6.5 kcal/mol, and the products state is 4.6 kcal/
mol below the reaction intermediate.
These calculations support a mechanism in which PatA is
able to acylate PIM2 in a two-step reaction mechanism in which
His126 acts as a general base to deprotonate the hydroxyl
group of a mannose ring in PIM2, facilitating the nucleophilic
Figure 5. QM/MM studies on PatA mediated catalysis. (a) Free energy landscape reconstructed from the metadynamics simulation of the ﬁrst step
of the enzymatic reaction (projection on CV1 and CV2). (b) Free energy proﬁle corresponding to the second reaction step. (c) Representative
structures along the reaction coordinate, obtained from the minimum free energy reaction pathway. Red broken lines represent bonds that are being
broken or formed, whereas dotted black lines represent relevant hydrogen bond interactions. (d) Proposed catalytic mechanism for PatA.
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attack on the thioester of C16-CoA (Figure 5d). The reaction is
assisted by Glu200, which modulates the pKa of the central
histidine as a general base or acid during the catalytic cycle,
similarly to the charge-relay system of serine proteases.43 Our
results also provide evidence of the formation of a tetrahedral-
like transition state, as previously found for the closely related
hotdog-fold acyl-CoA thioesterase.42 These results highlight the
relevance of the charge-relay glutamate, Glu200, and oﬀer
valuable detail on the reaction transition state that would serve
for the design of new chemotherapeutic drugs.
PIM2 Acyl Chains Are Essential for PatA Enzymatic
Activity. A detailed comparison of the PatA-Man-C16 complex
with that of AbLpxM in complex with an n-dodecyl-β-D-
maltoside provides insights into the molecular mechanism of
acceptor recognition (Figure 6a−d). As depicted in Figure S3,
the central β-sheet of AbLpxM superimposes very well with that
observed in PatA. Strikingly, (i) the main groove and (ii) the
acyl-binding pocket identiﬁed in the crystal structures of PatA-
Man-C16, PatA-S-C16CoA, and PatA-C16 complexes super-
imposed very well with the corresponding main groove and a
hydrophobic cavity observed in AbLpxM (Figure S8). On the
basis of the experimental location of the S-C16CoA in PatA,
and taking into account that AbLpxM displayed a strong
preference for lauroyl chains (C12) over other acyl chain
lengths tested (C10, C14, and C16),29 a lauroyl−CoA molecule
was ﬁtted into an equivalent cavity and subjected to energy
minimization (Figure S8a,b). The lauroyl moiety accommo-
dates into the hydrophobic cavity, which is shorter than that
observed in the PatA-S-C16CoA complex, pointing to the
occurrence of a hydrocarbon ruler mechanism.29,44,45 The walls
of the tunnel are covered with hydrophobic residues including
Leu118 (β2), Val120 (β2−α7 loop), Trp126 and Met129 (α7),
Met139 and Ile141(β3), Val188 (β5), and Leu190 (β5−β6
loop), with Ile97 and Ile100 (β1), Phe106 (α6), Trp132 (α7),
Phe136 (α7−β3 loop), Leu229 (β8), and Ile243 and Met241
(β9) building the bottom cap.29 The CoA-binding site observed
in PatA is also conserved in AbLpxM. Speciﬁcally, the 4-
phosphopantetheinate moiety of S-C16CoA is located at the
entrance of the main groove (Figure S8c,d). The two α-helices
α9 and α10, ﬂanking the entrance of acyl−CoA to the main
groove of PatA, are structurally equivalent to α9 (residues 170−
183) and α10 (residues 213−223) in AbLpxM, as also observed
in CmGPAT, pointing to a common binding mode (Figure
S8c,d).27,29 AbLpxM crystallized with one molecule of n-
dodecyl-β-D-maltoside, with the glucosyl residues deeply buried
into a hydrophobic pocket located on one side of the main
groove. Strikingly, the ﬁrst glucose moiety of n-dodecyl β-D-
maltoside (DDM) superimposed well with the Man residue of
Man-C16 located in the acceptor binding site of PatA. The
second glucose moiety of DDM superimposed well with the
Figure 6. Structural similarities between PatA and LpxM. (A,B) Cartoon representation showing two views of the structure weighted sequence
alignment of PatA with LpxM. PatA β-strands and α-helices are shown in orange and yellow, respectively. The Man-C16 product is shown in black
and red. The ﬁrst three N-terminal α-helices of LpxM are shown in green, whereas the remaining secondary structure elements are shown in gray.
(C) Structure weighted sequence alignment of a selected region of PatA and LpxM, comprising residues that code for the four N-terminal α-helices.
(D) Cartoon representation showing the structural superposition of PatA and LpxM. Both structures are colored as in panel A. The Man-C16
product is shown in black and red. The S−C16CoA acyl donor substrate derivative is shown in light blue and red. The DDM molecule is shown in
orange. (E) Enzymatic activity of full-length PatA against palmitoyl-CoA by using diacylated and deacylated PIM2 as acceptors of the reaction and in
the presence and absence of DOPC SUVs.
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inositol residue of PIM2.
8,27 Interestingly, the C12 acyl chain of
DDM localizes in a hydrophobic cavity formed by α1, α2, and
α4 in AbLpxM, conserved in PatA, suggesting a binding mode
for the acyl chains of the lipid acceptor substrates.29
To further understand how PatA recognizes its lipid acceptor
substrate, we explored the contribution of the fatty acid
moieties of PIM2 in the enzymatic activity. It is worth noting
that previous reports indicate that PIM2 is the preferred
substrate of PatA in vitro.21,46 Consequently, we chemically
synthesized PIM2 containing two palmitoyl groups as fatty acid
chains and compared its acceptor capacity with that of the
deacylated version of PIM2. We studied the speciﬁc hydrolysis
activity of full-length PatA against palmitoyl-CoA by using
diacylated and deacylated PIM2 as acceptors of the reaction and
in the presence and absence of artiﬁcial model lipid membrane
DOPC SUVs. We observed only residual speciﬁc hydrolysis
activity (up to 5%) of PatA against deacylated PIM2, similar to
that observed in the absence of any acceptor. We also observed
maximum hydrolysis activity in the presence of DOPC SUVs
and diacylated PIM2 (0.09 ± 0.004 μmol CoA/min/mg PatA),
about 10-fold higher than without DOPC SUVs. Thus, the
enzymatic activity assays indicate that (i) the presence of the
PIM2 acyl groups and (ii) an artiﬁcial model lipid membrane
(DOPC SUVs) are essential for the enzymatic activity of PatA,
strongly supporting the notion that the acyl chains of the
acceptor glycolipid play a prominent structural role in the
arrangement of its sugar moiety/moieties into the catalytic
center and the generation of a competent active site (Figure
6e).
A Model of Action for PatA. Biological membranes are
primarily used as physicochemical barriers allowing cells to be
functionally constituted and diﬀerentiated from the environ-
ment. Biological membranes also play critical roles in all living
organisms, mediating the selective transport of molecules across
the cell, the modulation of the cellular response, as well as the
occurrence of a diverse and important set of biochemical
reactions.47 Many of the enzymes that work in biological
membranes are required to interact/recognize both hydro-
phobic and hydrophilic substrates, located in the membrane
and the aqueous environment of the cytosol/organelles,
respectively.4 To perform their biochemical functions, these
enzymes interact with membranes by two diﬀerent mecha-
nisms. Whereas integral membrane enzymes are permanently
attached (e.g., through hydrophobic α-helices and trans-
membrane β-sheets), peripheral proteins temporarily associate
with membranes by (i) a cluster of solvent-exposed hydro-
phobic residues, (ii) electropositive surface patches that interact
with acidic phospholipids (e.g., amphipathic α-helices), and (iii)
protein−protein interactions and/or post-translational mod-
iﬁcations. PatA catalyzes a critical step in the biosynthesis of
PIMs in mycobacteria.8,12 The enzyme transfers a palmitoyl
moiety from a water-soluble substrate donor palmitoyl−CoA,
to the 6-position of the Manp ring linked to the 2-position of
myo-inositol of the membrane glycolipids PIM1 or PIM2.
24,27
Therefore, a close interaction of the enzyme with the cytosolic
face of the mycobacterial plasma membrane might be a strict
requirement for PIM1 or PIM2 modiﬁcation by PatA.
Interestingly, the electrostatic surface potential of PatA revealed
several hydrophobic/aromatic residues interspersed with
positively charged residues in the vicinity of the major groove
(Figure 7).27 This region comprises the amphipathic helices α3,
α4, α8, and α12 and the connecting loop β2−α8 (residues
148−154). Importantly, the opposite side of PatA displays a
negatively charged surface, certainly contributing to determine
the correct orientation of the enzyme into the membrane
(Figure 7). Moreover, the structural comparison of the PatA
and LpxM crystal structures suggest that α1 and α2 N-terminal
helices are deeply inserted into the lipid bilayer. Altogether, the
structural data support a model in which PatA is permanently
associated with the membrane (Figure 7).
Despite the fact that acyl transfer is catalyzed by PatA
between the palmitoyl moiety of palmitoyl-CoA and the
mannosyl group of PIM1 or PIM2, our experimental data
indicate the enzyme displays an absolute necessity for both fatty
acid chains of PI for the transfer reaction to take place, pointing
to a mechanism requiring a lipid−water interface (Figure 6e).
The fatty acid chains of the acceptor substrate seem to play an
important structural role in the generation of a competent
active site, assisting/guiding the glycosylated moiety to the
appropriate environment in the catalytic center. We thus
propose a model of interfacial catalysis in which PatA
recognizes the fully acylated PIM1 or PIM2 substrates with
Figure 7. A model of action for PatA. (a) Electrostatic surface representation of PatA. PatA is a polar protein, with hydrophobic and positively
charged residues oriented toward the plasma membrane. Negatively charged residues are facing the cytosol. The Poisson−Boltzmann electrostatic
color map spans from red to blue, ranging from −10 to +10 kcal/mol. The ﬁrst three N-terminal α-helices of LpxM are shown in green, whereas the
remaining secondary structure elements are shown in gray. (b,c) Two views of the active site of PatA and the location of the acyl donor and acceptor
binding sites.
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their polar heads within the acceptor binding pocket located in
the main groove and the fatty acid moieties are likely in close
contact with α1, α2, and α4. The positioning of the ﬁrst two α-
helices α1 and α2 in a membrane environment remains
intriguing. The palmitoyl CoA binding site involves two
grooves (Figures 2, 4, and 6d). The palmitoyl chain is deeply
buried into the hydrophobic pocket that runs perpendicular to
the main groove, in the core of the enzyme. The 4-
phosphopantetheinate moiety is located at the entrance of
the main groove, in close contact with a highly conserved
region ﬂanked by the β2−α8 (residues 149−153), β3− α9
(residues 174−180), and β4−β5 (residues 199−207) loops and
two alpha helices, α9 (residues 181−190) and α10 (residues
221−230). The adenosine 3′,5′-diphosphate (3′,5′-ADP)
moiety of the ligand (disordered in three of the four protomers
of the asymmetric unit) protrudes from the globular core and is
exposed to the bulk solvent. This structural orientation of the
acyl−CoA binding site seems to be preserved in LpxM and
CmGPAT, supporting a common binding mode for acyl−
CoAs.29,31 Interestingly, LpxM and CmGPAT prefer acyl-ACP
as donor substrates; nevertheless, they can also function with
acyl-CoA derivatives,2,33 suggesting the enzymes preserve
common structural features to recognize both acyl donor
substrates, which might involve important conformational
changes.
Inhibition Mechanism of PatA. patA (Rv2611c) is the
third gene of a cluster of ﬁve ORFs20,24,48 potentially organized
as a single transcriptional unit and likely to be involved in the
synthesis of PIMs. The second and fourth ORFs encode the
phosphatidylinositol phosphate synthase PgsA (Rv2612c)48,49
and the mannosyltransferase PimA, respectively (Rv2610c).20,21
In addition, the mannosyltransferase PimB is encoded by the
Rv2188c gene.22,23 Interestingly, the four enzymes involved in
the biosynthesis of the metabolic end product Ac1PIM2, PgsA1,
PimA, PimB, and PatA, are essential for the growth of M.
smegmatis and/or M. tuberculosis.20,21,24,48,50 Speciﬁcally, (i) a
patA mutant of M. smegmatis mc2155 exhibited severe growth
defects,24 while (ii) patA was conﬁrmed to be an essential gene
in M. tuberculosis H37Rv, by a combination of transposon high-
density mutagenesis and deep-sequencing.51
The crystal structure of PatA-Man-C16 provides one possible
mechanism of enzyme inhibition. The PatA-Man-C16 complex
revealed the presence of the product Man-C16 in three of the
four molecules (chains B, C, and D) of the asymmetric unit, as
a consequence of the chemical reaction between the palmitate
and α-D-mannopyranose. Careful inspection of the electron
density maps revealed that in the fourth molecule of the
asymmetric unit, the reaction between palmitate and D-
mannopyranose did not take place, showing (i) one molecule
of free palmitate located in the hydrophobic pocket and (ii) one
molecule of free β-D-mannopyranose, located in the acceptor
binding cavity (Figure 8a,b). The structural comparison of the
four molecules of the asymmetric unit revealed subtle but
important conformational change in the active site (Figure
8c,d). The carboxylate moiety moves away from the catalytic
center as observed in the PatA-S-C16CoA complex, in close
contact with the main chain of residues Val147 and Glu149.27
Importantly, the Man O1 in β conﬁguration is now stabilized
by new interactions with the side chains of Tyr83, Trp130, and
Arg164 residues (Figure 8b and d). The Man O4 makes a
hydrogen bond with a water molecule, which in turn interacts
with the carboxylate moiety of Glu149. Similarly, the Man O6
makes a hydrogen bond with the side-chain of His126 (Figure
8b). Thus, the structural data presented here oﬀer exciting
possibilities for inhibitor design and the discovery of chemo-
therapeutic agents against this major human pathogen.
■ METHODS
Details on methods, including (i) puriﬁcation of PatA from M.
smegmatis, (ii) N-terminal sequence analyses, (iii) PatA-Man-C16
complex crystallization and data collection, (iv) PatA-Man-C16
structure determination and reﬁnement, (v) quantum mechanics/
molecular mechanics molecular dynamics simulations, (vi) chemical
synthesis of PIM2, (vii) preparation of deacylated PIM2, (viii)
Figure 8. The crystal structure of PatA-Man-C16 suggesting a possible mechanism of enzyme inhibition. (A−D) Four views of PatA-Man-C16
crystal structure showing the palmitate chain deeply buried into the hydrophobic cavity and the β-Man residue located in the acceptor binding site, at
the end of the main groove.
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preparation of small unilamellar vesicles (SUVs), (ix) PatA enzymatic
activity assay, and (x) structural analysis and sequence alignment, can
be found in the Supporting Information Experimental Procedures.
■ ASSOCIATED CONTENT
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ACS Publications website at DOI: 10.1021/acschem-
bio.7b00578.
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methods and references (PDF)
■ AUTHOR INFORMATION
Corresponding Author
*E-mail: mrcguerin@cicbiogune.es.
ORCID
Carme Rovira: 0000-0003-1477-5010
Marcelo E. Guerin: 0000-0001-9524-3184
Author Contributions
○These authors equally contributed to this work
Notes
The authors declare no competing ﬁnancial interest.
■ ACKNOWLEDGMENTS
This work was supported by the European Commission
Contract HEALTH-F3-2011-260872, the Spanish Ministry of
Economy and Competitiveness Contracts BIO2013-49022-C2-
2-R and BFU2016-77427-C2-2-R (to M.E.G.), Juan de la
Cierva Program IJCI-2014-19206 (to B.T.), CTQ2014-55174-
P (to C.R.), and Centre National de la Recherche Scientiﬁque
(to M.G.). We gratefully acknowledge A. Marina (CIC
bioGUNE, Spain) for technical assistance. We acknowledge
Diamond Light Source (proposals mx15304) for providing
access to synchrotron radiation facilities.
■ REFERENCES
(1) Varki, A., Cummings, R., Esko, J., Stanley, P., Hart, G., Aebi, M.,
Darvill, A., Kinoshita, T., Packer, N. H., Prestegard, J. J., Schnaar, R. L.,
and Seeberger, P. H. (2017) Essentials of Glycobiology, 3rd ed., Cold
Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
(2) Raetz, C. R., Reynolds, C. M., Trent, M. S., and Bishop, R. E.
(2007) Lipid A modification systems in gram-negative bacteria. Annu.
Rev. Biochem. 76, 295−329.
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bovis Bacillus Calmette Gueŕin and Mycobacterium tuberculosis H37Rv
and its implication in toll-like receptor response. J. Biol. Chem. 278,
29880−29889.
(16) Chatterjee, D., Hunter, S. W., McNeil, M., and Brennan, P. J.
(1992) Lipoarabinomannan. Multiglycosylated form of the mycobac-
terial mannosylphosphatidylinositols. J. Biol. Chem. 267, 6228−6233.
(17) Khoo, K. H., Dell, A., Morris, H. R., Breman, P. J., and
Chatterjee, D. (1995) Structural definition of acylated phosphatidy-
linositol mannosides from Mycobacterium tuberculosis: definition of a
common anchor for lipomannan and lipoarabinomannan. Glycobiology
5, 117−127.
(18) Berg, S., Kaur, D., Jackson, M., and Brennan, P. J. (2007) The
glycosyltransferases of Mycobacterium tuberculosis: roles in the
synthesis of arabinogalactan, lipoarabinomannan, and other glyco-
conjugates. Glycobiology 17, 35R−56R.
(19) Albesa-Jove,́ D., and Guerin, M. E. (2016) The conformational
plasticity of glycosyltransferases. Curr. Opin. Struct. Biol. 40, 23−32.
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